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Most organisms utilize small RNAs (sRNA) to control diverse aspects of 
development, reproduction and physiology by regulating gene expression at the 
transcriptional and post-transcriptional levels. The essential ribonuclease Dicer is a key 
enzyme in the production of several types of sRNAs. Prior work on the nematode 
Caenorhabditis elegans (C. elegans) has uncovered PIR-1 – a small protein conserved in 
all metazoans – as an interacting partner of Dicer in vivo. The human ortholog of PIR-1 has 
RNA 5' tri- and diphosphatase activities in vitro, but its biological role remains unclear. 
With the intent of finding its function, we characterized various aspects of C. elegans   
PIR-1. We found this enzyme to be essential for general growth and development, 
germline proliferation, and sperm maturation. We confirmed that PIR-1 associates with 
Dicer in vivo and expanded its repertoire of known interactions. Profiling of sRNAs from 
pir-1 loss-of-function animals by high-throughput sequencing revealed that PIR-1 is 
required for the production of 26G-RNAs during spermatogenesis, a class of Dicer-
dependent sRNAs. 26G-RNAs are essential to promote appropriate sperm development, in 
agreement with the pir-1 mutant sperm defect. Additionally, we discovered a second, 26G-
RNA-independent role for PIR-1, in which it cooperates with Dicer and other canonical 
RNA interference (RNAi) pathway components to suppress the replication of the C. 
elegans Orsay RNA virus. By demonstrating that PIR-1 functions as its human counterpart 
in vitro, and that a pir-1 transgene with a mutated phosphatase active site cannot rescue 
any of the mutant defects, we concluded that PIR-1 acts as an RNA phosphatase in vivo. 
This is the first study in which concrete biological functions are assigned to this enzyme. 
Given its high degree of conservation, these results provide a solid basis for studies on the 
multiple functions of PIR-1 in more complex animals.   
 









A maioria dos organismos utiliza pequenos RNAs (sRNA) para controlar diversos 
aspectos do seu desenvolvimento, reprodução e fisiologia, através da regulação da 
expressão génica ao nível transcricional e pós-transcricional. A ribonuclease essencial 
Dicer desempenha um papel central na produção de vários tipos de sRNAs. Um estudo 
anterior realizado no nemátode Caenorhabditis elegans (C. elegans) revelou que PIR-1 – 
uma pequena proteína conservada em todos os metazoários – se associa à Dicer in vivo. A 
proteína ortóloga humana PIR1 funciona in vitro como uma tri- e di-fosfatase 5' de RNA. 
A sua função biológica, porém, não é clara. Com o objectivo de encontrar a sua função, 
procedemos à caracterização da PIR-1 de C. elegans. Esta enzima é essencial para o 
desenvolvimento geral e crescimento, proliferação da linha germinal e para a maturação de 
espermatozóides. Neste estudo comprovámos a interacção entre PIR-1 e Dicer in vivo, e 
expandimos o repertório de proteínas com as quais a PIR-1 se associa. Sequenciação 
“high-throughput” dos sRNAs de um mutante de pir-1, revelou que esta proteína é 
necessária, juntamente com a Dicer, para a produção de 26G-RNAs, que promovem a 
espermatogénese. Adicionalmente, descobrimos que em cooperação com a Dicer e outros 
componentes da via da interferência por RNA (RNAi), a PIR-1 suprime a replicação do 
vírus Orsay, que infecta especificamente C. elegans. Ao demonstrar que a PIR-1 possui a 
mesma actividade que a proteína humana in vitro, e que um transgene de pir-1 com o 
centro catalítico inactivo não permite a supressão de nenhum dos defeitos do mutante, 
concluímos que a PIR-1 funciona como uma fosfatase de RNA in vivo. Este é o primeiro 
estudo a atribuir funções biológicas a esta enzima. Dada a sua conservação, estes 
resultados formam uma base sólida para estudos futuros sobre as múltiplas funções da 
fosfatase PIR-1 em animais de maior complexidade.  
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OH  hydroxyl group 
ORF  open reading frame 
P  monophosphate group 
PAZ  Piwi Argonaute and Zwille 
PCR  polymerase chain reaction 
piRNA  Piwi Argonaute-interacting RNA 
PIWI  P-element induced wimpy testis 
PMSF  phenylmethylsulfonyl fluoride 
PNK  polynucleotide kinase 
Pol I/II/III DNA-dependent RNA polymerase I/II/III 
Pol II LS large subunit of RNA polymerase II 
PPP  triphosphate group 
PTP  protein tyrosine phosphatase 
qRT-PCR quantitative real-time PCR 
R  purine base 
RACE  rapid amplification of cDNA ends 
RDE  RNAi-defective 
RdRP  RNA-dependent RNA polymerase 
RFP  red fluorescent protein 
RLR  RIG-I-like receptor 
RNA  ribonucleic acid 
RNAi  RNA interference 
RNase  ribonuclease 
RNA-seq cloning, reverse transcription and deep-sequencing of RNA 
RNP  ribonucleoprotein 
rpm  reads per million 
RRF  RdRP family 
rRNA  ribosomal RNA 
scRNA  small cytoplasmic RNA 
SDS-PAGE sodium dodecyl-sulphate-polyacrylamide gel electrophoresis 
SEM  standard error of the mean 
sRNA  small RNA 
siRNA  small interfering RNA 
snoRNA small nucleolar RNA  
SNP  single-nucleotide polymorphism 
snRNA  small nuclear RNA 
SSC  saline-sodium-citrate 
ssRNA  single-stranded RNA 
TAE  Tris-acetate-EDTA 
TAP  tobacco acid pyrophosphatase 
TB  terrific broth 
TBE  Tris-borate-EDTA 
TE  Tris-EDTA 
Tris  Tris hydromethyl aminomethane 
tRNA  transfer RNA 
TSS  transcription start site 
UTR  untranslated region 
UV  ultra violet 
WAGO  worm-specific Argonaute 
Y  pyrimidine base 











This thesis is organized into five chapters and a global conclusion. Chapter I 
consists of an introduction intended to provide the reader with a foundation to understand 
and critically evaluate the results described in the following chapters. It presents a 
thorough, yet non-exhaustive, overview of the main C. elegans small RNA pathways; a 
summary of the current state of knowledge for orthologs of the protein PIR-1 (the focus of 
our study); and states the context from which this project was born. Results Chapters II, III, 
and IV contain very brief introductions describing the context, goals and main findings for 
the respective set of experiments. Results Chapter V includes a more extensive 
introduction of RNAi-based antiviral immunity in C. elegans, which, for simplicity, we 
found appropriate to exclude from Chapter I. In the final conclusion, we reiterate the main 
findings, state their significance and propose ideas for the continued study of PIR-1 in C. 
elegans and beyond.  
As a note to the reader not accustomed to C. elegans nomenclature, all genes, RNA 
transcripts, and mutants are written with lower case italicized letters (e.g., pir-1); proteins 
are written with upper case letters (e.g., PIR-1); and transcriptional or translational fusions 
are indicated by two colons (e.g., Psur-5::gfp (promoter::ORF), pir-1::gfp, PIR-1::GFP). 
Specific mutations designate the laboratory, the organization or the consortium that 
generated the mutant: for example, rde-1(ne300) is the mutant number 300 generated in the 
laboratory of Craig Mello (designated by the acronym ‘ne’) affecting the rde-1 gene. The 
central online repository for all C. elegans genetic and molecular information and data is 
WormBase.org and provides a useful reference to the reader about specific genes 
mentioned in this thesis. Lastly, we have chosen to refer to all Argonaute binding RNAs as 
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SMALL RNA PATHWAYS IN C. ELEGANS 
  
The discovery of microRNAs (miRNAs; Lee et al., 1993) and subsequently of 
sRNA-mediated RNA interference (RNAi; Fire et al., 1998) in the nematode C. elegans 
not only opened a new field of research that has been constantly expanding our view of 
how gene regulation is achieved in all organisms, but also revolutionized the way 
experimental biology is conducted. In the last quarter of a century we have witnessed an 
exponential increase in the number of processes regulated by antisense ~15-30 nucleotide-
long sRNAs across the entire evolutionary spectrum, from bacteria to humans. This is due, 
in no small part, to the recent advent of powerful high-throughput sequencing technologies 
that allowed the identification and characterization of endogenous sRNAs at an 
unprecedented scale. Nonetheless, akin to the years that followed the full sequencing of the 
human genome, we are still far from fully understanding how sRNA networks work 
together to orchestrate biological processes, and how disruption of those networks can lead 
to diseased states. 
C. elegans is a particularly well-suited model for surveying sRNA networks in 
animals. It combines a simple and thoroughly characterized anatomy, straightforward 
genetic manipulation, and ease with which experiments can be performed at distinct 
developmental stages of the whole animal. In contrast to more complex animals, these 
properties greatly simplify the difficult task of dissecting multiple sRNA pathways. 
Furthermore, despite its morphological simplicity, the C. elegans genome carries ~20,000 
protein-coding genes, approximately the same number as the most recent estimates for the 
number of genes in the human genome (~19,000; Ezkurdia et al., 2014). Since the need for 
a tight orchestration of the expression of this vast set of genes is just as essential in humans 
as it is in C. elegans, the study of sRNAs in this nematode is extraordinarily relevant. 
Indeed, this model organism already holds an impressive track record for providing 
generally applicable principles of sRNA-based gene regulation.  
At least two major categories of effector endogenous sRNAs coexist in C. elegans: 
miRNAs and 22G-RNAs. The C. elegans genome encodes ~250 miRNAs, which act in 
various combinations to recognize and silence an unknown number of transcripts (likely in 
the thousands). 22G-RNAs are generally produced from the transcripts that they target, 
which comprise ~50% of all protein-coding genes. This number is likely an 
underestimation, as existing studies are far from having reached saturation. While it was 
initially thought that 22G-RNAs functioned primarily by post-transcriptional silencing of 
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their target RNAs, it is now clear that they can either repress or activate gene expression at 
the transcriptional level, depending on which particular pathway they enter. A variety of 
recent studies have shown that sRNA-induced chromatin states can be inherited across 
generations. Evidence suggests that this occurs through the passage of sRNAs from parents 
to progeny, thus providing an epigenetic memory of parental gene expression programs to 
be recapitulated in the next generation.  
The synthesis of 22G-RNAs is itself controlled by highly complex populations of 
distinct sRNA species, namely 21U-RNAs and 26G-RNAs. The functional outcome of 
each type of sRNA is dictated by the association with specific members of the conserved 
Argonaute family of sRNA-binding proteins. C. elegans encodes 26 different Argonautes, 
a remarkably high number if compared to the eight Argonaute proteins encoded in the 
human genome. As it will become apparent in the following sections, these pathways are 
highly branched, interconnected and multi-functional. This complexity has only recently 
started to be unveiled and thus the number of solved problems still dwarfs the immensity 
of existing questions. It is therefore challenging to provide a concise integrated overview 
of these pathways, as models keep shifting at dizzying speeds. Rather, the goals of this part 
of the introduction are to (1) define each type of sRNA and introduce the main biogenesis 
steps and key enzymes required for their production, and (2) to illustrate the combined 
regulatory potential of these different sRNAs, which we currently, and somewhat 
artificially, separate into distinct pathways. Where identified, brief descriptions of 
biological functions will be given. In the interest of simplicity and space, we integrated 
relevant comparisons to other organisms in the Results and Discussion sections of each 
chapter. Table 1.1 on the next page summarizes the main sRNAs pathways occurring in C. 
elegans, and is intended to help the reader to navigate the descriptions in the sections that 
follow. Additionally, before diving into the complex world of C. elegans sRNAs, we begin 
with a short overview of C. elegans anatomy and germline development in order to provide 
a spatio-temporal context to sRNA pathways.  
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A Brief Primer on C. elegans Germline Development 
Due to its genetic tractability, short life cycle and relative simplicity of both 
somatic and germline tissues, C. elegans has been invaluable in dissecting the variety of 
sRNA pathways and functions that can coexist in an entire animal. The expression of 
sRNAs varies substantially during development, particularly in the germline where they 
are most abundant and diverse, with the notable exception of miRNAs, which are more 
abundantly expressed in the soma (Ruby et al., 2006; Gu et al., 2009; Claycomb et al., 
2009). In C. elegans, endogenous 22G-RNA-based gene regulation is particularly 
important in the germline, where stem cell proliferation and gamete differentiation 
processes occur simultaneously and continuously. Not only do 22G-RNAs control aspects 
of these processes, but also provide protection of germ cell genome integrity against 
internal or external agents (e.g., transposable elements or UV radiation, repectively). In 
order to facilitate the understanding of sRNA biogenesis and function in C. elegans it is 
therefore important to discuss key aspects of its anatomy, life-cycle and germline 
development (an extensive and up-to-date description of these and other aspects of C. 
elegans biology can be found at WormAtlas.org, Altun et al., 2002-2015).  
C. elegans has a diploid genome distributed across five autosomes (I-V) and one 
sex chromosome (X). It reproduces predominately by self-fertilization in its hermaphrodite 
form, dictated by the presence of two X chromosomes. Males, which only have one X 
chromosome (XO), normally exist at a frequency of ~0.1% and arise as the result of 
spontaneous non-disjunction of the X chromosome during meiosis in the hermaphrodite. 
Upon mating, male sperm out-compete stored hermaphrodite sperm and progeny can reach 
a male frequency of up to 50%. An adult hermaphrodite is composed of exactly 959 
somatic cells and ~1000-2000 germ cells, while an adult male has 1,031 somatic cells and 
~1,000 germ cells. Main organ-like systems include a large two-arm tubular germline (only 
one arm in males), a pharynx to process food and to help circulate fluid throughout the 
body cavity, and a large intestine that runs across the entire anterior-posterior axis of the 
animal. Under standard conditions of food and temperature (~20˚C), an adult 
hermaphrodite can lay around 300 eggs and live up to three weeks. Embryonic 
development is initiated inside the adult, but most of it occurs after egg-laying. Progeny 
hatch as fully autonomous larvae and go through four molting events, separating four 
larval stages (L1 to L4) before reaching the adult, fertile stage. At 20˚C the development 
from a single-celled embryo to an egg-laying adult takes only 60-70 hours (Fig. 1.1A). 
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Hermaphrodite germline development begins at the L1 stage through the division 
of pluripotent germ precursor cells that originate during embryogenesis, Z2 and Z3 (Fig. 
1.1B). From the L1 to L3 stages, germline growth occurs exclusively through mitotic 
divisions of germline cells. The distal tip cells (DTCs), which are of somatic origin, 
function at the growing ends of gonadal arms to continuously signal mitotic cell 
proliferation. Germ cells line the inner surface of the tubular structure of the germline and 
are only partially enveloped by a plasma membrane, sharing a common cytoplasm 
contained in the rachis (or the hollow center of the germline), effectively constituting a 
syncytium (Figure 1.1B). Meiosis does not begin until the L4 stage at the proximal end of 
the germline, near the section that unites the two gonadal arms, where two spermathecae, a 
uterus, and a vulva develop. As the germline grows, a higher proportion of the cells 
become meiotic. During the late L4 stage and the beginning of adulthood, meiosis is 
dedicated to hermaphrodite sperm differentiation. This starts with the formation of 
cellularized primary spermatocytes that detach from the germline wall. Completion of 
meiosis I divides the 4N primary spermatocyte into two, 2N, secondary spermatocytes. 
After meiosis II is completed, four haploid spermatids are generated. The sequence of 
events that go from a primary spermatocyte to a spermatid is termed spermatogenesis. 
These cells are stored in the spermatheca of the adult until the passage of oocytes leads to 
their activation in a process termed spermiogenesis, in which they become highly motile, 
fertilization-competent spermatozoa. During adulthood, meiotic cells start differentiating 
exclusively into oocytes which arrest at the diakinesis stage of meiosis I. Upon passage 
through the spermatheca, fertilization occurs, oocyte meiosis is resumed, and embryonic 
development is initiated. Embryos are stored in the uterus until they reach the gastrula 
stage (~30 cells) at which time they are expelled through the vulva.  
  





Figure 1.1. Life cycle of C. elegans and germline development. (A) Life cycle of a self-
fertilizing hermaphrodite. Major stages of embryogenesis are shown. Every larval stage is 
separated by molting to replace the cuticle. The last molting event occurs in the L4 to adult 
transition. Wild-type C.elegans grows over a range of temperatures (typically 15-25˚C in the 
laboratory), influencing brood size and the duration of each developmental stage. (B) General 
architecture and development of the hermaphrodite germline. In the L1 stage, the two pluripotent 
germ precursor cells Z2 and Z3 begin to divide mitotically. These mitotic divisions continue into 
adulthood, and are stimulated by signaling from the DTCs, one per each gonad arm. The DTCs, the 
cells that envelope the germline, and the cells composing the spermathecae, uterus and vulva are all 
part of the so called somatic germline. The core of each gonadal arm is termed the rachis and 
constitutes a common cytoplasm to the partially cellularized nuclei that line the inner surface of the 
germline. Meiosis initiates in the proximal part of the germline during the L4 stage, during which 
they undergo differentiation into spermatids that are stored in the spermatheca of the developing L4 
larva and adult. The sperm to oocyte switch occurs during adulthood. Oocytes are fertilized upon 
passage through the spermatheca, and embryos accumulate in the uterus for some time before being 
laid. Figures were adapted from WormAtlas.org (Altun et al., 2002-2015). 
 
 
The MicroRNA Pathway 
MicroRNAs represent the most abundant and well-studied class of sRNAs. C. 
elegans expresses ~253 distinct miRNAs (WormBase release WS248; WormBase.org, 
Harris et al., 2014). Mature miRNAs are ~23-nt long, with 5'-monophosphate and 3'-
hydroxyl termini. They act by binding to partially complementary sites in the 3' 
untranslated regions (UTR) of mRNAs, to direct their post-transcriptional silencing (Jonas 
and Izaurralde, 2015). mRNAs frequently have more than one miRNA binding site, such 
that one target may be subjected to simultaneous regulation by several different miRNAs. 
The rules that dictate the pairing of miRNAs with their targets, primarily based on studies 
of the most abundant and conserved miRNAs, are fairly consensual. However, as new 
exceptions to these rules continue to be discovered, the prediction that the majority of 
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protein-coding RNAs are susceptible to some degree of miRNA-mediated regulation is 
gaining ground (Bartel, 2009).  
Each miRNA is genomically encoded and transcribed by RNA polymerase II (Pol 
II) into a long, capped and polyadenylated RNA termed primary miRNA (pri-miRNA; Fig. 
1.2; Bracht et al., 2004). The miRNA sequence is embedded in the dsRNA portion of a 
stem-loop structure within the pri-miRNA, which is released by the joint activity of the 
endoribonuclease Drosha and the dsRNA binding protein Pasha/DGCR8 (DRSH-1 and 
PASH-1 in C. elegans, respectively; Denli et al., 2004). This stem-loop of ~70 nt, with a 3' 
2-nt overhanging terminus, termed pre-miRNA, is recognized by an ortholog of the human 
nuclear export protein exportin 5 (possibly XPO-1/IMB-4 in C. elegans) that transports it 
to the cytoplasm (Parry et al., 2004).  
The next processing steps require Dicer (DCR-1 in C. elegans) and two redundant 
Argonaute proteins, ALG-1 and ALG-2 (Argonaute-Like Gene 1 and 2); Grishok  et al., 
2001; Ketting et al., 2001; Hutvagner et al., 2001). Dicer is a large (~220 kDa in C. 
elegans), highly conserved endoribonuclease belonging to the RNase III family of dsRNA 
cleaving enzymes, to which Drosha also belongs. Dicer is composed of a helicase domain, 
a PAZ (Piwi Argonaute and Zwille) domain that binds the  substrate 3' end, two RNase III 
domains and a dsRNA-binding domain (Bernstein et al., 2001). As in humans, C. elegans 
only expresses one Dicer enzyme which is central for the synthesis of not only miRNAs 
but also for small-interfering RNAs (siRNAs; discussed in the next section) and certain 
endogenous sRNAs (endo-sRNAs). Argonautes are evolutionarily conserved sRNA-
binding proteins consisting of a highly variable N-terminal domain, a PAZ domain for 3'-
end nucleotide binding, a MID (middle) domain, which makes contact with the 5'-
phosphates of sRNAs, and a C-terminal PIWI (P-element induced wimpy testis) domain 
with an RNase H-like fold to promote RNA cleavage, an activity termed ‘slicing’ 
(reviewed in Hutvagner and Simard, 2008).  
DCR-1 binds the pre-mRNA using its PAZ domain to anchor the 2-nt 3' overhang 
generated by DRSH-1, and cleaves the dsRNA stem 22-23 nt away from the 3' end (Zhang 
et al., 2002; Macrae et al., 2007), resulting in a 22-23-nt long duplex RNA bearing 5'-
monophosphates and 2-nt 3'-overhanging termini. The duplex is loaded into ALG-1 or -2 
and one of the strands is cleaved (the passenger strand) by the slicer activity of the 
Argonaute, leaving the guide strand free to interact with its target (Bouasker and Simard, 
2012). In C. elegans the majority of mature miRNAs carry a 5' uridine, which is thought to 
promote the specific interaction of miRNAs with ALG-1/2 (Ruby et al., 2006). 
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MiRNA-loaded ALG-1/2 Argonautes interact with a variety of proteins to bind the 
partially complementary 3' UTR sites on target mRNAs. Collectively, these sets of proteins 
are termed miRNA-induced silencing complexes (or miRISCs). A variety of miRISCs 
exist, based on the composition of factors associating with the core Argonaute-miRNA 
complex. One type of miRISC includes the micrococcal nuclease-related TSN-1 (Tudor 
Staphylococcal Nuclease ortholog) in association with the dsRNA-binding factor VIG-1 
(ortholog of the Drosophila Vasa Intronic Gene) (Caudy et al., 2003). Another type is 
defined by the ortholog of human GW182, AIN-1 (ALG-1 Interacting Protein 1), which 
facilitates both miRNA loading and the interaction of miRNAs with their mRNA targets in 
association not only with ALG-1/2, but also with DCR-1 (Ding et al., 2005). AIN-2 acts 
redundantly with AIN-1 by also binding DCR-1 and ALG-1/2, but can additionally recruit 
TSN-1 and the mRNA-binding translational repressing protein GLD-1 (Defective in 
Germline Development 1). Moreover, AIN-2 has been shown to interact with components 
of the translation initiation machinery (Parry et al., 2007; Zhang et al., 2007). Finally, 
NHL-2 (carrying a TRIM-NHL domain, which defines a large class of metazoan proteins; 
Wulczyn et al., 2010) in association with the conserved DEAD-box (Asp-Glu-Ala-Asp 
motif) RNA helicase CGH-1 (Conserved Germline Helicase 1), is required to increase the 
strength of binding of miRISCs to their target mRNAs (Hammell et al., 2009). The DEAD-
box motif is present in numerous enzymes acting in sRNA pathways (including Dicer). 
Proteins carrying this motif form a subgroup within a large family of proteins present in all 
organisms defined more generally by the DExD/H motif, and are involved in a wide range 
of processes pertaining mostly to RNA metabolism (reviewed in Fuller-Pace, 2006 and 
Linder and Jankowsky, 2011). CGH-1 orthologs have been demonstrated to be required for 
miRISC activity, and are involved in several other aspects of mRNA post-transcriptional 
regulation and turnover (Chu and Rana, 2006; Eulalio et al., 2007; Rajyaguru and Parker, 
2009). 
All of the aforementioned proteins are required for effective silencing of miRNA 
targets, whether it occurs by translational repression, mRNA degradation, or both 
(Wightman et al., 1993; Bagga et al., 2005; reviewed in Jonas and Izaurralde, 2015). 
Notably, both AIN-1 and NHL-2/CGH-1 complexes localize to cytoplasmic domains 
called processing bodies (P-bodies), which contain a variety of ribonucleoprotein (RNP) 
complexes dedicated to processes such as nonsense-mediated decay, mRNA decay upon 
decapping and translational repression (Parker and Sheth, 2007). Through these molecular 
activities, miRNAs control various aspects of somatic development and physiology, 
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namely in aging, nervous system patterning and function, and general regulation of cell 
fate and developmental timing (Ambros, 2003; Abbott, 2011; Inukai and Slack, 2013). 
Interestingly, while individually deleting most miRNAs does not result in perceivable 
deleterious phenotypes (Miska et al., 2005), the collective deletion of some of the 23 
miRNA families found in C. elegans can have very dramatic developmental consequences 
(Alvarez-Saavedra and Horvitz, 2010). The best example is the mir-35-41 family, which is 
essential to enable proper embryonic development over a wide range of temperatures, and 
to ensure full reproductive capacity in adult animals (McJunkin and Ambros, 2014). 
Studies of miRNA function in C. elegans continue to support the increasingly consensual 
idea that miRNAs have evolved to confer robustness upon sensitive gene expression 
programs in the face of challenging environmental conditions (Burke et al., 2015; Ren and 
Ambros., 2015).  
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Figure 1.2. The microRNA pathway. Processing of miRNAs takes place in the nucleus and 
cytoplasm. Loading into ALG-1 or ALG-2 is thought to be concomitant with Dicer cleavage, as the 
two proteins stably interact in vivo. Loaded ALG-1/2 complexes then bind additional factors that 
recruit them to sites of RNA regulation, such as cytoplasmic P-bodies, where thay associate with 
target mRNAs, predominately via imperfect base pairing within 3' UTRs. This can lead to 
translational impairment and/or to direct degradation, upon recruitment of destabilizing factors 
such as RNA deadenylases.  
 
 
The RDE-1 Pathway: Canonical RNA Interference and Beyond 
 Experimentally, RNAi can be triggered in C. elegans by exposing cells to double-
stranded RNA (dsRNA) directly by injection or through feeding of dsRNA-expressing 
bacteria, in a process termed exogenous RNAi or exo-RNAi (Fig. 1.3 and Table 1.1). The 
process is strictly dependent on the Argonaute RDE-1, which is loaded with siRNAs 
resulting from the cleavage of dsRNA by Dicer. RNAi is both specific, leading to the 
silencing of sequences identical to the original dsRNA, and systemic, in that it is able to 
spread to most cells via the SID-1 (Systemic RNAi Defective 1) dsRNA specific 
transmembrane channel (Winston et al., 2002; Shih and Hunter, 2011). In association with 
the dsRNA-binding protein RDE-4 (RNAi-deficient 4; Tabara et al., 2002), DCR-1 cleaves 
the dsRNA to generate 23-nt duplex RNAs with 2-nt 3'-hydroxyl overhangs and 5'-
monophosphate termini (Grishok et al., 2001; Ketting et al., 2001; Knight and Bass, 2001). 
The small interfering RNA (siRNA) duplexes are loaded into the Argonaute protein RDE-
1, which also stably interacts with DCR-1 (Tabara et al., 1999). Similarly to ALG-1/2, 
after binding the siRNA duplex, RDE-1 cleaves one of the strands (the passenger strand) 
using its RNase H slicer activity, to retain a single strand that will serve as the guide strand 
to recognize and bind RNA target molecules (Steiner et al., 2009). Target RNA is cleaved 
near the RDE-1 binding site by the endonuclease RDE-8, followed by the addition of a 3' 
poly-uridine tract synthesized by the polynucleotidyl transferase RDE-3 (Chen et al., 2005; 
Tsai et al., 2015). This event is thought to signal the recruitment of the RNA-dependent 
RNA polymerases (RdRP) RRF-1 (RdRP family 1), expressed in the soma and germline 
(Sijen et al., 2001), and EGO-1 (Enhancer of Glp-One 1), expressed exclusively in the 
germline (Smardon et al., 2001).  
RdRPs use the RNA template to catalyze the primer-independent synthesis of 
antisense 22-23 nt siRNAs bearing a 5'-triphosphorylated guanosine, termed 22G-RNAs 
(Sijen et al., 2001; Aoki et al., 2007; Pak and Fire, 2007; Sijen et al., 2007). These siRNAs 
spread across the template RNA, 5' of the RDE-1 binding site, usually within a range of 
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100-180 nt (Alder et al., 2003). Both RRF-1 and EGO-1 must physically associate with 
two co-factors to produce 22G-RNAs: EKL-1 (Enhancer of KSR-1 Lethality 1), a Tudor 
domain protein (Kim et al., 2005; Robert et al., 2005; Rocheleau et al., 2008; Claycomb et 
al., 2009), and the helicase DRH-3 (Dicer-Related Helicase 3; Duchaine et al., 2006; Aoki 
et al., 2007; Nakamura et al., 2007; Claycomb et al., 2009; Gu et al., 2009). Loss-of-
function mutants for either of these factors are completely sterile and unable to produce 
22G-RNAs, including those that are triggered endogenously, as discussed ahead 
(Claycomb et al., 2009; Gu et al., 2009). 22G-RNAs are loaded into Argonautes belonging 
to a group of 12 semi-redundant worm-specific Argonautes (or WAGOs) to target 
complementary RNAs for silencing (Yigit et al., 2006; Gu et al., 2009; reviewed in Buck 
and Blaxter, 2013). C. elegans specifically requires four WAGOs for exo-RNAi silencing, 
as their combined deletion leads to complete RNAi resistance in somatic and germline 
cells (Yigit et al., 2006). The four Argonautes are WAGO-4, WAGO-7(PPW-1), WAGO-
6(SAGO-2), and WAGO-8(SAGO-1). PPW-1 (PAZ/PIWI Domain-Containing 1) is 
required predominately for germline RNAi, while the remaining Argonautes are employed 
in somatic RNAi (Tijsterman et al., 2002; Yigit et al., 2006). 
The RNAi process is thus divided into two main phases: the primary phase, in 
which low abundance siRNAs are directly derived from Dicer-mediated cleavage of the 
dsRNA trigger; and the secondary (or amplification) phase, in which primary siRNA-
loaded RDE-1 initiates the abundant RdRP synthesis of antisense 22G-RNAs (Fig. 1.3 and 
Table 1.1). The exo-RNAi response has been shown to be self-contained, in that (1) 
secondary 22G-RNAs are unable to initiate new rounds of RdRP-mediated amplification 
(Pak et al., 2012), and (2) RDE-1 cannot engage secondary 22G-RNAs or silence targets in 
the absence of 22G-RNA synthesis (Sijen et al., 2001; Yigit et al., 2006). Since the most 
critical Argonautes for exo-RNAi are assumed to be predominately cytoplasmic, the bulk 
of silencing is thought to occur post-transcriptionally. However, exogenously triggered 
22G-RNAs can also be loaded into WAGO proteins that translocate into the nucleus to 
elicit transcriptional silencing, a process termed nuclear RNAi (discussed ahead). 
RNAi can be triggered naturally by ingestion and uptake of dsRNA from the 
environment through the intestinal SID-2 transmembrane channel (Winston et al., 2007) or 
through infection by RNA viruses (Felix et al., 2011; introduced in Chapter V), to cite two 
known examples. Cells also make use of this pathway from endogenous sources of dsRNA 
arising, for instance, from transposons or highly-repetitive transgene arrays (Ketting et al., 
1999; Sijen and Plasterk, 2003; Vastenhouw et al., 2003; Grishok et al., 2005; Robert et 
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al., 2005). Additionally, the formation of regions of dsRNA within C. elegans transcripts 
has recently been shown to be widespread (Whipple et al., 2015). Several of these 
sequences overlap with protein coding genes that are known targets of endogenous 22G-
RNAs. In combination with other factors, Dicer is proposed to use these dsRNA regions as 
substrates to produce primary siRNAs that likely enter the RDE-1 pathway to elicit the 





Figure 1.3. The exogenous RNAi pathway. Exo-RNAi is triggered by the uptake of dsRNA from 
the environment via the intestinal dsRNA transmembrane channel SID-2, or experimentally by 
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direct injection of dsRNA. There are two types of siRNAs: the primary siRNAs, which are direct 
products of Dicer cleavage and are only as abundant as the dsRNA source; and the secondary 
siRNAs, the result of RdRP synthesis triggered by RDE-1-bound primary siRNAs in somatic cells 
(by RRF-1), and in the germline (by both RRF-1 and EGO-1). The diagram is a simplification of 
our current knowledge of the process, as many of the factors required for 22G-RNA accumulation 
have been omitted. The RDE-8/RDE-3 step is presumed, but not proven, to recruit RdRPs to the 
target RNA. Downstream silencing can occur through post-transcriptional mechanisms in germline 
P granules or somatic P-body-like granules, and through transcriptional mechanisms inside the 




The 21U-RNA/piRNA Pathway 
C. elegans expresses over 30,000 distinct, genomically encoded 21-nt RNAs 
carrying 5'-monophosphorylated uridines and 2'-O-methyl modified 3' termini, referred to 
as 21U-RNAs (Fig. 1.4A and Table 1.1; Ruby et al., 2006; Batista et al., 2008; Gu et al., 
2012). Owing to their predominant germline expression, 5' and 3' molecular features, and 
their Dicer-independent biogenesis, 21U-RNAs are considered the C. elegans equivalents 
of animal piRNAs (PIWI-interacting RNAs). This class of endogenous sRNAs has been 
demonstrated to promote proper germline development and gamete differentiation while 
protecting the integrity of germline genomes from the mutagenic effects of active 
transposing elements, from Drosophila to mice (reviewed in Luteijn and Ketting, 2013). In 
contrast to all other sRNAs that interact with either Argonaute-clade (RDE-1, ALG-1/2, 
ALG-3/4; conserved from plants to animals) or with C. elegans-specific WAGO-clade 
Argonautes, 21U-RNAs interact with a conserved PIWI-clade Argonaute named PRG-1 
(Piwi Related Gene 1; Batista et al., 2008), similarly to piRNAs in other species.  
21U-RNAs are transcribed by Pol II, and are subdivided into two groups depending 
on the elements that govern their expression (Fig. 1.4A; Ruby et al., 2006; Cecere et al., 
2012; Gu et al., 2012). Type-I 21U-RNAs are encoded primarily in intergenic clusters 
spread throughout chromosome IV or from sequences overlapping with other Pol II genes. 
Each Type-I locus is preceded by a two-part motif 25-60 nt upstream of the locus, which is 
recognized by specific Forkhead-family transcription factors (Ruby et al., 2006; Batista et 
al., 2008; Das et al., 2008; Cecere et al., 2012; Billi et al., 2013). Type-II 21U-RNAs arise 
from a subset of abortive Pol II transcription products at transcription start sites (TSS) of 
active promoters. These short (10-40 nt), capped products termed capped small RNAs 
(csRNAs), are often transcribed bi-directionally around the TSS (Gu et al., 2012). As part 
of their upstream motif, both Type-I and Type-II 21U-RNAs have a short consensus 
YRNT sequence (where Y is a pyrimidine, R is a purine, N is any nucleotide and T 
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encodes the first nucleotide of the mature 21U-RNA), that determines processing of a ~26-
nt long precursor capped at the R position of the motif. Type-II 21U-RNAs originate 
whenever a csRNA happens to contain the YRNT motif that determines the synthesis of a 
capped ~26 nt precursor (Gu et al., 2012). After decapping and cleavage by unknown 
factors, the 3' end is methylated by the conserved methyltransferase HENN-1 (HEN1 of 
Nematode; Billi et al., 2012; Kamminga et al., 2012; Montgomery et al., 2012). Recent 
screens have identified various new factors required for 21U-RNA processing and 
accumulation, the activities of which are still not clear (de Albuquerque et al., 2014; Goh  
et al., 2014).  
The loss of PRG-1 leads to the complete disappearance of 21U-RNAs and has 
severe phenotypic consequences. prg-1 null-mutant animals exhibit lower brood sizes at 
20˚C and complete sterility at 25˚C due to a failure to produce enough mature spermatids 
(Yigit et al., 2006; Batista et al., 2008; Das et al., 2008; Wang and Reinke, 2008). The 
proliferation of germ cells is also heavily affected, regardless of temperature (Batista et al., 
2008). PRG-1 is present in adults and embryos, localizing primarily to germline and 
embryonic P granules. In the germline, P granules are found on the cytoplasmic side of the 
nuclear membrane, surrounding nuclear pores (Pitt et al., 2000). These domains are 
functionally analogous to P-bodies and stress granules (Gallo et al., 2008). Intriguingly, the 
loss of PRG-1 does not lead to dramatic changes in the overall gene expression profile 
(Batista et al., 2008). The main exception concerns the Tc3 transposon, the upregulation of 
which resulted in a 100-fold increase in transposition rate. Tc3 silencing was found to 
depend both on PRG-1 and on WAGOs, revealing the first link between the 21U-RNA 
pathway and 22G-RNA effectors (Das et al., 2008).  
Exceptions aside, and unlike piRNAs in other species, most 21U-RNAs lack 
perfect complementarity to transposons or any other gene sequences (Siomi et al., 2011). 
Through the use of GFP reporter transgenes carrying sites complementary to particular 
21U-RNAs, it was demonstrated that PRG-1-21U-RNA complexes result in GFP silencing. 
This activity was shown not to require the slicer activity of PRG-1 and to tolerate up to 
four mismatches between the 21U-RNA and the target sequence, suggesting that 21U-
RNAs have the potential to interact with almost any sequence they encounter (Bagijn et al., 
2012; Lee et al., 2012). Furthermore, these studies demonstrated that 21U-RNAs trigger 
the production of secondary WAGO-associated 22G-RNAs, and that these 22G-RNAs are 
passed from parents to progeny to maintain transgene silencing via the establishment of 
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repressive chromatin marks (Ashe et al., 2012; Bagijn et al., 2012; Lee et al., 2012; Luteijn 
et al., 2012; Shirayama et al., 2012).  
Together, these findings have led to the hypothesis that the 21U-RNA pathway has 
evolved as a nucleic acid-based adaptive immune system primed to recognize and silence 
foreign, potentially deleterious sequences. Additionally, since prg-1 mutant animals 
become progressively less fertile after each generation, 21U-RNAs are thought to 
safeguard the integrity of germline genomes, thus maintaining the immortality of germline 
stem cells. This likely occurs via the control of the Tc3 transposon, but possibly through 
the control of additional destabilizing elements (Batista et al., 2008; Das et al., 2008). 
Finally, 21U-RNAs have been shown to regulate coding-gene expression by specifically 
promoting the accumulation of spermatogenesis transcripts in males to produce wild-type 
sperm (Wang and Reinke, 2008), and by directing the synthesis of distinct populations of 
22G-RNAs from male or female germline-specific transcripts (Billi et al., 2013; Shi et al., 
2013). The great diversity of regulatory outcomes imposed by the 21U-RNA pathway 
raises numerous questions. Perhaps the most important ones pertain to which factors and 
mechanisms are employed to ensure that 21U-RNAs are sorted into distinct functional 
groups.   
  





Figure 1.4. The 21U-RNA/piRNA pathway and the CSR-1 22G-RNA pathway of the 
germline. (A) 21U-RNA precursors are synthesized by Pol II from two types of loci. Type-I loci 
occur predominately in clusters located on chromosome IV where each 21U-RNA is expressed 
from its own promoter element. Type-II loci occur at promoter proximal regions associated with 
Pol II transcriptional units. At these loci, Pol II pausing and early termination in both directions 
produces csRNAs that are processed into 21U-RNAs, provided they are sufficiently long and 
contain the 5' YRNU motif. The stage at which the precursor is exported out of the nucleus into P 
granules and factors required for the 3' and 5' processing of the capped 26-nt precursor are still 
largely unknown. 21U-RNAs associate with PRG-1 to recognize their targets. Most 21U-RNAs do 
not exhibit perfect complementarity to endogenous transcripts, but are still able to elicit 22G-RNA 
synthesis by secondary RdRPs by an unknown mechanism. This property allows 21U-RNAs to 
scan the transcriptome for potentially deleterious sequences considered as non-self (transposons, 
recently acquired genes, pseudogenes, transgenes, etc…) and elicit their silencing by post-
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transcriptional and transcriptional mechanisms. Targeted genes likely remain stably silenced by 
repressive chromatin marks until germ cell transcription starts in the next generation. 22G-RNAs 
antisense to these sequences are passed on in gametes to reestablish repressive chromatin domains 
at the same sites in the germ cells of the progeny. (B) CSR-1 22G-RNAs (discussed in the last 
section dedicated to 22G-RNAs, page 51) target all expressed germline transcripts. For the most 
part, primary siRNA triggers are not known, suggesting that EGO-1, the only RdRP that produces 
CSR-1 22G-RNAs, may be recruited to its substrates by alternative mechanisms, namely in the 
nucleus, where it also localizes. CSR-1 does not silence its targets. Rather, it associates with 
nascent mRNAs in the nucleus to promote their transcription by stimulating the deposition of 
activating chromatin marks, and with mature mRNAs in cytoplasmic P granules to protect them 
from 21U-RNA targeting. Together, these activities led to the hypothesis that CSR-1 is the central 
agent of a protective “licensing” mechanism that ensures continuous germline gene expression, 
permanently counteracting the inhibitory effects of the 21U-RNA pathway. CSR-1 22G-RNAs are 
also thought to be inherited to the following generation to perpetuate active chromatin states, 




26G-RNAs and the ERI Complex 
  The discovery of 21U-RNAs was accompanied by the unveiling of an additional 
distinct group of endogenous sRNAs named 26G-RNAs, owing to their characteristic 
length of 26 nt and 5'-monophosphorylated guanosine (Ruby et al., 2006; Asikainen et al., 
2008; Han et al., 2009; Stoeckius et al., 2009; Gent et al., 2010). 26G-RNAs were found to 
constitute endogenous primary siRNAs that trigger the amplification of 22G-RNAs to 
regulate the expression of target genes at particular developmental stages (Table 1.1). 
26G-RNAs biogenesis depends on the activity of a stable ~850 kDa multi-protein 
complex known as the ERI complex. It consists of a core RdRP module containing RRF-3, 
DRH-3 and ERI-5, with the latter protein connecting it to a second module composed of 
DCR-1, RDE-4, ERI-1b and ERI-3 (Duchaine et al., 2006; Thivierge et al., 2012). Loss of 
RRF-3, ERI-5, ERI-1b or ERI-3 results in a temperature-sensitive sperm-related defect that 
renders animals sterile at the higher limit temperature of 25˚C, as well as in the 
enhancement of RNAi (Eri) phenotype. As the name implies, the Eri phenotype occurs 
whenever RNAi of genes that are normally insensitive or display mild phenotypes upon 
silencing, results in perceivable or stronger phenotypes (Simmer et al., 2002; Duchaine et 
al., 2006). Loss of DCR-1, DRH-3, and RDE-4 disables RNAi, and loss of the first two 
also leads to unconditional sterility and other defects due to pleiotropy (Tabara et al., 1999; 
Grishok et al., 2001; Ketting et al., 2001; Knight and Bass, 2001; Duchaine et al., 2006; 
Gu et al., 2009). Although the triggering and processing events that lead to a mature 26G-
RNA are still unclear, the properties of some of the ERI-complex proteins explain how 
some of the key steps may occur.    
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The RdRP RRF-3 is assumed to transcribe 26G-RNAs, since it is required for their 
accumulation (Simmer et al., 2002; Gent et al., 2009; Pavelec et al., 2009). Similarly to its 
paralogs RRF-1 and EGO-1, its products indicate that it prefers to initiate transcription 
with GTP (Aoki et al., 2007). Moreover, based on the activity of the other RdRPs, RRF-3 
products are expected to be short, despite the fact that 26G-RNAs, unlike 22G-RNAs, 
require processing by DCR-1 (Han et al., 2009). Synthesis appears not to occur 
processively, as 26G-RNAs do not exhibit regular phasing along their template RNAs and 
often overlap with other 26G-RNAs (Ruby et al., 2006; Vasale et al., 2010; Fischer et al., 
2011). Notably, as Dicer enzymes are not known to have dephosphorylation activity, and 
RRF-3 presumably generates 5'-triphosphorylated ends, the process through which 26G-
RNAs become 5'-monophosphorylated is unknown.  
DCR-1 was found to be required for 26G-RNA accumulation through the study of a 
mutant that impairs the activity of its conserved N-terminal helicase domain. dcr-1(mg375) 
helicase mutant animals exhibit both temperature-sensitive sterility and Eri phenotypes. 
Consistently, 26G-RNAs were found not to accumulate in this mutant, while the miRNA 
population was intact (Pavelec et al., 2009; Welker et al., 2010). When different RNA 
substrates were treated with cell-free extracts containing either intact or helicase mutant 
DCR-1, the cleavage of dsRNA with 2-nt 3' overhangs gave rise to 21-23 nt products 
regardless of the helicase domain. Since this substrate simulates the dsRNA end of a pre-
miRNA, it explains why dcr-1(mg375) mutant animals still express miRNAs. This 
property is conserved in Drosophila, where miRNA-processing Dicer-1 naturally lacks a 
functional helicase domain (flies express two Dicer enzymes, unlike humans and worms 
which express only one; Lee et al., 2004; Jiang et al., 2005). However, when the provided 
substrate was blunt-ended dsRNA, wild-type DCR-1 was able to generate a 5'-3' 26-nt 
product with an accompanying 22-23-nt 3'-5' product, while helicase-deficient DCR-1 was 
not (Welker et al., 2011). In agreement with this, Drosophila Dicer-2, which possesses a 
functional helicase domain and is dedicated to processing exo- and endo-siRNAs from 
long dsRNA, was also shown to require a functional helicase domain to cleave dsRNA, 
and it did so much more efficiently on blunt-ended dsRNA (Welker et al., 2011; Sinha et 
al., 2015). Therefore, the helicase domain of C. elegans Dicer allows the enzyme to adopt 
an altered mode of cleavage to produce 26-nt RNAs. This is currently the strongest piece 
of evidence to explain how DCR-1 is capable of generating 26G-RNAs from presumably 
longer RRF-3 dsRNA precursors. It also implies that a blunt end must be produced by 
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processing of the sense template strand in a way that results in the alignment of its 3' end 
with the 5'G of the antisense strand.  
The function of the helicase DRH-3 and of the dsRNA-binding protein RDE-4 in 
26G-RNA biogenesis is less clear. DRH-3 is found in association with all RdRPs in C. 
elegans (Duchaine et al., 2006; Gu et al., 2009; Claycomb et al., 2009; Thivierge et al., 
2012). Accordingly, it is essential for the accumulation of both 22G- and 26G-RNAs (Gu 
et al., 2009; Vasale et al., 2010). Current thought hypothesizes that due to an accumulation 
of a vestigial amount of 22G-RNAs at the 3' ends of transcripts in drh-3 mutants, this 
putative helicase may either promote loading of 22G-RNAs into Argonautes by unwinding 
the RdRP product from the template, or facilitate translocation of the RdRP complex along 
the template by weakening regions of intra-molecular base pairing (Gu et al., 2009). 
Regarding RDE-4, while it is required for accumulation of 26G-RNAs, the desilencing of 
their target RNAs in rde-4 mutant animals is less pronounced than in other Eri mutants, 
suggesting that a basal amount of 26G-RNAs may still be produced (Vasale et al., 2010; 
Gent et al., 2010; Zhang et al., 2011). Additionally, rde-4 mutant animals exhibit a milder 
temperature-sensitive defect, laying mostly inviable embryos at 25˚C (Blanchard et al., 
2011). This is an indication that RDE-4 may not be essential to generate 26G-RNAs, but 
may rather confer efficiency to the process as a co-factor of DCR-1.  
ERI-1b is strictly required for 26G-RNA accumulation, as null mutants show a 
complete loss of 26G-RNAs accompanied by the characteristic phenotypes (Kennedy et 
al., 2004; Duchaine et al., 2006; Han et al., 2009; Conine et al., 2010; Gent et al., 2010). 
ERI-1b contains the conserved DEDDh-like 3'-5' exonuclease domain, which is able to 
catalyze the removal of overhanging nucleotides from duplex siRNAs with 2-nt 3' 
overhangs in vitro, but does not degrade single-stranded RNA (ssRNA) or the ends of a 
large RNA hybridized to a small RNA (Kennedy et al., 2004). Its exonuclease activity was 
shown to be required for 26G-RNA accumulation (Gabel and Ruvkun, 2008). The 
mammalian ortholog of ERI-1b, Eri1, has been shown to play a role in the metabolism of 
histone mRNAs to promote their degradation at the end of the S phase of the cell cycle 
(Hoefig et al., 2013). Eri1 achieves this by binding to the terminal stem-loop structure in 
histone mRNAs, followed by the removal of two unpaired nucleotides at the 3' end. The 
subsequent addition of a poly-uridine tract to the 3' end prompts the recruitment of a 
complex that interacts with Eri1, which in turn is able to degrade the stem-loop nucleotide 
by nucleotide, making the transcript vulnerable to general RNA degradation mechanisms 
(namely via the exosome from the 3' end and through decapping followed by Xrn1-
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homolog exonucleolytic degradation from the 5' end). Although not yet explored, it is 
plausible that C. elegans ERI-1b may be recruited to 26G-RNA template regions of 
secondary structure and that, after RRF-3 synthesis, it helps to create the blunt end that 
DCR-1 requires for cleavage of 26-nt RNAs.  
ERI-3 is a nematode-specific protein without sequence homology to any known 
domains. However, a null mutant shows the characteristic phenotypes associated with loss 
of 26G-RNAs (Duchaine et al., 2006). Since it directly interacts with DCR-1, but not with 
the RdRP module of the ERI complex, it is thought to mediate the interaction between 
ERI-1b and DCR-1 (Thivierge et al., 2012). ERI-5 has been shown to also bind DCR-1 
directly and to bridge the RdRP module to the DCR-1 module of the ERI complex 
(Thivierge et al., 2012). Loss of ERI-5 leads to a dramatic, but not complete, loss of 26G-
RNAs, because the protein EKL-1 (a paralog of ERI-5) can partially compensate for its 
absence by interacting with DRH-3 bound to RRF-3. In this context the DCR-1 module no 
longer interacts with the rest of the complex, but can apparently still transiently engage the 
RRF-3/EKL-1/DRH-3 module (Thivierge et al., 2012).  
The 26G-RNA biogenesis pathway is still poorly-characterized. The biochemical 
activity of most components has either not been demonstrated or it is not known at all. 
How is the ERI complex recruited to its RNA targets? Which enzyme is responsible for 
cleavage and trimming of the target? How long and how stable are RRF-3 dsRNA 
precursors? These and other questions are worthy of further research, and should provide 
insight into how RdRPs and Dicer function together in other organisms. 
 
26G-RNAs Occur as Two Distinct Populations Defined by the ERGO-1 and 
ALG-3/4 Argonautes 
26G-RNAs associate with dedicated Argonautes that define two functionally 
distinct pathways: The ERGO-1 pathway and the pathway defined by the redundant ALG-
3 and ALG-4 Argonautes (Fig. 1.5 and Table 1.1). These pathways comprise two phases: a 
primary phase characterized by the production of primary 26G-RNAs, and a secondary, 
amplification phase during which targets are bound by 26G-RNAs to trigger the synthesis 
of effector 22G-RNAs (Gent et al., 2009; Han et al., 2009; Conine et al., 2010; Gent et al., 
2010; Vasale et al., 2010).  
ERGO-1 (endogenous RNAi-deficient Argonaute 1), a PIWI-clade Argonaute, is 
predominately expressed in the cytoplasm of cells during oogenesis and embryogenesis, 
and residually expressed during the L3 and L4 stages (Vasale et al., 2010; Billi et al., 
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2012). The ergo-1 null mutant manifests the Eri phenotype, but not the sperm-related 
sterility at 25˚C (Han et al., 2009; Pavelec et al., 2009). Molecularly, ERGO-1 26G-RNAs 
are different than ALG-3/4 26G-RNAs in that they carry a 3'-end 2'-O-methyl modification 
imparted by HENN-1. This feature was shown to confer extra stability to the ERGO-1 
26G-RNAs, as a henn-1 loss-of-function mutant expressed fewer 26G-RNAs and a higher 
frequency of untemplated 3' uridines on the remaining 26G-RNAs, which presumably 
promote their degradation (Kamminga et al., 2012; uridylation effects reviewed in Lee et 
al., 2014). Curiously, while the global stability of 21U-RNAs is only subtly affected in the 
henn-1 mutant, 21U-RNA-induced silencing is compromised (Kamminga et al., 2012). 
This suggests that the 2'-O-methyl modification may have a role beyond sRNA 
stabilization, perhaps as a specificity determinant for loading into the correct Argonaute.   
In addition to the ERI complex, ERGO-1 26G-RNA accumulation is dependent on 
a set of extra proteins which are dispensable for ALG-3/4 26G-RNA accumulation. ERI-9 
has been recovered in immunoprecipitates of DCR-1 and ERI-1 (Thivierge et al., 2012), 
and its loss leads to the same phenotypes exhibited by ergo-1 mutant animals (Pavelec et 
al., 2009). ERI-9 is not conserved beyond nematodes and its function is currently 
uncharacterized. ERI-6/7 is a cytoplasmic helicase which has never been identified in 
studies of the ERI complex (Fischer et al., 2008; Fischer et al., 2011). Based on homology 
with human Mov10, which associates with Argonautes (Meister et al., 2005), and 
Drosophila Armitage, which is required for the formation of RNA-induced silencing 
complexes (Tomari et al., 2004), ERI-6/7 is proposed to associate with ERGO-1 to perhaps 
facilitate its loading or activity.  
Finally, ERGO-1 26G-RNAs strictly require some proteins belonging to the 
Mutator group (Zhang et al., 2011). Mutants from this class of proteins were found in 
screens in which the rate of mutation induced by transposition of sequences of the 
Tc1/mariner family in the germline was increased (Ketting et al., 1999; Vastenhouw et al., 
2003). Some of these mutants are also RNAi-defective, highlighting the convergence of 
different sources of RNA into the central 22G-RNA pathway. The Mutator proteins 
required for ERGO-1 26G-RNAs are MUT-2 (or RDE-3), a nucleotidyltransferase 
mentioned earlier, MUT-7, a 3'-5' exonuclease, MUT-15, and MUT-16, both with 
unknown biochemical activities (Ketting et al., 1999; Vastenhouw et al., 2003; Chen  et 
al., 2005). MUT-16 is responsible for the aggregation of these proteins in cytoplasmic, 
perinuclear regions of germline cells, termed Mutator foci (Phillips et al., 2012). The 
dependence of ERGO-1 26G-RNAs on these proteins therefore suggests that these foci are 
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the primary sites for their biogenesis. Mutator foci normally locate adjacently to P 
granules, but they assemble independently of P granules (Phillips et al., 2012). In the 
germline, the majority of exported mRNAs have to pass through P granules (Sheth et al., 
2010). These highly dynamic sites contain numerous RNA-related proteins functioning in 
diverse processes such as RNAi (DRH-3, EGO-1, CSR-1, PRG-1 and WAGO-1) and 
regulation of mRNA stability and translation, among others (reviewed in Updike and 
Strome, 2009). It is therefore widely accepted that in the germline, P granules constitute 
the domain where most sRNAs first meet their targets, as they emerge from nuclear pores. 
The majority of 26G-RNAs associate with ERGO-1 to generate WAGO-loaded 
22G-RNAs, that specifically silence a restricted number of genes in cis (78 in embryos and 
75 in adults, with a 60-gene overlap). These include protein coding genes, pseudogenes 
and unannotated transcription units (Vasale et al., 2010; Fischer et al., 2011). Curiously, 
two-thirds of these genes share regions of high sequence identity, suggesting that this 
pathway evolved to downregulate the expression of recently duplicated non-conserved 
genes (Fischer et al., 2011). Examples of ERGO-1 acting in trans (i.e., on RNAs other than 
their template RNAs) have also been identified, in which loci from which no 26G-RNAs 
are produced, show an ERGO-1-dependent accumulation of 22G-RNAs (Vasale et al., 
2010; Montgomery et al., 2012). As trans-acting 26G-RNAs do not exhibit perfect 
complementarity with their targets, this implies that the ERGO-1 pathway may influence 
the expression of a much more vast set of genes (Montgomery et al., 2012). 
The biological relevance of the ERGO pathway is unknown, as ergo-1 mutant 
animals do not exhibit any noticeable developmental or physiological abnormalities, at 
least under laboratory growth conditions. Despite targeting very few genes, ERGO-1 26G-
RNAs (and the resulting 22G-RNAs) are very abundant during embryogenesis and early 
larval development (Gent et al., 2010). The Eri phenotype is solely manifested in mutants 
that are essential for ERGO-1 26G-RNA biogenesis and accumulation. This effect is 
thought to arise from the availability of somatic RNAi machinery that is normally engaged 
in ERGO-1 target silencing. This permits the processing of a larger amount of exogenous 
dsRNA which in turn elicits more potent silencing of cognate targets. Several groups have 
observed this competition phenomenon between endogenous and exogenous silencing 
pathways due to the limited quantity of RNAi machinery (Kennedy et al., 2004; Duchaine 
et al., 2006; Lee et al., 2006; Yigit et al., 2006; Guang et al., 2008; Gu et al., 2009; Sarkies 
et al., 2013). 
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The ALG-3 and ALG-4 Argonautes (belonging to the Argonaute-clade) and their 
associated 26G-RNAs are expressed exclusively during spermatogenesis (Han et al., 2009; 
Colin et al., 2010). In hermaphrodites, spermatogenesis occurs from the late L4 stage until 
early adulthood, and in males from the L4 stage onwards. ALG-3 is enriched in the P 
granules of developing spermatocytes, as well as in the cytoplasm surrounding them, but 
absent from mature spermatids (Colin et al., 2010, Colin et al., 2013). alg-3; alg-4 double 
mutants (but not single mutants) exhibit the fully penetrant temperature-sensitive sterility 
phenotype that characterizes many of the Eri mutants, while not manifesting the ERGO-1-
dependent Eri phenotype (Han et al., 2009; Colin et al., 2010). The sterility is due to a 
variety of sperm defects, such as a decreased production of sperm, defects in nuclear shape 
of developing spermatocytes (frequently arrested as multinucleated cells or with chromatin 
bridges that fail to resolve during budding of spermatids), and the inability to be activated 
into the motile stage that allows fertilization to occur (Gent et al., 2009; Pavelec et al., 
2009; Conine et al., 2010).  
In males, 26G-RNAs target as many as ~1,400 genes, 63% of which exhibit sperm-
specific expression (Conine et al., 2013). While ~200 of the mRNAs for these genes are 
downregulated in alg-3; alg-4 mutant animals, just as many mRNAs are upregulated. In 
wild-type males grown at 25˚C the expression of most positively regulated genes 
increased, whereas the expression of most negatively regulated genes decreased. The same 
tendency was verified at the protein level. Genes that are positively regulated by ALG-3/4 
26G-RNAs are mostly involved in sperm activation, motility and general spermatogenesis 
(Conine et al., 2013). This outcome explains why ALG-3/4 26G-RNAs are required for 
proper sperm function at elevated temperatures, as mutants for some of the upregulated 
genes exhibit the temperature-sensitive sterility phenotype. On the other hand, negatively 
regulated genes are not enriched for sperm-related functions. As their decrease was found 
to depend on the expression of WAGO Argonautes, it is assumed that their silencing 
occurs via 22G-RNAs (Conine et al., 2010; Conine et al., 2013). Interestingly, regarding 
positively regulated genes, it was found that the 22G-RNAs produced against them were 
loaded into the CSR-1 Argonaute (described in the next section), which correlated with the 
increased deposition of activating chromatin marks in spermatocytes developing at 25˚C 
(Conine et al., 2013).  
 The ERGO-1 and ALG-3/4 pathways are illustrative of how the differential 
expression of Argonautes at the cellular, tissue and developmental levels can serve 
dramatically distinct regulatory purposes. The mechanisms by which ERGO-1 and ALG-
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3/4 in complex with 26G-RNAs target their transcripts and recruit secondary RdRP 
machinery are currently uncharacterized. In the future it will be very interesting to know 
whether this process differs for each pathway, considering that ERGO-1 is 
phylogenetically closer to the 21U-RNA PRG-1 PIWI Argonaute, and that ALG-3 and 







Figure 1.5. The ALG-3/4 and the ERGO-1 26G-RNA pathways. Both pathways generate 
primary 26G-RNA primary siRNAs through the concerted activity of proteins grouped in the ERI 
complex. It is not known what characteristics of the substrates make them recognizable to the ERI 
complex. The RdRP RRF-3 synthesizes a complementary strand of unknown length (dashed green 
line), starting with a presumably triphosphorylated 5'G. Through as of yet uncharacterized 
processing steps, it is predicted that a blunt ended dsRNA at the RRF-3 initiation site is produced. 
This provides a substrate for cleavage by Dicer, to generate a non-canonical product of 26 nt. These 
26G-RNAs are loaded into specialized Argonautes that define two distinct pathways. (A) The 
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ALG-3 and ALG-4 Argonautes are expressed during spermatogenesis of hermaphrodites and 
males. They guide the production of secondary 22G-RNAs that can have a post-transcriptional 
silencing effect on targets, or activate the expression of a subset of targets that are specifically 
related to the development and activation of sperm cells. These engage the CSR-1 Argonaute 
pathway, which reinforces the expression of the corresponding genes and permits the paternal 
inheritance of gene expression information via the incorporation of loaded CSR-1 complexes in the 
mature sperm of males. (B) ERGO-1 protein expression predominately takes place in oocytes and 
embryos. In addition to the ERI complex, ERGO-1 26G-RNA accumulation requires additional 
factors that are dispensable by ALG-3/4 26G-RNAs. These include the RNA methyltransferase 
HENN-1, which modifies the 3' ends of the 26G-RNAs in order to promote their stability. The 
resulting 22G-RNAs predominately silence a small group of ~80 highly expressed genes in somatic 
cells of embryos and post-embryonic larvae, encoding mostly pseudogenes and duplicated 
sequences with no apparent biological functions. There are currently no clues suggesting the 
mechanism whereby 26G-RNAs recruit RdRPs to their targets.  
 
 
22G-RNAs Regulate Gene Expression by Remarkably Diverse Mechanisms: 
WAGO versus CSR-1 Pathways  
 All sRNA pathways, whether they are exogenously or endogenously triggered, 
converge on the production of effector, RdRP-synthesized antisense 22G-RNAs. The 
regulatory outcome of 22G-RNAs depends largely on which downstream WAGO-clade 
Argonautes they interact with (Table 1.1). There are two main 22G-RNA pathways 
determined by whether they interact with any of the 12 semi-redundant WAGO-clade 
Argonautes, or with the CSR-1 Argonaute (also a member of the WAGO clade). For 
simplicity we refer to these two pathways as the WAGO pathway and the CSR-1 pathway. 
The simultaneous deletion of the 12 WAGOs leads to a loss of the majority of 22G-RNAs, 
except for a low amount of germline 22G-RNAs associating specifically with CSR-1 (Gu 
et al., 2009; Claycomb et al., 2009). Globally, ~50% (~9,000) of all protein-coding genes 
in C. elegans are targeted by 22G-RNAs from both pathways and quantitatively, the 
majority of endogenous 22G-RNAs are produced in the germline (Gu et al., 2009). The 
WAGO pathway employs transcriptional and post-transcriptional mechanisms to silence 
protein-coding genes, transposable elements, repetitive sequences, pseudogenes and other 
unannotated expressed intergenic sequences (Gu et al., 2009). The CSR-1 pathway targets 
essentially all germline-expressed protein coding genes (~4,000), not to silence them, but 
rather to promote their expression and to protect them from the silencing effects of the 
PRG-1/21U-RNA pathway, in a process termed “licensing” (Fig. 1.4B, page 42 and Table 
1.1, page 29; Claycomb et al., 2009; Gu et al., 2009; Seth et al., 2013; Wedeles et al., 
2013; Cecere  et al., 2014).   
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WAGO pathway 22G-RNAs are triggered by the sRNAs associated with RDE-1, 
PRG-1, ERGO-1 and ALG-3/4, all of which can be considered primary sRNAs. Since 
PRG-1 and ALG-3 have been shown to concentrate in nuclear pore-associated P granules, 
these are thought to be the main sites where primary Argonaute complexes associate with 
their targets in the germline (Batista et al., 2008; Conine et al., 2010). WAGO 22G-RNAs 
are then amplified in adjacent Mutator foci, which harbor EGO-1 and RRF-1 RdRP 
complexes, as well as a variety of additional factors required for the robust accumulation 
of 22G-RNAs (Phillips et al., 2012, Yang et al., 2012; Zhang  et al., 2012). In contrast, the 
production of CSR-1 22G-RNAs does not require Mutator foci (Zhang et al., 2011). 
Rather, it depends mostly on EGO-1-mediated synthesis in P granules, where both proteins 
co-localize (Claycomb et al., 2009; Gu et al., 2009). In somatic cells, which lack 
perinuclear P granules, the cellular location of these events has not been elucidated. 
However, based on the observation that the proteins that aggregate in Mutator foci are 
equally required for RNAi in both germline and somatic cells, 22G-RNA synthesis and 
accumulation is presumed to take place in cytoplasmic P-body-like domains (Phillips et al., 
2012). 
The mechanism of 22G-RNA-mediated post-transcriptional silencing is still poorly 
understood. A reason for this knowledge gap stems from the fact that WAGO-pathway 
Argonautes lack the slicer-activity conserved residues that would allow cleavage of target 
RNAs (Yigit et al., 2006). The recent discovery of additional factors necessary for exo-
RNAi provided new ideas to explain how post-transcriptional silencing may occur in C. 
elegans. A complex composed of nematode-specific proteins RDE-10 and RDE-11 with 
potential RNA binding and nuclease properties, respectively, was shown to be required for 
RDE-1- and ERGO-1-driven 22G-RNA amplification in both germline Mutator foci and 
the cytoplasm of somatic cells (Yang et al., 2012, Zhang et al., 2012). Notably, RDE-10 
was shown to bind exo-RNAi targeted mRNAs, promoting their deadenylation and 
subsequent RDE-11-dependent degradation (Yang et al., 2012). In another study from our 
laboratory, the endonuclease RDE-8 (related to the human Zc3h12a RNase) was shown to 
exhibit a similar pattern of localization as RDE-10/RDE-11 and to generally promote the 
accumulation of both endogenous 22G-RNAs and of exo-RNAi triggered 22G-RNAs, both 
in the germline and soma (Tsai et al., 2015). In association with the nucleotidyltransferase 
RDE-3, target RNAs are cleaved by RDE-8 and untemplated uridines are added to the 3' 
end of the 5'-cleavage fragment. This event may trigger RdRP recruitment for 22G-RNA 
synthesis but also lead to the subsequent degradation of the mRNA fragment, as 3' 
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uridylation promotes RNA decay (Lee et al., 2014). The degradation activity of these 
complexes, together with the potential recruitment of mRNAs by loaded WAGOs to sites 
where canonical mRNA degradation pathways operate (P granules, cytoplasmic P-bodies, 
etc…) may collectively contribute to the post-transcriptional silencing of exo- and endo-
RNAi targets. Further work will be required to understand these processes in detail.  
At the transcriptional level, silencing can occur via two WAGO Argonautes 
capable of shuttling between the nucleus and the cytoplasm: NRDE-3(WAGO-12) and 
HRDE-1(WAGO-9). NRDE-3 (Nuclear RNAi-defective) mediates nuclear RNAi in 
somatic cells, while HRDE-1 (Heritable RNAi-defective) acts in germline nuclei (Guang  
et al., 2008; Buckley et al., 2012). The association of these Argonautes with exogenously 
and endogenously triggered 22G-RNAs, causes their translocation into the nucleus. In 
cooperation with other factors, namely NRDE-1, NRDE-2 and NRDE-4, they are able to 
simultaneously interact with chromatin and target nascent transcripts to inhibit Pol II 
elongation, and subsequently to establish a silent chromatin state through the deposition of 
repressive histone H3K9 trimethylation marks (Guang et al., 2008; Guang et al., 2010; 
Burkhart et al., 2011; Burton et al., 2011; Ashe et al., 2012; Buckley et al., 2012; Gu, S.G., 
et al., 2012; Luteijn et al., 2012; Shirayama et al., 2012).  
 NRDE-3 binds endogenous 22G-RNAs triggered by ERGO-1 26G-RNAs, 
evidenced by the fact that when the ERI complex is disabled, NRDE-3 becomes 
predominately cytoplasmic (Guang et al., 2008; Pavelec et al., 2009; Fisher et al., 2011). 
In this context, following exposure to dsRNA targeting any somatically expressed gene, 
NRDE-3 reacquires a nuclear localization, showing that it can also act in response to 
exogenous triggers (Guang et al., 2008). NRDE-3 may therefore cooperate with other 
secondary WAGO Argonautes to robustly silence genes via simultaneous transcriptional 
and post-transcriptional mechanisms. Consistent with an effector role in the ERGO-1 
pathway, nrde-3 loss-of-function mutants appear to be wild-type. In contrast, mutants of 
the nuclear counterpart hrde-1, exhibit a mortal germline phenotype (Mrt) at 25˚C in which 
the ability of the germline to produce oocytes and sperm decreases gradually over a few 
generations, ultimately resulting in animals that are completely sterile (Buckley et al., 
2012). In agreement with this phenotype, HRDE-1 was demonstrated to direct 
transgenerational silencing of germline-expressed transcripts targeted by exo-RNAi by 
maintaining H3K9 trimethylation on the corresponding genes (Ashe et al., 2012; Buckley 
et al., 2012; Gu, S.G. et al., 2012). Cloning of HRDE-1-associated endogenous 22G-RNAs 
revealed a large overlap with the 22G-RNAs associated with the P-granule WAGO-1 
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Argonaute, confirming that 22G-RNAs targeting the same gene can simultaneously 
execute transcriptional and post-transcriptional gene silencing (Shirayama et al., 2012). 
Since WAGO-1 shows a preference for 22G-RNAs targeting transposons and repetitive 
elements (Gu et al., 2009), the Mrt phenotype of the hrde-1 mutant is thought to arise from 
the inability to maintain repressive epigenetic marks on these elements, which in turn leads 
to the accumulation of mutations incompatible with stem cell maintenance.  
The Argonaute CSR-1 (Chromosome Segregation and RNAi-defective) is highly 
expressed in the germline, oocytes and embryos (Claycomb et al., 2009). As its name 
indicates, csr-1 mutants display lethal chromosome segregation defects during mitotic 
divisions in embryos, exhibit partial resistance to exo-RNAi in the germline, as well as 
changes in the morphology and proliferation of germline nuclei (Yigit et al, 2006; 
Claycomb et al., 2009). CSR-1 concentrates throughout the germline in P granules, 
localizes to meiotic chromosomes of oocytes and later to mitotic chromosomes of 
developing embryos (Claycomb et al., 2009). CSR-1 22G-RNAs depend strictly on the 
RdRP EGO-1, DRH-3 and EKL-1, mutants of which exhibit several overlapping 
phenotypes with csr-1 (Smardon et al., 2000; Vought et al., 2005; Duchaine et al., 2006; 
Nakamura et al., 2007; Gu et al., 2009; She et al., 2009). As mentioned earlier, CSR-1 
22G-RNAs target germline protein-coding mRNAs without leading to their 
downregulation, in contrast to the silencing effects of the 12 semi-redundant Argonautes 
composing the WAGO pathway (Claycomb et al., 2009). Consistent with this, the levels of 
CSR-1 22G-RNAs are much lower than those of the WAGO pathway (Gu et al., 2009). 
One identified reason for their lower abundance is the 3' poly-uridylation of a large portion 
of CSR-1 22G-RNAs by the conserved nucleotidyltransferase CDE-1 (Cosuppression 
Defective 1; also known as CID-1, Caffeine Induced Death Homolog of S. pombe 1, or 
PUP-1, Poly(U) Polymerase 1), which leads to their destabilization (van Wolfswinkel et 
al., 2009).   
The CSR-1 pathway has recently been shown to promote Pol II transcription of the 
germline expressed genes it targets (Cecere et al., 2014). This is consistent with prior 
observations that CSR-1 regulates the distribution of repressive H3K9 dimethyl chromatin 
marks (Maine et al., 2005; She et al., 2009), and that on embryonic chromatin, regions 
bound by CSR-1 and regions bound by the centromere-defining protein CENP-A 
(Centromere Protein A) are mutually exclusive (Claycomb et al., 2009; Gassmann et al., 
2012). These findings suggest that CSR-1 22G-RNAs may maintain zones of euchromatin 
among centromeres (which in C. elegans are found along the entire length of 
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chromosomes) to perhaps allow the maintenance of gene expression required for 
successful cell division and proper development of early embryos. Furthermore, CSR-1 
was shown to counteract the silencing effects of the PRG-1/21U-RNA pathway in the 
germline (Lee et al., 2012; Seth et al., 2013; Wedeles et al., 2013). These studies 
demonstrated that both transgenes and endogenous genes targeted by CSR-1 are 
completely immune to recognition and silencing by PRG-1. This immediately suggested 
the hypothesis that the CSR-1 and the PRG-1 pathways act simultaneously and in 
opposition of each other, as part of a system that discriminates “self” from “non-self” gene 
expression (Fig. 1.4., page 42). This system would ensure proper germline function while 
protecting its genetic material from the deleterious effects of invading or existing foreign 
sequences (e.g., retroviruses and transposable elements).  
Lastly, very little is known regarding the events that trigger CSR-1 22G-RNA 
synthesis. The first clue that some CSR-1 22G-RNAs may also be triggered by primary 
sRNAs came from a recent study of CSR-1 in males (Conine et al., 2013). CSR-1 was 
shown to interact with 22G-RNAs derived from ALG-3/4 target mRNAs, and to promote 
the transcription of those mRNAs in developing spermatocytes. Accordingly, csr-1 mutant 
males were shown to have the same temperature sterility phenotype of alg-3; alg-4 mutant 
males. When csr-1 homozygous males were mated to heterozygous hermaphrodites for 
successive generations, their fertility decreased gradually until the sixth generation, which 
was completely sterile. Since 22G-RNA-loaded CSR-1 was found in mature sperm, it was 
proposed that CSR-1 passes along 22G-RNAs that ensure proper expression of ALG-3/4-
class genes in the next generation (Conine et al., 2013).  
 The aforementioned examples illustrate an elevated degree of interconnectedness 
between sRNA pathways in C. elegans, which we have just recently begun to realize. 
Researchers still hold many loose pieces of this incredibly large and intricate puzzle. The 
discoveries made thus far in C. elegans, particularly those that implicated sRNAs as 
inheritable agents that propagate epigenetic programs from one generation to the next, 
have propelled an enthusiastic search for similar mechanisms in vertebrates. 
 




OVERVIEW OF DICER-ASSOCIATED C. ELEGANS PIR-1 AND ITS RNA 5' 
PHOSPHATASE ORTHOLOGS  
 
C. elegans PIR-1 
In 2006 our laboratory published a study aiming to complement previous sRNA 
pathway screens in C. elegans through a mass spectrometry-based proteomic survey of 
DCR-1 immunoprecipitates (Duchaine et al., 2006). At the time, the role of Dicer in the 
RNAi and miRNA pathways was already well characterized. The study aimed not only to 
expand the list of proteins necessary for these pathways, but also to discover new functions 
for Dicer. The chosen experimental approach had the advantage of allowing the 
identification of proteins also required for viability, which tend to be missed in traditional 
forward and reverse genetic screens. The results confirmed previously described Dicer 
interactors and provided the basis for the discovery of the ERI complex and its functions. 
Additionally, two essential proteins were uncovered: the helicase DRH-3, implicated in 
RNAi and fertility, and PIR-1, named after the human ortholog PIR1 (Phosphatase that 
Interacts with RNA/RNP complex 1; Yuan et al., 1998), which acts as an RNA 
phosphatase in vitro.  
The characterization of a C. elegans pir-1 null deletion mutant in the 
aforementioned study showed that PIR-1 is essential, as the animals exhibited a fully 
penetrant larval arrest before reaching reproductive age. The study also found that pir-1 
mutant animals were unable to silence genes via RNAi by not producing siRNAs. It was 
therefore proposed, based on its putative RNA 5' phosphatase activity, that PIR-1 could 
dephosphorylate the termini of long dsRNA products generated by the RdRPs RRF-1 and 
EGO-1 to allow Dicer-mediated cleavage of the dsRNA into effector siRNAs. This model 
has since been abandoned, however, in light of subsequent work from other laboratories 
showing that RRF-1 and EGO-1 directly generate effector 22G secondary siRNAs from 
template RNAs without the need for additional processing steps (Aoki et al., 2007; Pak and 
Fire, 2007; Sijen et al., 2007).  
As the initial characterization of a pir-1 loss-of-function mutant in Duchaine et al. 
(2006) did not exhaustively address the involvement of PIR-1 in sRNA biogenesis and 
development, numerous important questions were left unanswered.  For instance, at which 
step of the RNAi process is PIR-1 required for the accumulation of 22G-RNAs? Since 
miRNAs, 26G-RNAs and 21U-RNAs all bear a 5'-monophosphate, is the putative RNA 
phosphatase activity of PIR-1 required to achieve this phosphorylation state? Does PIR-1 
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function as an RNA 5' phosphatase in vivo? Is PIR-1 associated with every Dicer molecule 
or just a subset? These and other questions motivated the continued study of PIR-1. From 
the onset of this project, the pioneering studies of the baculoviral and human orthologs of 
PIR-1 provided an invaluable basis for our investigation. For this reason, in the following 
two sections, we provide a brief review about the current state of knowledge concerning 
these proteins.   
 
Baculovirus Phosphatase  
 Interest in human PIR1 was prompted by earlier studies of Baculovirus 
Phosphatase, or BVP, with which it shares 58% similarity at the amino acid level (Fig. 
1.6). This protein is encoded by the circular dsDNA baculovirus Autographa californica 
nuclear polyhedrosis virus, which carries over 100 genes and replicates in the nuclei of 
lepidopteran insect cells. BVP was identified based on its homology to eukaryotic protein 
tyrosine phosphatases or PTPs (Sheng and Charbonneau, 1993). The human genome 
encodes more than 100 PTPs required for the regulation of various processes, such as 
transcription, mRNA processing, cell proliferation, and signaling pathways, to ensure, for 
example, faithful development and appropriate immune responses (reviewed in Alonso et 
al., 2004). PTPs exhibit enormous diversity in size and structural organization, occurring 
as receptor-like transmembrane forms or smaller non-receptor forms. They all share a 
highly conserved active site motif – HCXXXXXR(S/T) – termed the P-loop (Phosphatase 
loop), in which the cysteine acts as the nucleophile that disrupts the phosphomonoester 
bond to release the protein phosphate (Zhang , 2003). 
BVP is one of the smallest known PTPs (~19 kDa), and has been shown to possess 
tyrosine phosphatase and serine/threonine phosphatase activities in vitro (Kim and Weaver, 
1993; Sheng and Charbonneau, 1993). Studies of infection in insect SF-21 cells established 
that BVP is expressed late in infection, when DNA replication occurs, localizing to the 
nucleus, cytoplasm and viral particles (Kim and Weaver, 1993; Li and Miller, 1995a). The 
infection of cells with a BVP-deletion mutant virus led to overall reduced viral titers 
(>50%) and heterogeneity among cells regarding the production of occluded viral particles, 
produced very late in the infective cycle to mediate transmission from one host to another 
(Li and Miller, 1995a; Li and Miller, 1995b). Intriguingly, when insect larvae were 
infected with either mutant or wild-type occluded viruses, the concentration of virus and 
the time required for animals to die did not differ between the two conditions (Li and 
Miller, 1995b). Curiously, the BVP ortholog of a silkworm baculovirus was demonstrated 




to be essential for virally induced light-activated locomotory behavior, which leads the 
animals to seek the tops of vegetation thereby facilitating virus dispersion (Kamita et al., 
2005). This observation suggests that BVP may be required to modulate aspects of host 
physiology (perhaps by altering host gene expression), rather than to promote viral 
replication.  
 BVP (as well as PIR-1) exhibits more extensive sequence homology with the 
triphosphatase domain of metazoan mRNA capping enzymes, than to PTPs (Fig. 1.6; 
Takagi et al., 1997). Studies of the C. elegans capping enzyme CEL-1 (mRNA Capping 
Enzyme-Like 1) demonstrated that its RNA triphosphatase domain removes the γ-
phosphate from the 5'-ends of RNA in vitro, but that it lacks phosphotyrosine or 
phosphoserine activity (Takagi et al., 1997; Takagi et al., 2003). Based on these findings, 
the in vitro activity of BVP was further scrutinized, leading to the discovery that it 
sequentially removes the γ- and β-phosphates from the triphosphorylated 5'-end of RNA 
molecules, resulting in a 5'-monophosphorylated molecule (Takagi et al., 1998). In 
contrast, dephosphorylation activity of BVP on phosphoprotein substrates was found to be 
two to three orders of magnitude lower than that of the budding yeast PTP Cdc14 (Cell 
division cycle 14). Finally, the substitution of the active site cysteine with a serine resulted 
in the complete loss of both activities. 
 As the mechanism of RNA dephosphorylation by metazoan RNA triphosphatases 
had not yet been elucidated, BVP was used as a model to solve this problem. It was shown 
that, similarly to the mechanism of protein dephosphorylation, BVP also forms a covalent 
protein-phospho-cysteinyl intermediate as a result of RNA 5'-phosphate hydrolysis 
(Martins and Schuman, 2000). The active site cysteine thiolate acts as the nucleophile that 
attacks the bond between two phosphates. The covalent phospho-cysteinyl intermediate is 
then hydrolyzed to release the inorganic phosphate. Further insights came from extensive 
mutational analyses of BVP, which led to the identification of several active-site and 
structural residues required for its triphosphatase activity (Martins and Shuman, 2002a; 
Martins and Shuman, 2002b). Ultimately, the analysis of the crystal structure of BVP in 
complex with phosphate helped to rationalize the influence of these mutations on protein 
activity (Changela et al., 2005). Moreover, the study revealed that there is extensive 
structural conservation between BVP and the mammalian capping enzyme triphosphatase 
domain, reinforcing its identity as a bona fide RNA 5' phosphatase. Finally, this 
comparison allowed the identification of the P-loop asparagine residue – essential for 
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formation of the phospho-cysteinyl intermediate – as the major structural signature of the 
active site of RNA 5' triphosphatases.   
 Despite extensive biochemical and structural characterization, the biological 
significance of BVP remains mysterious. Since it is expressed late in infection, and 
because BVP was shown to be able to functionally replace the RNA triphosphatase of 
Saccharomyces cerevisiae to allow mRNA capping in vivo (Martins and Shuman, 2002a), 
its influence in the capping of late viral transcripts was studied (Li and Guarino, 2008). 
The authors demonstrated that BVP is not required for capping of late transcripts. They 
also showed that LEF-4 (Late Gene Expression Factor 4), a putative viral capping enzyme 
carrying an N-terminal guanylyltransferase and C-terminal RNA triphosphatase domain, is 
not required for capping of late viral transcripts. This was surprising, given that LEF-4 is 
essential for viral replication and that the virus encodes no other capping enzymes. It was 
therefore proposed that the capping of late baculovirus transcripts is performed by a host 
enzyme, leaving ample room for speculation concerning the biological relevance of both 
BVP and LEF-4.  
Baculoviruses are unique among DNA viruses in that they use the host Pol II for 
transcription of early genes, and their own RNA polymerase for late transcription 
(reviewed in Hasnain et al., 1997). In the late phase of infection the levels of host 
transcripts drop dramatically, but viral transcription continues. Considering this, one 
hypothesis is that BVP disables host transcription by dephosphorylating the ends of 
nascent mRNA before they can be capped by the host capping enzyme, perhaps ensuring a 
higher allocation of cell resources for viral replication (Takagi et al., 1998). Another 
attractive possibility is that BVP could facilitate the replication of viral DNA, by 
dephosphorylating the 5'-ends of RNA replication primers to promote their removal and 
replacement with DNA (Takagi et al., 1998). However, it is currently not known whether 
the phosphorylation state of replication primers influences their removal during replication.  
 
Human PIR1  
 PIR1 is a ~39 kDa protein, also commonly known as DUSP11 (dual-specificity 
protein phosphatase 11). DUSPs constitute a subgroup within the PTP superfamily, unified 
by their ability to dephosphorylate both phosphotyrosine and phosphoserine/ 
phosphothreonine residues (reviewed in Patterson et al., 2009). Similarly to BVP, PIR1 
possesses the defining RNA 5' phosphatase catalytic domain HCTHGXNRT, that 
distinguishes it from its protein dephosphorylating family members (Changela et al., 




2005). PIR1 orthologs are found among all metazoans for which sequence information 
exists, but are conspicuously absent from plants, fungi, unicellular eukaryotes and 
prokaryotes. Beyond the P-loop, this enzyme shares no significant sequence similarity with 
other DUSPs and lacks any other recognizable functional motifs, apart from N-terminal 
and C-terminal arginine rich regions (Yuan et al., 1998). It also shares significant sequence 
similarity with the triphosphatase domain of metazoan mRNA capping enzymes (Fig. 1.6; 
Deshpande et al., 1999).  
 The establishment that PIR1 has a strong binding preference for RNA was followed 
by the demonstration that it recapitulates the in vitro biochemical activity of BVP on 5'-
triphosphorylated RNA (Yuan et al., 1998; Deshpande et al., 1999). Again, the P-loop 
cysteine residue was strictly required for both the tri- and diphosphatase activities of PIR1, 
and the activity on phospho-protein substrates was even lower than the one measured for 
BVP, making it unlikely that it is involved in endogenous protein dephosphorylation. 
Recently, the crystal structure of PIR1 was solved, demonstrating a high degree of 
structural conservation with BVP and the human capping enzyme (Sankhala et al., 2014). 
Examples of important structural features include (1) a wide, deep cleft at the bottom of 
which the P-loop is located, lined by positively charged residues (likely to neutralize the 
negatively charged RNA backbone and provide a good docking site for a di- or 
triphosphate), (2) two residues in the P-loop (the central histidine and the asparagine) that 
make close side contact with the incoming phosphate, and are thought to orient the 
attacking group (thiolate) and leaving group (phospho-RNA), and (3) the presence of an 
anion stabilizing the position of the basic arginine residue of the P-loop and making 
contact with the threonine next to the catalytic cysteine (Changela et al., 2005; Sankhala et 
al., 2014). Further work will be necessary to address important questions regarding the 
mechanisms of RNA 5' triphosphatases. As an example, it would be important to know 
which structural features determine that capping enzymes can only hydrolyze the γ-
phosphate, while PIR1 and BVP can hydrolyze both γ- and β-phosphates. 
 Lastly, existing work provides some clues as to what the biological roles of PIR1 in 
humans may be. PIR1 was found to associate with three splicing factors through yeast two-
hybrid screens in two studies, although only one interaction was validated in vivo (Yuan et 
al.,1998; Caprara et al., 2009). These interactions are consistent with an experiment in 
HeLa cells, which revealed that overexpressed PIR1 accumulated primarily in nuclei and 
co-localized with the splicing factor SC35 (SRSF2, Splicing Factor, arginine/serine-rich 2) 
in nuclear speckles (Yuan et al., 1998). These regions concentrate multiple pre-mRNA 
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processing factors and often overlap with domains of active transcription (reviewed in 
Spector and Lamond, 2011). Moreover, also in the context of cultured cells, expression of 
endogenous PIR1 was found to be under the control of the master regulator, tumor 
suppressor p53 protein, essential for the DNA damage response and cell cycle progression 
(Caprara et al., 2009). In the same study, the overexpression or RNAi knockdown of PIR1 
led to marked underproliferation and overproliferation of cell populations, respectively. 
Three further studies found correlations between specific diseases and the expression of 
PIR1 mRNA. PIR1 was found to be upregulated in HT-29 colon carcinoma cells grown in 
culture as multicellular tumor spheroids, in comparison to HT-29 cells growing in 
monolayer (Dardousis et al., 2007). In a study comparing the expression of 149 splicing 
factors in the mucosal tissue of patients with inflammatory bowel disease, PIR1 mRNA 
was found to be significantly downregulated, compared to its expression in healthy tissue 
(Hasler et al., 2011). A more recent study aiming to identify host factors required for 
intracellular growth of the bacterium Salmonella thyphimurium by siRNA screening, 
concluded that PIR1 is involved in the control of intracellular infection by this pathogen, as 
silencing of PIR1 mRNA led to the inhibition of Salmonella growth in infected human 
cells (Harald et al., 2014). These results suggest that PIR1 may play important roles in 
RNA metabolism and cell division/proliferation, and that its misexpression may give rise 
or sensitize humans to various pathologies. Therefore, more detailed studies of this highly 
conserved protein in model organisms are warranted, and should provide us with 
knowledge of biological and medical relevance.  
 
 





Figure 1.6. Sequence alignments of C. elegans PIR-1 to homologous proteins. (A) Alignments 
were produced using ClustalW2 software (Larkin et al., 2007; available at at the EMBL-EBI 
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website ebi.ac.uk/Tools). The following sequences were used: C. elegans PIR-1 (233 aa), human 
PIR1 (330 aa), Drosophila melanogaster CG13197 (343 aa), Autographa californica 
nucleopolyhedrosis virus BVP (168 aa), the triphosphatase domain (tp.) of the human capping 
enzyme HCE (residues 1-212), the triphosphatase domain of the C. elegans capping enzyme CEL-1 
(residues 1-236), and the C. elegans PIR-1 paralog F54C8.4 (359 aa). An asterisk (*) indicates a 
fully conserved residue, a colon (:) indicates conservation of residues with strongly similar 
properties, and a period (.) indicates conservation of residues with weakly similar properties. Gray 
highlighting indicates that at least one other aligned sequence has an identical residue. The red 
square delimits the P-loop sequence and red arrowheads indicate residues that are essential for BVP 
triphosphatase activity as defined by alanine scanning in Martins and Schuman, 2002b. (B) Local 
pairwise alignments between the sequences represented as a matrix of the percentage similarity 





RATIONALE FOR THIS PROJECT  
 
The discovery in our laboratory that PIR-1 associates with Dicer provided an 
exciting angle from which to dissect the biology of this relatively understudied RNA 
phosphatase. Importantly, it also opened a new door to learn more about Dicer-dependent 
processes, which are far from being completely understood. By utilizing C. elegans, we 
had the advantage of being able to probe for functions of PIR-1 that could potentially only 
be perceived in the context of a whole animal (a dimension that prior studies of PIR-1 
orthologs lacked). The central objectives of this project were to understand how PIR-1 
functions with Dicer to execute RNAi and whether it is involved in additional Dicer-
dependent sRNA pathways. With the intent of gathering further functional clues, we also 
set out to conduct a deeper study of the phenotypes associated with pir-1 mutant animals, 
and to characterize the PIR-1 protein at the biochemical, cellular and developmental levels. 
More broadly, we were interested in finding the function(s) of PIR-1 determining its 
essential role in C. elegans development, and whether such functions could be 
evolutionarily conserved. Below we provide a summary of key results and briefly state 
how they may influence the course of future PIR-1 studies. 
In Chapter II of this thesis, we show that PIR-1 is required for the proliferation of 
germ cells and for proper sperm differentiation. We also demonstrate that PIR-1 is 
expressed ubiquitously throughout C. elegans development with a preferential nuclear 
localization, and that a catalytically-inactive transgenic PIR-1 is unable to rescue the 
mutant phenotypes. In Chapter III we prove that PIR-1 interacts with the Dicer-containing 
ERI complex, and that this association extends to the nuclear compartment. In Chapter IV 
our results reveal that pir-1 mutant animals fail to accumulate spermatogenesis-associated 
5'-monophosphorylated ALG-3/4 26G-RNAs, explaining both the sperm defect of the pir-1 
mutant and the association of PIR-1 with the ERI complex. Importantly, we show that, 
similarly to its orthologs, PIR-1 is able to convert 5'-triphosphorylated RNA ends into 
monophosphates in vitro. Curiously, we also provide results implying that, unlike other 
sRNA species, ALG-3/4 26G-RNAs are enriched in cell nuclei, in agreement with the 
primary localization of PIR-1. Finally, in Chapter V we find that PIR-1 functions in the 
same pathway as Dicer to suppress the replication of an RNA virus by promoting the 
accumulation of virus-derived siRNAs. 
This work is the first to attribute concrete biological functions to this conserved 




production of Dicer-dependent sRNAs is of high significance in that it adds an unexpected 
step in sRNA biogenesis. However, as with any biological inquiry, our findings multiplied 
the number of our questions. Is the RNA 5' phosphatase activity of PIR-1 required to 
promote the processing of Dicer substrates? Does PIR-1 function in equivalent steps of the 
26G-RNA and the antiviral siRNA pathways? Is the nucleus a site of PIR-1-dependent 
sRNA production in association with Dicer and the ERI complex? Considering that the 
functions we describe are not strictly essential for C. elegans viability, what other 
processes is PIR-1 involved in? Does PIR-1 participate in sRNA biogenesis in vertebrates? 
Throughout this thesis we discuss our results in light of these questions and formulate 

















Characterization and Rescue of a  
Novel pir-1 Loss-of-Function Allele 
 





 In our initial approach to PIR-1, we wanted to expand the phenotypic 
characterizations associated with a pir-1 null mutant that were initiated in Duchaine et al. 
(2006), as well as to ask whether these phenotypes derive exclusively from PIR-1 loss. 
Additionally, we aimed to characterize aspects of pir-1 expression at the RNA and protein 
levels in a wild-type context in order to start formulating working hypotheses about PIR-1 
function.  
In this chapter we describe the phenotypes associated with the novel pir-1(tm3198) 
deletion mutant, specifically obtained for this study. We implicate the lack of PIR-1 as the 
cause of the severe developmental defects manifested in the new mutant by transformation 
with wild-type PIR-1 transgenes. Using fully rescued GFP-tagged PIR-1 transgenic lines 
we characterize the dynamics of PIR-1 expression during development at the tissue and 
cellular levels. Additionally, by taking advantage of the knowledge gathered in studies of 
Baculovirus Phosphatase, we study some key conserved amino acids in PIR-1 to explore 
functional analogies between the two enzymes. This initial characterization of the mutant 
phenotypes and rescued lines provided valuable clues regarding potential PIR-1 functions 
and where its association with Dicer may be necessary. 
 





A New Deletion Allele of pir-1 Exhibits Phenotypes that Are Different from 
Those of the Original  pir-1(tm1496) Deletion Allele  
The original phenotypic characterization of pir-1 described by Duchaine and 
colleagues (2006) was made using the tm1496 deletion allele. This deletion comprises not 
only a section of the pir-1 protein coding sequence, but also the entire upstream 246-base 
pair (bp) intergenic sequence and the first 48 bp of the first exon of the sec-5 gene (Fig. 
2.1A). The potential disruption of sec-5 could be masking the phenotype associated with 
the deletion of pir-1, and precluded us from performing essential transgene rescue 
experiments. We therefore requested a new, pir-1-restricted deletion mutant allele from our 
collaborator Shohei Mitani at Women’s Medical University School of Medicine in Tokyo. 
Since this process took a few months, our initial experiments to address the requirement of 
PIR-1 for sRNAs were performed with the existing pir-1(tm1496) mutant (described in 
Chapter IV). We thought that results obtained with the original allele could prove useful 
for future comparisons with a novel allele. However, this demanded a careful 
characterization of the pir-1(tm1496) mutant regarding the expression of sec-5 and pir-1 
mRNAs.  
sec-5 is the first of a three-gene operon transcribed opposite of pir-1 (CEOP2461). 
The SEC-5 (Yeast SEC Homolog 5) protein has been shown to be required for proper 
endocytosis and normal intestinal development (Fares and Greewald, 2001). By dsRNA 
injection, it is described to be embryonic lethal, with escapers arresting at late larval stages 
(Soennichsen et al., 2005). For confirmation, we synthesized dsRNA of sec-5 and injected 
it into N2 Bristol animals (wild-type reference strain), resulting in progeny that die as 
embryos. We also obtained an available 385 bp deletion allele – tm1443 – which lacks the 
first two exons of sec-5. tm1443 homozygotes exhibit a developmental arrest mostly at a 
larval L4-like stage, identical to that of tm1496 homozygotes. These results suggested that 
the arrest phenotype observed in pir-1 mutant animals could be a consequence of sec-5 
knockout or of any of the genes composing the operon, and not of pir-1, as originally 
proposed. RNAi knockdown of pir-1 by feeding of E. coli expressing pir-1 dsRNA, or 
more potently by direct injection of pir-1 dsRNA, failed to produce any discernible 
phenotypes.  
The new pir-1 deletion mutant – tm3198 – deleted a 407-bp segment confined to 
the pir-1 gene, removing almost all of the first intron and second exon (Fig. 2.1A). All 
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potential splicing variants of the remaining sequence give rise to out-of-frame products 
with premature stop codons. This allele was outcrossed six times against the N2 
background to eliminate other potential background mutations. Since it also gave rise to 
developmentally arrested sterile animals, the mutation was genetically balanced with mnC1 
(the same balancer used for tm1496) containing chromosomal rearrangements which 
suppress crossovers along the right arm of chromosome II, where the pir-1 locus is 
situated. This ensured that the allele could be stably maintained, as pir-1/mnC1 
heterozygotes are fully fertile, and mnC1 homozygotes are sterile. The tm3198 allele 
therefore allowed us to conclude that pir-1 may be essential for C. elegans development. 
Most importantly, while tm1496 animals never grow beyond the L4 stage, the majority of 
tm3198 animals develop into early adults with a larger germline. This phenotypic 
difference proved to be critical to understand pir-1 function, as will become apparent from 
the results we describe. This indicated that, indeed, the tm1496 deletion masked 
phenotypes associated with exclusive loss of PIR-1.  
Since RNAi of pir-1 failed to reveal any phenotypes, we measured the 
downregulation of pir-1 mRNA by quantitative real-time PCR (qRT-PCR). Following 
RNAi by feeding the pir-1 mRNA decreased by only ~50%, showing that silencing was 
specific but not effective (see Materials and Methods). Since injection of dsRNA typically 
leads to increased silencing relative to the feeding method, but still did not yield any 
phenotypes, we concluded that pir-1 mRNA is partially refractory to silencing by RNAi 
and/or that the existing PIR-1 protein pool is very stable. We tried to circumvent this 
problem by feeding pir-1 dsRNA bacteria to wild-type or Eri mutant animals with 
heightened sensitivity to RNAi (eri-1 and rrf-3) for several generations, or by injecting Eri 
mutants with pir-1 dsRNA. None of these strategies produced any obvious effects on 
growth and reproduction. Thus our experiments were confined to the developmental stage 
at which pir-1(tm3198) mutant animals arrested. 
pir-1 mutant homozygotes arise from heterozygous mothers, which could transmit 
maternal pir-1 material – mRNA or protein –  to the progeny. We thus assessed expression 
by qRT-PCR of pir-1 mRNA in both deletion mutants at different time points. In order to 
generate large quantities of arrested animals we placed the balanced mutations in a triple 
mutant genetic background (designated throughout this work as ‘avr3x’) that confers 
resistance to ivermectin, a drug that kills nematodes. Together with a gene expressed in the 
genetic balancer, this combination allowed counter-selection of deletion homozygote 
animals in the presence of the drug (see Materials and Methods for more details). We 
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counter-selected animals for five and seven days at 20˚C to compare depletion levels of 
both pir-1 and sec-5 transcripts. While the tm1496 deletion did abrogate pir-1 and sec-5 
mRNA expression, tm3198 interfered exclusively with pir-1 (Fig. 2.1B). pir-1 mRNA was 
nearly undetectable after five and seven days of counter-selection in tm3198 animals, 
whereas sec-5 mRNA accumulated at these time points in the tm3198 background. From 
this we concluded that both alleles are effectively null for pir-1 expression and that 
potentially maternally loaded pir-1 mRNA is almost completely cleared within at least five 
days in pir-1 homozygotes. 
 
 
Figure 2.1. Both tm1496 and tm3198 deletions constitute null alleles of pir-1. (A) Diagram of 
the pir-1 genomic locus on chromosome II and the regions deleted by the tm1496 and tm3198 
mutations. Boxes represent protein-coding exons and bent lines indicate introns. The gene position 
which encodes the catalytic site with the active cysteine is also highlighted, with protein alignments 
for some orthologs. Amino acid identity among at least two sequences is highlighted in gray, and 
between all sequences is highlighted in black. (B) qRT-PCR of pir-1 and sec-5 mRNAs normalized 
to gpd-2 (Glyceraldehyde 3-Phosphate Dehydrogenase 2) mRNA levels and relative to levels in N2 
wild-type young adults (YA). Mutants were counter-selected on ivermectin for five or seven days 
before RNA extraction.   
 
 
pir-1(tm3198) Mutant Animals Exhibit Somatic and Germline Defects  
When comparing a normally developing and fertile young adult pir-1/mnC1 
heterozygote hermaphrodite to a pir-1 homozygote of the same age and approximate size 
(~3.5 days at 20˚C; Fig. 2.2A) it becomes obvious that the latter are sterile. While 
heterozygotes have a fully developed U-shaped germline (highlighted in yellow) with a 
germ cell syncytium, oocytes and developing embryos, pir-1 homozygotes have a much 
smaller germline, apparently containing only mitotic/meiotic syncytial germline nuclei. 
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After seven days, pir-1(tm3198) animals exhibit a fully penetrant developmental arrest 
within a range of stages that vary between L3-like larvae to sterile young adults (Fig. 2.2B 
and C). Vulvae are frequently protruding and malformed, in some cases leading to bursting 
of the animals at this position (Fig. 2.2B). Signs of oogenesis can be seen in about 21% of 
adult animals, although oocytes exhibit serious malformations and never give rise to 
fertilized eggs (Fig. 2.2B and C). Further confirming that larger animals are adults, they 
possess a wild-type number of seam cells (16 on each side of the animal), as detected by 
expression of a nuclear GFP reporter under the control of a seam cell promoter in the pir-1 
background (see Fig. 4.3, page 168). Seam cells (or lateral hypodermal cells) produce alae, 
antero-posterior lines of thickened cuticle on both sides of the animal after the L4/adult 
molt. These typically adult structures are also normally formed in larger arrested pir-1 
animals (not shown). Most of the animals are very active and continuously feed, exhibiting 
a wild-type life-span of 16-18 days at 20˚C. A small fraction (~15%) of the animals is 
either sick or dead after seven days.  
The vulval phenotype is a strong indicator of abnormal somatic development and is 
also observed in Dicer dcr-1(ok147) deletion mutants, which, like pir-1, have to be 
maintained as genetically balanced heterozygotes (Knight and Bass, 2001; Welker, et al. 
2010). Dicer mutant homozygotes display a range of defects, the severity of which is 
thought to vary according to how much mRNA or protein each oocyte inherits and gets 
passed on to embryos. The majority have enough maternally loaded material to allow 
development into normal-sized adults with defective vulvae that often burst, and with 
gonads exhibiting relatively normal morphology at the distal end but with malformed and 
unfertilized oocytes at the proximal end (Knight and Bass, 2001). Similarly, the range of 
phenotypes in pir-1(tm3198) homozygotes is indicative of a variable maternal deposition 
of mRNA or protein in embryos. Additionally, when we allowed starved mutants to live in 
the dauer stage for a prolonged time period (2-3 weeks), pir-1 heterozygotes quickly 
resumed normal development to become fertile adults upon feeding, while pir-1 
homozygotes exited the dauer stage but never reached adulthood. The dauer stage is an 
alternative stress-resistant larval form that skips the L3 stage upon stresses such as 
overcrowding and prolonged starvation, and can live up to three months (reviewed in Hu, 
2007). We have seen an identical response with recovered dcr-1(ok147) homozygote dauer 
larvae. This observation suggests that the maternally deposited material is depleted during 
the starvation period, not allowing development to proceed as it does when feeding is 
uninterrupted.  
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We made multiple attempts at raising antibodies against C. elegans PIR-1 in rabbits 
by immunization with affinity purified recombinant fragments of PIR-1 (the N-terminal or 
the C-terminal half of the protein) and with short peptides of predicted high antigenicity. 
Unfortunately, we never obtained effective antibodies, even after affinity purification 
against the used antigens. Although this did not allow us to determine whether the onset of 
the pir-1 phenotypes coincided with depletion of maternally derived PIR-1 protein in 
mutants, we characterized the expression of pir-1 mRNA along development in N2 
animals by qRT-PCR (Fig. 2.2D). We found that in contrast to unc-22 (Uncoordinated 22), 
a muscle-specific gene whose expression is highest during larval growth, pir-1 mRNA 
expression is high in adults but even higher in embryos. This expression profile correlates 
with germline development and potentially with maternal deposition of pir-1 mRNA in 
embryos. However, because these embryo preparations also included late embryos, which, 
unlike early embryos, undergo active transcription, we cannot exclude the possibility that a 
large proportion of pir-1 mRNA is made during embryogenesis.  
Analysis of dissected gonads from adult pir-1 mutant arrested animals shows that 
they are much smaller than those of a wild-type animal of the same size (Fig. 2.3A). This 
appears to be a consequence of an under-proliferation of syncytial germ nuclei, as the 
normal distal-to-proximal architecture of the germline is maintained but the density of 
nuclei is much lower than expected for the apparent developmental stage of the pir-1 
mutant. A wild-type late L4 germline typically consists of (1) a mitotic proliferative 
region; (2) a transition zone that marks entry into meiosis (with characteristic “crescent”-
shaped chromatin) and comprises the leptotene and zygotene stages of meiotic prophase I, 
when homologous chromosomes pair, undergo synapsis, and start recombining; (3) a large 
region of nuclei in the pachytene stage of meiosis, when chromosomes complete synapsis 
and recombination events are finished; and (4) a spermatogenesis zone that includes nuclei 
undergoing diplotene, during which the synaptonemal complexes are broken down to 
reveal chiasmata, followed by diakinesis, when chromosomes condense in preparation for 
division (Lui and Colaiacovo, 2013). Considering their dimension and number of nuclei, 
pir-1 germlines roughly resemble the proliferative state of L3 larvae. However, unlike L3 
larvae, arrested pir-1 gonads exhibit signs of spermatogenesis, including the presence of 
mature spermatids which are visible as very small round DAPI stained foci at the proximal 
tip of the germline (Fig. 2.3A). In C. elegans hermaphrodites, meiotic nuclei first give rise 
to sperm during the L4 stage, and only during adulthood does meiosis shift to producing 
oocytes. Spermatids are stored in a spermatheca in each of the two gonad arms, through 
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which oocytes pass to be fertilized. In the small fraction (~21%) of adult pir-1(tm3198) 
animals that showed signs of oogenesis, it was clear that these cells were very defective 
(reminiscent of dcr-1(0k247)) and rarely reached more than one oocyte per gonadal arm 
(identified by the presence of a large oocytic nucleus undergoing diakinesis, in preparation 
for meiotic division). Even though pir-1(tm1496) arrested animals were the size of L4 
larvae, their germlines were more precocious, never reaching spermatogenesis (not 
shown).  
In addition to a severely under-proliferated mitotic zone, another feature suggests 
that the germline may arrest due to a defect in mitotic proliferation. In undifferentiated 
germ cells, all nuclei are surrounded by foci termed P granules. These foci aggregate 
mRNAs and a variety of proteins with RNA processing and regulatory roles, including 
components of the RNAi machinery, and play important roles in coordinating post-
transcriptional germline gene expression and maintaining overall germ cell identity and 
integrity (reviewed in Updike and Strome, 2010). We crossed an integrated pgl-1::rfp 
transgene into the pir-1 background in order to use PGL-1 (P-Granule Abnormality 1; a 
major component of P granules) as a marker of normal, undifferentiated germ cells. P 
granules appear to have a normal morphology and distribution in arrested pir-1 germlines 
when compared to a wild-type background (Fig. 2.3B). This is good evidence that those 
cells retain their germline identity, and that the arrest does not result from premature 
differentiation into other cell types.  
During spermatogenesis, pachytene nuclei condense and cellularize before 
undergoing the two sequential meiotic divisions that will give rise to haploid spermatids 
(Ellis and Stanfield, 2014). These spermatid precursors are termed spermatocytes (Fig. 
2.3A). While the diplotene condensation phase seems normal, arrested pir-1 germlines 
exhibit DNA bridging between dividing primary spermatocytes, implying that meiotic 
chromosome segregation is impaired (Fig. 2.3C). This defect is also observed in Eri 
mutants during sperm development, namely rrf-3, eri-1, eri-3, eri-5 and the dcr-1(mg375) 
allele which possesses an inactivating point mutation in the helicase domain (Gent et al., 
2009; Pavelec et al. 2009). These mutants are completely sterile when spermatogenesis 
occurs at the upper-limit temperature of 25˚C. Spermatids from Eri mutant hermaphrodite 
and male animals at 25˚C exhibit morphological defects and are unable to be activated into 
a motile stage required for proper fertilization, and, in the case of male sperm, for 
migration into the hermaphrodite spermatheca after mating. As a result, only unfertilized 
oocytes are laid. At lower temperatures (15˚C-20˚C) brood sizes are 30-50% lower than in 
Chapter II Results 
76 
 
wild type (Pavelec et al., 2009). We also observed identical morphological abnormalities 
in a fraction of pir-1 mutant spermatids (not shown). Additionally, at 25˚C their germlines 
never reach spermatogenesis, perhaps as a consequence of maternally deposited material 
being consumed more quickly due to accelerated development. Conversely, at 15˚C they 
undergo spermatogenesis and DNA bridging between dividing spermatocytes is 
widespread. We attempted to mate pir-1 homozygote males raised at 15˚C and 20˚C with 
wild-type hermaphrodites but never obtained cross progeny. pir-1 males are smaller (by 
~25%) than wild type and often exhibit an immature tail structure, which may not allow 




Figure 2.2. pir-1(tm3198) homozygote animals are unable to reach sexual maturity and 
exhibit developmental defects. (A) A gravid, balanced pir-1 mutant heterozygote (above) next to 
a sterile pir-1 mutant homozygote grown simultaneously for 96 hours at 20˚C. The two germline 
arms of each animal are highlighted in yellow and are partly concealed by intestinal tissue. The 
germline grows in a distal to proximal axis. In mature hermaphrodites, fertilized eggs accumulate 
proximally in the uterus and are expelled through the vulva. (B) Phenotypes associated with 
arrested mutants after seven days of growth. White arrowheads indicate the vulva and malformed 
oocytes. (C) Scoring of phenotypes in a population of arrested pir-1 homozygotes grown 
simultaneously for seven days. (D) qRT-PCR of pir-1 mRNA and unc-22 mRNA across 
development in wild-type N2 synchronous populations. Levels of each mRNA were normalized to 
18S rRNA and fold changes are relative to a mixed-stage population.  





Figure 2.3. The germline of pir-1(tm3198) arrested adults exhibits defects in proliferation and 
spermatogenesis. (A) Comparison of fixed DAPI stained germlines of late L3 and late L4 wild-
type N2 animals with a terminally arrested pir-1 mutant (all grown at 20˚C). After mitotic 
proliferation, the transition zone marks entry into meiotic prophase, in which the chromatin is 
polarized in the nucleus, adopting a crescent-shaped appearance. Subsequently, nuclei enter 
pachytene during which chromosomes are redispersed around the nuclear periphery and are said to 
have a “bowl of spaghetti” appearance. During the L4 stage spermatogenic diakinesis, nuclei 
condense along with chromatin, leading to highly compacted cells termed spermatocytes which 
will undergo two consecutive divisions to produce mature spermatids. (B) P-granule distribution 
and morphology in live wild-type L4 and arrested pir-1 animals. In both cases P granules can be 
seen surrounding undifferentiated mitotic and meiotic germ nuclei, marked by fluorescent PGL-
1::RFP, which disappears as nuclei commit to spermatogenesis. (C) Spermatogenesis in L4s and in 
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an arrested pir-1 mutant. The smaller DAPI stained dots are the nuclei of mature spermatids. 
Examples of healthy dividing spermatocytes are circled in red. In both the Eri mutant rrf-3 at 25˚C 
or in pir-1 at 20˚C spermatocytes fail to divide properly, forming chromosome bridges (red 
arrowheads). Spermatogenic divisions are fully rescued with a single-copy pir-1::gfp transgene 
(bottom image). ‘D’ is distal; ‘P’ is proximal. 
 
 
Defects in pir-1(tm3198) Mutant Animals Are Rescued by Tagged Wild-Type 
pir-1 Transgenes  
In order to rescue the aforementioned pir-1 mutant phenotypes, we produced 
transgenic lines using four different constructs carrying N-terminal GFP or 3xFlag tags, 
and C-terminal GFP or 3xFlag tags fused to the pir-1 gene. To ensure inclusion of essential 
regulatory sequences, the tagged genes were flanked on each side by 1,000 bp of native 
sequence. Multiple transgenic strains were first generated by biolistic bombardment, that 
gives rise to low-copy number, integrated transgenes with high frequency (Praitis et al., 
2001). Despite being more costly and labor intensive, we favored it over transformation by 
direct germline microinjection of plasmids. The latter method generates high-copy 
extrachromosomal arrays that tend to be silenced in the germline by RNAi mechanisms 
triggered by the highly repetitive nature of these recombined DNA assemblies (transgene 
silencing; Kelly et al., 1997). Furthermore, integration of extrachromosomal arrays into the 
genome requires an extra step involving irradiation with highly mutagenic doses of UV- or 
X-rays.  
The growth, fertility, and spermatogenesis defects of pir-1 mutant animals were 
rescued upon introduction of C-terminally tagged pir-1 transgenes into the tm3198 deletion 
background by genetic crossing (all of six C-GFP and all of three C-3xFlag integrated lines 
that were crossed led to rescue; figures 2.4-2.7 all show rescued pir-1 animals). Brood 
sizes were counted for a few independent lines, averaging 200-300 viable progeny per 
animal at 20˚C, in line with wild-type brood sizes. PIR-1::GFP integrated lines 
demonstrated that PIR-1 is expressed in most somatic and germline cells but that there was 
variation in the intensity of GFP expressed in germline versus soma between different 
lines. For further studies we chose a line that expressed GFP robustly in both somatic and 
germline cells (Fig. 2.4A), as well as a 3xFlag-tagged line. We used these lines for cell-
biological and biochemical characterization of PIR-1. Interestingly, N-terminally tagged 
transgenes did not rescue any of the phenotypes (seven N-3xFlag and one N-GFP were 
crossed into pir-1), nor did we ever observe GFP signal from a total of 29 integrated lines. 
We later found that this occurred due to a misprediction of the pir-1 start codon at the 
Chapter II Results 
79 
 
onset of this project. At that time the C. elegans pir-1 sequence was predicted to encode an 
extra 28 N-terminal amino acids, giving rise to a 261 aa protein. We later realized, through 
our own experiments (explained in Chapter III) as well as more recent curations of the pir-
1 gene based on high-throughput sequencing experiments, that PIR-1 is in fact 233 aa long, 
and consequently the tags should have been fused with the ATG at position 29 of the 
original gene model. Therefore, our N-terminal tagging likely disrupted the pir-1 promoter. 
During the course of this work, a new microinjection-based method for single copy 
insertion of transgenes was developed, termed MosSCI (Mos1-mediated Single Copy 
Insertion; Frokjaer-Jensen et al., 2008). Briefly, this method is based on the excision of the 
Mos1 transposon from Drosophila melanogaster inserted at known locations of the C. 
elegans genome by heterologous expression of the corresponding transposase. The 
excision, which takes place in the germline, happens in the presence of a plasmid carrying 
the sequence of interest flanked by sequences homologous to both sides of the site where 
Mos1 is inserted. The dsDNA break generated by excision of the transposon triggers repair 
of the DNA by homologous recombination with the genomic sequences in the plasmid, 
resulting in the integration of a single copy of the sequence of interest. We decided to use 
this technique in order to express PIR-1::GFP at a level closer to that of the native gene. 
Precise recapitulation of native expression is not guaranteed, however, as the genomic 
context of the insertion site is different than that of the original gene. With a single copy of 
pir-1::gfp on chromosome IV we were also able to rescue all phenotypes associated with 
pir-1. Although PIR-1::GFP intensity in the germline was similar to that of the 
bombardment line, somatic cells (and especially intestinal cells) expressed GFP more 
dimly (Fig. 2.4A vs Fig. 2.5A-C).  
 
PIR-1 Is Expressed in the Nucleus and Cytoplasm of Most Somatic and Germ 
Cells throughout Development 
In GFP-tagged lines PIR-1 is visibly concentrated in the nuclei of both somatic and 
germline cells (Fig. 2.4.A and B). In non-integrated lines obtained by bombardment that 
overexpress PIR-1::GFP in mosaic patterns, PIR-1 is also evidently present in the 
cytoplasm, most visibly in neurons (Fig. 2.4C). The expression pattern throughout 
development is identical in the bombardment and single-copy MosSCI strains. Consistent 
with expression from multiple copies of the transgene, the GFP signal is generally stronger 
in the bombardment rescued strain, particularly in somatic nuclei. Somatic nuclei are 
brighter in early larvae, and gradually decrease intensity as they approach adulthood. 
Chapter II Results 
80 
 
Interestingly, this is most noticeable in the nuclei of the intestine, which undergo a round 
of endoreduplication at each larval stage, progressing from a 2C (diploid) DNA 
complement at hatching to 32C in adulthood. Staining of PIR-1::GFP in fixed intestines 
shows that PIR-1 also co-localizes with chromatin, at the nuclear periphery (Fig. 2.4B). 
The fact that nuclear PIR-1::GFP is so abundant during intestinal development could 
suggest a role for it in promoting successful DNA replication. This does not explain, 
however, why somatic nuclei expression is retained in other cell types.  
In the germline the difference in GFP intensity between multi-copy and single-copy 
strains is not very perceptible, perhaps as a consequence of tighter expression regulatory 
mechanisms in this tissue. It is in the germline, however, that PIR-1 expression dynamics 
is most interesting. During hermaphroditic germline development, PIR-1::GFP expression 
starts becoming visible in all germline nuclei during the L2/L3 stages, during which the 
germline expands through mitotic proliferation of its nuclei (Fig. 2.5A). In L4, as the 
germline further differentiates, so does the distribution of PIR-1::GFP along the distal to 
proximal axis. Distally, from the mitotic to roughly the mid-pachytene region, PIR-1 
intensity is relatively high and uniform. After this it gradually fades out until a sudden 
increase occurs a little before nuclei begin to condense to become spermatocytes (Fig. 
2.4A, 2.5C and 2.7). In adults, after spermatogenesis is complete, meiotic nuclei start 
giving rise to oocytes. Pachytene is followed by diplotene, during which nuclei start 
enlarging and becoming cellularized. As both cytoplasm and nuclei expand, diakinesis 
progresses to give rise to mature oocytes. Unlike spermatocytes, in which nuclear volume 
is reduced, the highly condensed chromosomes that result from diakinesis can be seen 
individually in the oocyte nuclei (Fig. 2.6A), and separate only after fertilization. 
Throughout this process nuclei are dark and contrast with a faint signal in the surrounding 
cytoplasm in both live and fixed/stained germlines, suggesting that oogenesis does not 
require nuclear PIR-1 (Fig. 2.5D and 2.6A). The cytoplasmic signal is too faint to make a 
conclusion about whether it represents diffuse cytoplasmic PIR-1::GFP or simply 
cytoplasmic autofluorescence.  
In embryos PIR-1::GFP remains absent from nuclei until the eight-cell stage, after 
which it gradually increases its intensity in the multiplying nuclei (Fig. 2.4B and 2.5D). 
Once again, as we observed in the germline, PIR-1 expression overlaps with a highly 
proliferative stage of development, suggesting that it may have an important role in 
embryogenesis. Interestingly, in later embryos (past the 100-cell stage) the only cells that 
do not express PIR-1 in the nucleus are the two germline precursor cells, Z2 and Z3, 
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identified by the presence of PGL-1-containing P granules around their nuclei. These 
primodial germ cells remain PIR-1 negative well into the L1 larval stage, during which 
they begin to proliferate (Fig. 2.6B).  
 
 
Figure 2.4. PIR-1::GFP expression in bombardment lines. (A) Live rescued pir-1(tm3198) with 
integrated pir-1::gfp. GFP expression can be seen in somatic and germline tissue, concentrating in 
nuclei. Intestinal cell nuclei are particularly bright in this strain. Other somatic nuclei, namely those 
of neurons in the head and tail regions accumulate PIR-1. Germline nuclei are visible in a mid-L4 
larva and are brighter in the proximal region, where spermatogenesis occurs. The smaller bright 
spots in intestinal cells are autofluorescent intestinal granules that do not represent GFP signal. 
This strain was used for several experiments described in Chapter III. (B) Fixed embryos and adult 
intestine of the same strain followed by immunofluorescence against GFP and DAPI staining 
showing that PIR-1::GFP is also expressed in embryos and co-localizes with chromatin of intact 
nuclei, but not during cell divisions (note metaphase plates and anaphase in leftmost embryo). (C) 
Two live examples of non-integrated bombardment lines that overexpress PIR-1 in only a few 
cells. In this case, mostly neurons are visible in the mid and tail regions, showing that in addition to 
the nucleus, PIR-1 is also diffusely distributed throughout the cytoplasm. 
 




Figure 2.5. Expression pattern of PIR-1::GFP across development in live pir-1 animals 
rescued with a single-copy transgene. (A) In early larvae the most conspicuous nuclei are those 
of intestinal cells. PIR-1::GFP intensity in these nuclei decreases along development but it can 
always be detected. (B) In an L3 animal whose germline is proliferating mitotically and just 
initiating meiosis at the proximal end, PIR-1 uniformly accumulates in all germ cell nuclei. (C) L4 
animals continue to express PIR-1 in distal mitotic nuclei. In the proximal germline, where sperm 
development is taking place, PIR-1 accumulates more strongly in nuclei and cytoplasm. (D) In 
gravid hermaphrodites, PIR-1 is still in distal germ cell nuclei but gradually disappears as nuclei 
enter diplotene, and then diakinesis during oocyte formation. (E) During embryonic development 
PIR-1 gradually accumulates in nuclei and cytoplasm. In the first two divisions PIR-1 is excluded 
from the nucleus, but by the eight-cell stage it appears in nuclei and continues to build up in 
subsequent divisions. 





Figure 2.6. PIR-1 does not accumulate in the nuclei of oocytes and primordial germ cells. (A) 
Fixed germlines of rescued pir-1; pir-1::gfp young adult hermaphrodites were stained with anti-
GFP antibody to further confirm that oocyte nuclei do not accumulate PIR-1. The lower panel 
shows fixed oocytes double stained with anti-GFP and an anti-histone H4 antibody. DAPI staining 
reveals highly condensed chromosomes in diakinesis. (B) A live post-100-cell stage embryo shows 
that the only nuclei not expressing PIR-1 are the two primordial germ cells Z2 and Z3, identified by 
perinuclear PGL-1::RFP protein, expressed from an integrated transgene. In L1 larvae, in which 
germline proliferation begins, PIR-1 is still absent from germ nuclei, but gradually builds up as 




Male and Hermaphrodite Germlines Exhibit Distinct PIR-1 Expression 
Patterns 
Both male and hermaphrodite germlines robustly express PIR-1::GFP but exhibit 
curiously distinct expression patterns along the distal-proximal axis (Fig. 2.7A). In 
hermaphrodites, nuclear PIR-1::GFP is brightest at the distal mitotic region and transition 
zone, gradually fading away as nuclei go through pachytene. In L4/early adulthood, when 
all sperm cells are produced, nuclear and cytoplasmic GFP signal is abruptly turned on in 
the area where meiotic nuclei commit to spermatogenesis. Later in adulthood, as meiotic 
nuclei start being allocated for oocyte production, PIR-1::GFP is excluded from nuclei. 
This contrasts with male germlines – exclusively committed to sperm production – where 
nuclear PIR-1::GFP is weakly expressed in mitotic nuclei, but gradually accumulates 
without interruption as spermatogenesis progresses. PIR-1 clearly localizes to the nuclei 
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and chromatin of germ cells undergoing pachytene and diplotene and gradually weakens in 
spermatocytes (Fig. 2.7A and B). Unlike the germ cells that precede them, whose nuclei 
are only partially enveloped by a cell membrane and thus share a common cytoplasm, 
spermatocytes are fully cellularized. In spermatocytes, where chromatin starts a dramatic 
condensation process in preparation for the meiotic divisions that follow, PIR-1 no longer 
localizes to nuclei, but is still seen in the cytoplasm (Fig. 2.7B). Mature spermatids, on the 
other hand, seem completely devoid of PIR-1 (Fig. 2.7A and B). This implies that PIR-1 
activity is most important in earlier stages of differentiation. Consistent with the 
spermatocyte division defects observed in pir-1 mutants, these patterns of expression 
provide further evidence that PIR-1 may play an active role in sperm development.  
Another noteworthy difference concerns the distal tip cells, or DTCs. In both males 
and hermaphrodites, these somatically derived cells are located at the apex of the gonadal 
arms, and actively signal nearby germ nuclei to proliferate mitotically (Germline Stem 
Cells or GSCs) through GLP-1/Notch (Abnormal Germline Proliferation 1, a Notch family 
receptor) signaling (reviewed in Kimble and Crittenden, 2007). There are, however, 
important distinguishing features between hermaphrodite and male DTCs (hDTCs and 
mDTCs; Morgan et al., 2010). Hermaphrodites possess one DTC per gonadal arm and 
share their capacity to induce mitotic proliferation with distal gonadal sheath cells, which 
envelope the hermaphrodite germline. Sheath cells support much of the GSC proliferation 
during larval development (Korta and Hubbard, 2010). By contrast, males do not possess 
gonadal sheath cells, so that mitotic proliferative signals are presumed to originate 
exclusively from the two DTCs present in their single gonadal arm. Additionally, hDTCs 
have a morphological function in guiding proper migration of the germline arms within the 
growing animal as proliferation occurs, so that it acquires the characteristic U shape, while 
in males a different cell assumes this role (Chesney et al., 2009). We observed that both 
mDTCs express nuclear PIR-1::GFP very brightly, while the single hDTCs do not visibly 
express it. This difference may constitute an important clue linking PIR-1 to cell 
proliferation and to differences in how the process is orchestrated in the male and 
hermaphrodite germlines. In males PIR-1 may stimulate proliferation through the two 
distal tip cells, while in hermaphrodites this stimulatory effect may occur downstream, by 
intrinsic expression of PIR-1 in GSCs.  
 
 





Figure 2.7.  The distribution of PIR-1::GFP in hermaphrodite and male germlines is not 
equivalent. Germlines from bombardment rescued pir-1; pir-1::gfp L4 hermaphrodites and adult 
males were dissected, fixed and stained with anti-GFP. (A) At this stage of hermaphrodite 
development, spermatogenesis is still taking place and a burst of PIR-1 expression can be seen in 
the nuclei that have committed to sperm production. In males, all meiotic nuclei develop into 
sperm, which also coincides with increased PIR-1 accumulation. Expression decreases in the 
spermatocytes and spermatids. (B) Another example of an adult male germline showing a more 
detailed localization of PIR-1::GFP. The protein can be detected on chromatin during the pachytene 
and diplotene stages, but is no longer present in the nuclei of spermatocytes and spermatids. 
 
 
Targeted Mutagenesis of PIR-1 Shows that Its Phosphatase Activity Is 
Required for Rescue of All Mutant Phenotypes 
In order to investigate functional parallels between C. elegans PIR-1 and its 
orthologs, we used the rescuing pir-1::gfp transgene to alter conserved residues by site-
directed mutagenesis. We first replaced the critical active-site cysteine residue with a 
serine (C150S mutant; Fig. 2.8), which in baculovirus BVP and human PIR1 leads to a 
complete loss of RNA phosphatase activity (Takagi et al., 1998; Deshpande et al., 1999). 
The single-copy insertion line we obtained with the pir-1(C150S)::gfp transgene did not 
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rescue any of the mutant phenotypes, despite observing no change in GFP localization and 
still being able to detect full-length PIR-1::GFP by western analysis (shown in Fig. 3.6E 
and F, page 130). From this we concluded that the phosphatase activity of PIR-1 is 
required for its roles in promoting growth and fertility.  
 Besides the catalytic mutant, we also wanted to use some of the information 
gathered in previous structure/function studies of BVP to establish functional resemblances 
between the two proteins. Additionally we intended to generate a pir-1 transgene with 
weaker rescuing activity (i.e., a hypomorph) that would allow the extension of germline 
development and ideally give rise to embryos with compromised PIR-1 activity. This was 
an important goal considering our inability to use RNAi. We based our choice of residues 
to substitute on two studies from the laboratory of Stewart Shuman at the Sloan-Kettering 
Institute, in which the importance of conserved residues for enzymatic activity was 
determined in vitro and in vivo with mutated versions of BVP (Martins and Shuman, 
2002a; Martins and Shuman, 2002b). In these studies, in vitro activity was assessed in two 
ways: (1) ATPase activity measured by the release of inorganic phosphate from an ATP 
substrate compared to wild-type BVP, and (2) the amount of covalent intermediate 
phosphoenzyme 
32
P-BVP formed by the reaction between [γ-
32
P]ATP and BVP under 
conditions that stabilized this labile form. As an in vivo readout the authors used a 
heterologous Saccharomyces cerevisiae system in which the lethality associated with 
deletions in the yeast mRNA capping triphosphatase (cet) and guanylyltransferase (ceg) 
genes was rescued with a chimaera formed by BVP and the guanylyltransferase domain of 
the bifunctional mammalian capping enzyme (i.e., BVP functionally replaced the 
triphosphatase activity of the capping enzyme).  
The rationale for picking candidate mutations that could lead to partial PIR-1 
activity was based on the ability of BVP to still rescue yeast capping in vivo while 
exhibiting some degree of compromised ATPase activity, phosphoenzyme formation, or 
both (Table 2.1). Also considered was temperature sensitivity (ts) defined by absence of 
yeast growth at 37˚C as opposed to normal (++) or slow (+) growth at 30˚C. We prepared 
mutant MosSCI constructs, but found that rescue of pir-1 phenotypes did not require 
integration of the transgenes, as non-integrated lines of the wild-type pir-1::3xflag or pir-
1::gfp constructs always led to rescue. Since multi-copy transgenic arrays tend to be 
silenced in the germline very easily, we were surprised to observe that pir-1 was resistant 
to this phenomenon and speculate that it is related to its resistance to silencing by exo-
RNAi. 
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 With the exception of the R5A equivalent mutation, all equivalent BVP mutations 
that led to in vivo rescue in yeast also resulted in C. elegans rescue. R5A was the only 
studied case where phosphoenzyme formation was impaired without loss of ATPase 
activity. The fact that it did not rescue in C. elegans is interesting because the equivalent 
residue is necessary for triphosphatase activity of the mammalian capping enzymes 
(Changela et al., 2005). This implies that in PIR-1 this conserved residue may have a 
different function, perhaps related to its unique diphosphatase activity. This activity is not 
taken into account in the yeast capping rescue assay, as capping strictly requires removal 
of the γ-phosphate only, but the essential activity of PIR-1 may require removal of both γ- 
and β-phosphates from its RNA substrates. We also tested another critical arginine residue 
outside the P-loop (R153) that, as in BVP, did not lead to rescue in C. elegans despite 
being expressed, and was therefore demonstrated to be functionally conserved.  
The fact that the remaining mutants rescued PIR-1 activity robustly (both somatic 
growth and laying of viable embryos occurred, even at 25˚C), could mean that the 
approaches used to measure BVP activity should not be extrapolated to in vivo activity in 
C. elegans. Perhaps in vivo, even a weak PIR-1 activity is sufficient to restore function. 
Since this collection of mutants was not comprehensive, it is still possible that a more 
systematic approach could yield a version of PIR-1 with the desired partial rescue activity. 
Moreover, of the lines tested, only three were integrated as single copy insertions (C150S, 
T151S, and K118R). It is thus conceivable that in non-integrated lines, weakened PIR-1 
activity is compensated by overexpression from multi-copy extrachromosomal arrays. This 
line of investigation could therefore still provide useful strains for further study.  
Lastly, when we searched for additional motifs in C. elegans PIR-1 using the 
ScanProsite tool (De Castro et al., 2006, available at ExPASy.org) we found that it 
contains a low-confidence bipartite nuclear localization signal (NLS) sequence near its C-
terminus, comprising residues 194-208 (highlighted in Fig. 2.8). In human PIR1 a low-
confidence bipartite NLS is also predicted near the N-terminus (residues 13-27). However 
such a sequence cannot be found in the orthologs of mouse, fly and the nematode C. 
briggsae. Since this could explain its nuclear localization we created a few mutants and 
assayed their ability to rescue and to express nuclear PIR-1::GFP. Typically, interfering 
with basic residues such as lysines and arginines results in disruption of the signal (Lange 
et al., 2007). When we replaced the first two lysines with alanines (K194A; K195A), the 
mutant construct was unable to rescue. Conversely, a conservative substitution with 
arginines was able to restore rescuing activity. However, because we could never see GFP 
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signal or recover PIR-1::GFP by immunoprecipitation from the non-rescuing mutant, we 
concluded that significantly altering these two residues made the protein unstable and 
could not infer the ability of the sequence to act as an NLS. Predictably, deleting the entire 
sequence (Δ194-208) also did not lead to rescue or GFP expression. In contrast, when we 
changed the two lysines of the second portion to alanines (K204A; K205A) or when we 
deleted the entire second part of the motif (Δ204-208) these sequences were able to fully 
rescue pir-1 mutants and accumulate in the nucleus. We therefore conclude that this 





Figure 2.8. Alignment of BVP and PIR-1 with residues used for mutagenesis. Conserved 
residues are highlighted in black in the order that they appear in Table 2.1. Residues highlighted in 













Chapter II Results 
89 
 
Table 2.1. Rescue Assay of pir-1(tm3198) Defects by Different Point Mutants of      




Activity     




P-BVP           











rescue at 20 
and 25˚C? 
roles based on  




R5A 95 8 ++(ts) R28A No 
lines the rim of the 
active site pocket 
perhaps interacting 
with substrate 
K25R 11 10 ++(ts) K76R Yes 
may stabilize structure 
around entrance to 
active site pocket 
K82A 7 83 +(ts) K118A Yes 
important for structure 
of loop that moves 
upon substrate binding 
K82R 17 100 ++(ts) K118R Yes " 
C119S <0.1 n.d. - C150S No 
in the P-loop; forms 
covalent phospho-
cysteinyl intermediate 
T120S 26 n.d. ++(ts) T151S Yes in the P-loop 
T126A 8 n.d. ++ T157A Yes in the P-loop 
R153A <0.1 2 - R184A No 
stabilizes P-loop in an 
active conformation 
R159K 28 22 ++ R190K 
no lines 
obtained 
lines the rim of the 




From Martins and Shuman, 2000. 
b 
From Martins and Shuman, 2002b. 
c 
From Martins and Shuman, 2002a 
and Martins and Shuman, 2002b. 
d 
From Martins and Shuman, 2002a, Martins and Shuman, 2002b and 




All experiments in this chapter were performed by Daniel Chaves. 





The results described in this chapter establish that the highly conserved RNA 
phosphatase PIR-1 is essential for C. elegans development. From the phenotypes of the 
novel loss-of-function allele pir-1(tm3198), it is evident that PIR-1 is required for both 
somatic and germline growth. Consistent with this, the nearly ubiquitous expression 
pattern revealed by rescuing pir-1::gfp transgenes shows that PIR-1 is present throughout 
development. The germline temporal and spatial expression, in particular, is highly 
suggestive of PIR-1 being involved in the control of cell proliferation and sperm 
differentiation. Importantly, the ability of PIR-1 to rescue the severe mutant phenotypes 
requires a functional phosphatase active site. In this discussion we place this initial 
characterization of C. elegans PIR-1 in the context of previous studies and comment on 
additional observations. 
 
Maternal Load of pir-1 mRNA and pir-1 RNAi 
A recent study in which the mRNA profiles of oocytes, one-cell and two-cell 
embryos are compared, shows that pir-1 mRNA is very abundant in these three cell types 
(Stoeckius et al., 2014) but that its levels continually decrease during development until 
the L3 stage. During and after L4, coinciding with germline development, they increase 
gradually (Marlon Stoeckius, personal communication). This pattern is consistent with our 
developmental qRT-PCR measurements of pir-1 mRNA. Additionally, the fact that both 
oocytes and one to four cell embryos seem to express very little or no PIR-1 protein (Fig. 
2.5, page 82) leads us to conclude that the maternal contribution occurs predominately at 
the mRNA level. The inherited pir-1 mRNA in pir-1(tm3198) homozygote embryos is 
presumably translated during development. In the absence of zygotic pir-1 transcription, 
the gradual dilution and degradation of maternal transcripts and resulting PIR-1 protein 
eventually lead to the developmental arrest we observe. The fact that pir-1(tm3198) 
homozygotes arrest at a variety of stages ranging from L3-like larvae to small young adult 
sterile animals likely reflects slight differences in the rate at which maternal PIR-1 is 
depleted from one animal to the other. 
Despite having shown that pir-1 mRNA can be specifically knocked down by 
RNAi through feeding (see Materials and Methods), the fact that we could not obtain 
phenotypes by RNAi even by injection, did not allow us to determine whether PIR-1 is 
required for development at earlier stages. In agreement with our experiments, three large 
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scale RNAi screens where pir-1 RNAi was included found no associated phenotypes 
(Kamath et al., 2003 and Rual et al., 2004 both by feeding, and Soennichsen et al., 2005 by 
injection). One exception was the study of Piano et al., 2002, where injection of dsRNA 
against the genomic pir-1 sequence led to 30-80% embryonic lethality and less than 10% 
of the progeny gave rise to adults that burst at the vulva. We have difficulty reconciling 
this result with our thorough attempts at silencing pir-1 (including the same targeted 
sequence), but, if true, it is evidence that PIR-1 is also essential for embryonic 
development. This would agree well with PIR-1 protein expression onset in early 
embryonic development, with a gradual accumulation throughout embryogenesis.  
 
PIR-1 Is Required for Cell Proliferation 
 Our analysis of germlines from arrested pir-1 mutant animals revealed that they are 
much smaller than what would be expected for the overall size of the animal. Germline 
growth seems to lag behind somatic growth, indicating that the highly proliferative 
germline tissue is very sensitive to PIR-1 loss. In arrested pir-1 adults, the chromatin of 
germline nuclei undergoes normal changes during progression along the distal-proximal 
axis, qualitatively identical to those of an L4 germline. The distinction is the dramatically 
reduced number of nuclei present in each region of the germline. Additionally, we 
examined the distribution of P granules (marked by PGL-1) which associate with the outer 
nuclear membrane of every germline cell which has not yet committed to spermatogenesis 
or oogenesis. P granules had a wild-type appearance in all pre-spermatogenesis nuclei of 
pir-1 germlines, suggesting that the arrest was not due to loss of germline cell identity. 
These results pointed to a defect in overall proliferation of the germline, and not to a block 
induced by aberrant early differentiation of germline cells. In addition to this germline 
defect, the larval arrested animals and the defective protruding vulvae of adults are highly 
reminiscent of defects observed in numerous mutants for proteins required for cell 
division, such as the cyclin E homolog of C. elegans, CYE-1 (Fay and Han, 2000; 
Brodigan et al., 2003). 
To complement our observations of pir-1 mutants, we characterized the pattern of 
expression of rescuing PIR-1::GFP along development. We concluded that PIR-1 reaches 
its highest expression levels at stages of intense cell division, including not only the distal 
region of the hermaphrodite germline but also embryogenesis. Although our inability to 
silence pir-1 by RNAi did not allow us to investigate whether it is essential for 
embryogenesis, its abundant and increasing expression during this stage suggests that it 
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may be. Moreover, since a large proportion of animals do not grow beyond L3-L4-like 
stages, it may also be required to promote post-embryonic cell divisions. Again, this 
correlates well with a high accumulation of PIR-1::GFP in somatic cells of early larval 
stages. In male germlines, rather than being strongly expressed in mitotic germ cell nuclei, 
PIR-1 is very highly expressed in the two distal tip cells (DTCs) of the male germline. This 
suggests that PIR-1 may stimulate male stem cell division via its DTCs. Considering how 
little is known about male DTCs, this is a difficult problem to address. Ideally, PIR-1 could 
be expressed from a male DTC-specific promoter, in both its wild-type and catalytically 
inactive versions, to investigate changes in germline proliferation of pir-1 males and 
establish a direct cell-division stimulatory role. Additionally, the question of whether PIR-
1 is expressed in the DTCs of hermaphrodites needs to be addressed with co-expression of 
DTC markers. Further exploration of this surprising difference could contribute to our 
sparse knowledge of how sexual dimorphism is achieved in the C. elegans germline. 
In further support of a PIR-1 role in promoting cell proliferation we have made 
some observations regarding genetic interactions with key players in germline stem cell 
control (reviewed in Kimble and Crittenden, 2007). We have crossed the pir-1(tm3198) 
mutation into glp-1 and gld-1 mutant backgrounds that interfere with germline 
development. GLP-1 is a Notch-family receptor that along with its ligand, LAG-2 (LIN-12 
and GLP-1 Phenotype 2), promote germline mitoses. In hermaphrodites, LAG-2 is 
expressed in the DTC, confining mitosis to the proximal germline. Losing GLP-1 activity 
leads cells to enter meiosis prematurely, while constitutive activity generates a germline 
tumor in which cells are unable to leave the mitotic cycle (Austin and Kimble, 1987; 
Crittenden et al., 1994; Berry et al., 1997; Pepper et al., 2003). GLD-1 is an RNA binding 
protein that represses translation of GLP-1 and other mRNAs required for mitosis by 
binding to specific sites on their 5' or 3' UTRs. Its expression starts shortly before the 
transition zone, leading cells to enter meiosis by limiting, among others, GLP-1 translation 
(reviewed in Lee and Schedl, 2010). GLD-1 loss-of-function alleles lead to germline 
tumors by inducing meiosis-committed cells in pachytene to re-enter a mitotic cycle and 
proliferating uncontrollably (Francis et al., 1995; Jones et al., 1996). When combined with 
the glp-1(ar202) temperature-dependent gain-of-function allele (Pepper et al., 2003), pir-1 
homozygotes grown at 15˚C, like glp-1(ar202) on its own, do not develop a germline 
tumor. However, when grown at 25˚C, at which GLP-1 becomes constitutively active, pir-
1 mutants form a large germline tumor, likely at the expense of meiosis and while maternal 
PIR-1 is still available. Conversely, the gld-1(q485) loss-of-function allele (Francis et al., 
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1995), which leads to a germline tumor on its own, is not able to form one when combined 
with pir-1 (i.e., double mutants look like pir-1 homozygotes). This genetic interaction 
suggests that PIR-1 may be a factor involved in regulation of mitotic cell divisions 
downstream of GLP-1 and upstream of GLD-1. The inability of germline cells to reenter 
mitosis in the pir-1; gld-1 mutant is consistent with a positive role in mitotic proliferation. 
We believe that these observations should be expanded, namely by (1) investigating further 
genetic interactions with other key factors in germline stem cell regulation; by (2) directly 
comparing the expression of such factors by immunofluorescence or fluorescent reporters 
with PIR-1 expression; and (3) by studying their distribution in pir-1 mutant germlines 
and, complementarily, PIR-1::GFP distribution in germline tumors.   
Consistent with the genetic interaction between pir-1 and gld-1, a study found pir-1 
mRNA to be significantly enriched among a set of RNAs isolated from non-cross-linked 
GLD-1 immunoprecipitates in young adult hermaphrodites (Wright et al., 2011). A 
subsequent study that employed in vivo PAR-CLIP (in vivo Photoactivatable 
Ribonucleoside-Enhanced UV Cross-Linking and IP) to identify GLD-1 targets, also found 
pir-1 mRNA among 439 reproducibly identified mRNAs and that, upon RNAi of gld-1, the 
protein levels of all 439 targets were specifically upregulated (Jungkamp et al., 2011). 
Together, these findings established pir-1 mRNA as a target for GLD-1-mediated 
translational repression. This correlates well with our observation that PIR-1::GFP 
expression is reduced in germ cell nuclei undergoing the pachytene stage of meiosis, where 
GLD-1 protein expression is known to be highest (Fig. 2.7A, page 85). Since exit from 
mitosis depends on GLD-1 repression, this implies that PIR-1 expression is particularly 
important in actively proliferating cells, but that it needs to be downregulated during the  
transition from mitosis to meiosis.   
 Somewhat contrary to the idea that in C. elegans PIR-1 promotes cell proliferation, 
a study of human PIR1 (or DUSP11) demonstrated that its over-expression in U2OS 
osteosarcoma cells inhibited cell proliferation, while RNAi knock-down stimulated 
proliferation, even during exposure to DNA damaging agents (Caprara et al., 2009). The 
proliferation inhibitory effect depended on the phosphatase activity of PIR1, as a 
catalytically inactive mutant protein mutation failed to suppress cell division. The 
aforementioned study established that PIR1 mRNA is directly bound by p53 and that, 
following DNA damage, the level of PIR1 protein increases in a p53-dependent manner. 
These results imply that, at least in the context of cancer, PIR1 assumes the role of a tumor 
suppressing enzyme. Paradoxically, PIR1 mRNA levels obtained by mRNA-seq for 39 
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cancer cell lines from various organs and tissues are either very high for 18 cell lines or 
moderate for eight lines (data from the Cancer Genomics Hub deposited in the Expression 
Atlas database from the EMBL-EBI; Petryszak et al., 2014). While this dispels the idea 
that a high level of PIR1 necessarily leads to a dampening of cell proliferation, it does not 
prove whether high PIR1 expression in these lines is a cause or a consequence of 
unrestricted proliferation. Future studies using a wider range of conditions and cell lines 
will be necessary to address these intriguing results. As a final note, since p53 is conserved 
in C. elegans (CEP-1; C. elegans p53-Like Protein 1) it would be interesting to recapitulate 
these experiments in worms, by using the germline to measure effects on cell proliferation. 
In the course of our studies, we did produce a pir-1; cep-1 loss-of-function double mutant, 
predicting that loss of p53-regulated cell-cycle checkpoints could lead to increased 
germline cell proliferation in the pir-1 mutant background. These double mutant animals 
turned out to be phenotypically identical to the pir-1 single mutant, ruling out that the 
proliferative arrest of pir-1 is imposed by the activation of CEP-1/p53.  
 
The Lack of Nuclear PIR-1 in Specific Cells Suggests a Correlation with 
Transcriptional Activity 
 Nuclear PIR-1 is conspicuously absent from the nuclei of oocytes, in embryos until 
the four-cell stage, and in the two primordial germ cells, Z2 and Z3. One important 
common characteristic of these cell types is that they are transcriptionally quiescent. In 
oocytes, mRNA transcription is repressed as the cells enter diakinesis (Walker et al., 2007) 
until the four-cell stage, after which mRNA transcription is resumed (Seydoux  et al., 
1996; Seydoux and Dunn, 1997). In the developing embryo, the only cell that remains 
transcriptionally silent is the germ precursor cell, which at around the 100-cell stage 
divides into two cells, Z2 and Z3. These will only proliferate and become transcriptionally 
active post-embryonically, during the L1 stage, to give rise to all germline cells (Bender et 
al., 2004; Schaner et al., 2003). This striking overlap suggests that PIR-1 accumulates in 
nuclei undergoing active transcription, and reinforces the idea that its endogenous 
substrates are RNA molecules. Moreover, polyploid intestinal cell nuclei are the somatic 
cells with the highest accumulation of nuclear PIR-1. The intestine is the largest organ in 
C. elegans and one could assume that polyploidy evolved to support the demanding 
activity of this tissue by increasing transcriptional output. This would fit well with the 
hypothesis that PIR-1 accumulates in a transcription-dependent manner. The fact that we 
could see an overlap of PIR-1 with chromatin in intestinal nuclei is also in agreement with 
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this idea. Alternatively, PIR-1 could play a part in DNA replication during 
endoreduplication, compatible with its potential stimulatory effect on cell proliferation. 
Interestingly, a study established that genetically preventing or increasing ploidy in C. 
elegans leads to smaller or larger than wild-type adult sizes, respectively (Lozano et al., 
2006). Although the study focused on ploidy of hypodermal cells, future experiments in 
pir-1 mutants could address the DNA content of both hypodermal and intestinal cells to 
determine whether DNA replication is impaired when PIR-1 is not present, thereby 
interfering with overall growth. Finally, in one additional provocative connection to DNA 
replication, a MudPIT-based proteomic survey of proteins associated with human TRF-2 
(Telomeric Repeat-Binding Factor 2) found PIR1 as an interactor (Giannone et al., 2010). 
TRF-2 is a crucial telomere repeat binding factor, and part of a complex involved in all 
aspects of telomere function, including telomere replication. Despite being just one among 
many TRF-2-interacting partners, C. elegans could be a good system in which to further 
validate and explore this association. 
 Several studies of human PIR1 have pointed to connections with RNA processing. 
Human PIR1 was found to localize to nuclei when overexpressed in HeLa cells and this 
association disappeared when cells were pretreated with RNase A, but not DNase I (Yuan 
et al., 1998). This study also described interaction of PIR1 by yeast two-hybrid with 
splicing factors 9G8 (SRSF7, Splicing Factor, arginine/serine-rich 7), and SRp30C 
(SFRS9, Splicing Factor, arginine/serine-rich 9), both components of mRNA-splicing 
complexes. Another yeast two-hybrid screen from Caprara et al. (2009) revealed PIR-1 to 
interact with SAM68 (Src-Associated Substrate in Mitosis of 68 kDa), an RNA binding 
protein that has been implicated in multiple aspects of RNA metabolism, including 
alternative splicing, transcription and RNA transport (reviewed in Sanchez-Jimenez and 
Sanchez-Margalet, 2013). Importantly, this interaction was also validated in vivo. In 
another study, where the HeLa cell mRNA interactome was studied by mass-spectrometry 
of proteins associated with poly-adenylated RNA, PIR1 was recovered with relatively high 
abundance (Castello et al., 2012). Taken together these studies heavily suggest activities in 
the control of gene expression, namely by mediating aspects of mRNA processing. The 
fact that C. elegans PIR-1 is expressed in most post-mitotic adult cells is compatible with a 
role in mRNA metabolism, and that perhaps this is the way in which it supports the 
proliferation of cells and growth.  
We have performed experiments to address the involvement of PIR-1 in general 
transcription but have failed to obtain conclusive results (not shown). Specifically, we 
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immunostained Pol II in pir-1 germlines, including the initiating form (CTD repeat 
phosphorylated on Ser5) and elongating form (Ser2 phosphorylation), to find that Pol II 
still localized to germline nuclei with a similar distribution and intensity as in wild-type 
germlines. This experiment was limited given that the pir-1 arrest occurs prior to 
oogenesis, during which the most dramatic changes in transcription take place. We also 
knocked down ama-1 (Amanitin Resistant 1; encoding the large subunit of Pol II) by RNAi 
in the pir-1::gfp background. When L1s or L2s are fed ama-1 dsRNA-expressing bacteria, 
animals arrest mostly as L3s or sterile adults, respectively. Upon arrest and a few days 
thereafter, we looked for decreased levels of nuclear PIR-1::GFP under the microscope but 
were unable to detect differences (in Chapter III further experiments are shown). In another 
approach, we exposed animals of different developmental stages to a range of 
concentrations and exposure periods of the transcription inhibiting drugs DRB (5,6-
dichloro-1-β-D-ribobenzimidazole) and actinomycin D, but again failed to see an effect on 
PIR-1::GFP. Furthermore, we performed UV cross-linking followed by IP and RNA-seq 
(CLIP-seq) of PIR-1::GFP but obtained reads that resembled those of our negative control, 
deriving mostly from abundant tRNA fragments. Although the CLIP conditions were 
extensively optimized, it is possible that further optimization is required, or that the 
concentration of PIR-1 binding to RNA is low compared to the unbound fraction (in both 
nucleus and cytoplasm), severely limiting the sensitivity of this approach.  
Finally, it is important to consider that human PIR1 was detected in a thorough 
proteomic study of the nucleoli of HeLa cells (Andersen  et al., 2005). PIR1 was gradually 
depleted from nucleoli with increasing times of exposure to actinomycin D, implying not 
only that the association is transcription-dependent but also that human PIR1 may 
participate in ribosomal RNA (rRNA) transcription or processing. Another, more recent, 
study showed that this is indeed the case (Tafforeau et al., 2013). In that study, 625 
proteins associated with the nucleoli of HeLa cells were individually downregulated via 
RNAi and the effects on pre-rRNA processing were assessed by quantitative northern 
blotting. Knockdown of PIR1 led to a strong accumulation of the 47S primary transcript 
(containing the 18S, 5.8S and 28S rRNAs), of a 34S RNA intermediate, and of a 5' 
external transcribed spacer fragment. However, as the levels of mature 28S and 18S 
remained similar to wild type, and silencing of 50 other nucleolar proteins led to the same 
pattern of accumulated rRNA precursors, it is likely that some proteins act redundantly at 
these processing steps. Consistent with this possibility is the fact that knockdown of PIR1 
in cultured cells leads to increased cell proliferation, which is imcompatible with a loss of 
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functional ribosomes (Caprara et al., 2009). Regarding C. elegans, when we looked at 28S, 
18S and 5S rRNA bands from total RNA of seven-day old pir-1 mutant animals, their 
intensity and migration on an agarose gel stained by ethidium bromide and visualized 
under UV light was no different than in wild-type animals (not shown). While this 
indicates that there are no gross abnormalities in rRNA accumulation, a more complete 
study of rRNAs and its intermediates should be performed in pir-1 mutant animals. A 
deficiency in the processing of rRNA could explain the growth and proliferation defects 
that we observe. 
Curiously, a study of the C. elegans nucleostemin homolog nst-1 shows that the 
deletion mutant phenotype as well as the developmental expression pattern of this protein 
is highly reminiscent of PIR-1 (Kudron and Reinke, 2008). Mammalian nucleostemin is a 
predominately nucleolar GTP-binding protein that actively shuttles between the nucleolus 
and the nucleoplasm, and is crucial for several aspects of development (reviewed in Tsai 
and Meng, 2009), cancer progression (Lin et al., 2010) and regulation of stem cell 
pluripotency (Qu and Bishop, 2012), among other processes. In C. elegans, nst-1 loss-of-
function mutant animals arrest as L1 and L2 larvae, but, similarly to pir-1, retain a wild-
type lifespan during which they feed and move normally. NST-1::GFP concentrates in 
nucleoli and is diffusely present in the nucleoplasm at all developmental stages. Its 
expression is reduced in the most proximal oocyte and shuts off in early embryos, only to 
be turned back on around the 18-cell stage embryo. During this time window, despite 
continuing rRNA transcription, no processing of rRNA or ribosome assembly takes place 
(Saijou  et al., 2004). Consistent with the nucleolar localization of NST-1 and absence 
from cells where rRNA processing is halted, nst-1 mutant animals were shown to have a 
marked decrease in rRNA levels. This effect is thought to lead to fewer mature ribosomes 
and cause the developmental arrest. Similar effects have been reported in S. cerevisae, the 
fission yeast Schyzosaccharomyces pombe and flies. Studies of vertebrate nucleostemin, on 
the other hand, are contradictory when it comes to its role in promoting high levels of 
rRNA and ribosome assembly, which may be carried out instead by the paralog GNL3L. 
Mounting evidence now points to a role for vertebrate nucleostemin in maintaining 
genome integrity during DNA replication in the nucleoplasm via the p53 pathway and even 
to a telomere-protective role (reviewed in Tsai, 2014). It remains possible that in C. 
elegans, in addition to ribosome biogenesis, NST-1 takes on similar roles. When we placed 
the nst-1::gfp transgene in the pir-1::3xFlag background and performed reciprocal IPs, 
there was no indication that the two proteins stably interact. Nonetheless, given the results 
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gathered from human cells, and the striking similarity between the mutant phenotypes and 
pattern of expression of C. elegans NST-1 and those of PIR-1, a potential role for this 
enzyme in rRNA biogenesis should be thorougly investigated. 
 
PIR-1 Expression Patterns and Defects in pir-1 Mutant Animals Uncover                                           
a Role in Sperm Development and Link It to the Eri Pathway 
 One of the clearest phenotypes that result from the tm3198 pir-1 deletion is the 
inability of spermatocytes to correctly divide into mature spermatids. This is manifested by 
the formation of chromatin bridges between dividing spermatocytes, in everything similar 
to what has been reported for temperature-sensitive sterile Eri (enhancement of RNAi) 
mutants (Gent et al., 2009; Pavelec et al., 2009). This phenotype was not detected in the 
earlier pir-1(tm1496) arrested mutants because they never reached spermatogenesis. We 
have tested pir-1(tm3198) mutant animals for enhancement of RNAi by feeding them 
bacteria expressing dsRNA against genes that only manifest a phenotype in Eri RNAi-
hypersensitive strains. As explained in Chapter I, the Eri phenotype results from a loss of 
ERGO-1 26G-RNAs, leading to a release of downstream 22G-RNA synthesis proteins and 
Argonautes that become available to mediate a more potent exogenously triggered RNAi 
response. Since pir-1 animals are sterile, we were limited to testing Eri targets for which 
the phenotype appeared in the parental (P0) generation by feeding animals starting at the 
L1 stage. We tested unc-73 and dpy-13, which give rise to an uncoordinated movement 
phenotype and a severe dumpy phenotype, respectively, in Eri mutants (Simmer et al., 
2002; Kennedy et al., 2004; Duchaine et al., 2006). Unlike the positive controls (eri-1 and 
rrf-3 mutants), pir-1 mutant animals did not exhibit the phenotypes, arguing that PIR-1 
may not participate in the ERGO-1 pathway. Due to maternally derived PIR-1, however, 
and because RNAi at later developmental stages generally does not lead to phenotypes in 
Eri mutants, we could not definitively conclude that pir-1 mutant animals are not Eri.  
 Together with the sperm defect, the elevated expression of PIR-1 during 
spermatogenesis in both hermaphrodites and males make a very strong case for its direct 
involvement in sperm development. The ERI complex is required for ALG-3/4-dependent 
26G-RNAs, which were shown to be essential for proper sperm maturation (Han et al., 
2009, Conine et al., 2010, Conine et al., 2014). Unlike ergo-1 mutants, alg-3; alg-4 
mutants are not hypersensitive to RNAi, consistent with a role confined to spermatogenesis 
(Han et al., 2009). This potential association is explored in Chapter IV. Importantly, PIR-1 
may be required for sperm development beyond C. elegans. In Drosophila melanogaster 
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the mRNA of  the PIR-1 ortholog CG13197 was found to be expressed in almost every 
adult fly tissue tested, but was particularly elevated in testes, followed by ovaries (from 
FlyAtlas Anatomical Expression Microarray data and modENCODE tissue expression 
mRNA-seq data; Chintapalli et al., 2007; Celniker et al., 2009). In collaboration with Keith 
Boundy from the laboratory of Phillip Zamore in our department, we found that a P-
element insertion fly mutant (P{wHy}CG13197
DG30703
)  that leads to a pronounced 
decrease in CG13197 mRNA expression resulted in sterile adult males. Until the 
phenotype is properly rescued this observation remains preliminary, but it is nonetheless 
indicative that PIR-1 function in spermatogenesis may be evolutionarily conserved. Further 
exploration of the expression databases shows that in vertebrates PIR1 is expressed to 
varying degrees in most tissues, including testes. Extended studies of vertebrate PIR1 are 
therefore worthwhile, not only regarding sperm development, but also general 
development and cancer.  
 




MATERIALS AND METHODS 
 
Note: As many of the basic techniques for handling C. elegans are available through 
several printed and online sources (namely the WormMethods section in WormBook.org) 
the methods described in this thesis are not meant to exhaustively describe general C. 
elegans techniques. Detailed information is given for procedures that have either been 
created during this project or adapted from existing protocols, or where it is thought to help 
the reader understand and interpret the described results. 
 
Outcrossing and Balancing of the pir-1(tm3198) Deletion Allele 
 Due to its sterility phenotype, the new tm3198 deletion allele was sent to us as a 
mixed population of wild-type heterozygotes. In general, when mutations are generated by 
chemical mutagenesis other potential mutations in the background must be eliminated by 
successive genetic crosses with a wild-type strain, in a process termed outcrossing. This 
allows replacement of most of the original genome by intact genome sequence through 
recombination events at each cross. The deletion of interest is followed throughout the 
process by PCR-based genotyping. Primers flanking the deletion were designed (primers 
O1/O2, see Appendix B for sequences) to identify individual worms carrying the mutation 
by single worm PCR. For this single worms were lysed in 5 µl of worm lysis buffer (10 
mM Tris-Cl pH 8.3, 50 mM KCl, 2.5 mM MgCl2, 0.45% NP-40, 0.45% Tween-20, 0.01% 
gelatin) with 0.4 µg/µl Proteinase K in PCR tubes at 65˚C for 1 hr, followed by 15 minutes 
at 95˚C. Lysates were mixed with 5 µl of ultrapure water and 1 µl was used as template in 
a 25 µl PCR reaction using Roche Taq polymerase. A 56˚C primer annealing temperature 
and a 68˚C extension temperature for 30x cycles were used. 20 µl of PCR reaction were 
run on a 1% agarose/1X TAE buffer gel (1X TAE is 40 mM Tris, 20 mM acetic acid, 1 
mM EDTA, with a final pH of 8.0) to assess presence or absence of the deletion according 
to band size. This genotyping method was used to generate all strains carrying deletion 
mutations or transgenes that did not have an easily identifiable phenotype or visible 
fluorescent tags. Deletion heterozygote hermaphrodites were then mated with N2 males 
(first outcross). Cross-progeny males were used to establish several cross plates with one 
male and three N2 hermaphrodites per plate. After mating, hermaphrodites were 
transferred to single plates (or “singled”) and males were genotyped for the deletion. From 
the cross-progeny of heterozygote males at least 10 F1 males were selected to set up more 
individual crosses with N2 hermaphrodites. This process was repeated three more times for 
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a total of five outcrosses. The final outcross was done by mating heterozygote males with 
already outcrossed pir-1(tm1496)/mnC1* balanced hermaphrodites. This genetic balancer 
carries a bright, ubiquitously expressed nuclear GFP (Psur-5::gfp) that makes its carriers 
easily traceable under a fluorescence dissection microscope. GFP-positive (carrying 
mnC1*) hermaphrodite F1cross-progeny were then singled, allowed to have progeny and 
genotyped for tm3198. Heterozygote animals were the final 6x outcrossed balanced strain 
that was the base for making all other pir-1 strains in this study. 
 
Worm Culture, Synchronization and Developmental staging 
 Large scale cultures of worms were generally grown on 15 cm Nematode Growth 
Medium (NGM; 1.7% (w/v) agar, 50 mM NaCl, 0.25% (w/v) peptone, 1 mM CaCl2, 5 
µg/ml cholesterol, 25 mM KH2PO4, 1 mM MgSO4) with a 1:1 mix of agar and agarose to 
prevent burrowing of the worms into the medium when growing them for extended time 
periods. For most experiments worms were grown at 20˚C and fed with concentrated OP50 
E. coli. For cleaning and synchronizing populations, starved small plates were chunked 
onto large 15 cm plates with OP50 and allowed to grow until a large fraction of worms 
were gravid. They were then harvested with 1X M9 buffer (22 mM KH2PO4, 42 mM 
Na2HPO4, 85 mM NaCl, 1 mM MgSO4) into a 15 ml conical tube and bleached to recover 
embryos with bleach solution (10% bleach, 0.25 M KOH). Embryos were washed 3x with 
M9 buffer, and allowed to hatch in M9 buffer while shaking overnight at room temperature 
or 20˚C. To obtain synchronous populations at different stages, live hatched L1 worms 
were counted and the desired number of worms was transferred to fresh 15 ml tubes and 
centrifuged at 800x g for 1-2 minutes. The resulting pellet was mixed with OP50 and 
spread on a fresh NGM plate. As a rule, for a large plate of gravid adults, no more than 
150,000 worms were plated, since higher densities would cause animals to enter the dauer 
stage and not reach adulthood. For developmental staging of N2 animals at 20˚C the 
different stages were generally harvested at the following times: L1 larvae at 6 hours after 
plating, L2s at 15-18 hours, L3s at 24-26, L4s at 34-36 and young adults at 46-48. 
Embryos were obtained from just-bleached gravid adults. These timings varied with strain, 
and staging was always visually monitored for features that characterize each stage. 
Animals were harvested and washed 3x with 15 ml of M9 buffer in 15 ml conical tubes 
with 20-second centrifugations at 800x g. They were then incubated with 10 ml of M9 
buffer for 15-30 minutes in a rocking platform to allow full digestion of ingested bacteria, 
followed by one wash with ice-cold distilled water to remove salts and paralyze worms to 




form a compact pellet that allowed aspiration of as much water as possible. Pellets were 
flash-frozen in a dry ice/ethanol bath and stored at -80˚C or processed immediately for 
RNA or protein extraction. 
 
Ivermectin-Based Counter-Selection 
Counter-selection using ivermectin was employed in this work in order to obtain 
large numbers of pir-1 arrested homozygote animals to provide enough RNA and protein 
for many of the experiments performed. Ivermectin belongs to a class of macrocyclic 
lactones called avermectins, which interact with vertebrate and invertebrate GABA 
receptors and invertebrate glutamate-gated chloride channels. The pir-1 deletion alleles 
were crossed into an ivermectin-resistant triple mutant genetic background comprising the 
genes avr-14, avr-15 and glc-1, which encode glutamate-gated chloride channel subunits 
(Dent et al., 2000). Throughout this thesis this mutant combination is referred to as 
‘avr3x.’ Expression of the wild-type sequence of any one of the three genes is sufficient to 
restore sensitivity to ivermectin. The genetic balancer mnC1* used to propagate pir-1 
mutants contains a wild-type copy of avr-15 under the control of the pharyngeal myo-2 
promoter. This causes heterozygote carriers and balancer homozygote worms to become 
sensitive to ivermectin, due to compromised pharyngeal muscle activity that makes them 
unable to feed. Conversely, balancer-free pir-1 homozygotes are able to grow in the 
presence of the drug.  
In order to place pir-1(tm3198) in the avr3x background, avr3x males were crossed 
with pir-1(tm3198)/mnC1*. Several (~10-15) GFP-negative hermaphrodite cross-progeny 
(balancer-free pir-1 heterozygotes) were singled into small plates, and allowed to self-
fertilize until the plates were starved (about two generations). These plates were then 
chunked onto large ivermectin plates with OP50. After three days plates were screened for 
healthy gravid adults, which were singled onto small plates, allowed to have progeny and 
genotyped for the presence of the deletion allele. Progeny from positive mothers were 
mated with pir-1(tm1496)/mnC1*; avr3x males, and GFP-positive (with balancer) cross 
progeny were singled and allowed to have progeny. Animals carrying tm3198 were 
identified by the arrested phenotype, confirmed by PCR and tested for ivermectin 
resistance. 
Balanced pir-1 populations were expanded in regular NGM in order to obtain 
sufficient synchronous L1 larvae to plate on NGM supplemented with 25 µg/L of 
ivermectin. After plating, only pir-1 homozygotes grew while all others never passed the 
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L1 stage. Many of these arrested larvae remain alive, however, making it important to 
eliminate them when harvesting the counter-selected population. For this, worms were 
centrifuged in M9 buffer for up to 10 times at lower speeds than usual (~600x g for brief 
seconds). While this led to loss of some pir-1 arrested worms, it eliminated most live L1s. 
 
RNA Extraction and qRT-PCR 
Worms were collected from plates and washed 3x with 15 ml of M9 buffer in 15 ml 
conical tubes with 20-second centrifugations at 800x g. They were then incubated with 10 
ml of M9 buffer for 15-30 minutes in a rocking platform to allow full digestion of ingested 
bacteria, followed by one wash with 4˚C distilled water to wash away salts and paralyze 
worms thereby allowing formation of a compact pellet in order to remove as much water as 
possible. At least 5 volumes of TRI Reagent (MRC, Molecular Research Center) were 
added to pellets, which were either flash frozen in a dry ice/ethanol bath or processed 
immediately. Lysis was performed by crushing with a metal dounce with ~30 strokes at 
room temperature. Samples were aliquoted into 1.5 ml tubes and processed according to 
the manufacturer. BCP separation reagent (MRC) was used instead of chloroform. RNA 
pellets were dissolved in ultrapure water or TE buffer (10 mM Tris-HCl pH 7.5, 1 mM 
EDTA) depending on downstream experiments. 
Before cDNA synthesis, 100 µg of RNA were pre-treated with 6 U of Turbo DNase 
(Ambion) in the presence of 60 U Superasin RNase inhibitor (Ambion) in a 100 µl volume 
at 37˚C for 1 hour. After phenol:chloroform extraction and precipitation, RNA was 
resuspended in ultrapure water and quantified in a NanoDrop spectrophotometer. For each 
20 µl cDNA reaction, 2 µg of RNA were used, using Superscript III Reverse Transcriptase 
(Invitrogen) with random hexamers according to the manufacturer’s instructions. qRT-
PCR reactions were carried out using the ABI Prism 7500 Fast Sequence Detection System 
with Fast SYBR Green PCR Master Mix (Applied Biosystems). Each 15 µl reaction 
contained 7.5 µl of SYBR Green reagent, 400 nM of each primer and 2 µl of cDNA. The 
standard fast thermocycling program was used and for each primer pair a standard curve 
with 1:5 cDNA dilutions was generated to calculate mRNA amounts in samples. Per 
sample, 2-3 technical replicates were run. Primers used were O3/O4 (18S rRNA), O5/O6 
(gapdh/gpd-2 mRNA), O7/O8 (sec-5 mRNA), O9/O10 (pir-1 mRNA), and O11/O12 (unc-
22 mRNA), as listed in Appendix B. 
 
 





RNAi of sec-5 and pir-1 
To prepare dsRNA, primers containing T7 promoter tails were designed to amplify 
200-400 nt sequences from cDNA using iProof high-fidelity DNA polymerase (Bio-Rad). 
Products were gel purified and used as templates for dsRNA synthesis using the 
MEGAscript T7 kit (Ambion) according to the manufacturer’s instructions. dsRNA was 
verified on a 1% agarose/1X TAE gel, quantified, and microinjected in the body cavity or 
intestines of young adult worms at a concentration of 20 ng/µl and 1 µg/µl. In the case of 
pir-1, germline injections were also performed in an attempt to increase the potency of the 
treatment in this tissue. Phenotypes were scored in the progeny a day later at 20˚C after the 
injections. Primers used were O13/O14 for pir-1 and O15/O16 for sec-5. 
In addition to the available pir-1 dsRNA construct for RNAi by feeding available 
from the Ahringer Lab RNAi library (Kamath et al., 2003), containing a 1158 bp sequence 
amplified from genomic DNA in the L4440 double T7 vector from the Fire Lab C. elegans 
Vector Kit (1999, unpublished), two new constructs were generated. One was designed 
comprising the majority of the unspliced sequence of pir-1 with flanking T7 promoters in 
the pCR-2.1-TOPO vector backbone (Invitrogen) and transformed into the RNase III-
deficient E. coli strain HT115 (DE3), used for dsRNA feeding. The other construct used 
the same primers to amplify the spliced sequence from cDNA and cloned into the pCR-
Blunt II-TOPO vector (Invitrogen; primers O17/O18).  
RNAi food was prepared by growing a 3 ml overnight starter culture from a single 
HT115 E. coli colony on a tetracycline/ampicillin plate (or kanamycin for the pCR-Blunt 
vector) in LB medium (the tetracycline selects for a plasmid in HT115 encoding the T7 
polymerase). 1 ml of starter culture was added to 1 liter of TB medium (Terrific Broth; 1 
liter contains 12 g of tryptone, 24 of yeast extract, 4 ml of glycerol and 100 ml of 1 M 
Potassium Phosphate Buffer buffer pH 6.0 (0.72 M KH2PO4, 0.28 M K2HPO4)) 
supplemented with ampicillin (50 µg/ml) or kanamycin (50 µg/ml) and grown overnight at 
37˚C. The following day IPTG was added to a concentration of 2 mM for induction of T7 
polymerase expression and production of dsRNA and incubated for 3 hours at 37˚C. The 
bacteria were collected by centrifugation at 3,000x g for 15 minutes at 4˚C and 
resuspended in four pellet volumes of sterile M9 buffer. RNAi food was plated on NGM 
plates supplemented with 50 µg/ml of ampicillin and 1 mM of IPTG and left to dry and 
further induce at room temperature overnight and used immediately or stored at 4˚C. 
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Validation of the new dsRNA-expressing food was performed by feeding the 
rescued bombardment pir-1; pir-1::gfp in which a two-day exposure led to depletion of 
GFP signal in the bright intestinal nuclei, but not in the germline (further exposure did not 
change expression). Furthermore, qRT-PCR of pir-1::gfp mRNA following gfp RNAi by 
feeding showed a ~50% and ~40% reduction in mRNA level when using pir-1 or gpf 
primers (O19/O20), respectively. Again, only somatic GFP signal was down-regulated, and 
no phenotypes were observed. RNAi targeting pir-1 was therefore specific but was not 
enough to knock it down to a level that interfered with the activity of the protein. 
 
Generation of Tagged pir-1 Constructs 
In order to fuse expression tags to the pir-1 gene, we adopted a strategy based on 
homologous recombination in S. cerevisiae of the tagged portion of the sequence of 
interest into a yeast artificial chromosome (YAC) carrying the full genomic locus. N- or C-
terminally tagged versions of the pir-1 gene (with either gfp or 3xFlag sequences) were 
generated by amplifying 1 kb of sequence from genomic DNA surrounding the start or the 
stop codon of the gene with iProof high-fidelity enzyme (Bio-Rad). The primers were 
designed to make products containing terminal BamHI sites (for start sequence; primers 
O21/22) or terminal XbaI sites (for stop sequence; O23/O24) that are not present in these 
sequences or the tag cassettes. The fragments were TOPO cloned into vector pCR-Blunt II 
TOPO (Invitrogen), insertion was verified by PCR of colonies using Roche Taq 
polymerase and some positive clones were sequenced. They were then cut with NotI, 
treated with Klenow (NEB) in the presence of dNTPs to fill-in the overhangs and religated 
with T4 DNA ligase (NEB) in order to destroy the vector’s unique NotI site. After 
religation and transformation, the vectors were verified by NotI digestion (which should 
now not linearize the plasmid) then used for circular PCR with divergent primers that were 
designed to introduce a new NotI site immediately downstream of the start (primers 
O25/O26 and O27/O28) or upstream of the stop codon (primers O29/O30 and O31/O32). 
The PCR reaction was digested with DpnI to destroy the original vector and visualized 
after agarose gel electrophoresis for verification of the linear product. The blunt ends 
(generated by the iProof polymerase) were phosphorylated with PNK (NEB) in the 
presence of ATP, then ligated and transformed. Plasmids from a few clones were digested 
with NotI to verify the creation of the new site. Two positive clones of each fragment were 
then digested with NotI followed by CIP (NEB) dephosphorylation. In parallel, tagged NotI 
site-flanked cassettes with gfp or 3xFlag sequences were digested from vectors with NotI 




and gel-purified. These cassettes contain the yeast ochre supessor tRNA, sup4o, embedded 
in a synthetic C. elegans intron, which allows selection of recombined sequences in a 
specific auxotrophic yeast strain (Rocheleau et al., 1999). The purified fragments were 
phosphorylated with PNK, ligated to the vectors and transformed. Positive clones were 
identified by NotI digestion to release the inserted cassette and proper orientation was 
assessed by digestion with EcoRI, which cuts once within the cassettes and twice in the 
vectors. Clones were sequenced to screen for PCR errors and to confirm that the pir-1 ORF 
was in the same frame as the gfp and 3xFlag sequences. 
Correct constructs were linearized with BamHI or XbaI (to release pir-1 sequences 
fused to tag cassettes from the vector backbones) and transformed into a yeast strain 
carrying the Y51C5 YAC that contains the C. elegans pir-1 gene. Recombinant clones 
were selected through suppression of an ochre mutation in a lysine synthesis pathway gene, 
allowing it to grow on Ura- Lys- medium (unrecombined cells can only grow on Ura- 
medium). Genomic DNA was isolated from positive strains and recombination was 
confirmed with PCR using primers outside the insert to be recombined into the pir-1 locus 
(O21/O22 for N-terminal and O23/O24 for C-terminal). Although these genomic DNAs 
were intended for direct injection into pir-1(tm1496)/mnC1 animals for rescue, attempts to 
do it were unsuccessful. In the meantime the laboratory adopted the technique of 
transformation by bombardment, and we decided to use the tagged YACs to make 
bombardment-compatible constructs carrying the tagged pir-1 sequence only. 
 
Generation of Constructs for Transformation by Bombardment 
Using 250 ng of recombinant YAC genomic DNA per 25 µl reaction, sequences 
were amplified with iProof  at a low cycle number (20) to include 1 kb upstream and 1 kb 
downstream of the pir-1 start and stop codons, respectively (primers O33/O34). The 
sequences were then cloned into pCR-Blunt II-TOPO. Primers carrying Gateway 
(Invitrogen) cloning attB1 and attB2 sites (O35/O36) were used for PCR from the TOPO 
vectors (direct amplification from YAC DNA with the Gateway primers was not 
successful). PCR products were digested with DpnI to eliminate the original vector (which 
carries a kanamycin resistance gene that is also present in the Gateway vector), gel 
purified, eluted with ultrapure water and quantified. The BP clonase (Invitrogen) 
recombination reaction to introduce the pir-1 sequences into pDONR-201 (Invitrogen) was 
performed according to the manufacturer. Recombinant DH5α transformants were selected 
with kanamycin agar plates and through loss of the ccdB gene which is present only in the 
Chapter II Materials and Methods 
107 
 
unrecombined vector and causes bacterial death when expressed. For confirmation, the 
plasmids of clones were isolated by minipreparation and digested with NotI to release the 
gfp or 3xFlag cassettes. Two pDONR clones of each type were sequenced. 
For the next step, the pDONR vectors were recombined with pCG150 (pDESTR4-
R3 Destination vector carrying a 2.2 kb C. elegans unc-119 rescuing fragment (Merritt et 
al., 2008) using LR clonase (Invitrogen) according to the manufacturer’s instructions. 
Colonies were selected on ampicillin and recombined plasmids were confirmed by 
digestion with NotI. Plasmid minipreparations of the correct clones were performed to 
provide enough material for bombardment. 
 
Transformation of C. elegans by Biolistic Bombardment  
Instead of the traditional C. elegans DNA transformation method by germline 
microinjection (Mello et al., 1991), we preferred transformation by biolistic bombardment 
(Praitis et al., 2001). The advantage of this technique over microinjection is that it 
generates integrated, low-copy number transgenic lines with high frequency, lowering the 
possibility of transgene silencing in the germline. Germline transgene silencing occurs very 
frequently with the multi-copy extrachromosomal arrays that assemble when 
transformation is performed by microinjection. 
The bombardment transformation protocol we used is an adaptation of a protocol 
provided to our laboratory by John Reece-Hoyes then at Ian Hope’s laboratory at the 
University of Leeds, UK. A Bio-Rad PDS-1000/He machine with a hepta adaptor was 
used. 60 mg of 0.3-3 µm gold beads (Chempur) were prepared by vortexing in 2 ml of 70% 
ethanol for 5 minutes and then soaked for 15 minutes. After spinning, they were washed 3x 
with sterile distilled water. The pellet was resuspended in 1 ml of sterile 50% glycerol for a 
final concentration of 60 mg/ml. Coating of the particles with DNA was done on the day of 
the bombardment. The beads were vortexed for 20 minutes and, for each hepta shot (seven 
different spots on a 10 cm plate are hit with the gold microparticles), 7 µg of plasmid DNA 
in 30 µl of ultrapure water was added dropwise while slowly vortexing (to prevent bead 
clumping) to 70 µl of gold suspension in a siliconized 1.5 ml tube. Then 300 µl of 2.5 M 
CaCl2 and 112 µl of 0.1 M spermidine were added in the same manner. This mixture was 
vortexed for 5 minutes, the gold was pelleted and resuspended in 800 µl of 70% ethanol, 
pelleted again, and resuspended in 70 µl of 100% ethanol. The mixture was kept vortexing 
until ready to use. 




The strain used for bombardment was the unc-119(ed3) mutant which exhibits 
almost complete paralysis. To grow large numbers of animals, starved populations from 
several small (3 cm) plates were collected and washed with M9 buffer, pelleted by 
centrifugation and plated on large (15 cm) plates with concentrated OP50 and grown until 
most animals were fully gravid. They were then bleached to recover eggs, grown 
synchronously and expanded until large numbers were reached. For harvesting, 200,000 
hatched L1 larvae were plated per 15 cm plate with 3 ml of concentrated OP50. Per 
bombardment plate, 1 ml of packed young adults (with at most 2-4 eggs) are required 
(400,000 to 500,000 worms). Immediately before the procedure, worms were washed with 
M9 buffer and pelleted. Then 150 µl of concentrated worms were pipetted on each of the 
seven spots to be hit on a 10 cm NGM plate without OP50. The plate was pre-chilled on 
ice to minimize dispersion of the worms and kept over ice until ready to bombard.  
Macrocarrier discs were coated in the center with 10 µl of gold beads in a flow 
hood and allowed to dry. The macrocarriers were assembled into the hepta adaptor along 
with 1350 psi rupture disks and a stopping screen to hold the macrocarriers in the adaptor 
after they were shot (all from Bio-Rad). Inside the chamber the vacuum was kept at a 
pressure of 27 inches of Hg and the plate was placed on the second shelf from the bottom. 
Operation was carried out according to the machine’s manual. After bombardment, 1 ml of 
sterile M9 buffer was added to the plate and the worms were allowed recover for 1-2 hours 
at room temperature. 4 ml of M9 buffer were added and worms were equally distributed 
into 8x 10 cm plates pre-seeded with OP50. Worms were grown at 20˚C for 3-4 days and 
four wild-type moving gravid transformants (unc-119 rescued) were picked from each 
plate and placed on a drop of bleach solution in a 3 cm plate with OP50 to decontaminate. 
From each of these plates, 6-8 progeny (F1) animals were singled onto individual plates 
and transmission of the unc-119 construct was assessed. Whenever the transmission was 
100% in any of the plates, the transgene was assumed to have been integrated and was 
checked for a few generations. Both integrated and non-integrated lines were observed 
under the microscope for GFP signal and multiple lines were kept. Integrated lines were 
crossed with pir-1(tm3198)/mnC1* males and hermaphrodite progeny not carrying the 
nuclear Psur-5::GFP signal from the balancer were allowed to self-fertilize. Several F2 
animals were singled, allowed to produce offspring and subjected to PCR for the wild-type 
allele, transgene and homozygous deletion allele, using primers O21/O24. Animals in 
which only the transgene and deletion allele PCR products could be detected, were pir-1 
homozygotes rescued by the transgene. 
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Generation of Constructs and Strains for Transformation by MosSCI, and 
Transformation Protocol 
Single copy pir-1 transgenic strains were generated using the Mos1-Mediated 
Single Copy gene Insertion (MosSCI) system based on the protocols described in Frokjaer-
Jensen et al., 2008. Improved protocols and reagents are available at wormbuilder.com. 
Previously generated pDONR-201-pir-1::gfp plasmids, which had rescued the pir-1 
phenotype were recombined with LR clonase into the pCFJ201 destination vector, which 
carries a C. briggsae unc-119 rescuing fragment and has homology sites surrounding the 
cxTi10882 Mos1 insertion on chromosome IV to allow insertion of the transgene by 
homologous recombination following Mos1 transposon excision. Correct clones were 
screened by PCR with primers flanking the Mos1 insertion site (O37/038) and plasmids for 
injections were purified by minipreparation. At the time this was the only other genomic 
insertion site available besides the preferred chromosome II site, which could not be used 
due to its proximity to the pir-1 locus. The chromosome IV site was shown to have a lower 
efficiency of transformation compared to the chromosome II site, which did not allow 
insertion of all of the transgenes generated. Since then, a pir-1 mutant strain carrying the 
chromosome I ttTi4348 site was made, which should be used for future transgenic 
experiments. 
The cxTi10882; unc-119(ed3) strain (EG5003) was crossed with bombardment-
rescued pir-1(tm3198); unc-119(ed3); In[pir-1::gfp, unc-119]; avr3x in order to place it in 
the avr3x background. Heterozygotes were allowed to self-fertilize and unc-119 progeny 
(indicating loss of the transgene) was singled and checked for homozygous Mos1 
insertions by PCR with O37/O38. Positive animals were then nearly starved and plated on 
ivermectin plates to select for resistant fertile animals. These were then crossed to pir-
1(tm3198)/mnC1*; avr3x, and F1 progeny siblings were crossed using wild-type-moving 
GFP balancer positive males and balancer negative hermaphrodites to rebalance pir-1. 
From the sibling cross, balanced unc-119 cross-progeny was PCR tested for presence of 
the pir-1 deletion and of the Mos1 insertion. The resulting pir-1/mnC1*; unc-119; 
cxTi10882; avr3x strain was used for microinjection of the rescuing constructs. 
For germline microinjections, a mix of the following plasmids and respective 
concentrations were used: pCFJ201-pir-1::gfp (50 ng/µl), pCFJ90 (Pmyo-2::mCherry which 
labels the pharynx; 2.5 ng/µl), pCFJ104 (Pmyo3::mCherry, which labels body wall muscle; 
5 ng/µl); pJL43.1 (Pglh-2::transposase, which constitutively expresses the Mos1 
transposase in the germline; 30 ng/µl), and pJL43.1 (Phsp-16.48::transposase, for heat-shock 




induction of transposition; 30 ng/µl). Inclusion of both types of transposase constructs was 
meant to increase the frequency of insertion. Per construct, 40-60 animals were injected, 
isolated and allowed to grow at 20˚C for 2-3 days. Wild-type moving transformants were 
picked and assessed for high transmission. Transmitting lines were grown to a mixed stage 
population and heat-shocked for 75 minutes at 34˚C, following recovery at 15˚C for 90 
minutes and 20˚C for 1 hour. From each line ~400 motile young adults were picked and 
screened under a dissection fluorescent microscope to eliminate GFP-negative animals 
(which have lost the mnC1* balancer). About 25 worms were transferred to a 10 cm plate 
with OP50 for a total of 16 plates per line and grown at 20˚C for 2-3 days, then transferred 
to 25˚C until they starved. Then a 1/4 piece of the agar of each plate was chunked into a 
fresh 10 cm plate with OP50 and allowed to starve at 25˚C. Plates were screened for wild-
type moving worms that lost the mCherry red fluorescence and had therefore likely lost the 
extrachromosomal arrays. Animals were isolated and screened by PCR for the presence of 
the transgene at the Mos1 locus and later by immunoprecipitation (IP) of PIR-1::GFP. 
 
Site-Directed Mutagenesis of pir-1 Transgenes for Transformation by 
MosSCI 
For generation of pir-1 mutant transgenes, instructions from the QuikChange site-
directed mutagenesis kit (Stratagene) were followed using either the kit’s PfuUltra or 
iProof (Bio-Rad) DNA polymerase. Mutagenesis was performed on the smaller 
pDONR201 vectors, after which the pir-1 gene was sequenced and recombined into 
pCFJ201 with LR clonase. The deletions in the putative NLS (Δ194-208 and Δ204-208) 
were generated by divergent PCR primers lacking the targeted nucleotides followed by 
ligation. The PCR used iProof DNA polymerase for 15 cycles, and the product was 
digested with DpnI, gel purified and phosphorylated with PNK. Following purification 
with Qiagen Minelute columns, 200 ng of each vector was ligated in a 10 µl volume with 
LigaFast T4 DNA ligase (Promega) for 15 minutes at room temperature. As negative 
controls, the same amount of unligated vectors were transformed in parallel with ligated 
mixtures (5 µl per reaction). Colonies were screened by PCR with Roche Taq polymerase 
with primers O21/O22. Primers for PIR-1 mutagenesis (O39-O71) and the respective 
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Preparation of Tissues for Microscopy 
For visualization of live animals, washed worms were mounted on slides with a 2% 
agarose pad with M9 buffer containing 0.4% levamisole to induce paralysis. For live 
embryos, gravid adults were placed on the agarose pad and cut around the vulva with a fine 
hypodermic needle. Preparation of tissues for DAPI staining and immunofluorescence 
were carried out largely according to Phillips et al., 2009. For gonad dissection 40 to 50 L4 
to young adult worms were picked from plates and washed extensively with 1X Egg Buffer 
(25 mM HEPES-NaOH pH 7.4, 118 mM NaCl, 2 mM EDTA, 0.5 mM EGTA, 0.1% 
Tween-20) to eliminate bacteria. Then the buffer was replaced with Egg Buffer containing 
0.4 mM levamisole (15-30 µl) and transferred onto an 18x18 mm coverslip. By cutting the 
animals with the tip of a fine hypodermic needle at either the head (below the pharynx) or 
at the tail, gonads, and intestines were released. An equal volume of fixative solution 
(3.7% formaldehyde in 1X Egg Buffer without Tween-20) was added and pipetted up and 
down to further extrude and dissociate germline tissue from the rest of the animals. 
Fixation was allowed to occur for 5 minutes at room temperature. All but about 10 µl of 
solution were removed from the coverslip. The coverslip was picked up by touching the 
drop at the center of a positively charged slide (VWR VistaVision HistoBond) leaving a 
small corner of the coverslip protruding from the edge of the slide. Excess solution was 
wicked away from the edge of the coverslip using torn strips of absorbent filter paper to 
promote adherence of the tissues to the slide. The sample was then freeze-cracked by 
placing it on a pre-cooled aluminum block on dry-ice for at least 10 minutes and quickly 
flicking the coverslip from the slide using the protruding corner. The slide was 
immediately dipped in cold (-20˚C) methanol in a Coplin jar for 1 minute, and then 
transferred to 1X PBS buffer (10 mM Phosphate pH 7.4, 137 mM NaCl, 2.7 mM KCl) 
containing 0.1% Tween-20 (PBST) at room temperature. For DAPI staining only, the slide 
was washed in PBST for 10 minutes, followed by another 10-minute wash with PBST 
containing 0.5 µg/ml DAPI, and a final 30-minute wash in PBST, all at room temperature. 
Slides were mounted by first removing excess buffer from the slides without letting the 
sample dry completely and then inverting the slide and touching the sample on a drop of 10 
µl of Vectashield mounting medium placed at the center of a 22x22 mm coverslip. Excess 
medium was removed by pressing the inverted mounted slide on a paper towel, and the 
edges were sealed with transparent nail polish.  
For immunofluorescence, the wash step after methanol was followed by 3x 10-
minute washes in PBST, followed by a blocking step with 0.5% BSA in PBST. For this, 




100 µl of the solution were added onto the worms and covered with a square Parafilm 
coverslip to hold the liquid in the sample area. Slides were incubated in a humid chamber 
at room temperature for at least 30 minutes. The Parafilm slides were removed by dipping 
the slide in PBST. 100 µl of primary antibody diluted in blocking solution were placed on 
the sample and covered with a Parafilm coverslip, and incubated in a humid chamber for 2 
hours at room temperature or overnight at 4˚C. After 3x 10-minute washes in PBST at 
room temperature the slide was incubated with secondary antibody as described for the 
primary, followed by DAPI staining and mounting of the slide as described above. 
For enhancement of the PIR-1::GFP signal, worms were incubated with a 1:100 
dilution of anti-GFP mouse monoclonal antibody (WAKO) overnight at 4˚C. Secondary 
antibody incubation was performed for 2 hours at room temperature with a 1:500 dilution 
of FITC-conjugated donkey anti-mouse (Jackson). For histone H3 a rabbit polyclonal anti-
H3 (Cell Signaling) was used at a 1:100 dilution and incubated overnight at 4˚C, followed 
by a 2-hour, room-temperature incubation with 1:500 TRITC-conjugated anti-rabbit 



















Proteomic and Biochemical Studies  
of PIR-1 and Interacting Proteins 
 





In parallel with our characterization of PIR-1 at the cellular and developmental 
levels, we undertook biochemical approaches to find PIR-1 protein partners in vivo. Since 
DCR-1 integrates multiple complexes to produce distinct sRNA species, one of the main 
objectives of the project was to understand precisely which Dicer complexes PIR-1 
associates with. Our point of departure was the analysis of PIR-1 immunoprecipitates from 
the rescuing transgenic lines by Multidimensional Protein Identification Technology 
(MudPIT), the same approach that led to the discovery of PIR-1 as a partner of Dicer. With 
this method we confirmed the interaction of PIR-1 with DCR-1, and defined a new set of 
interactors that points to a role in Dicer-dependent sRNA biogenesis. Further, we validated 
these interactions by IP/western blotting across development. Unexpectedly, we found that 
PIR-1 is expressed as two isoforms with intriguing differences concerning the proteins they 
interact with, subcellular distribution, and developmental expression. These findings 
constitute an important groundwork from which to dissect the apparently wide range of 
PIR-1 functions.   
 






MudPIT of PIR-1 Immunoprecipitates Reveals Interactions with Proteins of 
the ERI Complex  
MudPIT is a highly sensitive technique for large-scale identification of proteins in 
highly complex mixtures (Wasburn et al., 2001; Wolters et al., 2001; reviewed in Yates et 
al., 2009). It combines fractionation of a peptide digest of the protein mixture by 
multidimensional microscale liquid chromatography, electrospray ionization, and tandem 
mass spectrometry. The origin of each peptide is then computationally determined by 
comparison to a protein database. In preparation for MudPIT, we performed silver-staining 
of PIR-1::3xFlag IPs, as the clear presence of specific bands in silver staining is a requisite 
for generating good-quality data through MudPIT. Three prominent bands that were 
present only in the transgenic rescued IP were sent for mass spectrometry (Fig. 3.1A). Two 
of them were identified as DCR-1 and the helicase DRH-3. The other band could not be 
identified due to contaminants, but was later confirmed to be the Eri RdRP RRF-3, in 
agreement with the molecular weight of the band on the gel. The IP material used for the 
first MudPIT experiment was tested by western blotting with antibodies available in the 
laboratory (Fig. 3.1B). This confirmed DCR-1 and DRH-3 to interact specifically with 
both PIR-1::3xFlag and PIR-1::GFP, and showed that ERI-1b, but not the shorter isoform 
ERI-1a, also interacts with PIR-1. ERI-1a has been shown to have a role in cytoplasmic 3'-
end processing of 5.8S rRNA which is distinct from the role of ERI-1b in 26G-RNA 
biogenesis (Gabel and Ruvkun, 2008). 
The IPs used for MudPIT were performed on a 1:1 mixture of extract from gravid 
adult transgenic animals fed normal bacteria and extract from gravid adult wild-type N2 
animals that were fed bacteria grown on 
15
N-containing  (heavy) growth medium. This 
allowed us to discern specific from unspecific interactions that occur with the affinity 
matrix, through analysis of heavy-to-light peptide ratios obtained for each protein. In other 
words, when only light peptides (from the transgenic extracts) for a given protein are 
recovered, it means that the interaction is PIR-1-specific. As an additional criterion for 
specificity we considered proteins that were detected in both PIR-1::GFP and PIR-
1::3xFlag IP experiments. Table 3.1 summarizes the results of this experiment, revealing 
that most of the proteins in common to both IPs are components of the ERI complex, 
namely DCR-1, DRH-3, RRF-3, RDE-4, and ERI-3. They rank among the highest 
abundance proteins recovered, as judged by the obtained spectral counts, the measurement 
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that most strongly correlates with relative protein abundance (Liu et al., 2004). As the IP of 
PIR-1::GFP was generally cleaner and free from immunoglobulin contaminants, we 
obtained higher spectral counts and detected additional peptides corresponding to ERI-1 
and ERI-5, not found in the PIR-1::3xFlag IP. Additionally, ERI-9 was detected in both 
IPs, albeit at a very low abundance. All of these proteins have previously been defined as 
components of the ERI complex (refer to Chapter I, page 43; Duchaine et al., 2006; 
Thivierge et al., 2012). To confirm these results, an independent PIR-1::GFP IP/MudPIT 
experiment was performed without a heavy-isotope control (Table 3.2). Again, we 
obtained high spectral counts for DCR-1, DRH-3, RRF-3, RDE-4, and ERI-3, and could 
still detect some peptides from ERI-1, ERI-5, and ERI-9.  
We then proceeded to verify some of these interactions by western blotting, as well 
as to test other important RNAi factors for which antibodies were available. In Figure 3.2A 
and B, IP of PIR-1::3xFlag robustly pulled down DCR-1, DRH-3, RRF-3 and ERI-1b (the 
RRF-3 antiserum cannot detect the protein in inputs and it normally detects an unspecific 
band above RRF-3). Surprisingly, we could also easily detect RDE-8 despite its very low 
abundance in the second PIR-1::GFP IP MudPIT run. This Zc3h12a-like endoribonuclease 
was discovered in our laboratory and shown to be required for exo- and endo-RNAi (Tsai 
et al., 2014). This constituted the first evidence that RDE-8 may integrate the fully 
assembled ERI complex. Other proteins tested included the essential Argonaute CSR-1 
(also detected at low abundance in the same MudPIT experiment as RDE-8), the 22G-RNA 
RdRPs RRF-1 and EGO-1, and the 3'-5' exonuclease required for 22G-RNA accumulation 
MUT-7, none of which could be detected. When analyzing the post-IP supernatants we 
could not detect a depletion of the proteins recovered in the PIR-1 IP, despite an almost 
complete depletion of PIR-1::3xFlag (Fig. 3.2A and B). This suggests that PIR-1 stably 
interacts with only a small fraction of the total available pool of these proteins, consistent 
with the fact that DCR-1 and DRH-3 are known components of other complexes. 
Interestingly, the IPs reveal that PIR-1 may exist as two isoforms migrating very closely 
within ~2-4 kDa, regardless of the tag present on its C-terminus (compare Fig. 3.2B and 
C). We named the isoforms PIR-1a (lower, lighter band) and PIR-1b (upper, heavier band). 
 
 






Figure 3.1. Validation of PIR-1 immunoprecipitations before MudPIT. (A) Silver staining of a 
PIR-1::3xFlag IP. Arrows point to bands found exclusively in the IP from the transgenic animals 
but not in the wild-type negative control. The bands were excised and sent for identification by 
mass spectrometry. The middle band was not identified due to contaminants, but migrated at the 
predicted molecular weight for RRF-3. (B) Western blotting of IPs from mixed extracts of rescued 
transgenic animals and 
15
N-labeled wild-type animals used for MudPIT analysis. ‘MM’ is the 

















Spectral counts represent the total number of tandem mass spectra that match peptides to each protein and is 
the best estimate of the protein abundance in a mixture. 
b
 High confidence interactions were defined as 
proteins that had >10 spectral counts in either IP and for which no heavy 
15
N peptides were recovered. 
c 
The 
data refer to the fusion proteins PIR-1::GFP (476 aa / 54.3 kDa), and PIR-1::3xFlag (263 aa / 30.5 kDa). 
d
 
Interactors that did not meet the specified spectral count cutoff but that have been found to interact with 




Table 3.1. List of Specific Interactors Obtained by MudPIT of PIR-1::GFP and 
PIR::3xFlag Immunoprecipitates from a Mixture of Unlabeled Transgenic with 
15
N-
labeled Wild-Type Protein Extracts from Gravid Adults 
Protein 
Length in aa/  















 233 / 27.1 202 / 12 29 / 7 42.9% / 22.3% 
DCR-1 1845 / 210.9 137 / 27 50 / 12 31.2% / 9.0% 
RRF-3 1780 / 203.1 68 / 15 27 / 9 18.0% / 6.1% 
DRH-3 1119 / 129.1 59 / 19 24 / 7 23.1% / 7.1% 
ERI-5 531 / 61.6 24 / 0 11 / 0 22.0% / 0% 
RDE-4 385 / 43.4 13 / 8 8 / 3 28.6% / 15.1% 
ERI-3 578 / 66.4 16 / 2 7 / 2 10.7% / 5.7% 
Additional Interactors Previously Found in Association with DCR-1
d
 
ALG-2 910 / 101.6 4 / 3 2 / 2 3.7% / 5.2% 
ERI-9 635 / 73.5 2 / 3 2 / 2 5.4% / 6.5% 
ERI-1 582 / 67.2 7 / 0 3 / 0 12.7% / 0% 
ALG-1 1002 / 110.9 3 / 0 2 / 0 3.3% / 0% 
B0001.2 926 / 105.1 0 / 3 0 / 2 0% / 2.7% 
Table 3.2. List of Interactors Obtained by MudPIT of PIR-1::GFP Immunoprecipitates 
from Young Adult Extracts 
Protein 
Length in aa/  







ERI Complex Proteins 
PIR-1::GFP 476 / 54.3 142 29 35.9% 
DCR-1 1845 / 210.9 118 41 22.8% 
RRF-3 1780 / 203.1 54 28 17.9% 
DRH-3 1119 / 129.1 50 25 24.8% 
ERI-3 578 / 66.4 23 10 14.9% 
RDE-4 385 / 43.4 15 6 17.1% 
ERI-1 582 / 67.2 11 6 11.3% 
ERI-5 531 / 61.6 9 4 8.7% 
ERI-9 635 / 73.5 2 2 3.8% 
Proteins with Roles in Exo- and Endo-RNAi Pathways 
RDE-8 
(ZC477.5) 
339 / 38.9 5 2 6.8% 
Other Dicer-Associated Proteins  
B0001.2 926 / 105.1 8 6 8.6% 






Figure 3.2. Immunoprecipitation/western analyses confirm interactions with ERI complex 
proteins and demonstrate that PIR-1 is expressed as two distinct isoforms. (A) PIR-1 interacts 
with DCR-1, DRH-3 and ERI-1b but not with other sRNA proteins not found in MudPIT. RDE-8 is 
abundantly pulled down by PIR-1 in spite of having been detected in only one MudPIT run at very 
low abundance. Analysis of supernatants after IP shows depletion of PIR-1::3xFlag but not of its 
partners. (B) Western blot confirmation of the interaction with RRF-3, which can only be detected 
upon IP enrichment. Two different PIR-1 isoforms are clearly enriched after IP. (C) The two 
isoforms are maintained when the PIR-1 is C-terminally tagged with GFP. PIR-1::GFP was 
normally difficult to detect in inputs, perhaps due to lower sensitivity of the antibody used or lower 
expression compared to PIR-1::3xFlag. Dashed lines separate the same samples run on separate 
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PIR-1 Co-Fractionates with the Fully Assembled ERI Complex and Maintains 
Most Interactions throughout Development 
 In order to further characterize the association of PIR-1 with ERI-complex proteins, 
we performed gel filtration followed by western analysis of extracts from young gravid 
adult pir-1::3xFlag rescued animals (Fig. 3.3A). The fully assembled ERI complex is 
estimated to be ~850 kDa (Thivierge et al., 2012), and consistent with PIR-1 assembling 
with the complex it is abundantly detected in high molecular weight fractions (to the left of 
the 440 kDa marker). Curiously, PIR-1b strictly overlaps with DCR-1, becoming 
undetectable in lower MW fractions where DCR-1 can also no longer be detected. In these 
lower molecular fractions, PIR-1a becomes enriched and still overlaps with DRH-3, ERI-
1b and RDE-8. This experiment strongly supports PIR-1b as the predominant form 
associating with the core ERI complex but it also points to the existence of lower MW 
complexes integrating primarily PIR-1a. This uneven distribution could reflect the 
involvement of PIR-1 in distinct processes.   
 During the optimization of IP and washing conditions for PIR-1 CLIP-seq, we 
made some observations regarding the properties of PIR-1 interactions. The inclusion of an 
ultracentrifugation step at ~130,000x g for one hour, for instance, did not deplete the 
extracts of PIR-1 and some of its partners, suggesting that the majority of PIR-1 molecules 
are not stably associated with very high MW complexes such as ribosomes, spliceosomes 
or other large RNP complexes (Fig. 3.3B). We increased the stringency of post-IP washes 
by first varying the amount of salt and then the detergent concentration and composition 
from the standard lysis and IP buffer (25mM HEPES-KOH pH7.5, 150 mM KCl and 0.5% 
NP-40). The inclusion of a five-minute washing step at 4ºC with different salt 
concentrations demonstrated that the tested interactions are stable in up to 1 M KCl, 
beyond which they begin to weaken (Fig. 3.3C). Using 1 M KCl, we tested different 
concentrations of non-ionic (NP-40) and anionic (SDS and sodium deoxycholate) 
detergents. When we included sodium deoxycholate, in addition to NP-40 and SDS, the 
interactions with DRH-3 and ERI-1b were partially lost, while the interaction with DCR-1 
remained as strong as with NP-40 alone (Fig. 3.3D, conditions 5 and 6). While this is far 
from being a systematic study of the stability of the complex, it does suggest that the 
interaction of PIR-1 with DCR-1 is particularly stable and helps explain why PIR-1 was so 
abundantly detected in DCR-1 proteomics, but less so in proteomics of ERI-1 and ERI-5 
(Duchaine et al., 2006; Thivierge et al., 2012). Lastly, incubating PIR-1 
immunoprecipitates with RNases followed by washes did not disrupt the association with 




DCR-1 or DRH-3 (Fig. 3.3E). Despite not entirely conclusive, together with the high 
tolerance of the interactions to harsh salt and detergent conditions, this result argues that 
PIR-1 complexes likely do not require RNA to assemble.   
In agreement with the expression pattern of PIR-1::GFP described in Chapter II, we 
could detect PIR-1::3xFlag at every developmental stage by western blotting (Fig. 3.4A). 
PIR-1 is expressed at a slightly higher level in embryos than in postembryonic stages, 
during which expression is relatively constant. DCR-1, DRH-3 and ERI-1b are highly 
expressed in embryos and L1 larvae compared to L2 and L3 larvae. During the L4 stage, at 
which the germline greatly expands and spermatogenesis takes place, the expression of the 
three proteins is again increased, only to suffer another slight decrease during adulthood. 
PIR-1 IPs at every developmental stage showed that both PIR-1 isoforms are recovered at 
all post-embryonic stages. Interestingly, only one form is expressed in embryos. An 
independent PIR-1::GFP IP clearly shows that the enriched form in embryos is PIR-1b 
(Fig. 3.4B), which we have shown in the previous section to preferentially co-fractionate 
with Dicer at high MW. At this developmental stage, the highest amount of all tested 
interactors is pulled down, including RRF-3, suggesting that the activity of a PIR-1-
containing ERI complex is particularly important in the developing embryo. During the 
rest of development, interactions are maintained throughout but are stronger in L1s, 
reaching a low during L3. They then start gradually increasing at L4 to coincide with 
intense germline development and, later, with embryogenesis in gravid adults. Interactions 
with RRF-3 and RDE-8 are also detected in both young and older gravid adults (Fig. 3.4C). 
 
 





Figure 3.3. PIR-1 co-fractionates with the fully assembled ERI complex and interacts very 
stably with Dicer and other proteins of the complex. (A) Gel filtration of PIR-1 
immunoprecipitates from young gravid adults followed by western blotting. PIR-1a is found in a 
very broad range of molecular weights, but PIR-1b tends to reside in MW fractions where the ERI 
complex is also found. (B) PIR-1a, PIR-1b and interactors remain in extracts subjected to 
ultracentrifugation, precluding stable and abundant association with very high MW complexes. (C) 
PIR-1 interactions are resistant to low and high salt washes after IP. (D) Under high salt conditions, 
the PIR-1/DCR-1 interaction is resistant to washing with high concentrations of anionic and ionic 
detergents. The buffer is 1M KCl, HEPES-KOH pH 7.5 with the following combinations of 
detergents in each lane:  (1) 0.5% NP-40; (2) 0.5% NP-40, 0.1% SDS; (3) 1% NP-40; (4) 1% NP-
40, 0.1% SDS (5) 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate; (6) 1% NP-40, 0.1% SDS, 
1% sodium deoxycholate. (E) PIR-1 interactions are maintained after treatment with RNases 










Figure 3.4. PIR-1 is expressed throughout development as two isoforms, except in embryos. 
(A) IP and western blotting of PIR-1::3xFlag at various developmental stages. ‘wt’ (wild-type) is 
N2; ‘tg’ (transgenic strain) is pir-1; pir-1::3xflag. The signal in the IP lanes detected with the 
tubulin antibody coincide with the IgG heavy chain from the antibody used for IP, and therefore 
reflect non-specific binding of the secondary antibody. (B) IP of PIR-1::GFP from the MosSCI 
single-copy rescued animals to show that only PIR-1b is expressed in embryos and that the RRF-3 
interaction is maintained. (C) IP of PIR-1::GFP from an independent rescued integrated 
bombardment line (not the bombardment line used for MudPIT). Non-gravid young adults and 
gravid adults maintain all interactions, including RRF-3 and RDE-8. Interactions are stronger in 
gravid adults, likely due to embryos where higher amounts of interactors co-immunoprecipitate 




PIR-1 Isoforms Likely Arise from Post-Translational Modifications 
 Given the intriguing differential expression and interaction pattern of PIR-1a and 
PIR-1b we sought to understand how these forms originate, with the ultimate goal of 
asking whether they are functionally distinct. In C. elegans about 70% of mRNAs begin 
with a 22-nt spliced leader (SL) donated by a 100-nt precursor RNA. The addition of this 
sequence, which has a trimethyl guanosine (TMG) cap at its 5' end, is spliced to the first 
exon to replace an “outron” sequence with a canonical monomethyl guanosine cap. This 
process is termed trans-splicing. There are a variety of SL sequences, but the predominant 
are SL1 and SL2. SL1 typically gets added to the mRNAs of single genes or to the first 
mRNA of polycistronic RNAs transcribed from multi-gene operons (~15% of C. elegans 
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genes are clustered in operons). SL2 gets spliced exclusively to pre-mRNAs that follow the 
first gene of an operon (reviewed in Blumenthal, 2012). We designed primers for SL1, 
SL2, and for a position ~180 nt downstream of the predicted pir-1 and sec-5 mRNA start 
codons. PCR products of a different size would indicate that trans-splicing occurred at a 
site other than the predicted start site for each mRNA. sec-5, being the first gene of an 
operon, served as our SL1 positive control. RT-PCR followed by TOPO cloning and 
sequencing demonstrated that sec-5 is indeed SL1 trans-spliced at the predicted site, 
whereas pir-1 RT-PCR gave rise to a product shorter than the expected 180 nt (Fig. 3.5A). 
We found that the SL1 got spliced seven nt upstream of a second ATG, located 83 nt 
downstream of the originally predicted ATG. This result was later confirmed by RNA-seq 
in our laboratory (Fig. 3.5B). The pir-1 gene depicted is the old model predicted to encode 
a 261 aa protein. Cap-seq, a method developed in our laboratory that primarily clones the 
5' ends of capped RNAs (Gu et al., 2012), confirmed that pir-1 mRNA is SL1 trans-spliced 
right before the second start codon. mRNA-seq is in agreement with the trans-spliced 
mRNA being the prevalent form. Additionally, data from the laboratory of Andrew Fire at 
Stanford University independently confirmed the size and exon usage by mRNA-seq, as 
well as the mRNA segments that are protected by ribosomes (i.e., undergoing active 
translation) by ribo-seq (Stadler et al., 2012). Finally, when we assembled all the PIR-1 
peptides detected in our MudPIT experiments, we never obtained sequence coverage 
upstream of the second ATG (not shown). Together, these results indicate that the 
maximum size of PIR-1 is 233 aa (and at least 27.1 kDa) in developmental stages where 
both PIR-1 isoforms are expressed. 
 In order to complement the aforementioned experiments, we individually 
mutagenized the three potential start sites in PIR-1::GFP to assess changes in rescuing 
ability and isoform expression (Fig. 3.6A and B). Abrogating ATG1 (in the original gene 
model) did not affect the transgene’s ability to rescue the pir-1 mutant phenotype and 
expression of the two isoforms. Mutagenizing ATG2, the start codon found immediately 
downstream of the SL1 sequence, led to no expression and no rescue. Interfering with 
ATG3 did not affect rescue and both isoforms were still expressed. Both ATG1 and ATG3 
mutations did not interfere with PIR-1 localization in the nuclei of live animals (Fig. 3.6C). 
These results define ATG2 as the sole PIR-1 start site, implying that the size difference 
between PIR-1a and PIR-1b is not due to alternative start sites. We examined the potential 
for protein variants generated by alternative splicing, including exon skipping and intron 
inclusion, but they either gave rise to ORFs of different sequences with premature stop 




codons or to proteins too small to explain the small size difference between the isoforms. 
On SDS-polyacrylamide gels, the PIR-1::GFP protein runs just above 50 kDa, in line with 
the 54 kDa size predicted from translation initiating at ATG2. It is therefore possible that 
the isoforms arise from post-translational modifications such as N-terminal cleavage or 
addition of small modifier molecules. Since PIR-1 is predicted to have at least nine 
phosphorylation sites (five at serine residues, three at threonine residues, and one at a 
tyrosine residue; predicted using the ScanProsite tool from Expasy.org), we digested 
immunoprecipitated PIR-1::3xFlag with calf intestinal phosphatase (CIP) or with Lambda 
protein phosphatase (λ PP). While CIP can remove phosphates from most residues, it 
prefers phosphotyrosine residues, whereas λ PP is a dual specificity protein phosphatase 
with high activity not only towards phosphorylated tyrosines, but also phosphoserines and 
phosphothreonines. Upon treatment with λ PP, but not CIP, the bands lost sharpness but 
did not collapse into one lower band, as one would expect if the only modification was 
phosphorylation and digestion was complete (Fig. 3.6D). This result suggests that PIR-1 is 
phosphorylated, but that it may not be the only post-translational modification it is 
subjected to.  
In order to directly identify post-translational modifications that would justify the 
existence of two isoforms, we performed MudPIT analysis of PIR-1 in the drh-3 mutant 
background. As detailed in the next section, when DRH-3 is not expressed, only PIR-1b is 
stable. We therefore took advantage of this fact to maximize peptide coverage of the 
heavier PIR-1 isoform. We intended to use the results to individually substitute every 
modifiable residue and find how each modification affects PIR-1 isoform composition, 
interactions it retains with protein partners, and its ability to rescue the mutant phenotypes. 
We were only able, however, to cover about 50% of the protein, precluding us from 
undertaking a systematic analysis of its modifications. We were able to confirm that 
peptides for which phosphorylations were predicted were indeed phosphorylated in vivo. 
This was observed for seven of the nine predicted phosphorylations at positions T49, S54, 
T90, T92, Y164, S196 and S210. Peptides containing the remaining two predicted 
phosphoserines were not recovered. Other predicted modification sites included an 
amidation site (residues 21-24), two N-myristoylation sites (residues 147-152 and 153-
158), and three N-glycosylation sites (155, 170 and 230). With the exception of residue 
N230, none of the other residues were covered. Interestingly, the peptide with N230 
contained a modification with a measured mass of 359 Daltons, coinciding with the sum of 
two mannose molecules. Thus the asparagine at position 230 of PIR-1 is confirmed to be 
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N-glycosylated in vivo, supporting the idea that the two isoforms result from differential 
post-translational modifications. Lastly, we considered other modifications such as 
ubiquitination and sumoylation, despite the fact that they usually add significantly more 
mass to the modified protein than the size difference we observe between PIR-1a and PIR-
1b (typically ~8.5 kDa for ubiquitin and ~12 kDa for SUMO). Nonetheless, we silenced 
key components of both pathways by RNAi and examined the effect on the size of the 
isoforms by IP/western blotting. In all cases both PIR-1a and b exhibited no differences 
relative to mock-RNAi treated animals (not shown).  
As mentioned in Chapter II, we analyzed immunoprecipitates of non-rescuing 
catalytically inactive PIR-1::GFP by western blotting. Intriguingly, we saw that in this 
strain we could only recover the highest MW isoform PIR-1b (Fig. 3.6E, upper and lower 
blots). The interaction with DCR-1 and the nuclear localization did not change in arrested 
animals, indicating that the lack of rescue is solely due to the loss of catalytic activity of 
PIR-1 (Fig. 3.6F). When we compared two other integrated rescuing transgenic strains 
carrying mutations that do not affect the ability of PIR-1 to rescue, they also only 
expressed PIR-1b (Fig. 3.6E, upper panel), and their association with DCR-1 was also not 
perturbed. This result bears the significant implication that expression of PIR-1b is 
sufficient to rescue the pir-1 mutant phenotypes. We speculate that the disappearance of 
PIR-1a upon mutagenesis could be due to slight structural changes that either render it 
inherently unstable or cause it to lose stabilizing interactions with crucial protein partners.   
 






Figure 3.5. pir-1 mRNA is trans-spliced to SL1 at its 5' end, giving rise to an open reading 
frame of 233 amino acids. (A) RT-PCR of a 5' segment of the sec-5 and pir-1 mRNAs with SL1 
or SL2 forward primers. Bands 1-4 were purified, TOPO-cloned and sequenced. Bands 1 and 3 
were unspecific products, band 2 corresponded to the predicted SL1-sec-5 size, and band 4 
Chapter III Results 
129 
 
corresponded to a shorter SL1-pir-1 sequence excluding the start codon predicted in the original 
gene model. (B) Deep-sequencing of PIR-1 mRNA by different methods. The depicted gene model 
gives rise to a 261 aa protein. In blue are exons separated by introns, and in black is the predicted 
5'-UTR. Sequencing of capped RNAs (cap-seq) demonstrates that most reads map to a position 
downstream of the predicted ATG. The normalized number of reads is represented as blue bars that 
map to the first nucleotide of each read. Below, full-length reads are mapped, with the thickness of 
the arrows proportional to the amount of each unique read. Black arrows represent non-SL capped 
reads, and the red arrow indicates that the sequence is preceded by SL1. The exact site where the 
SL1 sequence is fused is mapped above the gene diagram. mRNA-seq captured sequences from all 
exons and the predicted 5' UTR. The Fire laboratory experiments show that ribosomes start 
translation after the SL1 site and cover all predicted exons, but not the 5' UTR, as expected. 
mRNA-seq correlates well with our experiment, but defines exons more clearly. Sense reads are 
colored in blue and antisense are red. 
 
 






Figure 3.6. PIR-1 isoforms do not arise from alternative start sites and only PIR-1b is 
expressed when certain amino acids are substituted. (A) Diagram of PIR-1::GFP with potential 
start sites and mutations used to annul them (in red). Sizes are given for each of the three potential 
forms, including the original 261 aa version. (B) IP from extracts of non-integrated rescued 
transgenic young adults for PIR-1(mut ATG1)::GFP and PIR-1(mut ATG3)::GFP. “Ex” stands for 
extrachromosomal arrays. Transgenic lines with the PIR-1(mut ATG2)::GFP did not rescue the 
mutant phenotypes or expressed the protein. The dashed line separates two different gels with the 
same samples. (C) Microscopy of rescued PIR-1 ATG mutants shows unaltered nuclear PIR-
1::GFP expression. Head neurons can be seen on the left images and intestinal nuclei are prominent 
on the right. (D) Phosphatase treatments of PIR-1::GFP immunoprecipitates with CIP (Calf 
Intestinal Phosphatase) or λ PP (Lambda Protein Phosphatase). 1 M urea was added to create 
slightly denaturing conditions that could facilitate digestion of phosphorylated residues. (E) IP of 
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PIR-1::GFP from integrated single-copy lines with three different mutant sequences (refer to Table 
2.1, page 89), including the catalytically inactive C150S, which was counter-selected on ivermectin 
for seven days. The lower panel is an independent experiment with improved resolution to confirm 
that only the PIR-1b isoform remains in the phosphatase mutant. (F) Localization of PIR-
1(C150S)::GFP mutant protein in arrested animals. The left image shows mostly neuronal nuclei 




Dicer Stabilizes and Preferentially Interacts with the PIR-1b Isoform 
Given the distribution differences of PIR-1a and PIR-1b on the gel filtration 
experiment in Figure 3.3 (page 123), we wanted to better understand the contribution of 
each form to the interactions we uncovered, particularly with DCR-1. Since we did not 
have enough antibody to IP endogenous DCR-1, we created a pir-1; dcr-1 deletion mutant 
strain rescued with integrated pir-1::gfp and non-integrated 3xflag::dcr-1 transgenes (from 
Welker et al., 2010). While IP of PIR-1 pulled down PIR-1a and PIR-1b, IP of DCR-1 
pulled down only one PIR-1 isoform (Fig. 3.7A, top panel). This form appears to be PIR-
1b because when we performed a PIR-1 IP on an extract previously used for DCR-1 IP, we 
observed a decrease in the intensity of the top PIR-1b band relative to PIR-1a (Fig. 3.7A 
top and lower panels). In contrast, IP of DRH-3 recovered both PIR-1 isoforms (Fig. 3.7B). 
These results are consistent with DCR-1 co-fractionating predominately with PIR-1b, and 
with DRH-3 co-fractionating with both isoforms. 
We next asked how disruption of the ERI complex through genetic deletion of 
some of its components would affect interactions with PIR-1. We crossed the pir-1::gfp 
transgene and pir-1 deletion with dcr-1, drh-3, eri-1 and rde-4 null mutants. The animals 
carrying dcr-1 and drh-3 deletions were genetically balanced, as homozygotes develop into 
sterile adults. In order to obtain pure homozygous populations, we counter-selected 
animals for seven days on ivermectin, as described for pir-1 mutants in Chapter II. IP of 
PIR-1 from rde-4 animals led to no changes in interactions or changes in PIR-1 isoforms 
when compared to IP from a wild-type background (Fig. 3.7C). When ERI-1 was not 
expressed, interactions with DCR-1 and DRH-3 were maintained and both PIR-1 isoforms 
were present (Fig. 3.7D). In the absence of DRH-3 the association with both RRF-3 and 
RDE-8 was lost, and DCR-1 and ERI-1b interactions were weakened (Fig. 3.7C and D). 
Interestingly, the lighter PIR-1a isoform became nearly undetectable in the drh-3 
background. Conversely, in the absence of DCR-1, we observed a depletion of PIR-1b 
(Fig. 3.7E). Also in the dcr-1 mutant background, the association with DRH-3 became 




nearly undetectable and the interaction with ERI-1b was weakened. The apparent 
differential stabilization effect of DRH-3 and DCR-1 on the two PIR-1 isoforms again 
correlates with the gel filtration result and suggests that PIR-1 can interact separately with 
each of them. In Figure 3.7E, however, it is difficult to reconcile the presence of PIR-1a 
with the absence of DRH-3 in the dcr-1 mutant IP lane. In this case, it is possible that 
enough DRH-3 is interacting with PIR-1a to stabilize it, albeit at an undetectable level. 
Alternatively, PIR-1a may only be able to fold into a stable conformation in the context of 
a transient interaction with DRH-3. Finally, we examined the interactors recovered from 
the MudPIT of PIR-1 complexes in the drh-3 mutant background. As stated in the previous 
section, the goal of this experiment was to maximize coverage of PIR-1b to identify 
posttranslational modifications. The extracts and IPs were therefore subjected to 
ultracentrifugation and high stringency wash conditions for maximum enrichment of PIR-
1b (see Materials and Methods). Under these restrictive conditions, only the interactions 
with DCR-1, RDE-4 and ERI-3 remained (Table 3.3). This confirmed the strong 
association between PIR-1 and DCR-1, and suggested the existence of a strong core 
complex of these four proteins, independent of the DRH-3/RRF-3 RdRP module proposed 
by Thivierge et al. (2012). Supporting our result, the same study also demonstrated that 
ERI-3 directly interacts with DCR-1.  
Together, the results obtained from gel filtration, DCR-1 and DRH-3 IPs, and PIR-
1 IPs in dcr-1 and drh-3 mutants, point to potential functional distinctions between PIR-1a 
and PIR-1b. Because the two isoforms still overlap in high MW fractions, it is possible that 
slightly different complexes exist or even that both forms are present in the same complex. 
Since DRH-3 can pull down both isoforms and DCR-1 only pulls down one, it cannot be 
ruled out that DRH-3 is also able to bind PIR-1. Even though the destabilization of PIR-1 
in mutant backgrounds suggests direct binding, future experiments should specifically 
address this by resorting, for instance, to recombinant protein pulldown assays or targeted 
yeast two-hybrid screens.  
 
 





Figure 3.7. PIR-1 isoforms do not interact equally with DCR-1. (A) Sequential IPs of PIR-
1::GFP and 3xFlag::DCR-1. The order in which the IPs were performed is indicated below each 
panel. The second IP used the supernatant from the first IP. The two panels constitute independent 
experiments to emphasize the depletion of PIR-1b when DCR-1 IP is performed first. In the top 
panel the DCR-1 IP recovers only one PIR-1 band. (B) IP of endogenous DRH-3 recovers PIR-1a 
and PIR-1b. CSR-1 served as a negative control. (C) PIR-1::GFP IPs in rde-4 and drh-3 mutant 
backgrounds. Note that only one PIR-1 isoform is maintained in drh-3 and interactions with other 
proteins are lost or reduced. The asterisk signals an unspecific band. (D) PIR-1::GFP IPs in eri-1 
and drh-3 mutant backgrounds. This confirms that only PIR-1a is lost in the absence of DRH-3. (E) 
PIR-1::GFP IPs in the dcr-1 mutant background, in which only PIR-1b is not expressed. In all 
experiments animals were non-gravid young adults or, in the case of drh-3 and dcr-1, mature sterile 
adults. 
 






IP from sterile drh-3 animals counter-selected for seven days. Only the PIR-1b isoform was recovered. 
High-stringency conditions included ultracentrifugation of extracts and high-salt, high-detergent post-IP 
washes (see Materials and Methods).  
 
 
PIR-1b Is Enriched in the Nucleus Where It Interacts with Dicer and ERI 
Complex Proteins and Associates with Chromatin  
The localization of PIR-1 in cell nuclei raised the question of whether its 
association with the ERI complex occurs within the nuclear compartment. Initial 
purifications of nuclei followed by western blotting revealed that PIR-1b preferentially 
accumulates in nuclei, while PIR-1a is detectable primarily in total extract (Fig. 3.8A and 
B). This made it clear that a pool of cytoplasmic PIR-1 exists. However, because obtaining 
pure cytoplasmic extracts from C. elegans is not feasible, we were unable to determine 
whether only PIR-1a or both isoforms coexist in the cytoplasm. Next, we prepared a large 
amount of pure nuclei from non-gravid young adults to test protein interactions by IP of 
PIR-1::3xFlag in the nucleoplasm (i.e., the soluble portion of lysed nuclei, excluding 
chromatin). As a result DCR-1, DRH-3 and ERI-1b co-purified with PIR-1b from nuclear 
extracts (Fig. 3.8C). This was particularly obvious for Dicer, which could not be detected 
in the nuclear extract input sample, but became visible after IP. This finding strongly 
suggests that a PIR-1-containing ERI complex, and perhaps other types of PIR-1 
complexes operate in the nucleus. 
When we stained fixed tissues of pir-1::gfp rescued animals with DAPI, some of 
the GFP signal overlapped with chromatin (Chapter II, Fig. 2.4B). We therefore purified 
chromatin from transgenic animals and tested for the presence of PIR-1 and ERI proteins 
by western blotting. We found that PIR-1b (but again not PIR-1a) was easily detected in 
purified chromatin, as were DRH-3, ERI-1b, and DCR-1 (Fig. 3.8D and E). Tubulin and 
histone H3 served as negative and positive markers of pure chromatin, respectively. Since 
Table 3.3.  List of PIR-1 Interactors Obtained in an Independent MudPIT Experiment 




Length in aa/  







ERI Complex Proteins 
PIR-1::GFP 476 / 54.3 160 66 59.9% 
DCR-1 1845 / 210.9 21 18 11.4% 
RDE-4 385 / 43.4 16 7 17.4% 
ERI-3 578 / 66.4 16 9 17.8% 
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we suspect that PIR-1 activity may correlate with transcription, we took advantage of its 
robust association with chromatin to ask whether interfering with Pol II transcription could 
disrupt any of these interactions. AMA-1 (the Large Subunit of RNA polymerase II in C. 
elegans) was easily detected on chromatin, but not in total protein extracts (Fig. 3.8C and 
D). We were able to knock it down to a nearly undetectable level by feeding the animals 
ama-1 dsRNA-expressing bacteria such that they arrested development as sterile young 
adults (Fig. 3.8E). RNAi of ama-1 did not lead to significant changes in the levels of any 
of the tested proteins in total extracts or on chromatin. In fact, the amount of DCR-1, 
DRH-3, ERI-1b, RDE-8 and PIR-1 relative to histone H3 was higher in ama-1 RNAi 
chromatin than in control chromatin. This argues that PIR-1, as well as all the other 
proteins, may interact with chromatin in an RNA-independent manner. We cannot, 
however, completely exclude the possibility that even after most Pol II is depleted, some 
RNA remains associated with chromatin and permits attachment of these factors. 
Whichever is the case, the stable association of PIR-1 and its interactors with chromatin 
suggests that the ERI complex may be constitutively positioned to operate on nascent 
transcripts, perhaps using them as templates for sRNA biogenesis. 
 
 






Figure 3.8. PIR-1b interacts with the ERI complex in the nucleus and it associates with 
chromatin. (A) Western blot of total and nuclear extracts. As a positive control for nuclear 
enrichment we used the mAb414 antibody, which recognizes the FG repeats of several 
nucleoporins. Tubulin served as a negative control. (B) PIR-1b is enriched in nuclear extracts. Most 
DCR-1 is found in the cytoplasm. (C) IP of PIR-1::3xFlag from total and nuclear extracts. PIR-1 
interactions are maintained in the nucleus. (D) Western blot on increasing amounts of chromatin. 
AMA-1 is the Large Subunit of RNA Polymerase II, and along with histone H3 serve as positive 
markers for chromatin. Only PIR-1b associates with chromatin along with most tested interactors. 
Dashed lines separate different gels. (E) Western blot of chromatin upon ama-1 RNAi. Dicer can 
be seen to associate with chromatin more clearly than in panel C. Mock RNAi consisted of feeding 
with bacteria carrying the empty double-T7 promoter vector L4440 used to clone RNAi target 
sequences.  
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Human PIR1 May Also Interact with Dicer  
 At the onset of this project we asked whether human PIR1 (DUSP11) also interacts 
with Dicer. We started by testing the only commercially available anti-PIR1 antibody at 
the time on HeLa and HEK293T cell extracts (Human Embryonic Kidney transformed with 
the SV-40 large T antigen). A band just above 35 kDa was detected, consistent with the 
expected size of ~39 kDa (Fig. 3.9A). The higher amount of PIR1 detected in HEK293T 
cells compared to HeLa cells is in agreement with pir-1 mRNA expression levels reported 
in the Human Protein Atlas (mRNA-seq data; proteinatlas.org; Uhlen et al., 2015). We 
could not detect this band in simian COS cell extracts (CV-1 in Origin and transformed 
with SV-40 virus), consistent with the manufacturer’s claim that the antibody does not 
cross-react with non-human homologs. We attempted validation by RNAi against PIR1 
using two synthetic siRNAs, but only obtained a reduction of 40% of the PIR1 mRNA 
measured by qRT-PCR (not shown).  
Since the antibody was not able to IP endogenous PIR1, we cloned the PIR-1 full-
length cDNA into an expression vector in fusion with a 3xFlag tag. Simultaneously, we 
also obtained a full-length GST-Dicer fusion construct (Tahbaz et al., 2004). We then used 
these plasmids for transient transfection of HEK293T cells, in which both fusion proteins 
were robustly expressed (Fig. 3.9B and C). In order to detect both endogenous and fusion 
proteins, we used the anti-PIR1 and an anti-Dicer antibody for western blots. IP of 3xFlag-
PIR1 did not pull down endogenous Dicer and only pulled down a very small amount of 
GST-Dicer, possibly non-specifically (Fig. 3.9B). Upon reciprocal IP using the anti-Dicer 
antibody, however, we were able to recover 3xFlag-PIR1 even in the absence of GST-
Dicer (Fig. 3.9C). Despite this encouraging result, it should be noted that there was no 
enrichment for endogenous PIR1. Perhaps the fraction of Dicer associating with PIR1 is 
too low to detect in this manner, and only in conditions of overexpression can this 
association be observed due to out-competition of existing endogenous Dicer partners. 
These results hint that PIR1 and Dicer may also interact in vertebrates. Because the 
interactions were only seen in conditions of overexpression, further experiments should be 
conducted to conclusively validate the interaction.  
  






Figure 3.9.  Human PIR-1 is expressed in HEK293T cells and associates with Dicer when 
overexpressed. (A) Western blot of endogenous PIR1 (DUSP11) in human cell lines. The antibody 
does not crossreact with simian COS kidney cell extract. (B) IP/western of FLAG-PIR1 in cells 
transiently transfected with both FLAG-PIR1 and a full-length human Dicer GST fusion. Actin was 
used as an input loading control. The asterisks indicate that cells were transfected with double the 




Processing, running, and analysis of immunoprecipitated protein samples by MudPIT were 
performed by James Moresco, in the laboratory of John Yates III, at the Scripps Institute, 
La Jolla, USA. Gel filtration was performed with assistance from Hsin-Yue Tsai in our 
laboratory. All other procedures and analyses were performed by Daniel Chaves. 





 Through the work reported in this chapter we have confirmed the association of 
PIR-1 with Dicer in C. elegans. We further widened the scope of its interactions to include 
most proteins known to compose the ERI complex, pointing to an endogenous sRNA 
biogenesis function. Interestingly, at a time when evidence that sRNA pathways operate in 
the nucleus is steadily accumulating, we showed for the first time that the ERI complex is 
present in the nucleus. Below we discuss the implications of these discoveries and 
speculate about additional functions that may help us understand why pir-1 mutants exhibit 
such severe developmental phenotypes, beyond what can be explained from loss of ERI 
activity alone. 
 
The Stable Association of PIR-1 with the ERI Complex Suggests a Role in 
Dicer-Dependent 26G-RNA Biogenesis  
The first clue that PIR-1 could be part of the ERI complex came from MudPIT 
analysis of ERI-1, in which PIR-1 peptides were detected at very low abundance 
(Duchaine et al., 2006). Our characterization of PIR-1 immunocomplexes by MudPIT and 
western defined very clearly that this is indeed the case. From our results it is also clear 
that PIR-1 does not associate with proteins required for the canonical exo-RNAi response, 
contradicting initial studies which implicated PIR-1 in Dicer-mediated cleavage of dsRNA 
into effector siRNAs (Duchaine et al., 2006). We cannot rule out, however, that 
associations with exo-RNAi factors besides Dicer occur transiently and therefore could not 
be detected by the methods we employed.  
In the most complete validation to date of the interactions occurring within the ERI 
complex, MudPIT of ERI-5 immunoprecipitates also uncovered PIR-1 at very low 
abundance (Thivierge et al., 2012). The study resulted in the proposal of a two-module 
system for the ERI complex: the RdRP module, consisting of RRF-3, DRH-3 and ERI-5, 
and another consisting of DCR-1. The combination of the two modules is made possible by 
ERI-5, which was shown to bind directly to DCR-1. Our western analysis of extracts 
depleted of PIR-1 made it clear that PIR-1 must interact with only a small fraction of DCR-
1 and other components (Fig. 3.2, page 120). This is not surprising, given our knowledge 
that some of these factors integrate other complexes, namely DRH-3 in RdRP complexes 
consisting of RRF-1/EKL-1 or EGO-1/EKL-1 for production of 22G-RNAs, and DCR-1 
interacting with RDE-1/RDE-4/DRH-1 for synthesis of primary siRNAs (Tabara et al., 




2002; Duchaine et al., 2006; Gu et al., 2009; Thivierge et al., 2012). An important result of 
our study was the discovery that the endoribonuclease RDE-8 is part of the ERI complex. 
Since both the RdRP RRF-3 and RDE-8 cease to associate with PIR-1 in the drh-3 mutant 
background (Fig. 3.7, page 133), we propose that RDE-8 interacts with the RdRP module 
of the complex. RDE-8 has been shown to catalyze the cleavage of mRNAs at regions 
targeted by RNAi. The 3' ends of the resulting fragments are then stabilized via RDE-3-
mediated 3' polyurydilation, to be subsequently used as templates for multiple rounds of 
RdRP 22G-RNA production (Tsai et al., 2015). The addition of an endoribonuclease 
activity to the ERI complex has important implications to our current understanding of the 
molecular events that lead to the production of 26G-RNAs. In Chapter IV we will present a 
working model for 26G-RNA synthesis by the ERI complex.  
Western blots of PIR-1 indicated that it is found as two distinct isoforms 
throughout post-embryonic development. The indication that the isoforms may not be 
functionally equal came from our analysis of PIR-1 complexes in different genetic deletion 
backgrounds (Fig. 3.7, page 133). Strikingly, the heavier form PIR-1b was not detectable 
in dcr-1 deletion extracts. This isoform preference was corroborated by the differential co-
fractionation of the isoforms by gel filtration, where PIR-1b co-fractionates strictly with 
DCR-1 (Fig. 3.3, page 123). Together, these results demonstrate that PIR-1b is an 
obligatory Dicer cofactor. This protein stabilization effect is not unprecedented for DCR-1 
interactors, as dcr-1 deletion extracts have been shown to be depleted of the primary 
Argonaute RDE-1 and the helicase DRH-1 (Thivierge et al., 2012). The fact that we 
observe the PIR-1b and DCR-1 proteins cofractionating over a large range of molecular 
weights supports the notion that PIR-1 may not only be required to assist DCR-1 in 26G-
RNA biogenesis but also in other Dicer-dependent processes. The lighter isoform PIR-1a 
could not be detected in IPs from drh-3 deletion extracts, pointing to the possibility that 
PIR-1a is stabilized through a direct interaction with DRH-3. This is in agreement with the 
ability to recover both isoforms upon DRH-3 IP, but only PIR-1b upon DCR-1 IP.  
The possibility that PIR-1 interacts directly and separately with both DCR-1 and 
DRH-3 is not farfetched, as they are considered to be paralogs based on sequence and 
domain topology. They share four domains: a DEAD-box helicase domain, an ATP-
binding helicase superfamily 1/2 domain, a C-terminal helicase domain and a P-loop with 
nucleoside triphosphate hydrolase activity. It is possible that the functions that PIR-1 
assumes when interacting with DRH-3 are distinct from those dictated by its association 
with DCR-1. Intriguingly, only PIR-1b is detected in embryos (Fig. 3.4, page 124) further 
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highlighting the potential for functional differences between the isoforms. It is possible 
that PIR-1b is the form required to support intense cell division. This form alone is capable 
of recovering all of the ERI complex proteins we could detect. Additionally, when we 
mutagenized PIR-1 residues that did not affect the ability of the protein to rescue, only 
PIR-1b was expressed (Fig. 3.6, page 130). Although we cannot explain why PIR-1a was 
absent, this implies that PIR-1b may be necessary and sufficient for rescue. Perhaps PIR-1a 
represents a non-functional form that is processed from the heavier protein in order to 
induce delocalization or to sequester important protein partners, thus regulating the activity 
of PIR-1b. 
In trying to understand the origin of the two PIR-1 isoforms, one of our goals was 
to be able to create transgenic animals expressing them individually, to start teasing apart 
potential functional differences. Although it seems likely that the isoforms arise from post-
translational modifications, namely in the form of multiple phosphorylations and N-
glycosylations (some of which we have confirmed by mass spectrometry), we did not 
completely determine their identity and were therefore unable to address this issue. It 
would also be useful to know whether PIR-1 completely disappears in a dcr-1; drh-3 
double mutant. Should this be the case, then further study of PIR-1 and its isoforms could 
help uncover new biological functions for DCR-1 and DRH-3 that could explain their own 
essential roles in development and fertility.  
 
The Implications of a New Cellular Address for the ERI Complex  
Through isolation of nuclei from transgenic animals, we were able to show that 
PIR-1b is the isoform that primarily localizes to the nucleus. Having established that this 
isoform is only stable in the presence of DCR-1, we presume that PIR-1 functions in the 
nucleus in association with DCR-1. Additionally, PIR-1a is depleted from nuclear extracts, 
implying that PIR-1 also operates in the cytoplasm. Since we could not obtain pure 
cytoplasmic extracts, it is possible that PIR-1b is also present and functional in the 
cytoplasm. When we immunoprecipitated PIR-1 from nuclear extracts we found it to still 
associate with DCR-1, DRH-3, ERI-1b and RDE-8, suggesting for the first time that the 
ERI complex is assembled in the nucleus. One caveat of these experiments is the potential 
contamination of nuclear extracts with germline P granules, which assemble outside of the 
nuclei in association with nuclear pores. Although we do not know whether this association 
resists our nuclear isolation procedure, we believe that heavy contamination is unlikely. 
First, DRH-3, which normally concentrates heavily in P granules, is not detectable in 




nuclear inputs; second, we never saw PIR-1 concentrating at P granules; and third, the 
isolated nuclei are a mixture of germline nuclei and somatic nuclei, which do not have P 
granules in their outer periphery, diluting any residual P granules. Although we would 
have benefited from additional controls, we assume that most interactions recovered from 
nuclear extracts occur with nucleoplasmic PIR-1. The fact that these factors, including 
PIR-1, were found to also associate with chromatin, provides additional proof that they all 
reside in the nuclear compartment, independently of any association with cytoplasmic 
perinuclear domains.  
Current knowledge regarding the subcellular localization of most proteins of the 
ERI complex is fragmented and incomplete. ERI-1b, for instance, has been shown to 
localize primarily to the cytoplasm in the soma (Kennedy et al., 2004; Gabel and Ruvkun, 
2009), but nothing is known about its localization in the germline. DRH-3 has been 
assumed to localize in the cytoplasm of somatic cells based on its interactions with RRF-1 
but directly shown to localize to perinuclear germline P granules with EGO-1 throughout 
development (Gu et al., 2009; Claycomb et al., 2009). However, its reported functions in 
maintaining chromosomal integrity upon exposure to DNA-damaging agents (Nakamura et 
al., 2007) and in ensuring proper chromosome segregation in germline and embryos 
(Duchaine et al., 2006) argue that a nuclear pool of DRH-3 must exist. Regarding DCR-1, 
though most of its activity has also been assumed to occur in the cytoplasm, namely in 
exo-RNAi and miRNA processing, it has also been directly detected in the nuclei of 
germline cells (Beshore et al., 2011). In the germline, RDE-8 was found to localize to the 
cytoplasm and to co-localize with perinuclear Mutator foci (Tsai et al., 2015). Mutator foci 
were defined by the presence of several factors required for 22G-RNA synthesis, localizing 
to the cytoplasm of somatic cells, and adjacently to P granules around the nuclei of the 
germline (Phillips et al., 2012). Finally, no studies exist regarding the cellular localization 
of the RdRP RRF-3. Unfortunately, we were unable to detect RRF-3 when reprobing our 
western blots of nuclear extracts and IPs. We attribute this to an inneficient antibody 
combined with the partial loss of protein from the blotted membrane during the harsh 
stripping procedure. 
Numerous studies have shown the occurrence of Dicer-dependent processes in the 
nucleus. Examples include Dicer association with chromatin in S. pombe to promote 
centromeric heterochromatin assembly and to silence euchromatic genes co-
transcriptionally (Colmenares et al., 2007; Motamedi et al., 2004; Woolcock et al., 2011); 
nuclear Dicer associating with Pol II in human cells to restrict the accumulation of 
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endogenous dsRNA, thus preventing interferon-induced (IFN) apoptosis (White et al., 
2014); and the generation of transcription start site-associated sRNAs around the 
promoters of protein-coding genes in human cells (Zamudio et al., 2014; Rybak-Wolf et 
al., 2014). A few reports have begun to address the properties of Dicer that allow nuclear 
localization. Despite lacking classical nuclear localization signals, the putative double-
stranded RNA binding domain (dsRBD) of S. pombe Dicer was shown to be required not 
for substrate binding, but rather to allow nuclear retention of the enzyme (Emmerth et al., 
2010; Barraud et al., 2011). The dsRBD domain was also found to constitute a non-
canonical NLS that enables human Dicer to enter the nucleus (Doyle et al., 2013). 
Although overexpressed human Dicer has always been reported as being restricted to the 
cytoplasm, endogenous Dicer has recently been abundantly detected in the nucleus by 
immunofluorescence and western analysis of cytoplasmic and nuclear fractions from 
HEK293 cells (White et al., 2014). Another study went further to demonstrate that nuclear 
Dicer and other RNAi factors exist in the nuclei of several human cell lines at abundances 
close to those of cytoplasmic extracts and, importantly, that nuclear Dicer is catalytically 
active and found in multiprotein complexes (Gagnon et al., 2014). In C. elegans, a 
rescuing GFP::DCR-1 transgene revealed germline DCR-1 to be expressed predominately 
in the cytoplasm surrounding the nuclei of mitotic germ cells. Subsequently, during 
pachytene, it was shown to acquire a more prominent nuclear localization, including in 
oocytes (Drake et al., 2014). Moreover, DCR-1 has been found in germline nuclei to 
associate with the inner-facing nuclear membrane at nuclear pores connected to external P 
granules (Beshore et al., 2011).  
We have shown that PIR-1 and its interactors are stably associated with chromatin 
(Fig. 3.8, page 136). With the goal of finding target loci for PIR-1, we optimized and 
performed chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) of 
PIR-1::GFP from embryos and compared it to Pol II ChIP-seq from the same material. 
Although the initial result showed a strong overlap of PIR-1 with Pol II occupancy at 
numerous genes, we were not able to reproduce these results (not shown). Perhaps the 
association of PIR-1 with chromatin is too indirect, or the sensitivity of the method is 
compromised by the abundance of PIR-1 in the nucleoplasm and cytoplasm. Upon RNAi 
knockdown of Pol II the interactions with chromatin were not perturbed, which led us to 
infer that they may not depend on mRNA transcription. Consistent with this, we have not 
been able to co-IP Pol II with PIR-1, even from formaldehyde-crosslinked extracts (not 
shown). We cannot completely rule out, however, that enough residual Pol II activity is 




still taking place so as to allow mRNA-mediated tethering of the examined proteins to 
chromatin or that, alternatively, PIR-1 complexes interact with Pol I or Pol III RNA.  
Given the strong interaction between PIR-1 and DCR-1, studies of chromatin-
associated Dicer provide some of the few links that allow us to ask how PIR-1 may 
function there. In S. pombe, for instance, Dicer has been shown to promote transcription 
termination at highly transcribed protein coding genes (Pol II), tDNA (Pol III) and rDNA 
(Pol I), in order to avoid the DNA damage that results from the collision of DNA 
replication forks with these highly transcribed regions (Castel et al., 2014). Intriguingly, 
this function does not depend on the formation of siRNAs, as a catalytically-inactive Dicer 
still leads to Dicer-dependent termination at these loci. This suggests a novel mechanism 
for chromatin-localized Dicer, distinct from the co-transcriptional Dicer-dependent 
generation of siRNAs at centromeric repeats that leads to deposition of repressive histone 
H3K9me2, also in S. pombe (reviewed in Castel and Martienssen, 2013). In human cells, 
knockdown of Dicer leads to accumulation of dsRNA resulting in apoptotic cell death 
(White et al., 2014). In this study, the association of human Dicer with chromatin was 
found to be transcription-dependent, interacting with Pol II via double-stranded RNA 
(dsRNA). Small RNAs overlapping with regions of dsRNA accumulation were abundantly 
detected, implying that an RNAi mechanism may aid in the prevention of deleterious 
dsRNA accumulation. There are currently no reports providing evidence for a direct 
interaction of Dicer with chromatin. Considering the proliferation and growth arrest that 
we observe upon loss of PIR-1 in C. elegans, as well as its pervasive expression and 
interaction with DCR-1 in the nucleus, we speculate that these proteins could be degrading 
excess dsRNA in the nucleus. In this scenario, the absence of PIR-1 and DCR-1 from 
nuclei would lead to genomic instability in dividing cells. In turn, upon DNA replication, 
DNA damage checkpoints would be activated, and overall development would cease. We 
believe that determining whether dsRNA accumulates in pir-1 and dcr-1 mutants is a 
worthwhile avenue of future research.  
Lastly, a proteomic survey of proteins associated with C. elegans spermatogenic 
(spermatocytes and spermatids) and oogenic chromatin failed to find PIR-1, DCR-1 or any 
of the other ERI factors (Chu et al., 2006). While for oocytes this correlates well with the 
absence of nuclear PIR-1, the degree to which PIR-1 localizes to nuclei or chromatin in 
spermatogenic cells is not clear from our microscopy analyses. Based on the 
aforementioned study, PIR-1 is therefore not likely to associate with spermatocyte and 
spermatid chromatin. Rather, its spermatogenesis-promoting activity may be taking place 
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at earlier meiotic stages. This concurs with the expression pattern we found in male 
germlines (Fig. 2.7, page 85), where PIR-1 expression is highest in nuclei preceding 
spermatocytes. At our current level of knowledge, we can only speculate about the 
assembly of the complete ERI complex on chromatin. Assuming that it does occur, a good 
candidate for direct binding to chromatin would be the Tudor domain ERI-5 protein. The 
conserved Tudor structural motif has been shown to bind methylated histone tails to 
facilitate DNA damage repair and regulate transcription (reviewed in Lu and Wang, 2013). 
This association could poise the ERI complex to directly engage nascent transcripts and 
use them as templates for 26G-RNA synthesis in the nucleus. This would allow for rapid 
triggering of 26G-RNA-dependent synthesis of 22G-RNAs for efficient silencing of 
transcripts. Such a model is supported by data presented in Chapter IV, where we will 
expand this discussion point.  
 
Clues to PIR-1 Functions beyond the Nonessential ERI Complex 
The activity of the ERI complex is required for the biogenesis of 26G-RNAs that 
allow spermatogenesis to proceed at high temperatures (ALG-3/4 class) and silencing of a 
few genes in somatic cells (ERGO-1 class), but it is dispensable for critical aspects of 
development (Han et al., 2009; Pavelec et al., 2009; Gent et al., 2010; Vasale et al., 2010; 
Conine et al., 2010; Fischer et al., 2011; Conine et al., 2013). Since DCR-1 and PIR-1 are 
both essential for normal development, their activity must extend to other ERI-unrelated 
processes. DCR-1, in particular, has long been known to associate with other proteins to 
produce miRNAs. Many of the developmental defects observed in dcr-1 loss-of-function 
mutants are attributed to a global depletion of miRNAs which coordinate expression at a 
genome-wide level. Since PIR-1 associates with DCR-1, we hypothesized that it could aid 
miRNA production. However, as we demonstrate in Chapter IV, pir-1 mutants do not 
exhibit defects in miRNA accumulation. We therefore presume that PIR-1 must partner 
with different proteins to participate in other pathways. Moreover, given the abundance of 
the PIR-1/DCR-1 interaction, and that the PIR-1b isoform only accumulates when DCR-1 
is expressed, it is plausible that some of the essential processes may require the joint action 
of both proteins.  
Since IP experiments cannot reveal transient interactions or interactions that occur 
in a small number of cells, we cannot exclude that further important PIR-1 or PIR-1/DCR-
1 partners exist. Additionally, as an example of the limitations of adopting a single 
experimental approach, we noted that despite the low abundance of ERI-1b and RDE-8 




peptides obtained through MudPIT, we were able to detect them robustly by western 
blotting. This discrepancy could reflect protein specific properties that make them less 
suitable for detection by mass spectrometry combined with a very high affinity of the 
antibodies developed against them. On the other hand, some proteins detected in some of 
the MudPIT experiments as abundantly as ERI-1b and RDE-8 turned out to be 
undetectable by western, despite the effectiveness of available antibodies (including the 
essential Argonaute CSR-1 and the nucleostemin homolog NST-1, discussed in Chapter 
II). With such examples we should not rule out that many of the low abundance proteins 
we detected may constitute true PIR-1 interactors, warranting validation with additional 
experiments. We therefore curated some of the most interesting factors, mostly related to 
RNA metabolism and processing, from all the MudPIT runs (Table in Appendix C, page 
297). We excluded typical contaminants such as ribosomal proteins, actins, or vitellogenins 
(abundant components of C. elegans egg yolk). Our list includes some factors that were 
only found in PIR-1 IPs, but it also includes proteins that were recovered from the negative 
control. This takes into account the fact that reassociation of RNA binding proteins 
between RNA molecules has been proven to occur in lysates used for immunoprecipitation 
(Mili and Steitz, 2004). One could thus imagine that in some cases factors indirectly 
associated to PIR-1 via common RNA targets could be replaced by the same 
15
N-labelled 
proteins derived from the negative control extract. Below we discuss potential interactors 
which we think are worthy of further pursuit. 
The proteins comprising the list in Appendix C function in processes that could 
explain some of the most severe pir-1 mutant phenotypes, as several of those proteins are 
essential themselves. Some interesting examples include the redundant miRNA Argonautes 
ALG-1 and ALG-2. Both proteins were found at low abundance in DCR-1 and ERI-1 
immunoprecipitates by MudPIT (Duchaine et al., 2006; Thivierge et al., 2012), suggesting 
that a small subset of ERI complexes may incorporate these Argonautes. The fact that we 
can recover them through PIR-1 corroborates this and suggests that ALG-1/2 may have 
miRNA unrelated roles. Another interesting example is the worm-specific nuclear RNAi 
component NRDE-1, which was recovered in MudPIT under high stringency. This protein 
localizes to the nucleus and is required, along with other factors, to inhibit Pol II 
elongation and deposit repressive histone marks in genes targeted by exogenous and 
endogenous 22G-RNAs (Burkhart et al., 2011). Even though this process is not 
immediately essential for development, mutants for any of its factors, including the nuclear 
Argonaute HRDE-1, exhibit a loss of gamete formation and function over generations, 
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culminating in completely sterile animals (mortal germline phenotype; Buckley et al., 
2012). PIR-1 could conceivably participate in this process by dephosphorylating 
triphosphorylated 22G-RNAs in germline nuclei to regulate the deposition of repressive 
histone marks that maintain germline immortality.  
We have also found components of important protein complexes found in germline 
P granules and cytoplasmic granules equivalent to P-bodies. So far, more than 40 proteins 
found to associate with P granules are proteins with RNA-binding domains or are predicted 
to regulate translation (Updike and Strome, 2010) and, similarly to P-bodies, also contain 
Argonautes. In C. elegans, the Argonautes ALG-3, CSR-1, PRG-1, and WAGO-1 were 
found to accumulate in P granules, establishing them as regions of intense sRNA-based 
regulation of transcripts (Batista et al., 2008; Claycomb et al., 2009; Gu et al., 2009; 
Conine et al., 2010). Among the factors we found by MudPIT, are the helicase CGH-1 
(Conserved Germline Helicase 1) and the RNA-binding Sm domain protein CAR-1 
(Cytokinesis, Apoptosis, RNA-Associated 1) which are known to interact via RNA 
(Audhya et al., 2005). Both proteins are conserved and are essential for formation and 
maintenance of P granules and P-bodies. Curiously, we also found the conserved poly(A)-
binding proteins PAB-1 and PAB-2, which regulate the stability and translation of 
mRNAs. PAB-1 has been shown to interact with AIN-1, the C. elegans ortholog of the 
Argonaute-interacting P-body GW182 protein, which in turn interacts with the miRNA 
Argonaute ALG-1 and with deadenylase complexes (Eulalio et al., 2009; Kuzuoglu-Ozturk 
et al., 2012). Mutants of PAB-1 display impaired germline mitotic proliferation, and the 
protein was found to physically associate with CGH-1 and CAR-1 in P granules (Ko et al., 
2010; Ko et al., 2013). While we have not seen PIR-1 concentrating in P granules, we 
cannot exclude that some of it exists in these important ribonucleoprotein centers. 
Alternatively, these interactions may be taking place in cytoplasmic granules of somatic 
and germline cells.  
Another P-granule component that should be validated is the germline VASA-
related DEAD-box helicase GLH-1 (Germline Helicase 1). This constitutive P-granule 
protein is essential for C. elegans fertility by promoting germline proliferation and P-
granule integrity (Kuznicki et al., 2000; Schisa et al., 2001). Importantly, it has been 
shown to localize in proximity to nuclear DCR-1 located at nuclear pores, and 
demonstrated to physically interact with DCR-1, the loss of which also disrupts P granules 
(Beshore et al., 2011). Since pir-1 mutants do not exhibit visible P-granule defects as 
judged by the localization of PGL-1, (Chapter II, Fig. 2.3), it is possible that germline P 




granules and other DCR-1/GLH-1 RNP granules still assemble normally, but that 
regulation of specific mRNAs is compromised. It will therefore be important to validate 
these interactions and deepen the study of these granules in the absence of PIR-1.  
In line with the discoveries that human PIR1 interacts with pre-mRNA splicing 
factors, we detected peptides for some conserved C. elegans splicing proteins, all with 
essential roles in development or fertility. HRP-1 (Human HnRNP A1 Homolog 1), HRP-2 
and SQD-1 (homologous to Drosophila SQD/Squid Protein) are orthologs of various 
heterogeneous nuclear ribonucleoproteins (hnRNPs) that coordinate not only aspects of 
pre-mRNA processing, mRNA metabolism and transport, but also DNA replication, DNA 
damage repair and telomere maintenance (reviewed in He and Smith, 2009). We also 
found UAF-1 (U2AF Splicing Factor 1), an ortholog of the large subunit of splicing factor 
U2AF which recognizes specific RNA polypyrimidine sequences preceding 3' splice sites. 
U2AF has been shown to determine the accumulation of alternatively-spliced variant 
transcripts, depending on the strength of its association with pre-mRNA (Zorio and 
Blumenthal, 1999; Ma and Horvitz, 2009). The participation of PIR-1 in pre-mRNA 
splicing would be in agreement with the ubiquitous nuclear localization in somatic and 
germ cells throughout development and with the deleterious effects on development and 
fertility described for splicing protein mutants. In light of the precedent for interaction with 
splicing factors in humans, we believe that these interactions should also be the focus of 
future studies. Specifically, the occurrence of splicing defects in pir-1 mutants should be 
examined in genes for which splicing variants have been well defined, but also at a global 
level by RNA-seq approaches. Lastly, we have identified a variety of nucleolus-associated 
proteins. Considering that human PIR1 was found to localize to nucleoli in a transcription-
dependent manner (Andersen et al., 2005), and that its silencing leads to the accumulation 
of some rRNA precursor intermediates (Tafforeau et al., 2013), we do not rule out that 
PIR-1 could have a direct role in rRNA processing or metabolism in C. elegans. 
Alternatively, PIR-1 could indirectly affect rRNA metabolism by assisting small nucleolar 
RNA processing. Such roles would be consistent with the impairment of growth and cell 
proliferation. 
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MATERIALS AND METHODS 
 
Immunoprecipitations 
 Protein extraction was generally performed in ~3 worm-pellet volumes of lysis/IP 
buffer containing 25 mM HEPES-KOH pH 7.5, 2 mM EDTA, 0.5% NP-40, and 150 mM 
KCl, supplemented with protease and phosphatase inhibitors (Roche protease and 
phosphatase inhibitor cocktail tablets, 1 tablet of each per 10 ml of buffer). All steps were 
performed on ice or 4˚C. Animals were crushed with 75-100 strokes in a metal dounce. 
Lysates were cleared by centrifugation at 10,000x g for 10 minutes. Protein concentration 
was measured using the Lowry-based DC Protein Assay from Bio-Rad according to the 
manufacturer’s instructions. We generally obtained concentrations of 10-12 mg/ml. Per 1.5 
ml microtube, 5 mg of protein in 1 ml of IP buffer were pre-cleared with 25 µl of Protein 
A/G PLUS-Agarose beads (Santa Cruz Biotechnologies) for 30 minutes to 1 hour. 
Antibody was then added to the cleared lysate and incubated for 1 hour. The lysate was 
transferred to a fresh tube containing 25 µl of protein A/G beads and incubated for 1 hour. 
Beads were washed at least 3x 5 minutes with lysis buffer. After complete removal of the 
buffer, the immunoprecipitates were eluted by incubating the beads with 25-30 µl of 2X 
protein sample buffer (1X is 50 mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.01% (w/v) 
bromophenol blue, 100 mM DTT) for 5 minutes at 95˚C. Generally, the entire sample was 
loaded on 4-15% SDS-polyacrylamyde gels. Inputs were typically diluted to 5 µg/µl in 2X 
protein sample buffer and 50 or 100 µg were loaded on gels. Antibodies for IPs were used 
as follows: 25 µl of anti-Flag M2 affinity gel (Sigma-Aldrich) for Flag IPs; 6 µg of anti-
GFP mouse monoclonal antibody (WAKO) per GFP IP; 10 µl of affinity purified 
polyclonal antibody for IP of DRH-3 (Gu et al., 2009).  
 
Western Blotting  
 For most experiments, proteins were resolved by SDS-PAGE using precast 
polyacrylamide gradient 4-15% gels (Bio-Rad Criterion gel system). Optimal resolution of 
PIR-1 isoforms was achieved using 10% gels. Proteins were transferred to Hybond-C Extra 
nitrocellulose membranes (GE Healthcare) using a Bio-Rad Trans-Blot SD semi-dry 
apparatus with protein transfer buffer (20% methanol, 0.04% SDS, 48 mM Tris, 39 mM 
glycine). Membranes were blocked with PBST with 5% (w/v) of nonfat dried milk for 30 
minutes to 1 hour at room temperature. Antibodies were diluted in PBST/milk. Primary 
antibodies were incubated at 4˚C overnight and secondary antibodies at room temperature 




for 1-3 hours. Membranes were washed 3x 5 minutes in PBST after each incubation. 
Chemiluminescence from the HRP-conjugated secondary antibodies was developed with 
the Western Lightening ECL kit (Perkin Elmer) and detected with an LAS-3000 Intelligent 
Dark-Box system (Fujifilm). Primary antibodies were used at a 1:250 or 1:500 dilution if 
they were antisera (unless otherwise noted, these antibodies were developed in our 
laboratory). These include anti-DCR-1, anti-ERI-1, anti-RRF-3 (a gift from Thomas 
Duchaine, McGill University, Canada), anti-RRF-1, anti-EGO-1 and anti-MUT-7 (all 
rabbit polyclonals). Affinity-purified primary antibodies were generally used at 1:500 to 
1:1000 dilutions and include anti-DRH-3, anti-CSR-1, anti-RDE-8, anti-RNA Pol II 
8WG16 (ChIP-grade from Abcam), anti-nuclear pore complex proteins mAb414 
(Covance), anti-histone H3 (Cell Signalling), HRP-conjugated M2 anti-Flag (Sigma-
Aldrich), rabbit anti-GFP (Torrey Pines Biolabs or Invitrogen) and rat anti-tubulin (used at 
1:2000, Jackson Laboratories). Anti-rat, mouse or rabbit HRP-conjugated secondaries 
(Santa Cruz Biotechnologies) were incubated at 1:1000 to 1:2000 dilutions.   
 
Silver Staining and Mass Spectrometry 
 Polyacrylamide gels were silver-stained using the SilverQuest Kit (Invitrogen) 
according to the manufacturer’s instructions. Excised bands were sent for analysis by mass 
spectrometry at the Taplin Mass Spectrometry Facility from Harvard Medical School. 
 
Immunoprecipitations for MudPIT Proteomics 
For comparison of proteins immunoprecipitated by PIR-1::GFP and PIR-1::3xFlag, 
IPs for each protein were carried out in the presence of an equal amount of N2 (wild-type) 
worm extract labelled with 
15
N (heavy isotope). During analysis, this allowed to 
discriminate which proteins bound to the IP matrix nonspecifically by comparing the 
heavy-to-light ratio of peptides (
15
N peptides were not expected to bind specifically). The 
transgenic strains used were the integrated lines obtained by bombardment and were grown 
to be young gravid adults on HB101 E. coli. 
15
N-labelled N2 animals were grown for three 
generations on nitrogen-free plates with HB101 E. coli grown on Spectra9-N medium 
(SpectraGases) and harvested as young gravid adults. Immunoprecipitations were generally 
carried out as described above. 5 mg of heavy N2 extract was mixed with 5 mg of either of 
the unlabeled transgenic extracts in 2 ml microtubes at a concentration of 5 mg/ml for a 
total of 40 mg per strain. After pre-clearing with protein A/G beads, extracts were 
incubated with either anti-Flag M2 agarose beads (Sigma) or with protein A/G beads 
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(Santa Cruz Biotechnologies) crosslinked to anti-GFP monoclonal antibody (Wako). The 
crosslinking was performed with DMP (dimethyl pimelimidate, Sigma) to prevent IgG 
contamination of eluted material. IPs proceeded at 4˚C for 2 hours and were followed by 
5x washes of 5 minutes each with lysis/IP buffer containing protease and phosphatase 
inhibitors. Bound protein was eluted with 2 bead volumes of 2X protein sample buffer 
without dye or glycerol (100 mM Tris-HCl pH 6.8, 4% SDS, 200 mM DTT) followed by 2 
minutes at 65˚C and 5 minutes at 95˚C with constant shaking. The supernatant was 
collected and another bead volume of protein sample buffer was added and recovered. The 
pooled supernatants were run through a 0.45 µm filter to eliminate agarose residue. Protein 
was precipitated with 4 volumes of cold acetone followed by overnight incubation at -
20˚C, and finally collected by centrifugation at 20,000x g for 10 minutes at 4˚C. The 
pellets were washed again with acetone and air-dried. For the 
15
N total protein (required 
for later analysis), 100 µg of N2 extract were precipitated by adding 250 µl of 
trichloroacetic acid in 1 ml of the diluted protein, followed by incubation at -20˚C for 10 
minutes, centrifugation as above, and two brief washes with acetone. For PIR-1::GFP IP 
MudPIT the procedure was identical, except that there was no addition of a labelled wild-
type extract and worms were non-gravid young adults. For PIR-1::GFP IP in the drh-3 
mutant background, animals were counterselected on ivermectin for 7 days at 20˚C (sterile 
adults). Lysis, IP and washes were performed under more stringent conditions in order to 
further minimize recovery of nonspecific interactors. Lysis buffer was 25 mM HEPES-
KOH pH 7.5, 150 mM KCl, 0.5% NP-40, 0.5% sodium deoxycholate, with protease and 
phosphatase inhibitors. Before IP the lysate was ultracentrifuged for 1 hour at 100,000x g 
at 4˚C to further clean up the sample from large mRNPs. The first wash after IP was with 
lysis buffer, followed by 2x 5 minutes high-stringency washes with 25 mM HEPES-KOH 
pH 7.5, 1 M KCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, and finally 2x 5 
minutes washes with 25 mM HEPES-KOH pH 7.5, 150 mM KCl, 0.5% NP-40 (to wash 
away salt and ionic detergents). 
 





N experiment, air-dried pellets were dissolved in 60 µl of 0.1% 
Rapigest SF (Waters Corporations) in 50 mM ammonium bicarbonate. Proteins were 
reduced with 5 mM Tris(2-carboxyethyl) phosphine hydrochloride (Sigma-Aldrich) and 
alkylated with 10 mM iodoacetamide (Sigma-Aldrich). Proteins were digested for 18 hours 
at 37˚C with 0.5 µg trypsin (Promega). The digestion was stopped with formic acid (5% 




f.c.). After 1 hour at 37˚C, debris were removed by centrifugation for 30 minutes at 
18,000x g. For the PIR-1::GFP IP experiment, the air-dried pellets were dissolved in 100 
mM Tris-HCl pH 8.5, 8 M urea. Protein reduction and alkylation were performed as above. 
Proteins were digested for 18 hours at 37˚C in 100 mM Tris pH 8.5, 2 M urea, 1 mM CaCl2 
with 2 µg of trypsin (Promega). Digestion was stopped with formic acid (5% f.c.). Debris 
were removed by centrifugation for 30 minutes at 18,000x g. For the PIR-1::GFP IP in the 




N experiment, except for 
protein digestion, which occurred for 3 hours at room temperature with 1 µg of 
chymotrypsin (Princeton Separations). Deionized water (18.2 MΩ cm
-1
, Barnstead) was 
used for all preparations. 
A MudPIT microcolumn (Wolters et al., 2001) was prepared by first creating a 
Kasil frit at one end of an undeactivated capillary with a 250 µm inner diameter (ID) and a 
360 µm outer diameter (OD) (Agilent Technologies). The Kasil frit was prepared by 
briefly dipping a 20-30 cm glass capillary tube in well-mixed 300 µl Kasil 1624 (PQ 
Corporation) and 100 µl formamide at 100
˚
C for 4 hours, and cutting the frit to ~2 mm in 
length. Strong cation exchange (SCX) particles (SCX Luna, 5 µm diameter, 125 Å pores, 
Phenomenex) were packed in-house from particle slurries in methanol. An additional 2.5 
cm of reversed phase particles (C18 Aqua, 3 µm diameter, 125 Å pores, Phenomenex) 
were then packed into the capillary using the same method as SCX loading, to create a 
biphasic column. An analytical RPLC column was generated by pulling a 100 µm ID/360 
µm OD capillary (Polymicro Technologies) to generate a 5 µm ID tip.  Reversed phase 
particles (Aqua C18, 3 µm diameter, 125 Å pores, Phenomenex) were packed directly into 
the pulled column at 800 psi until reaching 12 cm. The MudPIT microcolumn was 
connected to an analytical column using a zero-dead volume union (Upchurch Scientific; 





N experiment, liquid chromatography (LC)-MS/MS analysis was 
performed using an Eksigent nano liquid chromatography pump and a Thermo LTQ-
Orbitrap using an in-house built electrospray stage. Samples were run in a stepwise 
fashion, where each step corresponded to 0, 30 and 100% buffer C (500 mM ammonium 
acetate and 5% acetonitrile) being run for 5 minutes at the beginning of each gradient of 
buffer B (80% acetonitrile 0.1% formic acid). Electrospray was performed directly from 
the analytical column by applying the electrospray ionization voltage at a tee (150 mm ID, 
Upchurch Scientific). Electrospray directly from the LC column was executed at 2.5 kV 
with an inlet capillary temperature of 250
˚
C. Data-dependent acquisition of MS/MS spectra 
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with the LTQ-Orbitrap was performed with the following settings: MS/MS on the 5 most 
intense ions per precursor scan, 1 microscan, charge state 1 and >3 rejected; dynamic 
exclusion repeat count 2, repeat duration of 15 seconds; exclusion list size 50; and 
exclusion duration of 120 seconds. The same procedure was followed for the PIR-1::GFP 
IP in the drh-3 mutant background, except for the following LTQ-Orbitrap settings: 
dynamic exclusion repeat count 1, repeat duration of 30 seconds; exclusion list size 150; 
and exclusion duration of 180 seconds. For the PIR-1::GFP IP experiment, LC-MS/MS 
analysis was performed using an Agilent 1100 pump and a Thermo LTQ using an in-house 
built electrospray stage. Samples were run with incremental steps consisting of 0, 20, 30, 
40, 70, 100% buffer C being run for 5 minutes at the beginning of each gradient of buffer 
B. Data-dependent acquisition of MS/MS spectra with the LTQ was performed with the 
following settings: MS/MS on the 8 most intense ions per precursor scan, 1 microscan, 
dynamic exclusion repeat count 2, repeat duration of 30 seconds; exclusion list size 50; and 
exclusion duration of 60 seconds.  
 
MudPIT Data Analysis 
Protein and peptide identification and protein quantitation were performed with 
Integrated Proteomics Pipeline - IP2 (Integrated Proteomics Applications 
http://www.integratedproteomics.com). Tandem mass spectra were extracted from raw 
files using RawExtract 1.9.9.2 (McDonald et al., 2004) and were searched (both light and 
heavy) against the WormBase database (WP236) with reversed sequences using the 
ProLuCID program (Peng et al., 2003; Xu et al., 2006). The search space included all fully 
tryptic peptide candidates. Carbamidomethylation (+57.02146) of cysteine was considered 
a static modification. Peptide candidates were filtered using the DTASelect program, with 
the parameters -p 2 -y 1 --trypstat --pfp .01 -DM 10 --DB --dm -in (McDonald et al., 2004; 
Tabb et al., 2002). Quantitation was performed using the Census program (Park et al., 
2008). 
 
Gel Filtration Analysis 
 For gel filtration, 20 mg of young adult total protein extract in lysis/IP buffer were 
run in a Superose 6HR 10/30 column (Amersham Biosciences) using a Bio-Rad Biologic 
FPLC system. 500 µl fractions were collected and 25 µl aliquots were mixed with 5 µl of 
6X protein sample buffer and denatured at 95˚C for 5 minutes. Every other fraction was 




run on a Bio-Rad precast 4-15% SDS-polyacrylamide gel. Western blotting was performed 
as described above. 
 
RNase Treatments of IP Complexes 
 PIR-1::3xFlag was immunoprecipitated from 6.25 mg of total protein extract from 
mixed-stage worm populations. The washed beads were split into 4 tubes: one for 
immediate elution (no treatment control) and three for equilibration in PBS with 2 mM 
MgCl2. Beads were then resuspended in 100 µl of PBS, 2 mM MgCl2. Treatments were 
performed with 2 µl each of RNase T1 and RNase A, or 2 µl of RNase V1 (all from 
Ambion, Biochemistry Grade at 1 U/ml, 1 µg/ml and 0.1 U/ml, respectively). Reactions 
were incubated at 37˚C for 1 hour, after which beads were washed 2x 5 minutes with PBS, 
and 2x 5 minutes with PBST, all at room temperature. All samples were eluted with 2X 
protein sample buffer for SDS-PAGE and western blot analysis. 
 
SL1/SL2 PCR of pir-1 and sec-5 mRNAs 
 For each 25 µl PCR reaction, 0.5 µl of cDNA made from total RNA of mixed-stage 
wild-type animals were used. ExTaq DNA polymerase (Takara) was used with two 
different annealing temperatures (55 and 58˚C). PCRs were run on a 1.2% agarose/1X 
TAE gel and products that seemed specific were gel-extracted with the Qiagen Minelute 
kit. 4 µl of eluted material was used for TOPO cloning into pCR2.1-TOPO (Invitrogen) 
according to the manufacturer’s instructions. Ligations were transformed into E. cloni 10G 
chemically competent E. coli cells (Lucigen) and grown on ampicillin/X-gal agar plates for 
blue/white selection. A few colonies of each product were selected for plasmid 
minipreparation and digested with EcoRI to confirm the presence of the insert. Positive 
clones were sequenced with M13 forward and reverse primers. Primers used in this 
experiment were O72-O75 (Appendix B).   
 
Generation of Start Site Mutant Constructs and Strains 
 The PIR-1(M1A), PIR-1(M29L) and PIR-1(M89L) mutants (assuming a 261 aa-
long PIR-1 sequence) were generated by site-directed mutagenesis of pDONR-201-pir-
1::gfp with primers O66-O71 as described in Chapter II Materials and Methods. pir-
1/mnC1*; unc-119; cxTi10882; avr3x animals were injected with wild-type and mutant 
vectors, but no integrated lines were obtained. All experiments were thus performed with 
non-integrated lines exhibiting a high rate of transmission. 
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Phosphatase Treatments of IP Complexes 
 PIR-1::3xFlag was immunoprecipitated from 2x 5 mg of total protein extract from 
young adult worms using buffer without EDTA. For each treatment condition, the 
equivalent of a 1 mg IP was used. Reaction volumes were of 100 µl. For CIP (NEB) 
treatment, beads were incubated with 1X NEB Buffer 3 (50 mM Tris-HCl pH 7.9, 10 mM 
MgCl2, 100 mM NaCl, 1 mM DTT) and 2 µl of CIP with or without 1 M urea for 1 hour at 
37˚C with constant shaking. For Lambda Protein Phosphatase (NEB) treatment, beads 
were incubated with 1X NEB Buffer for PMP (50 mM HEPES pH 7.5, 10 mM NaCl, 2 
mM DTT, 0.01% Brij 35), 1 mM MnCl2, 2 µl of enzyme with or without 1 M urea for 1 
hour at 30˚C with constant shaking. Beads were then eluted at 95˚C for 5 minutes using 2X 
protein sample buffer and analyzed by SDS-PAGE/western blotting. 
 
Isolation of Nuclei and Chromatin 
From frozen worm pellets, 2 volumes of Buffer A (10 mM Tris-HCl pH 8.0, 250 
mM sucrose, 10 mM MgCl2, 1 mM EGTA) without detergents and with protease and 
phosphatase inhibitors (Roche protease and phosphatase inhibitor cocktail tablets and 1 
mM PMSF) were added and pellets were allowed to thaw. All steps were carried out on ice 
or 4˚C. For inputs, a fraction of this worm suspension was briefly spun down and Buffer A 
was replaced with 3 volumes of lysis buffer (25 mM HEPES-KOH pH 7.5, 150 mM KCl, 
0.5% NP-40, 0.1% Triton X-100, protease and phosphatase inhibitors) and crushed with a 
metal dounce on ice with 100 strokes. Lysates were cleared by centrifugation at 10,000x g 
for 15 minutes and set aside for quantification and later use. For nuclear isolation worms 
were crushed with 30 strokes on ice, and debris were cleared briefly by centrifugation in 2 
ml tubes at 500x g for 1 minute. This step was repeated with the resulting supernatant, after 
which it was again transferred to fresh 1.5 ml tubes to spin down nuclei at 4,000x g for 5 
minutes. Nuclear pellets were gently resuspended in at least 10 volumes of Buffer A with 
inhibitors.  1 ml of nuclear suspension was gently overlayed over 10 ml of sucrose cushion 
solution (10 mM Tris-HCl pH 8.0, 1 M sucrose, 10 mM EDTA) in a 15 ml conical tube 
and the interphase was gently disrupted by swirling a pipette tip to create a gradient (no 
more than 1 cm into the sucrose solution). This was repeated for the entire volume of each 
lysate. These tubes were centrifuged at 3,200x g for 1 to 1.5 hours, until a uniform white 
pellet corresponding to nuclei accumulated at the bottom of the tubes. The supernatant was 
aspirated and nuclei were carefully resuspended in Buffer A with inhibitors (about 10 
volumes). A second sucrose flotation step was carried out in 1.5 ml tubes by overlaying 




150 µl of resuspended nuclei onto 1 ml of sucrose solution, again gently disrupting the 
interphase. The preparations were spun at 20,000x g for 10 minutes, and the resulting 
pellets were resuspended in 10 volumes of lysis buffer with detergents and inhibitors (as 
above for inputs) and crushed with a dounce with 150 strokes to completely disrupt nuclei. 
This suspension was cleared at 8,000x g for 5 minutes and the supernatant was kept for 
protein quantification and use as a nuclear extract for IP. Pure chromatin is gray when 
pelleted. The presence of white patches indicates that intact nuclei remain. When this 
occurred, the pellet was resuspended in lysis buffer with detergent and crushed a further 
100 times until the pellet was uniformly gray. The pellet was then washed once with 10 
mM Tris-HCl pH 7.5 with 0.1% Triton X-100 and another two times with 10 mM Tris-Cl 
pH 7.5 (with 8,000x g centrifugations in between and the last one at 20,000x g for 5 
minutes). Pellets were weighed and resuspended in 9 volumes (for a 1:10 dilution) of 
protein sample buffer for a 1X final concentration and such that the chromatin 
concentration was between approximately 50-100 µg/µl. Before loading onto a denaturing 
protein gel, the chromatin was heated to 95˚C for 5 minutes.  
 
RNAi of ama-1  
 Silencing of ama-1 was achieved by feeding animals with dsRNA-expressing 
HT115 E. coli from the Ahringer feeding RNAi library. Cultures were prepared and 
induced as described in Chapter II. Animals were grown on OP50 E. coli until they 
reached the L2 stage, after which they were collected, washed and transferred to large 
plates with ama-1 HT115 at a density of ~100,000 worms per plate. After ~2 days at 20˚C, 
all animals were arrested as sterile adults with no embryos. One day later they were 
collected and frozen for protein and chromatin extraction. Placing animals on RNAi food 
as L1s gave rise to an L3 arrest. When they were placed as L3s, they arrested at a range of 
sterile to gravid adults that laid some dead eggs, and when RNAi started at the L4 stage, all 
animals arrested as gravid adults that laid many eggs, most of which did not hatch (the 
ones that did hatch exhibited an L2-L3 arrest).  
  
Cloning of Human PIR1 and Immunoprecipitations from Transfected Human 
Cells 
The human PIR1 (DUSP11) cDNA sequence was amplified from the pOTB7 
IMAGE cDNA clone construct with primers carrying terminal XbaI and NotI sites (O76 
and O77) using iProof Taq DNA polymerase (Bio-Rad). The product was digested with 
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XbaI and NotI and column-purified (Qiagen gel purification kit). The p3xFLAG-Myc-
CMV-26 vector (Sigma) was digested with the same enzymes, dephosphorylated with CIP 
and gel purified. After ligation with T4 DNA ligase (NEB), the reaction was transformed 
and the plasmids from a few positive clones were digested with XbaI and NotI to check for 
the release of the insert. Two clones were sent out for sequencing of the PIR1 cDNA. The 
full-length GST-Dicer fusion construct is cloned into the pDEST27 vector (Life 
Technologies) and was a kind gift from the Filipowicz laboratory at the Friedrich Miescher 
Institute in Switzerland (described in Tahbaz et al., 2004). 
 HEK293T cells in 6 cm plates at 80-90% confluency were transfected with 4-8 µg 
of each vector using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
specifications. Transfected cells were collected after 24 hours for protein extraction. All of 
the following steps were done on ice or at 4˚C. After cells were washed with 1X PBS, 1 ml 
of lysis buffer was added (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 0.5% NP-40, 2.5 
MgCl2, 2.5% glycerol, supplemented with 1 mM DTT, protease and phosphatase inhibitor 
cocktail tablets (Roche, 1 tablet of each per 10 ml)). Cells were scraped of the plates, 
transferred to 1.5 ml microtubes and lysed by passage through a 20 gauge needle 15 times 
followed by rotation for 10 minutes to completely release cell contents. Extracts were 
cleared by centrifugation at 10,000x g and quantified. For inputs, 250 µg of protein were 
acetone-precipitated and resuspended in 1X protein sample buffer. Per IP, 1 mg of extract 
was used in 1 ml of lysis buffer with inhibitors. For Flag IPs, 25 µl of M2 anti-Flag 
agarose beads (Sigma) were used. For Dicer IPs, 5 µg of anti-Dicer [13D6] monoclonal 
antibody were used (Abcam, ChIP-grade) and captured with 20 µl of Protein A/G PLUS-
Agarose beads (Santa Cruz Biotechnologies). After incubating for 2 hours, beads were 
washed 4x 5 minutes with IP buffer and eluted with 25 µl of 2X protein sample buffer at 
95˚C for 5 minutes. 50 µg of inputs and half of each 1 mg IP were loaded onto a 4-15% 
gradient polyacrylamide gel (Bio-Rad). Western blot analysis was performed as described 
above. Dicer was detected with the same antibody used for IP at a 1:250 dilution; PIR1 
was detected with a chicken affinity purified anti-DUSP11 at a 1:250 dilution 
(USBiological); actin was detected with a mouse anti-actin at 1:2500. Secondary 
antibodies were HRP-conjugated anti-mouse (1:5000, Santa Cruz Biotechnologies) and 


















Small RNA and mRNA Profiling  
of pir-1 Mutant Animals 
 







 At the beginning of this project, the known repertoire and genetic requirements of 
endo-sRNAs was very limited and the ERI pathway was just beginning to be defined 
(Duchaine et al., 2006). We therefore started exploring the possibility of sRNA defects in 
pir-1 mutants through a northern blotting-based candidate approach using a limited number 
of endo-sRNAs. However, it was not until high-throughput sequencing (deep-sequencing) 
technologies became available that we were able to address this problem at a genome-wide 
level. We thus set out to conduct a thorough comparative analysis between the sRNA 
populations of wild-type and pir-1 mutant animals. 
 In our initial analyses of pir-1 mutants, we did not observe depletion of sRNA 
species such as miRNAs, 21U-RNAs (piRNAs), ERGO-1-dependent 26G-RNAs, and ERI-
independent 22G-RNAs (refer to Table 1.1, page 29 for an overview of sRNA pathways). 
Unexpectedly, we did find that both pir-1(tm1496) and pir-1(tm3198) deletion mutants 
could still produce functional siRNAs in response to exogenous dsRNA triggers, 
challenging the initial model for PIR-1 function in RNAi. Through deep-sequencing we 
found that the sRNAs most clearly affected by the loss of PIR-1 belonged to the ALG-3/4-
dependent 26G-RNA class. These endo-sRNAs regulate sperm differentiation in both the 
hermaphrodite germline (preceding female gamete production) and in the male germline 
(Han et al., 2009; Conine et al., 2010; Conine et al., 2013). This result is in agreement with 
the spermatogenesis defect of the pir-1 mutant (Chapter II) and the interaction of the 
protein with the ERI complex (Chapter III), which generates all 26G-RNAs. Additionally 
we showed that recombinant PIR-1 is able to convert 5'-triphosphorylated RNAs to 5'-
monophosphorylated RNAs, and that this property requires the active-site cysteine. Since 
the molecular events that lead to the production of mature 26G-RNAs are still largely 
undefined, these discoveries allowed us to refine the current working model of how this 
process occurs. Most importantly, this was the first concrete biological function attributed 
to PIR-1 in any organism. 






Developmentally Arrested pir-1 Animals Are Competent for Exogenously 
Triggered RNAi 
 In its initial characterization, pir-1(tm1496) mutants were reported to be resistant to 
exogenously triggered RNAi due to a lack of accumulation of siRNAs (Duchaine et al., 
2006). In trying to confirm and expand these observations, we discovered that pir-
1(tm1496) animals were actually able to accumulate exogenously triggered siRNAs. In 
these experiments, we induced RNAi by feeding animals with bacteria expressing dsRNA 
targeting the sel-1 (Suppressor/Enhancer of LIN-12 1) mRNA, expressed in both somatic 
and germline cells, and from which exceptionally abundant RNAi-induced 22G-RNAs are 
produced. We used pir-1(tm1496) homozygote animals that had been counter-selected on 
ivermectin for seven days to avoid any maternally loaded pir-1 product. After 24 hours of 
feeding, not only were we able to detect sel-1 siRNAs but also showed that their levels 
increased with longer exposure to the trigger dsRNA (Fig. 4.1A). The RNAi-defective 
mutant rde-1(ne300) was used as a negative control, as it is unable to accumulate Dicer-
dependent primary siRNAs and resulting 22G-RNA RdRP products. Additionally, in a pir-
1(1496); rrf-1 double mutant, we could still detect a time-dependent accumulation of sel-1 
siRNAs, albeit at lower levels than in the pir-1 single mutant (Fig. 4.1B). RRF-1 is the 
main 22G-RNA RdRP operating in somatic cells, whereas in the germline it acts 
redundantly with the EGO-1 RdRP. The fact that we could still detect sel-1 siRNAs in the 
absence of RRF-1 means that pir-1 mutant animals are able to mount an RNAi response in 
both the soma and the germline. It should be noted that the ivermectin resistant strain 
(avr3x DA1316) we used as a positive control along with N2, exhibited a defect in siRNA 
accumulation which we could not explain at the time. We describe the resolution of this 
issue later in this section. 
We then targeted the body wall muscle-specific unc-22 transcript. Expression of 
unc-22 increases throughout development, and RNAi against it leads to a progressively 
stronger twitching phenotype that culminates in almost complete paralysis of the animals. 
In contrast to wild-type N2 animals, when arrested pir-1(tm1496) homozygotes were 
exposed to unc-22 dsRNA-expressing bacteria for 48 hours they did not manifest any of 
the unc-22-associated phenotypes (not shown), despite the accumulation of unc-22 siRNAs 
(Fig. 4.1C). Avr3x worms twitched with the same treatment, although the onset of the 
phenotype was delayed relative to N2, and, paradoxically, siRNAs were not detected. From 




the same samples we measured unc-22 mRNA levels by qRT-PCR and found that, similar 
to avr3x alone, pir-1 mutants had a ~50% reduction in mRNA, not far from the 75% 
reduction in N2. This indicated that, under our experimental conditions, the pir-1(tm1496) 
mutant is able to produce functional siRNAs.  
We have identified reasons for the discrepancy between the results reported in 
Duchaine et al. (2006) and the aforementioned results, regarding the production of exo-
siRNAs. First, northern analysis of sel-1 siRNAs was conducted in animals that had been 
exposed to sel-1 dsRNA bacteria for 12 hours, which we found to not always be sufficient 
to generate robust amounts of siRNAs relative to wild-type N2 animals. Second, the 
inability of pir-1(tm1496) animals to twitch upon unc-22 RNAi was erroneously 
interpreted as an inability to produce unc-22 siRNAs. UNC-22 protein associates with 
myosin and is required for regulation of actomyosin contraction-relaxation and normal 
muscle morphology (Moerman et al., 1988). We speculate that the inability of pir-1 
mutants to acquire the twitching and paralysis phenotype may reflect a lowered need for 
UNC-22, allowing them to maintain proper muscle function with existing UNC-22 in the 
absence of further growth (in other words the turnover of this protein at the arrested stage 
is low). 
Assuming that PIR-1 functions as an  RNA 5' phosphatase, we next asked whether 
different types of endogenous sRNAs exhibited changes in abundance or 5'-
phosphorylation state in the pir-1(tm1496) mutant background (Fig. 4.1D). For this, we 
treated total RNA depleted of high MW RNAs with Terminator 5' phosphate-dependent 
exonuclease, and analyzed it by northern blotting (Fig. 4.1D). This enzyme destroys single-
stranded RNA (ssRNA) bearing 5'-hydroxyl (5'-OH) or 5'-monophosphate (5'-P) ends, but 
not 5'-PPP ends. 5'-PPP 22G-RNAs were unaffected by Terminator digestion, regardless of 
the source of trigger (exogenously by sel-1 dsRNA or endogenously by abundant 
ERI/ERGO-1-dependent 26G-RNA-1 and 26G-RNA-263). miRNAs, 26G-RNAs and 21U-
RNAs, all normally carrying a 5'-P, were destroyed by the treatment in both wild-type and 
pir-1 backgrounds, suggesting that these sRNA species do not require PIR-1 for proper 5'-
end processing. Additionally, non-ERI endogenous 22G-RNA species such as those 
targeting F37D6.3 and bath-20 in the germline or Y47H10A.5 in the soma (Gu et al., 
2009), also kept intact 5'-PPP ends in pir-1 animals. Importantly, the levels of most sRNAs 
tested did not change considerably in pir-1 mutant animals relative to wild-type N2. The 
only exceptions were 26G-RNA-1 and 263, which were reduced, and Y47H10A.5 22G-
RNAs, which were dramatically increased. The lowered accumulation of 26G-RNAs in 




pir-1 is explained by the fact that ERGO-1 26G-RNAs are synthesized predominately 
during oogenesis and embryogenesis (Han et al., 2009; Pavelec et al., 2009; Gent et al., 
2010; Vasale et al., 2010), processes that do not occur in pir-1 animals. Y47H10A.5 22G-
RNAs are known to steadily accumulate with age (Weifeng Gu, unpublished observation), 
so we attribute the discrepancy in siRNA levels to the age difference between N2 control 
animals (2.5-day old L4s) and pir-1 (seven days old). The strong accumulation of 
Y47H10A.5 siRNAs in pir-1 arrested animals further implies that PIR-1 is not required for 
22G-RNA synthesis. 
 After obtaining the new pir-1(tm3198) allele, we proceeded to validate the results 
we obtained with pir-1(tm1496) (Fig. 4.2). Although arrested pir-1(tm3198) mutants never 
twitched (either through feeding or injection of unc-22 dsRNA), they still produced 
abundant unc-22 22G-RNAs, which led to an almost wild-type decrease in unc-22 mRNA 
(Fig. 4.2A). In this experiment we included seven-day counter-selected eft-3(q145); avr3x 
homozygote animals derived from genetically-balanced wild-type mothers. eft-3 encodes 
an essential translation elongation factor, and homozygote animals grow to become adults 
without germline tissue (accordingly, they do not express F37D6.3 22G-RNAs). These 
animals served as a control for aging and exposure to ivermectin to more fairly compare 
the accumulation of unc-22 siRNAs. In comparison to the level of unc-22 siRNAs in the 
eft-3 mutant, pir-1(tm3198) animals showed only a modest reduction in the accumulation 
of siRNAs. 
Since the use of an isogenic avr3x control for further experiments using pir-
1(tm3198); avr3x animals was imperative, we had to address the defects in exo- and endo-
siRNA accumulation of the original avr3x triple mutant DA1316 (avr-14(ad1305); glc-
1(pk54::Tc1) avr-15(ad1051)). The fact that in this strain dsRNA feeding led to target 
downregulation, and that in some northern blots we were able to detect low levels of sel-1 
siRNAs (not shown) told us that the RNAi pathway was not completely compromised. We 
outcrossed the original strain against N2 animals six times and resegregated the avr3x 
mutant combination from the pir-1(tm1496)/mnC1*; avr3x strain. Additionally, we 
obtained control strains which included the avr-14(ad1305); glc-1(pk54::Tc1) double 
mutant, the avr-15(ad1051) mutant and the eat-2(ad1113) mutant. The eat-2 and avr-15 
genes encode ligand-gated ion channel subunits which are required for normal rates of 
pharyngeal pumping, and when defective interfere with feeding (Dent et al., 1997; Raizen  
et al., 1995). Since avr3x mutants exhibit a two to three hour delay in development relative 
to N2 at 20˚C likely due to slower feeding, we wondered whether this could also contribute 




to decreased RNAi efficiency. After feeding all of these strains unc-22 dsRNA bacteria, 
only the original avr3x DA1316 retained the exo- and endo-RNAi defects (Fig. 4.2B). 
Even though the feeding mutants eat-2 and avr-15 still showed a delayed onset of the unc-
22 RNAi phenotypes compared to N2 or avr-14; glc-1 doubles, they produced abundant 
unc-22 siRNAs. We concluded that the original strain must carry one or more unidentified 
mutations that affect the accumulation of some types of sRNA. Henceforth, we used the 
outcrossed avr3x strain as the wild-type control for all experiments involving ivermectin 
counter-selection. 
With this new control in hand, we performed the unc-22 RNAi experiment in 
triplicate with pir-1(tm3198) animals. We measured the relative amount of unc-22 siRNAs 
and the relative amount of unc-22 mRNA in order to correlate them (Fig. 4.2C). We 
concluded that pir-1(tm3198) generated wild-type levels of unc-22 siRNAs that led to 
silencing of the cognate mRNA, although at a lower efficiency than in N2 and avr3x 
(~50% versus ~80%). Moreover, we targeted the germline mRNA pos-1 by feeding RNAi 
and registered a dramatic drop in the relative level of this transcript in the pir-1 mutant 
(Fig. 4.2D). Lastly, we crossed a nuclear GFP reporter expressed in the lateral seam cells 
(16 across each side of L4s and adults) into the pir-1(tm3198) background (non-avr3x). 
Although aged control pir-1 worms did not express GFP as brightly as wild-type, both 
strains exhibited marked silencing of GFP after being fed bacteria expressing gfp dsRNA 
(Fig. 4.3). Taken together, these results suggest that PIR-1 is not required for exogenously 
triggered RNAi, nor for the production of certain endogenous 22G-RNAs. 
 
 






Figure 4.1. pir-1(tm1496) arrested animals can mount an RNAi response and are not 
generally deficient in endogenous small RNAs. (A) Northern blot of sel-1 siRNAs after being fed 
bacteria expressing sel-1 dsRNA. The miR-66 miRNA, expressed at a constant level throughout 
development, was used as a loading control. Sense (‘S’) or antisense (‘AS’) sel-1 RNA oligos were 
run as probe specificity controls. (B) Northern blot of sel-1 siRNAs in the rrf-1(pk1417) mutant 
background to determine germline RNAi contribution.  The SL1 trans-splicing precursor (~100 nt) 
was used as an additional loading control. (C) Northern blot of unc-22 siRNAs and corresponding 
unc-22 mRNA levels measured by qRT-PCR and normalized to GAPDH (gpd-2). (D) Northern 
blots of sRNAs before and after treatment with Terminator 5' phosphate-dependent exonuclease 
which cannot digest 5'-capped, 5'-di- or 5'-triphosphorylated RNA. pir-1 animals were counter-
selected for seven days on ivermectin prior to feeding with dsRNA-expressing bacteria. The 
remaining strains were grown for 10-12 hours, then transferred to RNAi plates so as to be 
harvested as L4s (after 12 hours of RNAi), or grown since L1s on RNAi plates to be collected as 
L4s (after 24 hr) or young adults (after 48 hr). In (A) and (B) total RNA was used. In the remaining 
blots sRNA fractions were used. All no-RNAi controls used induced bacteria carrying the empty 
double T7-promoter vector. 
  
 






Figure 4.2. pir-1(tm3198) arrested animals also mount an effective RNAi response. (A) 
Northern blot of unc-22 siRNAs and corresponding unc-22 mRNA levels measured by qRT-PCR 
and normalized to GAPDH (gpd-2). miR-66 served as the sRNA loading control. Asterisks indicate 
growth on OP50 E. coli. In the other conditions animals were transferred to either mock RNAi or 
unc-22 RNAi food plates and grown for an additional 24 hours. N2 and avr3x animals were 
harvested as non-gravid young adults, ivermectin counter-selected eft-3(q145) animals were 
harvested as five-day old sterile adults, and pir-1 animals were harvested as five-day old arrested 
L4s and young adults. (B) Northern blot of sRNAs from outcrossed and resegregated avr3x strains 
to restore wild-type sRNA accumulation. pir-1 animals were counter-selected for seven-days. The 
other strains were transferred to RNAi food after 24 hours on OP50 and harvested as non-gravid 
young adults. (C) qRT-PCR measurements of unc-22 mRNA normalized to act-3 (Actin 3) mRNA 
levels and siRNA levels normalized to miR-66. Experiments were performed in triplicate. Error 
bars show the standard error of the mean (SEM). siRNA northern intensities were calculated using 
ImageQuant software (GE healthcare). (D) qRT-PCR of germline pos-1 mRNA normalized to actin 
(act-3) mRNA levels after pos-1 RNAi in seven-day counter-selected pir-1 animals. Small RNA 




fractions were used for all northern blots. All mock RNAi samples used induced bacteria carrying 







Figure 4.3. pir-1(tm3198) arrested animals can silence a GFP reporter upon gfp RNAi. Wild-
type or pir-1 mutant animals expressing nuclear GFP from a seam cell promoter were fed gfp 
dsRNA-expressing bacteria for 24 hours, followed by fluorescence microscopy to assess GFP 
protein knockdown.  All images were acquired with identical exposure settings. pir-1 animals were 
at least seven days old when placed on RNAi plates.  
 
 
pir-1 Mutant Animals Are Not Deficient in miRNAs or 21U-RNAs but Express 
Reduced Levels of Germline 22G-RNAs  
In order to globally study the effect that loss of PIR-1 could have on endogenous 
sRNA populations, we cloned and deep-sequenced 18-30 nt RNAs from ivermectin 
counter-selected pir-1 animals. We adopted a cloning strategy that allows the cloning of 
most sRNA classes, regardless of their 5'-phosphorylation state. For this, RNA is treated 
with Tobacco Acid Pyrophosphatase (TAP) prior to RNA size selection and 5' linker 
ligation. This enzyme converts 5'-PPP and capped 5' ends to 5'-P, and does not alter 




molecules that were originally 5'-P. We refer to this method as 5'-independent cloning or 
TAP cloning. To exclude differences due to age and ivermectin exposure period, we 
sequenced sRNAs from pir-1 arrested animals counter-selected for three, seven and ten 
days. As a wild-type control we used avr3x animals grown on ivermectin until the 
population consisted of a range of L4 larvae to young adults (ivermectin affects the 
population’s synchronicity).  
 Taking the ten-day counter-selection animals as an example, we compared levels of 
the main categories of endo-sRNAs with those of the wild-type control (Fig. 4.4), using the 
total number of genome-matching sRNA reads as a normalization standard. These reads 
excluded structural reads, which we assume to be degradation fragments of ncRNAs (non-
coding), tRNAs, rRNAs, snoRNAs (small nucleolar), snRNAs (small nuclear) and scRNAs 
(small cytoplasmic). The scatter plots provide information about the relative abundance of 
each type of sRNA by displaying the number of normalized reads in reads per million 
(rpm; Fig. 4.4A). miRNAs, which are predominately expressed in the soma and represent 
the most abundant sRNA class, were slightly upregulated in pir-1 animals regardless of age 
(Fig. 4.4B and C, orange bars). The upregulation likely arises from a lower germline-to-
soma ratio compared to wild type. Germline-expressed 21U-RNAs decreased slightly in 
pir-1 animals, consistent with the small germlines of the mutants. Moreover, western blots 
of DCR-1 (which generates mature miRNAs) and PRG-1 (the PIWI Argonaute that 
interacts with 21U-RNAs) revealed that these proteins are expressed in pir-1 at wild-type 
levels (Fig. 4.4D). From these results we conclude that PIR-1 is not required for the 
accumulation of miRNAs or 21U-RNAs.  
Regarding all sRNAs antisense to protein-coding sequences (targeting over 9,000 
genes, nearly 50% of all C. elegans genes), we observed a general decrease in pir-1 
animals (Fig. 4.4B and C, gray bars). In order to better understand this decrease, we 
considered 22G-RNA subpopulations that belong to the two major pathways according to 
which Argonautes they interact with. The CSR-1 pathway is required for accurate germline 
gene expression, while the WAGO pathway, which includes 12 different Argonautes, is 
involved in silencing repetitive elements, transposons as well as various somatic- and 
germline-expressed mRNAs (refer to Chapter I for details). These 22G-RNA populations 
were experimentally defined in our laboratory, as explained in the Materials and Methods 
section (page 215). WAGO-class 22G-RNAs were reduced in the pir-1 mutant, with at 
least 50% of targets exhibiting a two-fold or higher downregulation of 22G-RNAs 
compared to wild type (Fig. 4.4, dark blue bars). CSR-1-class 22G-RNAs were reduced 




more pronouncedly, with at least 75% of targets exhibiting a downregulation upwards of 
two-fold (Fig. 4.4, red bars). As most 22G-RNAs derive from the germline, we attribute 
this difference at least in part to the lower germline-to-soma ratio of the mutant animals. 
However, because germline 21U-RNA levels are not significantly affected in pir-1 
mutants, we cannot exclude that there are additional reasons for WAGO- and CSR-1-22G-
RNA depletion.  
In agreement with loss of 22G-RNAs in pir-1 animals due to germline immaturity, 
ivermectin counter-selected dcr-1 deletion mutants, which arrest as adults with a large 
germline, do not exhibit reductions in these WAGO- or CSR-1-dependent 22G-RNAs (Fig. 
4.5B). In contrast, these animals exhibited a marked decrease in miRNAs, in agreement 
with the role of DCR-1 in miRNA processing, and also reinforcing the idea that PIR-1 is 
not required for miRNA biogenesis. Lastly, we analyzed sRNA populations in arrested pir-
1; dcr-1 double mutants (Fig. 4.5C), which are phenotypically indistinguishable from pir-1 
single mutants. Not surprisingly, the most noticeable difference relative to the pir-1 single 
mutant, was a downregulation of miRNAs, albeit less pronounced than in dcr-1 single 
mutants. 
The WAGO-class 22G-RNA population is very complex in terms of the variety of 
functions performed along development, in distinct tissues and cell compartments. This 
makes it difficult to find direct causes for the deregulation of 22G-RNAs as a whole. 
However, when we focused on WAGO-dependent 22G-RNAs targeting transposons only, 
the differences in their levels in pir-1 compared to wild type were less pronounced than 
when considering the expanded WAGO 22G-RNA population (Fig. 4.5D and E). This led 
us to conclude that the silencing of transposons by the WAGO pathway in the germline of 
pir-1 animals is not compromised. We extended our analysis to other populations of 
sRNAs targeting specific types of transcripts, namely non-coding RNA, pseudogenes, 
repetitive elements and introns (Fig. 4.5F). In order to provide an idea of the proportion of 
each sRNA population in the entire set of cloned RNAs, we displayed non-normalized 
reads from each category as a percentage of the total reads matching the genome (minus  
nonstructural reads). miRNAs, by far the most abundant class, were cloned in pir-1 at a 
higher proportion as a result of the decrease in sRNAs antisense to coding RNA (including 
WAGO, CSR-1, and ALG-3/4 pathway sRNAs; gray line) as reflected in the analysis of 
normalized reads in the box-and-whisker plots. All of the remaining classes, including 
21U-RNAs (in green), exhibited no change in cloning frequency between wild-type and 
mutant animals.  




Importantly, since CSR-1-targeted mRNA (enriched in germline transcripts) or 
WAGO mRNA-targets are not generally downregulated in pir-1 mutant animals, we 
cannot attribute the 22G-RNA reduction to a decrease in the amount of template molecules 
(mRNA-sequencing results, Fig. 4.7A and B, page 179). Furthermore, CSR-1 and some 
WAGO Argonautes concentrate in germline P granules, and loss of CSR-1 leads to a 
dramatic disassociation of P granules from germline nuclei (Gu et al., 2009; Claycomb et 
al., 2009). Since pir-1 mutants have intact P granules, as shown in Chapter II (Fig. 2.3C, 
page 77), we cannot justify the reduction of these 22G-RNA classes with the disassembly 
of P granules. While we cannot completely rule out that the downregulation of WAGO- 
and CSR-1-pathway 22G-RNAs indirectly arise from the germline immaturity of the 
mutants, our results suggest that PIR-1 plays a role in promoting the accumulation of these 
two classes of 22G-RNAs. Unfortunately, the inability to silence pir-1 by RNAi confined 
us to a developmental stage where phenotypes associated with defects in the CSR-1 and 
WAGO pathways cannot be adequately studied.   
  
pir-1 Mutant Animals Fail to Accumulate Spermatogenesis-Associated  
ALG-3/4-Class 26G-RNAs  
We next considered ERI-class sRNAs, which we subdivided into ERGO-1 and 
ALG-3/4 classes and further into primary 26G-RNAs and corresponding secondary 22-
RNAs. Regarding ERGO-1-class 22G-RNAs, we did not observe dramatic changes in their 
levels between pir-1 and wild-type animals (Fig. 4.4 and 4.5, magenta bars). These 22G-
RNAs are synthesized primarily during postembryonic development in somatic tissues, 
triggered by 26G-RNAs produced during oogenesis and embryogenesis (Vasale et al., 
2010; Fischer et al., 2011). Consistent with ERGO-1 26G-RNA production starting at 
oogenesis, pir-1 animals, which almost never reach oogenesis, as well as dcr-1 animals, 
which have severe oogenesis and embryogenesis defects, express lower levels of ERGO-1 
26G-RNAs (Fig. 4.4 and 4.5 rightmost magenta bars). We infer that the ERGO-1 26G-
RNAs in the mutant homozygotes derive from synthesis during oogenesis in the 
heterozygous mother, and later during embryogenesis using maternally-derived PIR-1 or 
DCR-1. Interestingly, in the pir-1; dcr-1 double mutant, ERGO-1 26G-RNAs exhibited the 
strongest depletion of any of the samples analyzed (Fig. 4.5C). Since these sRNAs require 
Dicer, it is tempting to interpret this change as a synergy between the absence of both PIR-
1 and DCR-1, perhaps hinting that some ERGO-1 26G-RNAs may be synthesized prior to 
oogenesis. Regardless of this, we cannot make a definitive conclusion regarding a role for 




PIR-1 in the production of ERGO-1 26G-RNAs. Addressing this issue will require RNA 
analysis at the peak developmental stages for ERGO-1 26G-RNA biogenesis. When we 
looked at ALG-3/4-class 22G-RNAs, however, we observed a decrease similar to what we 
saw for CSR-1 22G-RNAs in pir-1 arrested mutants (Fig. 4.4 and 4.5A, left light blue 
bars). Interestingly, ALG-3/4 26G-RNAs were almost completely depleted in pir-1 mutant 
animals regardless of their age (Fig. 4.4 and 4.5A, rightmost bars), strongly suggesting that 
the reduction in 22G-RNAs could be a direct consequence of the absence of trigger sRNAs 
and that PIR-1 could promote the accumulation of spermatogenesis-associated 26G-RNAs.  
In contrast to pir-1 mutant animals, the dcr-1 mutant expressed wild-type levels of 
ALG-3/4 22G-RNAs (Fig. 4.5B). The lack of ALG-3/4 26G-RNAs in dcr-1 mutant 
animals is explained by the fact that the animals were collected as mature adults where 
spermatogenesis was no longer occurring. Since dcr-1 homozygotes reach adulthood due 
to a strong maternal load of DCR-1 protein (Duchaine et al., 2006), we presume that ALG-
3/4 22G-RNAs were abundantly triggered during spermatogenesis by ALG-3/4 26G-RNAs 
produced by inherited DCR-1. In pir-1 arrested animals, because the amount of 26G-RNAs 
may have never reached wild-type levels, the triggering of 22G-RNAs was consequently 
much weaker. 
In contrast to spermatogenesis in hermaphrodites, which is confined to a relatively 
short time frame preceding female gamete production, males continuously undergo 
spermatogenesis. ALG-3/4 26G-RNAs against a greater variety of transcripts can therefore 
be detected in adult males, at all stages of spermatogenesis – and associated sRNAs – are 
simultaneously captured. We found that males also exhibit a strong depletion of 
spermatogenesis-associated 26G-RNAs in the absence of PIR-1 (Fig. 4.6A and B). The 
reduction was not as pronounced as in hermaphrodites, possibly because the mRNA 
templates are expressed at higher levels, which in turn leads to a more abundant synthesis 
of 26G-RNAs while maternal PIR-1 is still available. We obtained this result using either 
the standard TAP-cloning method (5'-independent) or a 5'-dependent direct cloning (no 
enzymatic treatment), which excludes all 5'-PPP species (i.e., 22G-RNAs). The fact that 
we could still abundantly clone ALG-3/4 26G-RNAs with the direct method implied that 
they are still predominately 5'-monophosphorylated in the pir-1 mutant germline (Fig. 
4.6C). Unexpectedly, 21U-RNAs became enriched in pir-1 males regardless of cloning 
method and normalization standard (total nonstructural reads for TAP cloning and 
miRNAs for direct cloning). Since male germlines only produce sperm, the reduction in 
ALG-3/4 26G-RNAs may have a more widespread effect on deregulation of germline gene 




expression, and the rise in 21U-RNA expression may be a consequence of that. The fact 
that 21U-RNAs are actually enriched, however, does increase our confidence that PIR-1 is 
not required for their biogenesis. Additionally, 22G-RNAs targeting protein-coding 
transcripts are also significantly reduced in pir-1 males (Fig. 4.6B, gray bar), once again 





Figure 4.4. Deep-sequencing analysis reveals that specific classes of germline endogenous 
small RNAs are downregulated in pir-1(tm3198) mutant animals. Small RNA libraries for deep 




sequencing were constructed by the 5'-independent TAP cloning method, which captures all known 
species of sRNA. Wild-type hermaphrodite avr3x animals were grown on ivermectin and collected 
as a range of L4 to young adults, serving as the control for all comparisons. (A) Scatter plots of 
sRNA reads in ten-day counterselected pir-1 arrested hermaphrodites (y axis) versus avr3x wild-
type hermaphrodites (x axis). Each dot represents a unique miRNA and 21U-RNA, or in the case of 
22G-RNAs and 26G-RNAs, represents all the sequences mapping to an individual gene, measured 
as the number of reads per million (rpm). Normalization was performed with total nonstructural 
reads. No read number cutoff was applied to the graphed data, and all data points were transformed 
by adding one read (such that one rpm in reality corresponds to zero reads). (B) Box-and-whiskers 
plot of the ratio of reads per million pir-1/(pir-1 + wild type) from data in (A), such that a ratio of 
0.5 corresponds to no change in read number between the two samples, and ratios above or below 
correspond to an enrichment or depletion of reads in the pir-1 mutant compared to wild-type, 
respectively. (0.3(3) represents a two-fold downregulation in pir-1, and 0.6(6) represents a two-fold 
upregulation in pir-1). Boxes contain 50% of the sRNA loci (between the 25th and 75th percentiles). 
The line inside the box represents the median value and the ends of the whiskers represent the loci 
with the most upregulated or downregulated sRNAs. All box-and-whiskers plots consider genes 
with sRNAs displaying ≥10 rpm in either mutant or wild-type. Above each bar is the number (n) of 
genes that met the cutoff. The ‘all coding sRNA’ category in gray includes all sRNA reads 
mapping to protein-coding genes, including, but not restricted to the specific 22G-RNA and 26G-
RNA categories shown. (C) Box-and-whiskers analysis of sRNAs from three-day counter-selected 
pir-1 mutants. (D) Western blot on seven-day arrested pir-1 total protein extracts, revealing wild-
type expression levels of DCR-1, DRH-3, the 21U-RNA Argonaute PRG-1 and the WAGO 
Argonaute SAGO-1(WAGO-8).  
 
 






Figure 4.5. Comparison of small RNA profiles from pir-1 and dcr-1 loss-of-function mutants 
and analysis of transposon and repeat-associated small RNAs in pir-1 mutant animals. (A) 
Box-and-whiskers analysis of sRNAs from seven-day counter-selected pir-1 animals. (B) Box-and-
whiskers analysis of sRNAs from seven-day counter-selected dcr-1 loss-of-function mutant 
animals arrested as sterile adults. (C) Box-and-whiskers analysis of sRNAs from seven-day 
counter-selected pir-1; dcr-1 double mutant animals, which are phenotypically identical to the pir-
1 single mutant. (D) Scatter plots of reads for sRNAs targeting all expressed transposons at 
different times of counter-selection. The represented data is from the same sRNA libraries analyzed 




in Figure 4.4. and 4.5A (E) Box-and-whisker plot representation of the ratio of reads pir-1/(pir-1 + 
wild type) after applying the ≥10 rpm cutoff. Normalization was performed with total nonstructural 
reads. (F) Representation of the percentage of different sRNA populations in wild-type and seven-
day old pir-1 animals when considering all genome-matching reads minus sense structural reads. 
The absolute number of these reads in the libraries is indicated in the figure. All classes consider 
antisense reads, except miRNAs and 21U-RNAs (only sense reads) and reads mapping to repetitive 






Figure 4.6. Deep-sequencing analysis of pir-1 mutant males confirms the downregulation of 
spermatogenesis-associated 26G-RNAs. (A) Scatter plots of sRNAs from a population of single-
picked worms compared to wild-type avr3x males of the same age, and not grown in the presence 
of ivermectin. Data was normalized with total nonstructural reads. (B) Box-and-whisker 
representation of the same data in terms of the ratio of reads pir-1/(pir-1 + wild type) after applying 
a ≥10 rpm cutoff. (C) Analysis of the same samples cloned by a direct cloning (5'-independent) 








The ALG-3/4 26G-RNA Defect Is Not Due to Lack of Expression of Target 
mRNAs  
 Conceivably, the downregulation of ALG-3/4 26G-RNAs in pir-1 mutant animals 
could be due to a lack of expression of template/target mRNA. We therefore deep-
sequenced mRNA from three- and ten-day counter-selected pir-1 mutant populations. 
Normalization was performed using total coding sense reads and some targets were 
validated by qRT-PCR (Fig. 4.7). Despite considerable variation in expression levels of 
numerous individual mRNAs between pir-1 and wild type, the majority of genes expressed 
in the control are also expressed in pir-1 mutant animals (i.e., there appears to be no global 
decrease in gene expression in pir-1; Fig. 4.7A and B, gray bars). When subdividing genes 
into different Argonaute-target classes, this trend held true for WAGO, CSR-1 and ALG-
3/4 classes. Curiously, for the eight ERGO-1 targets that were sequenced above the 50 
read-per-million (rpm) cutoff used to build the box-and-whiskers plot there was a marked 
increase in the pir-1 mutant, suggesting some deregulation, likely due to decreased levels 
of ERGO-1-class 22G-RNAs (Fig. 4.4, page 173). In three-day animals, the general 
mRNA abundance was closer to wild type, while in ten-day animals mRNAs were overall 
slightly upregulated. We speculate that this may reflect a gradual loss of mRNA silencing 
due to persistent lowered abundance of germline 22G-RNAs (Fig. 4.4).  
Concerning the use of mRNAs as templates for 26G-RNA biogenesis, we needed to 
consider that transcripts are often targeted by multiple sRNA pathways, making it difficult 
to distinguish between Dicer-independent 22G-RNAs and Dicer-dependent 22G-RNAs 
(i.e., triggered by 26G-RNAs generated by Dicer cleavage). For instance, according to the 
data sets used in our study, out of a total of 3,659 CSR-1 target mRNAs, 424 are also 
targeted by ALG-3/4 26G-RNAs (from a total of 1,684 ALG-3/4 mRNA targets). In turn, 
the 2,911 WAGO target mRNAs overlap with 130 ALG-3/4-class targets. As an example, 
the 26G-RNAs produced from the ZK973.8 gene are not detected in pir-1, yet WAGO-
dependent 22G-RNAs still accumulate significantly (all sRNAs, Fig. 4.8A). In cases such 
as this we cannot determine which fraction of 22G-RNAs arises from Dicer-independent 
triggering or through Dicer-synthesized 26G-RNAs. We therefore focused on a subset of 
ALG-3/4 targets that were not only missing 26G-RNAs, but also exhibited a severe 
depletion of 22G-RNAs (K03H1.12 as an example in Fig. 4.8A). In other words, we 
wanted to analyze a representative set of mRNAs from which all 22G-RNAs were 
triggered by ALG-3/4 26G-RNAs, and not from other pathways (such as CSR-1 or 
WAGO). The criteria used to create this set were that the ALG-3/4-class mRNAs should 




not be targeted by WAGO or CSR-1-class 22G-RNAs; that both 26G-RNAs and 22G-
RNAs should be expressed at at least ten rpm in wild type and should exhibit a ten-fold or 
higher depletion in pir-1; and that the mRNAs should be expressed at at least 50 rpm in 
either wild type or mutant. After ten days of counter-selection, we found 101 genes that 
met these sRNA criteria. For 99 of these we had corresponding mRNA-seq data that met 
our 50 rpm cutoff. For this set of targets the average read number was higher in pir-1 
(359.4 rpm) than in wild type (318.3 rpm) (Fig. 4.8D). At three days we found a 
comparable set of 129 genes and found that the average mRNA-seq reads in pir-1 (515.5 
rpm) was only slightly lower than in wild-type (673.6 rpm). Only 57 mRNAs overlapped 
between the two sets, providing added confidence that PIR-1 is crucial for the 
accumulation of 26G-RNAs. Since pir-1 mutants express mRNAs that are exclusively 
regulated by ALG-3/4 26G-RNAs at levels close to or higher than those of wild-type 
animals we conclude that the absence of 26G-RNAs is not attributed to a lack of templates.  
When we compared mRNA levels of these exclusive ALG-3/4 26G-RNA targets 
measured by mRNA-seq in pir-1 mutant animals with levels obtained by tiling microarray 
analysis of alg-3; alg-4 double mutant animals (from Conine et al., 2009) we observed that 
after ten days these mRNAs were upregulated almost as much as in the alg-3; alg-4 mutant 
(Fig. 4.8B). This result indicated that these mRNAs are also desilenced in the pir-1 mutant, 
as one would expect to observe if the targets are being actively expressed. Consistent with 
this, a previous study found that sperm genes were upregulated in eri-1 and rrf-3 mutant 
hermaphrodites, both of which lack 26G-RNAs (Asikainen et al., 2007). At three days, the 
mRNAs were more upregulated in the alg-3; alg-4 mutant than in pir-1, perhaps due to the 
fact that in pir-1 mutant animals the expression of target mRNAs had still not recovered 
from a more recent loss of silencing 22G-RNAs due to maternal load.  
 One last possible cause for the absence of ALG-3/4 26G-RNAs could be the lack of 
expression of the Argonautes themselves, which would lead to destabilization of the 
sRNAs. Two observations rule out this possibility. First, mRNA-seq showed that in both 
three- and ten-day old pir-1 animals the mRNAs of alg-3 and alg-4 are expressed at similar 
or higher levels than in the L4-young adult wild-type control animals (Fig. 4.9A). Second, 
when examining arrested pir-1 hermaphrodites expressing a rescuing gpf::alg-3 transgene 
(Conine et al., 2010), GFP::ALG-3 could be detected in the spermatogenic area of the 
germline, in a pattern identical to that of the wild-type background (Fig. 4.9B). Taken 
together, all the aforementioned results indicate that the lack of 26G-RNAs in pir-1 




arrested animals is due to a problem in their synthesis or accumulation, and not from a lack 





Figure 4.7. Deep-sequencing analysis of poly(A)-selected RNA in pir-1 mutant animals. The 
RNA samples used in this experiment were the same used for sRNA analysis. (A) Scatter plots of 
sRNA reads in ten-day counter-selected pir-1 arrested hermaphrodites versus avr3x wild-type 




animals obtained by TAP cloning. Each dot represents the number of reads per million (rpm) that 
map to a unique gene. Normalization was performed with total sense reads derived from protein 
coding genes. No read number per gene cutoff was applied to the graphed data, and all data points 
were transformed by adding one read (a value of one rpm in corresponds to zero reads). The gray 
data points correspond to all sequences not belonging to the four categories considered. The 
accompanying box-and-whiskers plot represents the ratio of reads pir-1/(pir-1 + wild type) after 
applying a ≥50 rpm cutoff for either pir-1 or wild-type reads. The number of genes that met this 
cutoff value is depicted above the graphed bars. (B) Identical analysis applied to three-day counter-
selected pir-1 animals. (C) qRT-PCR validation of some mRNAs from each of the different sRNA-
target categories considered (blue bars). Measurements were performed on three independent 
replicates for wild-type and pir-1 animals counter-selected for seven days. Transcript levels were 
normalized to actin mRNA (act-3) and are relative to wild-type. Error bars report the SEM. 
Relative fold changes from RNA-sequencing were calculated by normalizing transcript rpm to total 
actin rpm, relative to normalized rpm in avr3x wild type (orange bars). Note that qRT-PCR fold 
changes best match the mRNA levels from the ten-day counter-selected sequencing data, as 
expected from a more similar developmental state and age.  
 
 






Figure 4.8. pir-1 mutant animals express ALG-3/4 mRNA templates from which 
downregulated 26G-RNAs are derived. (A) Genome browser representation of two ALG-3/4 
26G-RNA target mRNAs. Each bar maps the first nucleotide of each read and the height indicates 
the associated rpm value on the scale. In both cases the transcripts are expressed in both wild-type 




and ten-day pir-1 animals. sRNAs (mostly 22G-RNAs) are expressed in pir-1 from ZK973.8 in the 
absence of ALG-3/4 26G-RNAs, because it is also targeted by a 26G-RNA-independent WAGO 
pathway. In wild type most of these WAGO-dependent sRNAs are distributed along the exons of 
the entire gene, in contrast with 26G-RNAs which are located primarily at the 5'-end. Conversely, 
sRNAs targeting K03H1.12 are exclusively triggered by 26G-RNAs as no sRNAs are present in 
pir-1 animals and all sRNAs map around the sites of 26G-RNA accumulation. (B) Comparison in 
ten-day pir-1 animals of 22G-RNA, 26G-RNA and mRNA reads per million for a set of genes 
whose 22G-RNAs are entirely dependent on ALG-3/4 26G-RNAs, of which K03H1.12 is an 
example. The criteria for building this gene set were the following: (1) ALG-3/4-class mRNAs not 
targeted by WAGO or CSR-1-class 22G-RNAs, (2) expression at ≥10 rpm for both 26G-RNAs and 
22G-RNAs in wild-type, (3) ≥10-fold 26G-RNA and 22G-RNA depletion in pir-1 relative to wild 
type, and (4) ≥50 rpm for the corresponding mRNAs in pir-1 or in wild type. ‘n’ indicates the 
number of genes that met the criteria and the red bar marks the mean rpm value for each group. The 
box-and-whisker plot compares the ratio of mRNA measurements mutant/(mutant + wild type) 
obtained by mRNA-seq comprised in the analyzed sets to the same RNAs measured in a tiling 







Figure 4.9. pir-1 mutants express alg-3 and alg-4 mRNAs, and ALG-3 protein. (A) alg-3 and 
alg-4 mRNAs are expressed in pir-1 animals at a wild-type or higher level. Fold-change was 
calculated based on total coding sense RNA-normalized reads. (B) Expression of GFP::ALG-3 
from an integrated transgene with native regulatory elements in a live wild-type L4 hermaphrodite 
or in a live arrested pir-1 homozygote hermaphrodite. GFP signal can be seen near the vulva in the 
proximal germline where spermatogenesis occurs, localizing to the cytoplasm but also surrounding 
the nuclei in P granules. In pir-1 animals the signal is partially masked by the presence of an 
abnormal amount of fluorescent intestinal granules frequently observed in older arrested animals. It 
is still clear, however, that GFP::ALG-3 exhibits a wild-type localization. 
 
 




pir-1 Mutants Exhibit an Upregulation of Innate Immunity Pathway Gene 
Expression 
 Continuing the characterization of pir-1-associated phenotypes, we analyzed our 
mRNA-seq libraries for changes in the expression of specific mRNAs. In order to create a 
stringent, high-confidence list of misregulated mRNAs, we only considered genes that 
were at least two-fold down- or upregulated in both three- and ten-day counter-selected 
pir-1 animals. The inclusion of the three-day old pir-1 animals provided a control for age-
dependent effects, since the wild-type avr3x worms were grown for the same period of 
time. Additionally we set a cutoff of at least 50 rpm for each mRNA in any of the three 
samples considered. With these criteria, we obtained a list of 813 downregulated and 1,393 
upregulated genes. We organized the genes for which functions are known or predicted 
into informative biological categories. These genes, along with their descriptions, fold de-
regulation relative to wild-type, and read numbers are compiled in electronic Appendix D. 
The top ten categories for up- and downregulated mRNAs are depicted in Figure 4.10.  
 Generally, downregulated genes are associated with processes that are expected to 
function during active growth. Examples include a variety of collagens, which are heavily 
expressed at every larval molt to build successively larger cuticles (outer extracellular 
matrix); proteins related to protein metabolism, including several ribosomal proteins;  
regulators of cell division, including the essential cyclin-dependent kinase cdk-1, required 
for cell cycle progression in both meiosis and mitosis; and histones. Consistent with the 
absence of oocytes and fewer mature spermatids in pir-1 mutant animals, we also observed 
a heavy downregulation of mRNAs for oocyte vitellogenins and other yolk proteins, as 
well as numerous mRNAs associated with mature sperm, especially of the major sperm 
protein (MSP) family. Additionally, we registered a downregulation of several genes 
encoding hedgehog-like intracellular signaling proteins that perform essential roles in 
growth and morphogenesis. This gene list is in agreement with the developmental arrest 
that characterizes pir-1 mutants. 
  Unexpectedly, when we analyzed the list of upregulated mRNAs, we found an 
enrichment for genes involved in innate immunity and response to various stresses, along 
with genes for the upstream signaling pathways that activate those responses. Specifically, 
central components of the TGF-β-like pathway (Transforming Growth Factor β), 
p38/MAPK pathway (Mitogen-Activated Protein Kinase), DAF-2/DAF-16 insulin-like 
receptor pathway (Abnormal Dauer Formation), and apoptosis pathway were upregulated 
(pathways reviewed in Ermolaeva and Schumacher, 2014). Downstream effectors included 




factors required to combat oxidative stress, heat-shock, and bacterial infection: 
carbohydrate-binding C-type lectins, a variety of antimicrobial peptides, lysozymes, 
proteins associated with vesicles (including lysosomes), autophagy and endocytosis, 
ubiquitination proteins, and factors required for the misfolded protein response. 
Interestingly, our results match those reported in a microarray-based study of gene 
expression in C. elegans dcr-1, rde-4 and rde-1 loss-of-function mutants (Welker et al., 
2007). All mutants showed enrichment for innate immunity mRNAs, uncovering an 
important role for RNAi factors in the suppression of stress and immunity pathways in C. 
elegans. The addition of PIR-1 to this repertoire further underscores the possibility that 
these important pathways can be specifically downregulated via endogenous siRNAs. 
However, we do not have enough knowledge to exclude the possibility that this response is 
an indirect effect from a global shift in sRNA populations and consequent gene expression 
changes. In spite of being beyond the scope of our study, this finding deserves further 
investigation. 
 Importantly, pir-1 mutant animals exhibited higher levels of mRNAs for several 
sRNA factors, consistent with the absence of defects in exo- and non-ERI endo-RNAi, 
miRNA and 21U-RNA pathways. For RNAi, these included mRNAs encoding the primary 
Argonaute RDE-1, the secondary Argonaute WAGO-8(SAGO-1), RDE-2 (a germline 
RNAi factor found in complex with the 3'-5' exonuclease MUT-7; Tops et al., 2005), the 
RdRP RRF-1, and CDE-1 (also known as CID-1 or PUP-1), a poly(U) polymerase required 
for regulation of CSR-1-associated 22G-RNAs by 3' uridylation (van Wolfswinkel et al., 
2009). Regarding miRNAs, these included mRNAs for the Argonautes ALG-1, ALG-2 and 
for miRISC-associated factors AIN-1 and NHL-2, which promote miRNA-mediated 
silencing (Ding et al., 2005; Hammell et al., 2009). Lastly, the 21U-RNA Argonaute PRG-










Figure 4.10. Analysis of mRNAs depleted or enriched in pir-1 mutant animals according to 
biological category. From our mRNA-sequencing data we identified mRNAs that were 
consistently down- or upregulated in both three- and ten-day pir-1 animals relative to wild-type. 
We established a cutoff of ≥50 rpm for at least one of the samples and a ≥2-fold misregulation. The 
categories were manually curated following gene ontology analysis from the WormBase Ontology 
Browser (WormBase.org; Harris et al., 2014). Only the top ten categories are represented, with the 
number of genes for each category in parenthesis. The complete list of genes accompanied by the 
corresponding read counts, relative fold misregulation, and gene description can be found in 
electronic Appendix D.  
 
 
ALG-3/4 26G-RNAs Are Enriched in Nuclear Extracts  
Due to the primarily nuclear localization of PIR-1, we wanted to examine the 
sRNA populations in nuclei isolated from whole wild-type animals. Since we were unable 
to isolate pure cytoplasmic sRNAs, we used total sRNAs as a control. Consistent with 
studies that compared miRNA abundance in cytoplasm versus nucleus of human cells 
concluding that the concentrations in the two compartments were similar (Liao et al., 2010; 
Gagnon et al., 2014), the ratio of nuclear to total miRNAs in C. elegans indicated no 
significant change in their abundance (Fig. 4.11A and B).  
Regarding 21U-RNAs, we were surprised not to observe an appreciable change, 
given the fact that PRG-1 predominately localizes to P granules, on the outer nuclear 
periphery. However, since no studies have directly addressed 21U-RNA localization, it is 
plausible that a sizeable population of 21U-RNAs may reside inside the nucleus. Unlike 
mouse and flies, where piRNAs exert their function directly in the nucleus to deposit 
repressive chromatin marks, in C. elegans 21U-RNAs are thought to promote these 
silencing events by triggering 22G-RNA synthesis in P granules (reviewed in Cecere and 
Grishok, 2014). These 22G-RNAs associate with the nuclear RNAi machinery to induce 
chromatin silencing, but this does not conflict with the possibility that many 21U-RNAs 
may enter the nucleus to exert this and other functions.  




Analysis of WAGO 22G-RNAs revealed that they were slightly depleted from the 
nuclear extract, consistent with the majority of WAGO Argonautes exerting post-
transcriptional silencing in the cytoplasm and in P granules. When we considered CSR-1 
we were surprised to find that they were also slightly depleted. Since CSR-1 heavily 
localizes to P granules throughout the germline and is also known to interact extensively 
with chromatin, we expected instead to see an enrichment of CSR-1 22G-RNAs in the 
nuclear fraction. The fact that that P-granule associated 22G-RNAs were depleted from our 
nuclear extracts, indicated that our nuclear isolation method likely disrupts P granules from 
the outer surface of nuclei. 
Since the ALG-3 Argonaute also accumulates in P granules (Conine et al., 2010), 
we would expect ALG-3/4 26G-RNAs to behave like CSR-1 22G-RNAs regarding their 
relative nucleo-cytoplasmic abundances. Instead, ALG-3/4 26G-RNAs were the most 
enriched sRNAs in nuclear fractions, contrasting with ERGO-1 26G-RNAs which were 
depleted. Additionally, the fact that (1) only a small proportion of germline cells undergo 
spermatogenesis, that (2) we used total instead of cytoplasmic extracts in our comparison, 
and that (3) there was a slight cytoplasmic contamination in our nuclear extract (Fig. 
4.11D), implies that the nuclear enrichment for ALG-3/4 26G-RNAs measured in our 
experiment is likely an underestimation of the actual enrichment of 26G-RNAs in the 
nuclei of spermatogenic cells. Paradoxically, the P-granule localization of ALG-3 suggests 
that its 26G-RNAs function mainly at these sites. Nonetheless, it is conceivable that a large 
fraction of Argonautes in P granules are not loaded with sRNAs and that enough nuclear 
ALG-3 and ALG-4 exist to stabilize the 26G-RNAs in that compartment. In contrast, and 
consistent with activity outside the nucleus, stands our result that the 26G-RNA-dependent 
ALG-3/4 22G-RNAs are not enriched in the nucleus. Since we demonstrated that the ERI 
complex assembles in the nucleus with PIR-1 (Fig. 3.8, page 136), and that PIR-1 is 
present in the nuclei of germ cells undergoing spermatogenesis (L4 larvae and male 
germlines in Fig. 2.4A, page 81, Fig. 2.5C, page 82 and Fig. 2.7, page 85), it is plausible 
that ALG-3/4 26G-RNAs may be synthesized within the nucleus, and subsequently 
exported into P granules perhaps already in association with their target mRNAs. However, 
the synthesis of some ALG-3/4 26G-RNAs may also take place in the common cytoplasm 
of the spermatogenic syncitial germline, where both PIR-1::GFP and GFP::ALG-3 are also  
found to be diffusely distributed (compare Chapter II figures with Fig. 4.9, page 182).  
We extended the analysis to other sRNA categories that we would predict to be 
enriched in nuclei, measured as fractions of total nonstructural reads (Fig. 4.11C). In 




comparison to miRNAs or 21U-RNAs, which were cloned at similar frequencies in total 
and nuclear extracts, and to antisense sRNAs derived from protein-coding RNAs, which 
were cloned less frequently in nuclear extracts, only transposon and repetitive-element-
associated sRNAs were cloned more frequently in nuclear extracts. The enrichment of 
these categories likely reflects the need to control transposition and expansion of repeat 
elements to limit their deleterious effects on genome integrity. This result also reinforced 
our confidence that the nuclear enrichment we observed for ALG-3/4 26G-RNAs is not 
artifactual.  
In a prior study from our laboratory it was observed that, for specific targets, ALG-
3/4 26G-RNAs tend to accumulate at the 5' or at the 3' regions of mRNAs (Conine et al., 
2010). Considering this information, we split all mRNA templates into 20 separate bins of 
equal length within each gene, and added all 26G-RNAs reads falling into each bin to 
interrogate their global distribution (Fig. 4.12A). When examining the first four and last 
four bins, which concentrate the bulk of 26G-RNA reads, we saw that there were twice as 
many reads derived from 5' ends than from the 3' ends (1.9-fold for total extracts and 2.3-
fold for nuclear extracts from wild-type animals). We wondered whether this unusual 
preference for the 5' regions of mRNAs could be related to the nuclear enrichment of 
ALG-3/4 26G-RNAs we observed. Interestingly, in pir-1 mutants this bias disappeared 
completely, although the 26G-RNA read number may be too low to confidently infer 
biological relevance. In contrast, ERGO-1 26G-RNAs accumulated predominately along 
the 3' half of its targets. 22G-RNAs, on the other hand, are abundantly distributed across 
the entire mRNAs, but tend to show an increased accumulation at the 3' ends (Gu et al., 
2009). We confirmed this for 22G-RNAs against ALG-3/4, CSR-1 and WAGO targets. 
Curiously, ERGO-1 22G-RNA distribution profiles more closely resembled the 
corresponding 26G-RNA distribution, suggesting that the majority of 22G-RNAs are 
triggered directly by 26G-RNAs within the ERGO-1 mRNA target set. Collectively, all of 
the aforementioned findings are highly suggestive that the nucleus is a site of synthesis for 
spermatogenesis-associated 26G-RNAs. 
 






Figure 4.11. ALG-3/4-dependent 26G-RNAs are enriched in nuclear extracts of wild-type 
animals relative to other small RNA species. (A) Scatter plots of sRNA rpm in nuclear enriched 
RNA (y axis) compared to total RNA (x axis). Normalization was performed with total 
nonstructural reads. (B) Box-and-whisker plots of relative sRNA abundances from cloning of total 
RNA or RNA isolated from purified nuclei of avr3x wild-type L4 to young adult hermaphrodites. 
The vertical axis represents the ratio of nuclear reads/(nuclear reads + wild-type reads) such that a 
value above 0.5 is interpreted as sRNAs that are enriched in the nucleus in comparison to the total 
pool of sRNAs. (C) Representation of the percentage of different sRNA populations cloned from 
total and nuclear RNA, considering all genome-matching nonstructural reads. The absolute number 




of these reads in the libraries is indicated in the figure. (D) Western analysis of nuclear extracts 
used for RNA purification, showing a depletion of cytoplasmic tubulin and an enrichment for the 
large subunit of Pol II (AMA-1) and histone H3. (E) Ethidium-bromide stained denaturing 15% 
polyacrylamide gel of RNAs to assess the integrity of the samples used for the nuclear sRNA deep-
sequencing experiments.  
 
 
Figure 4.12. ALG-3/4 26G-RNAs map predominately to the 5' regions of template/target 
mRNAs. (A) The distribution of ALG-3/4 26G-RNAs is expressed as the total normalized number 
of reads derived from one of 20 bins into which all matching mRNA sequences were divided. 




Distributions were compared with ERGO-1 26G-RNA and with 22G-RNA distributions from the 
four Argonaute classes we considered (inside red rectangle). We also considered total and nuclear 
sRNAs (notice differences in read numbers), as well as the distribution of ALG-3/4 26G-RNAs in 
seven-day counter-selected pir-1 mutant animals. (B) Genome browser representation of reads 
targeting the gene T27A3.3. This gene expresses a short (330 nt) intronless transcript targeted by 
ALG-3/4 26G-RNAs, which are distributed in a relatively uniform manner along its length (in red). 
All other antisense sRNAs (pink) map close to 26G-RNAs and are downregulated in dcr-1 and pir-
1 mutants, implying that they are triggered by the DCR-1- and PIR-1-dependent 26G-RNAs. Sense 
sequences in blue are mostly pieces of degraded transcript with no 5'G bias.  
 
 
PIR-1 Removes the Two Terminal Phosphates from 5'-Triphosphorylated 
RNA in Vitro 
 Similarly to what has been shown for the baculoviral and human homologs (Takagi 
et al., 1998; Deshpande et al., 1999), we wanted to test whether C. elegans PIR-1 also 
possesses RNA phosphatase activity. We therefore cloned wild-type and catalytically 
inactive mutant (negative control) pir-1 cDNA sequences into an expression vector 
allowing C-terminal fusion with a 6x-histidine tag. Proteins were expressed in E. coli, 
purified and incubated with in vitro synthesized single-stranded RNAs of about 26 nt. As 
the substrate RNAs are 5'-triphosphorylated, we incorporated Terminator 5' phosphate-
dependent exonuclease in the reaction to degrade RNAs that would become 
monophosphorylated if PIR-1 functioned as predicted. PIR-1-untreated RNA was resistant 
to Terminator relative to the no-treatment control (Fig. 4.12A). RNA that was treated with 
wild-type PIR-1 was almost entirely degraded, indicating that it became 
monophosphorylated and therefore susceptible to Terminator digestion. Incubation with 
catalytically inactive PIR-1(C150S) protein did not allow Terminator-mediated 
degradation, showing that the cysteine-based catalytic activity of PIR-1 is required for 5' 
dephosphorylation. Since, under certain reaction conditions, Terminator exonuclease can 
also degrade 5'-hydroxyl RNAs, we repeated the experiment with an added control where 
the RNA was pre-treated with CIP to completely dephosphorylate its 5' ends (Fig. 4.12B). 
This control was necessary to discard the possibility of contaminating phosphatases in the 
purified PIR-1 fractions used in the assays. In this experiment, the CIP-treated RNA was 
still resistant to Terminator, while the PIR-1-treated RNA suffered degradation, proving 
that indeed the activity of C. elegans PIR-1 in vitro is to remove the first two phosphates 
from the 5' ends of RNA molecules. 
 
 






Figure 4.13. PIR-1 catalyzes the dephosphorylation of 5'-triphosphorylated RNA, leading to a 
5'-monophosphorylated product. (A) Denaturing PAGE analysis of digestion of an in vitro-
transcribed 5'-triphophorylated 26 nt RNA with recombinant wild-type or catalytically inactive 
(C150S) PIR-1. Terminator exonuclease was included in the same reaction for simultaneous 
digestion. The depletion of substrate indicates that phosphate groups were removed. The double 
bands are two sizes from the same transcription reaction, which were co-recovered following 
PAGE purification. (B) Independent experiment where the same 26-nt RNA (purified 
independently from the one in (A)) was digested first with recombinant PIR-1 (wt and mutant) or 
CIP and subsequently with Terminator exonuclease. The CIP control showed that the digestion by 
wild-type PIR-1 resulted in a 5'-monophosphate and not a 5'-hydroxyl RNA, both of which can be 
digested by Terminator under certain reaction conditions. (C) SDS-PAGE/Coomassie staining 




Daniel Chaves constructed and grew all C. elegans strains, extracted RNA and performed 
RNAi experiments, northern blots, qRT-PCRs and western blots. Some cloning libraries 
were prepared by Daniel Chaves, but most, including mRNA libraries, were prepared in 
our laboratory by Weifeng Gu. Mapping of reads and preliminary analyses of deep-
sequencing data were performed by Weifeng Gu, and subsequent analyses were performed 
by Daniel Chaves. Recombinant PIR-1 in vitro dephosphorylation assays were performed 
by Weifeng Gu in his own new laboratory at the University of California Riverside, with 
contributions from his students Ruidong Li, who purified wild-type PIR-1, and Lichao Li, 
who purified the catalytically inactive PIR-1.  





   
In this chapter we described results that conclusively implicate PIR-1 in sRNA 
biogenesis, particularly of the ALG-3/4 26G-RNA class, which promotes sperm 
development (Gent et al., 2009; Han et al., 2009; Pavelec et al., 2009; Conine et al., 2010). 
Furthermore, we have shown that, similarly to its human and baculoviral orthologs, C. 
elegans PIR-1 catalyzes the removal of the two terminal phosphates from 5'-
triphosphorylated RNAs. Below we present and discuss a model that incorporates these 
findings to explain why PIR-1 activity is required for 26G-RNA accumulation. 
Additionally, we explore the intriguing possibility that ALG-3/4 26G-RNAs may be 
synthesized in the nucleus. 
 
Enzymatic Activity of PIR-1 in the Context of the ERI Complex: a New Step in 
26G-RNA Biogenesis 
 After having determined that PIR-1 interacts with proteins of the ERI complex, 
analysis of the sRNAs expressed in the pir-1 loss-of-function mutant uncovered a defect in 
the accumulation of sperm-specific 26G-RNAs that associate with the Argonautes ALG-3 
and ALG-4. This molecular phenotype is in line with the spermatogenesis defect and the 
expression pattern of PIR-1::GFP in the male and hermaphrodite germline described in 
Chapter II. While many of the molecular events and respective order that lead to a mature 
26G-RNA are still not defined, we propose a model based on the activities of some of the 
proteins that compose the ERI complex (Figure 4.14).  
Synthesis of dsRNA is initiated by the RdRP RRF-3 on the mRNA template. 
Similarly to RRF-1 and EGO-1, RRF-3 preferentially starts synthesis on a cytidine residue 
of the template strand, originating a 5'-triphosphorylated guanosine as the first nucleotide 
of its product. This makes it unlikely that the synthesis is primer-dependent, raising the 
long-standing question of how 26G-RNA synthesis is triggered. Findings from a recent 
study in C. elegans showed that Dicer binds to thousands of regions of secondary structure 
predominately within the coding and 3' UTR regions of mRNAs, without, however, 
generating a detectable amount of sRNAs (Rybak-Wolf et al., 2014). In light of this 
finding, it is plausible that the ERI complex binds its targets via the interaction of Dicer 
with such dsRNA structures, perhaps in cooperation with partners capable of binding 
dsRNA, such as RDE-4 and DRH-3. Studies of DRH-3 activity in vitro have shown that 
even though its preferred substrate is dsRNA, and that it is activated upon binding dsRNA 




(as judged from the induction of strong ATP-hydrolyzing activity), this enzyme is not 
capable of unwinding annealed RNA strands (Matranga and Pyle, 2010). Additionally, 
DRH-3 is also capable of binding ssRNA at an affinity four-fold lower than dsRNA. Since 
DRH-3 is an ortholog of the cytoplasmic viral sensor RIG-I (Retinoic Acid-Incucible Gene 
I), which has been shown to translocate along dsRNA in an ATP-dependent manner, it has 
been proposed that DRH-3 could possess a similar translocase activity (Myong et al., 
2009). With this possibility in mind, we can imagine a scenario wherein the binding of the 
ERI complex to an internal mRNA stem, possibly accompanied by its cleavage or 
unwinding, enables DRH-3 to scan the mRNA in a 3'-5' direction until a cytidine 
nucleotide is encountered and RRF-3 can start synthesizing a complementary strand.  
Since Dicer requires dsRNA termini to cleave, it is not likely fully engaged by the 
newly synthesized dsRNA substrate until the template strand has been cleaved close to the 
site of RdRP initiation. We speculate that, upon binding of the ERI complex to the target 
RNA, such a step could be mediated through endonucleolytic cleavage by one of the 
proteins in the complex. A putative candidate is RDE-8, which our laboratory recently 
implicated as having endonucleolytic activity on mRNAs targeted by RNAi (Tsai et al., 
2015). The mRNA cleavage event mediated by RDE-8 is proposed to promote the 
engagement of secondary RdRPs, such as RRF-1, to produce silencing secondary 22G-
RNAs. Importantly, consistent with our finding that RDE-8 is pulled down with PIR-1 
complexes, RDE-8 was found to be required for the accumulation of 26G-RNAs. Another 
potential candidate that has also been pulled down with PIR-1 is the protein ERI-9, which, 
despite sharing significant homology with RDE-8, has thus far only been implicated in 
ERGO-1 26G-RNA biogenesis (Pavelec et al., 2009; Zhuang and Hunter, 2012). However, 
because catalytically inactive RDE-8 is able to rescue the 26G-RNA defect of an rde-8 
loss-of-function mutant, and because ERI-9 lacks the conserved catalytic residues that 
characterize the Zc3h12a family of nucleases, it is likely that such an mRNA cleavage step 
is not executed by either of these factors. We therefore cannot exclude that other 
unidentified nucleases may perform this role, by either stable or substrate-dependent 
transient interactions with the ERI complex.  
According to a study using embryo extracts to process dsRNA with different types 
of termini, it was demonstrated that C. elegans Dicer cleavage can result in a 26-nt 5'-3' 
sRNA and a shorter antisense 22-23-nt strand, provided the dsRNA substrate has a blunt 
terminus (Welker et al., 2011). Additionally, under these conditions and following the first 
cleavage, Dicer adopts an ATP-dependent processive cleavage mode to generate phased 




23-nt duplexes with 2-nt 3' overhangs from the remainder of the dsRNA molecule. This 
activity implies usage of Dicer’s helicase domain, which is strictly required for 26G-RNA 
accumulation (Gent et al., 2010; Pavelec et al., 2009; Welker et al., 2010). In contrast, 
dsRNAs with 3'-overhanging termini can be cleaved in the absence of ATP to produce 21-
23 nt duplexes. This scenario recapitulates miRNA cleavage from pre-miRNAs and 
primary siRNA cleavage from long dsRNA, which have been shown not to require a 
functional Dicer helicase domain in the studies referenced above. Bearing these properties 
in mind, one could imagine that following an endonucleolytic cut of the template RNA, 3'-
5' digestion could occur concurrently with scanning of the target mRNA for cytidines by 
the ERI complex. ERI-1b, which was shown to have 3'-5' exonuclease activity by 
degrading the 3'-overhangs of siRNA duplexes (Kennedy et al., 2004) could provide such 
an activity. Digestion would stop at the initial site of RRF-3 synthesis, as ERI-1b is unable 
to hydrolyze dsRNA, thus generating a blunt end for Dicer to act on.  
But where does PIR-1 fit in this model? Unlike mature 22G-RNAs, which have 5' 
triphosphates, 26G-RNAs have monophosphate 5' ends. Since RNA polymerases typically 
initiate synthesis with a triphosphorylated nucleotide, we assume that all 26G-RNAs are 
originally triphosphorylated. Human Dicer is known to cleave dsRNA substrates with 
different 5' phosphorylation states with the same efficiency in vitro (Zhang et al., 2002). 
Should this also be true for C. elegans Dicer, it is unlikely that PIR-1-mediated 
dephosphorylation is required for Dicer cleavage of the 26G-RNA precursor dsRNA. 
Instead, PIR-1 could remove phosphates to ensure productive loading into the correct 
Argonautes. In support of this hypothesis, a variety of studies, particularly in plants (which 
encode ten distinct Argonautes), have shown that 5'-end nucleotide identity of the sRNA 
and its physical interactions with the MID domain of Argonautes are crucial to determine 
which Argonaute it gets loaded into (Mi et al., 2008; Takeda et al., 2008; Frank et al., 
2010; Frank et al., 2012). One report describing the structure of an Archeal PIWI 
Argonaute complexed with a 5'-phosphorylated sRNA demonstrated that the MID domain 
makes contacts with the 5’-phosphate and that eliminating this phosphate lowers the 
binding affinity of the sRNA to the PIWI protein by about an order of magnitude (Ma et 
al., 2005). A similar observation was made regarding the 5'-phosphates of sRNAs 
interacting with human Argonaute-2 (Rivas et al., 2005). It is therefore conceivable that 
the phosphorylation state of sRNA 5' ends is a major determinant in sorting sRNAs into the 
appropriate Argonautes. This is particularly important in C. elegans, which encodes 26 




different Argonautes, in contrast to humans expressing only eight Argonautes and (to date) 
a less diverse repertoire of endogenous sRNAs.  
Therefore, in our model, we consider that in addition to size, 5'-nucleotide identity 
and 3' methylation, the 5' phosphorylation status is a crucial signature that allows the 
distinction between different sRNA classes in C. elegans, effectively separating 5'-PPP 
22G-RNAs secondary siRNAs from 5'-P primary endo- and exo-siRNAs. Lack of 
dephosphorylation by PIR-1 would thus preclude binding of 26G-RNAs to ALG-3 and 
ALG-4, resulting in their degradation. This dephosphorylation step could occur at any 
point after RRF-3 synthesis. However, since we cannot disprove that in vivo DCR-1 
activity may be influenced by the 5' phosphorylation of its substrates, we also present an 
alternative model where pir-1 mutant animals fail to accumulate 26G-RNAs due to the 
inhibition of Dicer cleavage by the 5'-PPP nucleotide. Although the stability of intact RRF-
3 dsRNA precursors in the absence of cleavage is probably low, it remains possible that if 
PIR-1 dephosphorylation is indeed required for Dicer cleavage, these species may 
accumulate to high enough levels in the pir-1 mutant background to allow detection. In the 
future, this possibility may be worth exploring via RNA-seq strategies that favor the 
cloning of dsRNA molecules (such as those described in Saldi et al., 2014 and Whipple et 
al., 2015). The characterization of such precursors could provide us with key insights into 
the mechanism of action of the ERI complex. 
One last consideration pertains to the passenger strand that arises as a byproduct of 
Dicer cleavage. Normally, the removal of the passenger strand occurs via the slicer activity 
of the Argonaute during loading (Matranga et al., 2005; Leuschner et al., 2006). Both 
ERGO-1 and ALG-3/4 Argonautes have intact catalytic residues that presumably remove 
the passenger strand, as demonstrated previously for RDE-1 (Yigit et al., 2006; Steiner et 
al., 2009). In ergo-1 deletion mutant animals, a two-fold accumulation of putative 26G-
RNA passenger strands has been observed relative to wild-type animals for the most 
heavily targeted ERGO-1 locus, E01G4.5 (Fischer et al., 2011). Intriguingly, this strand 
does not have the 22-23-nt length with a 3'-receded end predicted by the results from 
Welker et al. (2011), but is rather predominately 18-19 nt, with both a 5'- and a 3'-receded 
end relative to the 26G-RNA. Although the authors speculate that ERI-1b may be 
responsible for generating the 5' three-nucleotide receded end, there is no proof that this is 
the case. In both the pir-1 and the alg-3; alg-4 mutant backgrounds we do observe rare 
instances of sequences antisense to ALG-3/4-dependent 26G-RNAs that match these 
characteristics, although we do not have evidence that they accumulate (Colin Conine, 




unpublished observation and this work; see Fig. 4.12B, page 189 for two 5'-end examples 
of antisense passenger strands in blue). At the very least, our observations hint that ALG-
3/4 passenger strands are identical to those of ERGO-1 in that they are not generated by a 
canonical Dicer processing mechanism.  
 
 




Figure 4.14. Models for the involvement of PIR-1 in 26G-RNA biogenesis. The assembled ERI 
complex could interact with template RNA in a variety of ways. One interesting possibility is that 
this happens through Dicer recognition (without cleavage) of regions of secondary structure, 
perhaps aided by other RNA-binding proteins of the complex (RDE-4, DRH-3, RRF-3, PIR-1 and 
ERI-1b). Endonucleolytic cleavage 3' of the binding site could occur through the unidentified 
activity of one of the complex components. Unwinding of the duplex structure would allow 
translocation of the complex along the mRNA, perhaps through DRH-3 activity. The complex 
would only stop upon recognition of a cytidine by the RRF-3 polymerase, prompting it to initiate 
RNA synthesis. In the meantime, ERI-1b exonuclease activity could digest the 3' tail of the cleaved 
template mRNA. Digestion would halt at the beginning of the new region of dsRNA to give rise to 
a blunt end consisting of a 3'C-hydroxyl paired with a 5'G-triphosphate (at this point most of the 
complex proteins were omitted from the figure for clarity). In Model A, PIR-1 dephosphorylates 
the 5'G during or following DCR-1 cleavage (the sites for which are marked by the red arrowheads) 
to generate a 26G-RNA (green) and a passenger strand with a 2-4 nt 5'-receded end (according to 
Welker et al., 2011). The duplex is then loaded into the Argonaute and the passenger strand is 
removed via its slicer activity. In the absence of PIR-1, Dicer would still cleave the dsRNA 
precursor, but the resulting 5'-PPP 26G-RNA/passenger strand duplex would be unable to stably 
interact with the Argonaute and would be subsequently degraded. In Model B, Dicer cleavage only 
occurs after PIR-1-mediated dephosphorylation of the 5'G. In the pir-1 mutant background, 26G-
RNAs are never produced and dsRNA precursors are degraded or perhaps accumulate.  
 
 
PIR-1 Is Not Required for Secondary Exogenously Triggered siRNA 
Synthesis 
We found that pir-1 mutants are able to silence mRNAs in the germline and soma 
in response to dsRNA triggers. Since primary siRNAs are the direct cleavage products of 
Dicer, they are already monophosphorylated and would therefore not be predicted to 
require additional modification as 26G-RNAs do. One can argue, however, that when 
injecting or feeding dsRNA to worms, the 5'-PPP termini are degraded by pervasive 
phosphatases present in the intestinal lumen and in the animal’s body cavity, bypassing any 
mechanism that would rely on 5'-PPP recognition. Therefore, while we can say with 
confidence that PIR-1 is not required for the amplification stage of RNAi, in which 22G-
RNA effector siRNAs are generated in a Dicer-independent manner, we cannot exclude 
that the presence of 5' triphosphates in the trigger dsRNA could affect its processing in the 
pir-1 background (if their stability could be guaranteed). Additionally, since PIR-1 
interacts stably with DCR-1 and RDE-4, and both are required for primary siRNA 
generation, we cannot entirely discard a role for PIR-1 in the process. Ideally, this problem 
should be addressed biochemically by studying the processing of different dsRNA 
substrates with in vitro reconstituted DCR-1 primary processing complexes, with and 
without PIR-1. 
  




Is PIR-1 Required for Synthesis of ERGO-1 26G-RNAs? 
Due to the inability to silence pir-1 by RNAi, we could not determine whether we 
could arrest animals at the oogenesis and embryogenesis stages, during which ERGO-1 
26G-RNAs are produced. Therefore, we could not make any conclusions about the 
involvement of PIR-1 in the pathway. The ERGO-1 26G-RNAs we do detect in our 
experiments are likely of maternal origin and persist in somatic tissues to induce 22G-
RNAs against about 80 genes (detailed in Chapter I, page 46; Vasale et al., 2010; Fischer 
et al., 2011). ALG-3/4- and ERGO-1-dependent 26G-RNAs are differentiated by other 
features and requirements besides the targets that they regulate and the developmental 
stage at which they are produced. First, ERGO-1 26G-RNAs, like 21U-RNAs, are 
methylated at their 3' ends by the conserved HENN-1 methylase, which primarily resides 
in P granules (Kamminga et al., 2012). Generally, 2'-O-methylation has a stabilizing effect 
on sRNAs by preventing them from being uridylated and targeted for degradation 
(Kamminga et al., 2010; Ameres et al., 2010). This is consistent with their persistence 
throughout postembryonic development. Additionally, because the 3'-interacting PAZ 
domains of some Argonautes have been shown to have higher affinity to 3'-methylated 
sRNAs (Tian et al., 2011), this molecular signature could have evolved to ensure 
specificity of interaction with ERGO-1 and exclusion from the ALG-3 or ALG-4 
Argonautes. Second, only ERGO-1 26G-RNAs require ERI-9, a putative RNA transferase 
(Pavelec et al., 2009; Zhuang and Hunter, 2012), and the helicase ERI-6/7 (Fischer et al., 
2011). The former interacts with the ERI complex (Thivierge et al., 2012), while the latter 
does not and is located primarily in the cytoplasm (Fischer et al., 2008). Third, ERGO-1 
26G-RNAs specifically require a variety of Mutator proteins, including MUT-2/RDE-3, 
MUT-15 and MUT-16, which concentrate in Mutator foci adjacent to P granules, where 
the bulk of WAGO-dependent 22G-RNA amplification occurs (Phillips et al., 2012). 
Finally, our own results indicate that ERGO-1 26G-RNAs are not enriched in nuclei and 
have a more uniform distribution along their targets than ALG-3/4 26G-RNAs. 
 While the above differences highlight important distinctions in how these two 
classes of primary endo-siRNAs function, they do still retain the same requirement for the 
ERI complex and a need for dephosphorylation of the 5' end. Since PIR-1 seems to be 
expressed in the cytoplasm of oocytes and early embryos, it may function during the peak 
of ERGO-1 expression. However, as PIR-1 also accumulates heavily in nuclei of embryos 
after the eight-cell stage, it should not be entirely ruled out that ERGO-1 26G-RNA 
synthesis could also take place in the nucleus. Furthermore, we found that the PIR-1/ERI 




complex also assembles during developmental stages that do not yet have a germline (Fig. 
3.4, page 124), suggesting that ERGO-1 26G-RNA synthesis may extend beyond 
embryogenesis. Lastly, we have pulled down ERI-9 in PIR-1 immunoprecipitates, 
implying that at least a fraction of the complexes incorporate this ERGO-1 26G-RNA-
specific factor, the function of which remains to be elucidated. This collection of results 
strongly implies that ERGO-1 26G-RNAs do require PIR-1 activity.  
 
The Case for Biogenesis of ALG-3/4 26G-RNAs in the Nucleus  
To our knowledge, this study is the first to characterize a nucleus-enriched 
population of sRNAs in C. elegans, despite prior studies demonstrating that 22G-RNA 
pathways operate in the nucleus. The clearest example pertains to the 22G-RNAs binding 
to the WAGO-family nuclear Argonautes NRDE-3 (in somatic cells) and HRDE-1 (in the 
germline). These Argonautes lead to the establishsment of repressive chromatin marks with 
diverse functional outcomes such as the silencing of ERGO-1 targets, behavioral 
adaptation to odor, maintenance of heritable gene silencing, and transgenerational 
maintenance of germ-cell totipotency (Juang et al., 2013; Buckley et al., 2012; Burton et 
al., 2011; Burkhart et al., 2011; Guang et al., 2010; Guang et al., 2008). The 
predominately germline-expressed CSR-1 Argonaute also localizes to nuclei where it 
promotes proper chromosome segregation in the early embryo, represses antisense 
transcription and ectopic transcription from silent chromatin regions, and assists processing 
of histone mRNAs (Claycomb et al., 2009; Cecere et al., 2014, Avgousti et al., 2012). 
Within P granules, CSR-1 can also silence the expression of sperm-specific genes in the 
adult hermaphrodite germline, while in the exclusively spermatogenic male germline it can 
activate the expression of genes required for sperm differentiation at the chromatin level 
(Conine et al., 2013; Campbell and Updike, 2015). Nuclear-acting 22G-RNAs are thought 
to be produced predominately in the cytoplasm of somatic cells or in germline P granules. 
It is only upon association with specific Argonautes that 22G-RNAs travel to the nucleus. 
This was strikingly demonstrated for NRDE-3, which only localizes to nuclei when 
ERGO-1-dependent 22G-RNAs are produced (Guang et al., 2008). As discussed in 
Chapter III, however, several examples from other organisms prove or strongly suggest 
nuclear synthesis of Dicer-dependent sRNAs.  
Our results have shown that in contrast to the expected depletion of 22G-RNAs in 
nuclear extracts, ALG-3/4 26G-RNAs were enriched. Since we know that ALG-3 is mainly 
localized to the P granules and cytoplasm of cells committed to sperm differentiation, this 




unexpectedly indicated that a substantial population of 26G-RNAs resides in the nucleus. 
Two possibilities thus arise: these RNAs are synthesized in P granules and are 
subsequently imported into the nucleus, or their biogenesis is entirely nuclear and is 
followed by export to P granules, possibly in concert with nascent transcripts. In Chapter 
III we have demonstrated that PIR-1/ERI complexes assemble in the nucleus, and that most 
of its components also stably interact with chromatin (Fig. 3.8, page 136). Additionally, 
other studies have shown that ALG-3/4 26G-RNAs can trigger CSR-1-dependent 22G-
RNAs, and that both the EGO-1 RdRP (which predominately makes CSR-1 22G-RNAs) 
and the helicase DRH-3 also localize to the nucleus and chromatin (Maine et al., 2005; 
Claycomb et al., 2009; Conine et al., 2013). It is therefore plausible that at least a small 
population of ALG-3/4-bound 26G-RNAs could lead to 22G-RNA production without ever 
leaving the nucleus. However, given that ALG-3 concentrates in P granules, most 26G-
RNA targeting of mRNAs probably takes place in those regions. In contrast, our 
experiment showed that ERGO-1 26G-RNAs were not enriched in nuclei. This could result 
from a combination of two factors: (1) the accumulation of the 22G-RNAs that they trigger 
require proteins located in cytoplasmic Mutator foci (Zhang et al., 2011; Phillips et al., 
2012); and (2) the animals used for sequencing were not in the developmental stage during 
which most ERGO-1 26G-RNA synthesis occurs.  
When we analyzed the distribution of 26G-RNAs along mRNAs, we observed that 
the majority of ALG-3/4 26G-RNAs are derived from the 5' regions of mRNAs (Fig. 4.12, 
page 189). Although we cannot yet explain the reason for this asymmetry in sRNA 
distribution along targets, it is tempting to speculate that the preferential accumulation of 
ALG-3/4 26G-RNAs at mRNA 5' ends is related to a predominant synthesis in the nucleus. 
Perhaps as a way of ensuring tight regulation of spermatogenesis mRNAs, 26G-RNAs are 
synthesized co-transcriptionally, as nascent transcripts emerge from Pol II complexes. 
Since there is a strong depletion of ALG-3/4 26G-RNAs in the middle of genes relative to 
the ends, it is plausible that mRNA-processing RNPs such as the spliceosome physically 
block access of the ERI complex to these regions. Consistent with this idea is the fact that 
shorter genes with no introns, such as the abundant mRNAs for major sperm proteins, have 
a more uniform distribution of ALG-3/4 26G-RNAs along their sequences. In contrast, 
22G-RNAs, which are primarily made in the cytoplasmic P granules and Mutator foci, 
abundantly cover the entire length of their target mRNAs. In support of PIR-1 operating in 
the nucleus, the 5' bias disappears completely in the few 26G-RNAs that remain in pir-1 
arrested animals, which likely reside in P granules, bound to ALG-3 and ALG-4 (Fig. 4.12, 




page 189). This suggests that 26G-RNAs only accumulate in the nucleus while they are 
being synthesized, to be subsequently exported to P granules for triggering of 22G-RNA 
production. Under this scenario, in wild-type hermaphrodites undergoing active 
spermatogenesis, nuclear synthesis of 26G-RNAs would outpace the rate of export and 
accumulation in P granules, leading to a temporary nuclear retention of 26G-RNAs. In 
Figure 4.15 we present a model illustrating this process.  
As an important note, it must not be forgotten that in these experiments we are not 
capturing the sRNA distribution along individual transcripts. Rather, for each mRNA, we 
are considering sRNAs derived from a population of transcripts expressed in a variety of 
cells with distinct gene expression outputs. Each type of transcript is likely subjected to 
very different regulatory schemes depending on which point along germline development 
it is expressed. In other words, the same gene in early spermatogenesis may be regulated 
by a set of sRNAs completely distinct from the set of sRNAs present in late 
spermatogenesis. It is therefore plausible that 5'- and 3'-26G-RNAs derived from the same 
sequence may actually have been produced in different compartments and/or distinct 
differentiation stages, imparting very different fates on the mRNAs that they target. Since 
PIR-1 and ALG-3 also localize to the syncytial cytoplasm of early spermatogenesis, the 
synthesis of 26G-RNAs is likely to also take place there, perhaps to synthesize 
predominately 3' species. Further experimental exploration of these differences could 
potentially help us gain a more detailed understanding of how sRNAs contribute to the 
precise orchestration of highly complex and dynamic biological processes such as sperm 
cell differentiation. 
 







Figure 4.15. Model for ALG-3/4 26G-RNA biogenesis in the nuclei of germ cells. Our data are 
compatible with a model where the ERI complex (ERIC) synthesizes 26G-RNAs in the nucleus. 
Nuclear and chromatin-associated ERI complexes engage nascent RNA Pol II transcripts in the 
vicinity of nuclear pores (NP) to use them as RdRP templates, in competition with other nuclear 
mRNA processing factors for binding. ERIC activity leads to both cleavage and production of 26G-
RNAs from the 5' ends of the nascent transcripts. A small population of empty ALG-3 and ALG-4 
Argonautes localizes to the intranuclear perifery of the NP to allow loading and stabilization of 
26G-RNAs. These complexes are subsequently exported to NP-associated P granules in the 
cytoplasm, where they recognize target RNAs to promote synthesis of effector 22G-RNAs. 
Alternatively, loaded ALG-3/4 Argonautes could exit through the nuclear pore in association with 
intact mRNAs. The enrichment of 26G-RNAs in the nucleus is due to an elevated rate of synthesis 
during spermatogenesis which outpaces the rate of nuclear export of loaded Argonautes. The 
majority of ALG-3/4 proteins, however, still reside at their site of action in cytoplasmic P granules. 
There, loaded ALG-3/4 can trigger the synthesis of 22G-RNAs by the EGO-1 RdRP, which in turn 
associate with the CSR-1 Argonaute to regulate spermatogenic gene expression at the post-
transcriptional and transcriptional levels. Additionally, ALG-3/4 may also trigger the production of 








PIR-1 May Promote the Synthesis of Endogenous 22G-RNAs Targeting 
Protein-Coding Transcripts  
We observed a significant decrease in the accumulation of 22G-RNAs antisense to 
protein-coding genes in pir-1 arrested animals (Fig. 4.4, page 173 and Fig. 4.6, page 176 
gray bars and gray line). We initially attributed this effect to a lower germline-to-soma 
ratio compared to wild-type control animals. However, as the levels of germline 21U-
RNAs do not significantly change in pir-1 mutant animals, the aforementioned argument is 
a weak one. Rather, we justify this result with the possibility that PIR-1 promotes the 
accumulation of 22G-RNAs in the germline. Within the WAGO-pathway, we 
demonstrated that 22G-RNAs targeting transposons do not exhibit a decreased abundance 
in pir-1 mutant animals (Fig. 4.5, page 175), although WAGO 22G-RNAs are globally 
downregulated. This downregulation therefore occurs mainly at the expense of 22G-RNAs 
targeting protein-coding transcripts in the context of the WAGO pathway. Regarding CSR-
1 22G-RNAs, they exhibit a more pronounced reduction in pir-1 mutant animals,  
consistent with the fact that all identified CSR-1 targets are protein-coding transcripts.  
Since csr-1 mRNA levels remained at wild-type levels in both three- and ten-day arrested 
pir-1 animals, the 22G-RNA reduction is unlikely to be caused by decreased CSR-1 
protein (mRNA-seq data; not shown).  
The work of Conine et al. (2013) demonstrated that in male animals a subset of 
ALG-3/4 target genes required for spermatogenesis and spermiogenesis is directly targeted 
by CSR-1 22G-RNAs to promote their expression. This implied that ALG-3/4-bound 26G-
RNAs can act as primary triggers for the synthesis of a subset of CSR-1 22G-RNAs. Since 
pir-1 arrested animals exhibit a marked decrease in ALG-3/4 26G-RNAs, it is also 
plausible that the extra downregulation of CSR-1 22G-RNAs in the pir-1 mutant reflects 
the reduction of this specific set of 26G-RNAs. We found that from the 1,852 genes for 
which CSR-1 22G-RNAs are downregulated more than two-fold in pir-1 males (with a 10 
rpm cutoff), merely 183 overlap with the 1,156 genes targeted by ALG-3/4-dependent 
CSR-1 22G-RNAs (from Conine et al., 2013). It is therefore unlikely that the heavy 
reduction of CSR-1 22G-RNAs in pir-1 arrested animals is due to the interaction between 
the CSR-1 and the ALG-3/4 pathways.  
 The inability to study the effects of PIR-1 loss in more advanced developmental 
stages (e.g., by RNAi of pir-1) prevented us from adequately addressing this interesting 
result with further experiments. It is difficult to envision how PIR-1 would be able to 
promote 22G-RNA accumulation, as these RNAs are 5'-triphosphorylated in their active 




form. Perhaps PIR-1 functions upstream, by regulating the production of primary sRNAs 
to trigger the production of all 22G-RNAs targeting protein-coding sequences. Since we 
still do not understand how most endogenous 22G-RNAs are triggered, the possibility that 
PIR-1 may play a role in the process should be seriously considered in future studies. 
Finally, RNAi of csr-1 has long been known to impair the proliferation of germ cells 
(Maine et al., 2005; Vought et al., 2005; Duchaine et al., 2006; She et al., 2009). It is thus 
tempting to speculate that a possible cause for the underproliferation we observe in the 
germlines of pir-1 mutants could be directly attributed to defects in processes regulated by 
CSR-1. Should this be true, it would still fall short of explaining why PIR-1 is also 
required for somatic cell division and growth. 
 
Potential for Conservation of PIR-1 Small RNA-Related Functions in Other 
Animals 
 Given that PIR-1 is highly conserved among metazoans, it is pertinent to ask 
whether other animals could require this enzyme for endo-sRNA production. In 
Drosophila and mice, endo-sRNA studies have been typically restricted to miRNAs and 
piRNAs, the latter with a prevalent role in the suppression of transposition in the germline. 
In recent years, however, several groups have reported the discovery of many other types 
of Dicer-dependent endo-sRNAs processed from a variety of dsRNA substrates, such as 
transcripts with inverted repeats or hairpins, convergent transcription, and pairing of 
transcripts expressed in trans (reviewed in Piatek and Werner, 2014; Svoboda , 2014). In 
the mouse, endo-siRNAs have been cloned from embryonic stem cells, oocytes and male 
germ cells where they were shown to regulate gene expression (Watanabe et al., 2008; 
Tam et al., 2008; Babiarz et al., 2008; Song et al., 2011). Whether silencing by such endo-
sRNAs occurs transcriptionally, post-transcriptionally, or at both levels, however, is still an 
open question. Interestingly, all of the aforementioned cell types are similar in their 
insensitivity to the dsRNA-induced interferon response that often results in cell death 
(Wianny and Zernicka-Goetz, 2000; Yang et al., 2001; Stein  et al., 2003). These cells are 
therefore able to accumulate sufficient dsRNA to be processed by Dicer, and thus add 
another layer of regulation to coordinate their complex differentiation gene expression 
programs, concurrently with the miRNA and piRNA networks. Vertebrate PIR1 could 
conceivably play a regulatory part in the processing of endogenous dsRNA via its 
association with Dicer, analogous to the activity we report for C. elegans germline endo-
sRNA biogenesis. 




Fungi and plants lack PIR-1 orthologs but, similarly to C. elegans, generate endo-
sRNAs through Dicer cleavage of RdRP-generated dsRNA intermediates. With the 
exception of fungi, in which Dicer products are the effector sRNAs (Dang et al., 2011), 
plant and nematode Dicer-dependent sRNAs trigger an RdRP-mediated secondary 
amplification step that produces effector sRNAs (reviewed in Ghildiyal and Zamore, 
2009). In C. elegans, effector 22G-RNAs can be triggered by a variety of sRNA species, 
including Dicer-dependent 26G-RNAs, Dicer-dependent RDE-1-associated sRNAs, and 
Dicer-independent 21U-RNAs/piRNAs (Table 1.1, page 29; Pak and Fire, 2007; Sijen et 
al., 2007; Das et al., 2008; Gent et al., 2010; Vasale et al., 2010; Lee et al., 2012; Ashe et 
al., 2013). The effector endo-sRNAs described for Drosophila and mice (both of which not 
appearing to encode RdRPs) are similar to those of yeast, in the sense that Dicer generates 
them directly by cleavage of dsRNA precursors. By bypassing the requirement for an 
amplification step, these organisms obviate the need for RNA species equivalent to the 
nematode-specific monophosphorylated 26G-RNAs. Nonetheless, future investigations of 
PIR-1 homologs in Drosophila and vertebrates should not disregard potential changes in 
the composition of endogenous sRNA populations in the absence of this RNA 
phosphatase. 
 




MATERIALS AND METHODS 
 
RNAi of sel-1, unc-22, gfp, and pos-1 
The HT115 E. coli strains used for RNAi silencing in this chapter carried plasmids 
with the sequences of interest flanked by T7 promoters. The sel-1 construct consisted of 
the BglII restriction fragment of the respective gene (from Duchaine et al., 2006). The unc-
22 construct carried a 40-nt sequence corresponding to a coding portion of the unc-22 gene 
repeated five times in tandem (from Yigit et al, 2006). The gfp construct also expressed 
dsRNA from a tandem repeat of five short identical sequences from the gfp open reading 
frame (Pedro Batista, unpublished). The pos-1 RNAi feeding strain was taken from the 
Ahringer Lab RNAi library (Kamath et al., 2003). Bacterial culture, induction and 
preparation of RNAi plates was performed as described in Chapter II.   
 
Extraction of RNA 
For large worm populations, RNA extraction was performed as described in the 
Materials and Methods section of Chapter II. For extraction of RNA from a single animal 
or a small number (10-20) of animals (as performed for deep-sequencing of male sRNA), 
live worms were washed several times with M9 buffer containing 0.5% Tween-20 using a 
handmade glass capillary mouth pipette. Alternatively, 100-200 worms were washed 3-4x 
in PCR tubes by successive suspension in M9 buffer and pelleting using a mini centrifuge. 
Clean individual worms were transferred to 0.25 ml PCR tubes, centrifuged, and all but 2-3 
µl of M9 was removed, making sure that the worms were left in the tube. Per tube, 10 µl of 
lysis buffer were added (40 mM Tris-HCl pH 7.5, 10 mM EDTA, 300 mM NaCl, 0.5% 
SDS, 0.4 µg/µl proteinase K) and incubated at 45-65˚C for 5-10 minutes. After checking 
that the worms had been lysed under a dissecting microscope, 100 µl of TE buffer and 20 
µg of glycoblue (Ambion) were added. For a larger quantity of worms (100-200), 50 µl of 
lysis buffer and 50 µl of TE buffer were used. One volume of phenol:chloroform was then 
added and mixed. Adapted phase-lock tubes were made by transferring gel from Phase-
Lock tubes (Eppendorf) to a PCR tube with a pipette tip (~20-30 µl) and spun at 10,000x g 
for 2 minutes in adaptor tubes. The lysis/phenol mixture was transferred to the tube, 
remixed by tapping, and centrifuged at 10,000x g for 4 minutes at room temperature. The 
aqueous phase was transferred to a fresh tube with 10 µl of 3 M sodium acetate pH 5.2, 
followed by addition of 130 µl of isopropanol and precipitation at -20˚C for at least 30 
minutes. RNA was pelleted at 15,000x g for 15 minutes at 4˚C, washed with cold 75% 




ethanol and resuspended in 5-10 µl of ultrapure water. For sRNA cloning, this RNA was 
run on a 15% polyacrylamide/0.5X TBE gel and stained with SYBR Gold dye for 
increased sensitivity. At this scale, sRNAs are recovered in the picogram (femtomole) 
range and are therefore difficult to visualize under UV light. 
 
qRT-PCR and Calculation of Standard Error of the Mean 
cDNA synthesis and qRT-PCR were performed as described in Chapter II. 
Additional primers for pos-1 mRNA and for validation of mRNA-sequencing target 
mRNAs can be found in Appendix B (O95-O114). For experiments performed in triplicate, 
we reported the standard error of the mean (SEM), instead of the standard deviation (SD), 
because it provides a better indication of the uncertainty associated with the estimate of the 
mean, namely by taking into account the sample size (i.e., number of replicates). The SEM 
was calculated as follows: the quantity of mRNA in each sample, as estimated from a 
standard curve with serial dilutions of cDNA, was normalized by dividing it to the quantity 
of actin or gapdh mRNA. The mean of the three normalized quantities was used to 
calculate the SD associated with each group of replicates. The relative fold change was 
calculated by dividing the mean quantities of mutant or treated samples to the mean 
quantity of the wild-type or untreated sample (reference). The reference quantity is divided 
by itself to become one, making it meaningless to report an associated SEM, as all other 
samples are now compared to a standard value which we assume not to vary. For the 
remaining samples the SD was calculated by the using the formula for propagation of SD 




)), where x is the 
calculated relative fold value of the sample, rf pertains to the reference and sp to the 
sample for which the SD is being calculated. The SEM was then calculated using the 
formula SE = SDdiv/√(sample size). 
  
Northern Blotting of Small RNAs  
Small RNAs were enriched by using the MirVana sRNA isolation kit (Ambion) 
skipping the binding column step. For this, up to 1 mg of total RNA in an 80 µl volume 
was mixed with 400 µl of MirVana lysis/binding buffer and 48 µl of MirVana homogenate 
buffer, mixed and incubated for 5 minutes at room temperature to denature RNA. A 1/3
 
volume (176 µl) of ethanol was added, mixed and centrifuged at 2,500x g for 4 minutes at 
room temperature to pellet large (>200 nt) RNA. The supernatant was transferred to a new 
tube, mixed with 1 volume of isopropanol and incubated at -20˚C for at least 30 minutes. 




RNA was pelleted by centrifugation at 20,000x g at 4˚C for 15 minutes and washed once 
with cold 75% ethanol. RNA was dissolved in either 50 µl TE buffer or ultrapure water 
depending on downstream treatment. Quantification was performed using a NanoDrop 
spectrophotometer. The sRNA yield using this protocol was typically ~8% of total RNA. 
Between 5 and 20 µg of sRNA-enriched RNA was denatured in formamide-
containing RNA gel loading buffer II (Ambion) in a maximum volume of 20 µl to ensure 
good electrophoretic resolution. In cases where RNA was too dilute, the appropriate 
amount of RNA was mixed with loading buffer and excess volume was evaporated in a 
SpeedVac instrument at a low temperature setting. Samples were separated on a denaturing 
15% polyacrylamide/7 M urea/0.5X TBE buffer gel (17 cm wide and 15 cm long) at 15 W 
(to reach a maximum of 700 V) until the xylene cyanol dye reached approximately half the 
length of the gel. The gel was then stained with ethidium bromide in 0.5X TBE buffer for 
10 minutes and destained for 10-15 minutes before visualization with UV light to assess 
integrity of the RNA. For samples with low degradation, a sRNA band corresponding 
mostly to 22G-RNAs could be easily distinguished. Large, in-sample endogenous size 
markers include 5.8S rRNA (~160 nt), 5S rRNA (~120 nt) and tRNA (~70-80 nt). RNA 
was transferred to a Hybond N+ charged nitrocellulose membrane (Amersham) with 0.5X 
TBE buffer using a semi-dry TransBlot apparatus (Bio-Rad) for 1 hour at 25V, and 
crosslinked with UV in a Stratalinker instrument (Stratagene). In order to minimize non-
specific probe binding, membranes were pre-treated with 10 ml of Ultrahyb Oligo buffer 
(Ambion) for 30 minutes at 42˚C in hybridization flasks undergoing constant rotation in a 
hybridization oven. Probes against different targets consisted of labelled custom Starfire 
oligos (IDT) labelled with [α-32P]-dATP according to the manufacturer’s instructions and 
purified with Micro Bio-Spin P-30 chromatography columns (Bio-Rad). Probes were 
added to the buffer used for pre-hybridization blocking, and incubated overnight at 42˚C. 
Washes were 2x 5 minutes with 2X SSC/0.1% SDS, followed by 2x 15 minutes with 0.1X 
SSC/0.1% SDS, all at 42˚C (20X SSC buffer is 3 M NaCl and 300 mM sodium citrate 
dehydrate). Membranes were wrapped in plastic cling wrap and exposed to a Phosphor 
screen (GE) for a few hours to 2 days (depending on the RNA target) and scanned with a 
Phosphorimager instrument (GE). For multiple hybridizations, membranes were stripped 
with 0.1% SDS at 85˚C with constant shaking for 45 minutes. After cooling, membranes 
were re-blocked and hybridized with a new probe. The sequences of the Starfire probes 
used can be found in Appendix B (O86-O94). 
 





Treatment of RNA with Terminator 5' Phosphate-Dependent Exonuclease  
For Terminator 5' phosphate-dependent exonuclease (Epicentre) treatment of RNAs 
for northern analysis, 6-10 µg of MirVana-purified RNA resuspended in ultrapure water 
was digested with 2 Units of Terminator and 1X Terminator Buffer A in a total volume of 
15 µl. In the negative controls, ultrapure water was used instead of enzyme. Reactions 
were incubated at 30˚C for 5 hours, and stopped by adding 10 µl of formamide RNA 
loading buffer. 
 
Small RNA Cloning and Deep-Sequencing 
Small RNAs in this study were cloned by one of two methods: 5'-independent or 5'-
dependent. In the 5'-independent method, RNA was treated with Tobacco Acid 
Pyrophosphatase (or TAP; Epicentre), which removes 5' cap moieties and terminal 
phosphates, leaving only one 5'-terminal phosphate. Since it does not alter sRNAs that 
were originally 5'-monophosphorylated, this approach clones the widest range of sRNA 
types. This method constitutes an improvement from an earlier method which completely 
dephosphorylated all RNAs using CIP, followed by the addition of one 5' phosphate by T4 
Polynucleotide Kinase (PNK). This had the disadvantage of allowing the cloning of 
unphosphorylated RNA degradation fragments, lowering the representation of sequences 
of interest in the sRNA libraries. The use of TAP minimizes this problem. In the second, 
5'-dependent approach, also known as direct cloning, sRNAs are not subjected to any 
enzymatic treatment prior to 5' adaptor ligation leading to preferential cloning of 5'-
monophosphorylated sRNAs. The direct cloning method is therefore suited for analysis of 
Dicer products such as miRNAs, primary sRNAs (including 26G-RNAs and viral-23-
mers), and 21U-RNAs. 
Generally, 10 µg of total RNA (the sRNA fraction in C. elegans total RNA is 
~0.01%) in TE buffer (10 mM Tris-Cl pH 7.5, 1 mM EDTA) was denatured in formamide 
loading buffer II (Ambion) at 65˚C for 5 minutes and run on an 18-well (~0.5 cm wide) 
denaturing gel (15% polyacrylamide/7 M urea/0.5X TBE buffer) poured into a Bio-Rad 
Criterion disposable cassette. The loaded volume was kept to a minimum (10 µl or less, 
ideally). For size markers, three RNA oligos (18, 26 and 40 nt; 1 µl of 1 µM) were used. 
Samples were run at 20W until the bromophenol blue dye migrated two-thirds the length of 
the gel (7 cm long). The gel was then stained with SYBR Gold dye (Invitrogen) in 0.5X 
TBE buffer for 10 minutes and destained in 0.5X TBE buffer for 5-15 minutes. The gel 




was visualized with UV light and each lane was sliced just below the 18 nt position and 
between the 26 and 40 nt positions to include the desired 18-30 nt range. Gel fragments 
were transferred to 1.5 ml siliconized tubes (used throughout the rest of the procedure) and 
crushed to fine pieces with a 1 ml pipette tip, to which 750 µl of elution buffer (0.3 M 
NaCl in 1X TE buffer) was subsequently added. Elution occurred overnight at room 
temperature with constant rotation or shaking in a thermomixer. Eluates were filtered using 
Spin-X 0.45 µm filters (Costar) for 1 minute at 10,000x g. After transfer to fresh tubes, 20 
µg of glycogen and 1 volume of isopropanol were added and precipitation was allowed to 
occur at -20˚C for at least 30 minutes. RNA was pelleted by centrifugation at 20,000x g at 
4˚C for 15 minutes and washed once with cold 75% ethanol. All ethanol was thoroughly 
removed and each pellet was allowed do dry for about 1 minute (residual ethanol interferes 
with the TAP reaction). 10 µl of TAP reaction mix (1X TAP buffer, 1 U/µl Superasin 
RNAse inhibitor (Ambion), 0.25 U/µl TAP) was added per pellet, making sure the RNA 
completely went into solution, followed with mixing by pipetting and transfer to a PCR 
tube. Reactions were incubated for 1 hour at 37˚C, after which the volume was brought to 
100 µl with ultrapure water and extracted with phenol:chloroform at room temperature. 
The aqueous phase was recovered by centrifugation in Phase-lock tubes (Eppendorf) and 
RNA was precipitated by the addition of a 1/10
th
 volume of 3 M sodium acetate, pH 5.2, 
under the conditions described above (glycogen added previously remained in the aqueous 
phase). For direct cloning, dried RNA pellets after the first precipitation were used for 3' 
ligation straight away, as explained below. 
The washed, dried pellets were then subjected to the ligation of the 18-nt 3' linker. 
This RNA oligo is “activated” through adenylation of the 5' end (rApp), which results in 
extremely efficient ligation and precludes the use of ATP. At the 3' end it possesses a 
dideoxy cytidine modification (ddC) in order to prevent ligation between linkers. For the 
reaction, a T4 RNA ligase buffer without ATP was prepared (10X buffer is 0.5 M Tris-HCl 
pH 7.5, 0.1 M MgCl2, 0.1 M DTT). To each pellet, 10 µl of the reaction was added 
consisting of 1X ligation buffer, 1U/µl Superasin, 0.1 mg/ml BSA, 2 U/µl T4 RNA ligase 
(Takara), 5 µM 3' linker, and 10% DMSO. A no-reaction control was performed in parallel 
to monitor the extent of ligation between linkers, which can occur to some extent because 
the 3' ddC modification is not present in 100% of the molecules. After mixing, the reaction 
proceeded in a PCR machine at 15˚C for 2 hours and then 4˚C overnight. The ligation 
mixtures were then mixed with RNA loading buffer (with no need for heating) and run on 
a denaturing 15% polyacrylamide gel as before, but letting the bromophenol blue dye reach 




the bottom. As size markers, 1 µl of a 1 µM mixture of DNA oligos with sizes representing 
different ligation product sizes (33, 48, 50, 54, 65, and 69 nt for both 3' and 5' ligations) 
were run in parallel. The gel was stained with SYBR Gold as above. Ligated products were 
recovered from gel slices cut between the 33 and 54 nt markers as described above, except 
that 20 µg of glycogen were added before precipitation.  
For 5' ligation a 21-nt linker was used. It consists of a hybrid oligo, in which the 
first 5 nucleotides are DNA and the remaining sequence is RNA. The last 4 nucleotides 
comprise the variable barcode used to multiplex several samples in one deep-sequencing 
run. Again, each dried pellet was resuspended in 10 µl of ligation mixture containing 1X 
T4 ligation buffer with ATP, 1 U/µl Superasin, 0.1 mg/ml BSA, 2 U/µl T4 RNA ligase, 5 
µM 3' linker, and 10% DMSO. Incubation occurred at 15˚C for 6 hours and then at 4˚C 
overnight. Ligation products were separated in a gel as described for the 3' ligation 
procedure, and recovered from slices cut just below the 54 nt marker and ~0.5 cm above 
the 69 nt marker. RNA was recovered as in the 3' ligation. cDNA synthesis followed, using 
a DNA oligo complementary to the 3' linker. For this, pellets were resuspended in 13 µl of 
0.5 mM dNTPs and 2 µM of RT (reverse transcription) oligo, and incubated 5 minutes at 
65˚C, followed immediately by incubation on ice for 2 minutes. The remaining 
components were then added on ice for a final volume of 20 µl with the following final 
concentrations: 1X first-strand buffer, 10 mM DTT, 0.5 U/µl Superasin, 0.5 U/µl 
Superscript III reverse transcriptase (Life Technologies). The reactions were incubated at 
50˚C for 1 hour, 85˚C for 5 minutes, followed by 20 minutes at 37˚C after adding 1 µl (2 
U) of RNase H (Life Technologies). 
To produce the PCR products for sequencing, two rounds of PCR were performed: 
a first round with short oligos complementary to the linkers, and a second round with 
longer oligos containing the linker sequences plus the Illumina P5 sequence at the 5' end or 
the Illumina P7 sequence at the 3' end, required for attachment of the molecules to the flow 
cells and sequencing by synthesis in the Illumina instrument. The shorter primers are used 
because the longer primers tend to generate a significantly higher amount of primer dimers 
if used during the whole amplification reaction. For the first PCR, a 50 µl reaction per 
sample was assembled with 2 µl of cDNA, 1X ExTaq buffer, 0.5 µM of each short oligo, 
0.25 µM dNTPs, and 0.025 U/µl ExTaq polymerase (Takara). Cycling conditions were as 
follows: 94˚C/30 seconds, at least 5 cycles of 94˚C/20 seconds, 55˚C/20 seconds, 72˚C/20 
seconds, and stopped at 4˚C. For the second PCR the following components were added to 
the first: 4 µl of ultrapure water, 1 µl of 10X buffer, and 2.5 µl of 10 µM solutions of each 




long oligo (2.5 µM f.c.). The PCR was then resumed with the same cycling conditions as 
above, taking 3 µl every two cycles (2, 4, 6, and 8 or higher cycle numbers depending on 
the amount of starting material). These samples were mixed with DNA loading dye and 
loaded onto a non-denaturing 8% polyacrylamide/0.5X TBE buffer gel along with a 10 bp 
DNA ladder (5 µl of 0.1 µg/µl; Invitrogen). The xylene cyanol dye was allowed to reach 
2.5 cm from the bottom of the gel. The gel was stained with ethidium bromide in 0.5X 
TBE for 10 minutes and destained for 10-20 minutes. The optimal cycle number for each 
sample was chosen based on the highest amount of 110 nt amplicons produced and the 
least amount of larger, bulged products. The latter products form when primers begin to be 
depleted and full-length sequences denature and anneal at the linkers to generate larger 
products that are not fully hybridized. Once the best PCR conditions were found, 3x 50 µl 
reactions for each sample were prepared, pooled and extracted with phenol:chloroform. 
The aqueous phase was recovered using phase-lock tubes and concentrated to a ~30 µl 
volume by centrifugation in Amicon Ultra 0.5 ml filters (EMD Millipore) at 13,500x g, 
4˚C for 20 minutes, but checking the sample every 3 minutes after 12 minutes of 
centrifugation. The concentrated products were then mixed with 6X DNA loading buffer 
and loaded onto two wells of a non-denaturing 8% polyacrylamide/0.5X TBE buffer gel 
and run and stained as above. The DNA band around 110 bp was excised, being careful to 
avoid primer dimers below. At this point the DNA may easily denature if excessive drying 
occurs, so all steps were performed as quickly as possible. The crushing of each gel slice 
was immediately followed by addition of elution buffer and eluted as described above. 
Precipitation was performed with 20 µg of glycogen and 1 volume of isopropanol at -20˚C 
for at least 30 minutes. After pelleting and removing the isopropanol, cold 70% ethanol 
was immediately added. After centrifugation, isopropanol was completely removed and 15 
µl of 10 mM Tris-Cl pH 7.5 buffer was added immediately without having allowed the 
pellet to dry. DNA concentrations were measured using a NanoDrop spectrophotometer. 
The typical concentration range obtained was 50-70 ng/µl.  
For quality control of the libraries before sequencing, 2 µl of each one was treated 
with Taq polymerase (Roche) to create adenine 3' overhangs and allow cloning into a 
TOPO-TA vector (pCR-2.1 TOPO vector; Invitrogen). The 4.5 µl reaction included 1X 
Taq buffer, 0.25 mM dNTPs, and 0.5 U of Taq polymerase, and was incubated at 72˚C for 
15 minutes. Then 1 µl of salt solution from the TOPO kit and 0.5 µl of TOPO-vector 
enzyme mix were added, incubated at room temperature for 30 minutes and transformed by 
heat shock into chemically competent E. coli (E. cloni 5-alpha from Lucigen). Cells were 




plated on ampicillin/X-gal plates, grown overnight at 37˚C, and screened for blue/white 
colonies. White colonies were picked and subjected to PCR in a 20 µl mixture of 1X 
Roche Taq buffer, 0.2 µM M13 reverse and M13 forward primers, 0.25 mM dNTPs and 
0.05 U of Taq polymerase (Roche). Cycle conditions were 94˚C/120 seconds, 30 cycles at 
94˚C/20 seconds, 50˚C/20 seconds, 72˚C/30 seconds, and stopped at 4˚C. Size and purity 
of the products was checked on a 1% agarose/1X TAE gel and each reaction was cleaned 
using the E.Z.N.A. extraction kit (Omega). After quantification, about 5-10 PCR products 
per sample were sent for Sanger sequencing using a T7 primer. Sequences were checked 
for the appropriate barcode, as well as for high frequency of C. elegans sequences 
matching protein coding genes (in the case of TAP cloning) or miRNAs and 21U-RNAs 
(for direct cloning) using BLAST. Libraries were mixed together for a 1 ng/µl final 
concentration and submitted to the UMass Deep-Sequencing Core Facility where the 
sample quality was verified in a Bioanalyzer and sequenced on either an Illumina Genome 
Analyzer II or Hi-Seq 2000 instrument. 
For cloning from single or just a few worms (pg/femtomole range), the following 
adjustments were made: TAP was used at 0.1 U/µl; 3' and 5' ligations were performed with 
half the linker amount (25 pmole instead of 50 pmole) with half the amount of T4 RNA 
ligase (1 U/µl); after 3' ligation, the xylene cyanol was run until it was 2 cm from the 
bottom of the gel for complete separation from 3' adaptor dimers (crucial because the 
starting amount of RNA was extremely low); for cDNA synthesis the RT primer amount 
was reduced from 20 to 10 pmole and Superscript III contentration was reduced to 2 U/µl; 
finally, the first round of PCR consisted of 20 cycles. 
The sequences for all oligos used above are listed in Appendix B (O115-O124).  
 
mRNA Cloning and Deep-Sequencing 
mRNA was isolated from total RNA using the Promega PolyATract mRNA 
Isolation System IV according to the instructions of the manufacturer. ~100 ng of mRNA 
was partially degraded by alkaline hydrolysis using 0.2 M of Na2CO3/NaHCO3 (1:1 ratio), 
and RNA fragments of 100-200 nt were excised from a denaturing 10% polyacrylamide/   
7 M urea/0.5X TBE gel and purified as described above. The purified RNA was treated 
with 10 U of CIP (NEB) for 3 hours at 37˚C in a 40 µl reaction, phenol:chloroform 
extracted, and precipitated at -20˚C with 1/10
th
 volume of 3 M sodium acetate, pH 5.2 and 
3 volumes of ethanol, followed by pelleting and washing as described previously. 
Subsequently, the RNA was phosphorylated at the 5' ends with polynucleotide kinase (T4 




PNK; NEB) in a 40 µl reaction consisting of 1X PNK buffer, 0.5 U/µl Superasin, 0.4 mM 
ATP, and 0.5 U/µl T4 PNK, incubated for 1 hour at 37˚C. The RNA was again 
phenol:chloroform extracted, and precipitated. As described for sRNA cloning, the RNA 
was ligated with the 3' linker, reverse-transcribed, and ligated with the barcoded 5' linker. 
Illumina adaptors of full size were added during the PCR step. The final amplicons were 
sequenced using an Illumina Genome Analyzer II set to sequence 100-nt single reads. 
 
Analysis of Small RNA and mRNA Deep-Sequencing Libraries 
Illumina sequencing reads of 36-100 nt were sorted according to the barcode at the 
5' end of each read to de-group the mixed sequences into individual samples, and then the 
barcodes were removed. Because the 3' end of each read could contain the 3' linker 
sequence used to build Illumina libraries, our script searched for CTGTAG – the beginning 
of the 3' linker – and removed this and any other upstream sequence. This trimming 
process was achieved using a custom PERL (5.10.1) script. Mapping of reads of at least 17 
nt to the annotated C. elegans genome sequence (WormBase WS215) was performed with 
Bowtie 0.12.7 (Langmead et al., 2009) with the parameters -v 3 -a --best --strata -m 400. 
Reads smaller than 17 nt often match multiple genomic loci, and some of these are derived 
from contaminant E. coli RNA that can still match the C. elegans genome. These smaller 
sequences were therefore excluded from the analysis. The parameter ‘-v 3’ allows maximal 
3 mismatches in the seed region; ‘-a --best --strata’ returns the best matches within the seed 
region, using 26 as default; ‘-m 400’ pertains to the filter used to remove reads that match 
more than 400 loci (repetitive loci). Additionally, our script also maps reads derived from 
exon-exon splicing junctions.  
 A custom PERL pipeline was used for post-matching analyses. A maximum 
number of mismatching nucleotides per read size was allowed as follows: 0 mismatches 
for size 17–18 nt, 1 for 19–23 nt, 2 for 24–30 nt, and 3 for longer than 30 nt. Again the 
parameters were used to achieve specificity and high confidence of matches. For RNA 
reads that mapped to multiple loci, the read number was split evenly among them. The read 
number was then normalized to 1 million miRNA reads, or 5 million nonstructural sRNAs 
including miRNAs, 21U-RNAs, and 22G-RNAs, depending on the experiments. The script 
also summarized the sense and antisense reads derived from each protein-coding gene and 
non-coding gene. Custom scripts were used to analyze the first nucleotide frequency and 
the size distribution of reads. The Generic Genome Browser GBrowse 1.70 (Stein et al., 
2002) was used to visualize the alignments as first nucleotide histograms, which were 




displayed using a log or non-log scale, and whole reads, which were displayed as arrows 
with height representing the read number using a log scale. 
For mRNA sequencing analysis, the parameters used in Bowtie were -n 3 -e 150 -a 
--best --strata -m 400, and the number of mutations allowed was calculated using the 
formula (length of read-14)/√(length of read). The parameter ‘-n 3’ allows a maximum of 3 
mismatches in the seed region; ‘-e 150’ allows up to 5 mismatches; ‘-a --best --strata’ 
returns the best matches within the seed region, using 26 as default; ‘-m 400’ is the filter to 
remove reads that match more than 400 loci (repetitive loci). For mRNA analysis, we used 
the total sense mRNA reads for normalization. Otherwise, the analysis was very similar to 
that of sRNAs. Lists of sRNA reads or mRNA fragments matching to each of the four 
Argonaute pathways were generated by custom PERL scripts. These lists were then parsed 
using Microsoft Excel to analyze the presented data. Graphs were drawn using GraphPad 
Prism software.  
 
Definition of Argonaute-Specific Small RNA Target Loci 
Genes targeted by endogenous siRNAs were grouped according to the Argonaute 
proteins they engage. Such Argonaute-based categories of sRNAs were experimentally 
defined as follows: (1) WAGO-class sRNAs, targeting 2,911 loci, were based on three 
mutant hermaphrodite sRNA libraries: rde-3, mut-7 and MAGO12 (a combination of 
deletion mutations of all 12 WAGO Argonautes), all of which compromise 22G-RNA 
accumulation. Only targets that were depleted of sRNAs (≤5 normalized reads) in at least 
two of the mutant libraries were considered (Gu et al., 2009); (2) CSR-1-class sRNAs, 
targeting 3,659 loci, were based on sRNAs obtained from two independent CSR-1 
IP/sRNA cloning libraries and considered sRNAs that overlapped between the libraries 
with at least a two-fold enrichment in the CSR-1 IP relative to the input libraries 
(Claycomb et al., 2009; Gu et al., 2009); (3) ERGO-1-class sRNAs (49 loci) were based on 
26G-RNAs enriched in an ERGO-1 IP/sRNA cloning library from wild-type embryos, 
where ERGO-1 26G-RNAs are most abundantly expressed, and corresponding to a two-
fold or higher depletion of 22G-RNAs from the target genes in a sRNA library obtained 
from ergo-1 deletion mutant embryos (Vasale et al., 2010); (4) The ALG-3/4-class set of 
1,684 loci was based on the overlap of two independent sRNA libraries from a fog-2; alg-
3; alg-4 mutant background (male enriched populations), with a requirement for a two-fold 
or higher depletion of 22G-RNAs in the mutant relative to wild type (Conine et al., 2010). 
These gene sets are a conservative, yet high-confidence list of sequences targeted by these 




pathways. Sequences targeted by CSR-1 and WAGO pathways practically do not overlap 
(only 33 genes), while many ALG-3/4 targets are also targeted by WAGO (126) or by 
CSR-1 (420). Ten ERGO-1 targets overlap with WAGO targets.  
 
Relative Distribution of Small RNAs Along mRNAs (Bin Analysis) 
To analyze the relative distribution of 22G-RNAs and 26G-RNAs along all protein 
coding genes (using WormBase release WS215), each gene was divided into 20 equal bins, 
with each bin representing 5% of the coding sequence. For genes with multiple splicing 
forms, all coding exons were collapsed into one spliced genomic locus, before division into 
20 bins. 22G-RNAs and 26G-RNA reads for each gene were normalized to the total 
nonstructural reads, and were mapped to each bin. For sRNAs spanning two bins, 50% of 
reads for each sRNA were assigned to the 5' bin and 50% were assigned to the 3' bin. The 
total number of reads in each bin was calculated by adding all reads for all genes in that 
bin. For this analysis, all annotated protein-coding genes were considered, regardless of 
whether they contained annotated 3' UTRs or not (annotated 3' UTRs were included in the 
bins).  
 
Nuclear Small RNA Isolation and Sequencing 
 Nuclei were isolated from predominately L4 avr3x animals grown on ivermectin 
and from seven-day counter-selected pir-1 homozygotes, as described in Chapter IV 
Materials and Methods. The yield was lower for pir-1 animals, possibly because of the 
relatively smaller germlines. We also noticed that following purification, pir-1 nuclei 
tended to clump more after purification than wild-type nuclei. This indicated a tendency to 
lyse, which could be intrinsic to the pir-1 phenotype (i.e., nuclei from PIR-1-deficient cells 
may be structurally weaker). After the second purification over a sucrose solution, nuclear 
pellets were lysed by resuspension in TRI Reagent (MRC) and processed for RNA 
extraction as previously described. The integrity of the RNA was verified by running 0.5 
µg of denatured RNA in a denaturing gel (15% polyacrylamide/7 M urea/0.5X TBE 
buffer), followed by staining with ethidium bromide and visualization with UV light. Intact 
control worms were processed directly with TRI Reagent (as described in Chapter II 
Materials and Methods). A fraction of the whole animal and purified nuclei samples were 
set aside for immediate protein extraction in order to test the purity of the nuclear extracts 
(as described in Chapter III Materials and Methods).  




Cloning of sRNAs and read analysis was performed as described above. sRNAs were 
normalized using total nonstructural reads.  
 
Cloning, Expression and Purification of Recombinant PIR-1 
Wild-type or mutant PIR-1 cDNA sequences lacking the first ATG (of the 233 aa 
protein) were inserted between the NdeI site and BamHI sites of the pET-28a expression 
vector (Novagen) in fusion with the N-terminal 6x Histidine tag. The resulting constructs 
were transformed into BL21 (DE3) RIL E. coli cells, which were grown in 1 liter of LB 
medium at 37˚C to an OD600 of 0.4, and induced for 4 hours with 1-2 mM IPTG at room 
temperature. Cells were pelleted at 5,000x g for 10 minutes at 4˚C and lysed by sonication 
in 25 ml of lysis/binding buffer (50 mM Tris-HCl pH 7.5, 700 mM NaCl, 5 mM β-
mercaptoethanol, 5% glycerol, 15 mM imidazole, 0.01% NP-40). S100 fractions were 
prepared by ultracentrifugation at 100,000x g at 4˚C for 1 hour. In a 15 ml conical tube, 2 
ml of HisPur beads (Thermo Scientific) were washed 3 times with binding buffer and 
centrifuged at 3,000x g between washes. The beads were mixed with the S100 supernatant 
and transferred to a 50 ml conical tube for rotation at 4˚C for 1 hour. Beads were 
transferred to an empty Poly-Prep chromatography column (Bio-Rad) and washed with at 
least 200 bead volumes of the lysis/binding buffer at 4˚C. Elution was performed at 4˚C 
with 500 µl of imidazole buffer per fraction (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 
mM β-mercaptoethanol, 5% glycerol, 400 mM imidazole, 0.01% NP-40). Peak fractions 
were analyzed by SDS-PAGE (10% gel) followed by Coomassie Blue staining. Proteins 
were dialyzed using a solution containing 50 mM Tris-HCl  pH 7.5, 100 mM NaCl, 1 mM 
EDTA, 1 mM DTT, 50% glycerol and 0.01% Triton X-100. Final protein concentration 
was estimated by A280 absorbance using a NanoDrop instrument. 
 
PIR-1 Dephosphorylation Assay 
 The reactions from Figure 4.13A were performed in a 10 µl volume containing 1X 
Terminator exonuclease buffer A, 1 U/µl Superasin and 1 µM of in vitro transcribed 
triphosphorylated single-stranded RNA substrate, ~0.25 µM of recombinant PIR-1 (wild-
type or mutant), and 0.025 U/µl of Terminator exonuclease (Epicentre). The reactions, 
including the no-enzyme control, were incubated for 1 hour at 30˚C. They were then mixed 
with formamide gel loading buffer II (Ambion), and run on a denaturing 15% 
polyacrylamide/7 M urea/0.5X TBE buffer gel. The RNA was visualized with UV light 
after staining with SYBR Gold dye (Invitrogen) as described previously.  




 The reactions from Fig. 4.13B were performed differently, with a lower amount of 
substrate, and the Terminator digestion performed after treatment with recombinant PIR-1 
or with CIP (NEB). Each 10 µl reaction contained 1X Terminator exonuclease buffer A, 1 
U/µl Superasin and 0.5 µM of in vitro transcribed triphosphorylated single-stranded RNA 
substrate, ~0.25 µM of recombinant PIR-1 (wild-type or mutant), or 0.5 U/µl of CIP. The 
no-enzyme control and PIR-1 reactions were incubated at room temperature for 1 hour, and 
the CIP reaction was incubated at 37˚C for 1 hour. Subsequently, 2 µl of each reaction was 
set aside and placed on ice (these were loaded in lanes 1-4 and served as controls for 
degradation by potential contaminant nucleases in the PIR-1 or CIP enzyme mixtures). To 
the remaining 8 µl of each reaction, 0.25 µl (or 0.25 U) of Terminator exonuclease was 
added, and reactions were incubated at 30˚C for 1 hour. All samples were analyzed on a 
polyacrylamide gel and visualized as described above. 
 The triphosphorylated RNA substrate consisted of the 26-nt sequence 
rGrGrArUrCrCrTrTrGrArArArUrGrGrArArCrArUrCrUrGrArArU and was transcribed 
with T7 polymerase using the MAXIscript T7 Kit (Ambion) according to the 
manufacturer. The dsDNA template resulted from the annealing of two DNA oligos 
carrying the T7 promoter (O125 and O126). The RNA product was purified by PAGE in a 
denaturing 15% polyacrylamide/7M urea/0.5X TBE gel. The band was detected by UV 
shadowing, excised from the gel, and eluted as detailed in the sRNA cloning procedure. 
RNA was precipitated, resuspended in ultrapure water, and the concentration was 






















PIR-1 and Antiviral Immunity 
 





Following the discovery of RNAi, one of the earliest proposed biological roles for 
the pathway was to provide defense against viruses. Until recently, the lack of a C. 
elegans-specific virus limited the use of this model organism for the investigation of 
antiviral immunity. Early studies were performed using a heterologous, transgene-based 
replication model of the ssRNA Flock House virus (FHV; Lu et al., 2005; Lu  et al., 2009), 
widely used to study antiviral pathways in Drosophila, or to infection of C. elegans 
isolated primary cells by the mammalian Vesicular Stomatitis virus (Schott et al., 2005; 
Wilkins  et al., 2005), among a few other systems (reviewed in Diogo and Bratanich, 
2014). Nonetheless, this important initial body of work revealed that C. elegans relies on 
the RNAi pathway to restrict viral replication. Components found to be crucial for the 
antiviral response included the primary Argonaute RDE-1, the dsRNA-binding protein 
RDE-4, the RdRP RRF-1, DCR-1 and the DEAD-box protein DRH-1.  
The discovery of Orsay virus in a wild C. elegans strain opened the door for studies 
of RNAi-based antiviral immunity without the confounding effects of heterologous viral 
infection models (Felix et al., 2011). Orsay is distantly related to the Nodaviridae family, 
to which FHV belongs. Similarly to nodaviruses, it has a bipartite RNA genome composed 
of two segments of sense or (+)-strand polarity, containing merely three ORFs (Fig. 5.1A). 
Genome segment RNA1 encodes an RdRP (ORF A) for viral genome replication. RNA2 
encodes the capsid protein (ORF α) and a protein of unknown function (ORF δ). This 
novel delta product distinguishes Orsay from nodaviruses, and has been recently shown to 
fuse with the capsid protein by means of a frameshift, and to incorporate mature viral 
particles (Jiang et al., 2014; Guo et al., 2014). The Orsay 982-aa RdRP shares ~27% 
amino-acid identity with the RdRPs of known nodaviruses. Curiously, in contrast to 
nodaviruses, the Orsay genome does not encode any homologs of RNAi inhibitors (e.g., 
the dsRNA-binding B2 protein of FHV; Li et al., 2002).  
Orsay only propagates horizontally, as embryos isolated from infected mothers are 
never themselves infected (Felix, et al., 2011). Both the wild-isolate JU1580 strain, in 
which the virus was found, and an rde-1 loss-of-function mutant exhibit severe intestinal 
morphology defects, including degeneration of cell nuclei, cell fusion and formation of 
multimembrane structures (Felix, et al., 2011). In spite of these defects, animals are still 
able to move and feed, have a wild-type lifespan and normal brood sizes, although 
embryos are produced at a slower rate. N2 wild-type animals are not immune to infection 




but exhibit ~100-fold lower viral RNA levels than JU1508 or mutants of the RNAi 
pathway, and do not manifest visible phenotypes. Through northern analysis, genomic, 
sense (+)RNA and template (-)RNA strands were detected, although the latter were 
significantly less abundant (Felix et al., 2011). Orsay virus replication and accumulation 
was found to be limited to the cytoplasm of one to six contiguous intestinal cells in the 
anterior part of the animal, out of the 20 large cells composing the adult intestine (Franz et 
al., 2014). Infected cells were identified by the presence of the RdRP, the capsid protein, 
and of viral RNA, and could be detected in JU1580 and rde-1 animals, but not in wild-type 
N2. 
Genome sequencing of the JU1580 wild-isolate strain, revealed a deletion in the 
drh-1 gene (Ashe et al., 2013). DRH-1 (Dicer-Related Helicase 1) was previously shown to 
be required for antiviral RNAi (Lu et al., 2009), despite the fact that it is entirely 
dispensable for exogenously triggered RNAi (Lu et al., 2009) or for endogenous sRNA 
pathways (Gu et al., 2009). By virtue of its conserved helicase and RIG-I-like C-terminal 
domains, DRH-1 is considered an ortholog of the cytoplasmic receptor RIG-I of mammals.  
Through its ability to recognize and bind 5'-triphosporylated viral dsRNA, RIG-I triggers a 
signaling cascade that leads to the induction of the interferon (IFN) response. As a 
consequence, an extensive immunity expression program is activated in infected and 
surrounding cells (Jiang et al., 2011; Luo et al., 2011; reviewed in Chan and Gack, 2015). 
Despite the absence of an IFN response or knowledge of analogous pathways in C. 
elegans, DRH-1 is considered to be a functional equivalent of RIG-I. This is based on a 
study using the C. elegans FHV-based replicon model in which it was demonstrated that a 
chimaera of the N-terminal domain of DRH-1 fused to the helicase and C-terminal domain 
of RIG-1 (replacing those of DRH-1) was able to fully rescue the inability of drh-1 
mutants to execute antiviral RNAi (Guo et al., 2013). 
High-throughput sequencing of sRNAs from infected drh-1 mutant animals 
revealed that, unlike infected N2 animals, they did not produce a ~23-nt population of 
sense and antisense viral RNAs. These sRNAs possessed all the signs of Dicer cleavage: 
they did not exhibit a 5'-nucleotide identity bias, had 5'-monophosphorylated ends, were 
present at a similar proportion of antisense and sense strands, and exhibited a bias for 2-nt 
3' overhangs when paired in silico (Ashe et al., 2013). This was concordant with similar 
observations regarding the antiviral RNAi response against FHV in flies, in which it was 
shown that such RNAs were the products of Dicer-2 cleavage from a dsRNA replication 
intermediate rather than from regions of secondary structure within the viral genome (Flynt 
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et al., 2009). Sequencing of viral siRNAs from additional mutants made it clear that these 
23-mer species constituted the primary siRNAs which presumably would be loaded into 
the primary Argonaute RDE-1, to trigger the secondary amplification of effector 22G-
RNAs (Ashe et al., 2013). In agreement with this, abundant antisense 5'-triphosphorylated 
22G-RNAs were detected in infected N2 animals, but were eliminated is mutants defective 
for 22G-RNA synthesis, such as rrf-1 or drh-3. Furthermore, these sRNAs were proven to 
be bona fide effector 22G-RNAs, because they were absent from the MAGO12 mutant, in 
which none of the 12 WAGO Argonautes are expressed. In large part the silencing of viral 
RNA was attributed to the cytoplasmic SAGO-2(WAGO-6) Argonaute, shown previously 
to play a predominant role in exo-RNAi (Yigit et al., 2006). Importantly, Ashe and 
colleagues also demonstrated that Orsay genome segments bearing 5'-PPP ends do exist in 
infected animals, by employing a 5'-RACE method in which the ligation of the adaptor 
depended on the conversion of a 5'-PPP to a 5'-P by a bacterial polyphosphatase. This did 
not address, however, the question of whether capped genome segments are also produced. 
Overall, the aforementioned work placed DRH-1 at the top of the viral RNAi pathway in 
C. elegans, leading to the hypothesis that this protein may be responsible for the initial 
recognition of replicating viral RNA molecules. Lastly, because DRH-1 was found to co-
purify with RDE-1, RDE-4, and DCR-1 after immunoprecipitation of RDE-4 or DCR-1 
(Tabara et al., 2002; Duchaine et al., 2006), it was also proposed that recognition of viral 
RNA is accompanied by Dicer-mediated cleavage. A schematic overview of the pathway 
summarizing these findings is depicted in Figure 5.1B. 
Since PIR-1 recognizes RNA 5' triphosphates and stably interacts with Dicer, we 
hypothesized that PIR-1 could function within or in parallel to the antiviral RNAi response. 
We began by asking whether pir-1 arrested animals could suppress Orsay virus replication 
in comparison to rde-1 mutant animals. Surprisingly, we found that the pir-1 mutant was 
unable to limit viral replication, leading us to conduct further experiments aimed at 
understanding whether PIR-1 acts in the same pathway initiated by DRH-1. The results we 
gathered suggest that PIR-1 acts between DRH-1 and RDE-1, although other scenarios are 
currently not ruled out.  
 
 






Figure 5.1. Genomic organization and current model for small RNA-based suppression of 
Orsay virus.  (A) Schematic of the genomic arrangement of Orsay virus. The sizes of the whole 
genome segments were defined using reads from our sRNA deep-sequencing libraries of infected 
C. elegans. The gray boxes map the predicted open reading frames. (B) Diagram highlighting the 
major steps in suppressing Orsay virus infection by an RNAi-like mechanism, according to current 
knowledge. Upon release of the viral RNA into the cell cytoplasm the expression of the viral RdRP 
allows the replication of the viral genome to begin. Despite no available evidence for Orsay, based 
on current knowledge of nodaviruses, both genomic and viral mRNA (+) strands are presumed to 
carry a 5' cap, although the step at which this may occur is unknown. In the course of RNA 
replication, a low amount of dsRNA intermediate molecules (denoted by the dashed arrow) is 
presumed to accumulate. Similarly to FHV, and based on the finding that 5'-PPP Orsay viral RNAs 
exist in vivo, the 5'-ends of the dsRNA intermediates are thought to be triphosphorylated, thus 
providing a substrate for DRH-1 recognition and DCR-1 cleavage. The resulting 23-mer duplexes 
are incorporated into the primary Argonaute RDE-1, which, upon passenger-strand removal, 
recognizes viral ssRNAs and triggers the synthesis of abundant secondary anti-viral 22G-RNAs. In 
association with secondary WAGOs, viral 22G-RNAs lead to the degradation of viral RNA. 





pir-1 Mutant Animals Fail to Suppress Orsay Virus Replication  
 In order to test the susceptibility of pir-1 mutant animals to infection by Orsay 
virus, synchronous populations of animals were infected by feeding OP50 E. coli mixed 
with viral filtrates derived from infected JU1580 animal populations. The level of viral 
replication was estimated from qRT-PCR measurements of Orsay RNA1 from total RNA 
normalized to the actin mRNA level of the host, and using the RNAi-deficient rde-1 
mutant as a positive control of infection. We found that regardless of exposure to Orsay 
virus during growth on counter-selective medium or after arresting terminally for a few 
days, the increase in viral load in pir-1 animals relative to wild-type always closely 
followed that of the positive controls (Fig. 5.2A-C). The viral load in pir-1 was identical to 
that of the rde-1 mutant, and did not change in a pir-1; rde-1 double mutant, suggesting 
that the two factors may act in the same pathway. We also tested a loss-of-function mutant 
for the RdRP RRF-1, which compromises the RNAi pathway downstream of RDE-1 by 
preventing effector 22G-RNAs from being made (Fig. 5.2B and C). Again, we detected as 
much viral RNA in pir-1 as in the rrf-1 mutant, with the pir-1; rrf-1 double mutant not 
exhibiting an additive effect on viral replication. A similar viral load was detected in the 
dcr-1(ok137) mutant under the same counter-selection conditions as pir-1 (Fig. 5.2C). As 
with other phenotypes, the wild-type pir-1::gfp transgene restored viral suppression to the 
wild-type level, while the catalytically compromised pir-1::gfp transgene (C150S) was 
unable to completely suppress viral replication. Although in the latter case the increase in 
viral load is not as pronounced as in pir-1 alone, we conclude that the phosphatase activity 
is necessary, at least partially, for PIR-1 to exert its antiviral role (Fig. 5.2C).  
 PIR-1 is required for Dicer-dependent 26G-RNA synthesis. We therefore tested 
whether Eri 26G-RNA pathway mutants disrupted viral silencing. These included eri-1,  
rrf-3, ergo-1, and the dcr-1(mg375) helicase mutant, which is defective in 26G-RNA 
biogenesis but is still able to generate miRNAs and primary siRNAs in response to 
exogenous dsRNA triggers (Pavelec et al., 2009; Gent et al., 2010; Welker et al., 2010). 
None of these Eri mutants exhibited a significant increase in Orsay viral load compared to 
wild-type, using rde-1 as a positive infection control (Fig. 5.2D). This result indicates that 
unlike its role in 26G-RNA biogenesis, PIR-1 acts in the antiviral pathway likely through 
association with DCR-1 and probably RDE-4. The dsRNA-binding Dicer co-factor RDE-4 
is required both in the canonical exo-RNAi pathway and in 26G-RNA endogenous 




pathways (Tabara et al., 1999; Tabara et al., 2002; Duchaine et al., 2006; Lee et al., 2006; 
Vasale et al., 2010; Welker et al., 2010). We tested the susceptibility of an rde-4 mutant to 
infection, in which we observed a higher increase in viral load than in the rde-1 mutant. 
This implied that RDE-4 may function in concert with DCR-1 and RDE-1 to promote an 
adequate initiation of the antiviral sRNA response. The higher viral load measured in the 
rde-4 mutant, however, may be indicative of an additional function for RDE-4 in the 
antiviral process, perhaps related to its reported ability to cooperatively bind long, but not 
short, dsRNA molecules both in vitro (Parker et al., 2006; Parker et al., 2008) and in vivo 
(Tabara et al., 2002). One could imagine that this property could interfere with the 
replicative cycle of the virus, by not allowing intermediate dsRNA molecules to 
disassociate into productive ssRNA molecules.  
Taken together, these findings indicate that PIR-1 is required to suppress the 
replication of Orsay virus in somatic cells. Its activity likely occurs in association with 
DCR-1 and in concert with all other enzymes thus far implicated in the antiviral response. 
Importantly, since we have shown that this function does not rely on 26G-RNA biogenesis, 




Figure 5.2. PIR-1 is required to suppress Orsay virus replication. Orsay RNA1 was measured 
in different mutants by qRT-PCR. Replicates correspond to three independent infections of the 
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same strain. Error bars represent the SEM. Levels of Orsay RNA1 were normalized to host actin 
mRNA and represent the fold-change relative to wild-type normalized RNA1 levels (equal to 1). 
Each panel represents a different experiment where all strains were of the same age and infected 
with the same stock of virus for identical periods of time. Strains in A, B, and C are all in the avr3x 
genetic background, and the wild-type strain is avr3x. (A) Animals were counter-selected on 
ivermectin for seven days before being exposed to virus for two additional days (see Chapter II 
Materials and Methods, page 102 for a description of selection by ivermectin). Wild-type worms 
were aged on ivermectin to seven days and purged of all progeny before being infected. (B) 
Animals were aged or counter-selected on ivermectin for four days before being exposed to virus 
for three days. (C) Animals were grown on ivermectin since the L1 larval stage to 
adulthood/arrested stage for four days with simultaneous exposure to virus. (D) Animals were 
grown since the L1 larval stage to adulthood for 2.5 days with simultaneous exposure to virus.  
 
 
PIR-1 Likely Functions Downstream of DRH-1  
 In order to understand how PIR-1 contributes to suppression of Orsay replication at 
the molecular level, we cloned and deep-sequenced sRNAs from infected samples of pir-1 
and key RNAi mutants. In order to study the Orsay 23-mer and 22G-RNA populations as 
extensively as possible, we employed the 5'-dependent/direct cloning method to follow 
monophosphorylated 23-mers, and the 5'-independent/TAP cloning method to measure 
triphosphorylated 22G-RNAs. We report most Orsay reads normalized to miRNAs, as 
these were cloned efficiently by both methods. Consistent with results from previous 
studies, the majority of sequences cloned from the wild-type N2 background are 22G-
RNAs (Fig. 5.3A, normalized-read histograms and percentage of guanosine as the first 
nucleotide in the antisense sRNA population). Through direct cloning, only a very small 
amount of antisense 22-mers were cloned (note differences in scale), and even these were 
primarily 5'G, having likely resulted from 5'-PPP 22G-RNAs that were dephosphorylated 
intracellularly or during the cloning process of this particular library. Also, as previously 
reported, anti-viral 22G-RNAs targeted the entire length of the viral genome (Fig. 5.3B). 
Reflecting the low amount of viral replication, the cloning of duplex 23-mers in wild-type 
N2 by the direct method was reduced but still detectable (Fig. 5.3A, direct cloning). 
Conversely, in the rde-1 mutant background, the 22G-RNA peak was lost in favor of a 
drastic accumulation of 23-mers exhibiting no nucleotide bias (Fig. 5.3A, histograms and 
almost equal distribution of the four nucleotides of the antisense sRNA population). The 
inexistence of a nucleotide bias is consistent with DCR-1 not exhibiting a nucleotide 
preference, and matches the nucleotide proportions found in the entire Orsay genome 
(RNA1 + RNA2, rightmost panel of Fig. 5.3A). As expected for products of Dicer 
cleavage from viral dsRNA precursors (i.e., not loaded into Argonaute proteins), 23-mers 




mapped across the entire viral genome and, compatible with being free-standing sRNA 
duplexes, they were cloned in roughly equal proportions from the sense and antisense 
strands (Fig. 5.3 A and B).  
 When we conducted the same analysis in infected pir-1 animals we observed a 
strong 23-mer duplex peak (Fig. 5.4B compared to A). These 23-mers still distributed 
along the entire length of the Orsay genome, with similar levels of sense and antisense 
reads (Fig. 5.4F). Unlike rde-1, however, pir-1 animals still produced abundant antisense 
22G-RNAs. Since the animals used had been infected over the course of four days since 
the L1 larval stage, we concluded that the 22G-RNAs accumulated while a substantial 
amount of maternal PIR-1 was still present in the developing animals. Confirming that this 
was the case, when we profiled the sRNAs of pir-1 animals that were infected after having 
been counter-selected for seven days, the 22G-RNA peak decreased substantially (Fig. 
5.4C). In both situations, however, the accumulation of large amounts of 23-mers was 
dramatic and reminiscent of the response observed in the rde-1 mutant. This pattern was 
reverted to the wild-type pattern in the rescued pir-1 background, in which the 23-mer 
levels were much lower but the 22G-RNA peak remained high (Fig. 5.4D; compare scales 
between wild-type, pir-1 and rescued pir-1).  
In dcr-1 loss-of-function animals, and consistent with the 23-mer duplexes being 
the direct product of Dicer cleavage, the 23-mer peak was lost, but again, a strong 22G-
RNA peak was still produced (Fig. 5.4E). Unlike pir-1, antisense 22G-RNAs accumulated 
whether dcr-1 mutant animals were counter-selected as they were being infected, or 
whether they were infected after a prolonged period of counter-selection. In these libraries, 
sense read abundance varied substantially (blue bars) due to a high degree of viral (+)RNA 
degradation during RNA extraction and/or cloning. The heightened levels of sense relative 
to antisense reads, accompanied by their distribution over a wide range of sizes and an 
absence of clear peaks, reliably imply nonspecific RNA degradation.  
Analysis of drh-1 mutant animals revealed a loss of the 23-mer peak, consistent 
with the results of Ashe et al. (2013), which placed it as the component that initiates the 
viral silencing process by recognizing the viral 5'-PPP (Fig. 5.5A). However, we have 
trouble reconciling this conclusion with the fact that we could still detect a strong 22G-
RNA peak of about 15,000 rpm through the TAP cloning method (Fig. 5.5A, lower graph, 
red bars). Based on the overall size profile of all the sense reads cloned by both the direct 
and TAP methods (blue bars, Fig. 5.5A), we assumed that the antisense 23-mer reads were 
mostly degradation products. Even so, we cannot exclude the possibility that a residual 
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amount of bona fide 23-mers are made by Dicer to trigger the production of antisense 22G-
RNAs downstream. Given that the viral load in the drh-1 mutant is high, the 22G-RNAs 
were probably generated late in the viral replicative cycle, and consequently not able to 
silence the vast amount of viral RNA that accumulated in the meantime. We next 
compared the viral sRNA profiles of pir-1 and drh-1; pir-1 animals of the same age that 
had been counter-selected for four days before being infected (Fig. 5.5B and C). We 
observed that in the absence of DRH-1, the viral sRNA profile of pir-1 arrested animals 
resembled that of the drh-1 single mutant: the prominent 23-mer peak was lost, while 
abundant antisense 22G-RNAs were still produced. This result strongly suggests that 
DRH-1 acts upstream of PIR-1 in the antiviral pathway. Finally, supporting the idea that 
DRH-1 and PIR-1 function in separate complexes, we never detected a physical 
association between the two proteins by MudPIT, or through IP of PIR-1 and western 
blotting of DRH-1 with and without Orsay infection (not shown). We cannot, however, 
rule out that the two proteins interact very transiently or below our experimental detection 
thresholds, particularly during the most acute stages of viral infection. 
 






Figure 5.3. rde-1 mutant animals infected with Orsay virus accumulate viral 23-mer siRNAs 
but not downstream 22G-RNAs. Small RNA deep-sequencing library profiles and distribution of 
reads across the viral genome in wild-type N2 and rde-1 mutant animals. (A) Comparison of 
miRNA-normalized reads from direct (5'-dependent) and TAP (5'-independent) cloning libraries 
with regard to size, polarity and first (5') nucleotide identity for all Orsay reads (RNA1 and RNA2). 
The y axis indicates rpm and the x axis the read size in nucleotides. The first nucleotide distribution 
is expressed as a percentage of all reads combined. The data relative to the N2 and rde-1 samples 
were obtained using the same populations used for RNA1 qRT-PCR in Figure 5.2D (left panel, 
page 226). The rightmost panel shows the proportion of each nucleotide in the entire Orsay genome 
for comparison with sRNA read first nucleotide fractions. ‘AS’, antisense. ‘S’, sense. (B) Genome 
browser representation of miRNA-normalized reads mapping to RNA1 only. Each peak 
corresponds to the first nucleotide of each read. Blue reads are sense (same polarity as the viral 
genome and mRNA) and pink reads are antisense. The vertical axis represents rpm in a log2 scale.  
 
 





Figure 5.4. pir-1 mutant animals infected with Orsay virus accumulate viral 23-mers but still 
produce 22G-RNAs due to maternally loaded PIR-1. Small RNA deep-sequencing library size 
profiles in wild type, pir-1, rescued pir-1 and dcr-1 mutants, and distribution of reads across the 
viral genome in pir-1 mutants. In panels A-E, sRNA reads map to Orsay RNA1 and RNA2. All 
samples are normalized to miRNAs except for dcr-1, in which reads were normalized to total 
nonstructural reads. A, B, D, and E are samples corresponding to those represented in Fig. 5.2D, 
page 226. ‘inf. L1’ refers to infection starting at the L1 larval stage, while ‘inf. 7d’ means that 
animals were only infected after seven days of ivermectin counter-selection. The presence of 
abundant sense reads of all sizes derived from the predominant viral (+) RNA indicates that 
extensive degradation occurred in those samples (note panels C and E, blue bars). (A) In wild type, 
very few viral 23-mers are produced relative to the abundant effector 22G-RNAs that keep the viral 




load at a low level. (B) pir-1 mutant animals accumulate abundant 23-mers, but produce 22G-
RNAs even more abundantly, despite having a much higher viral load than wild-type animals. (C) 
This pir-1 mutant sample, in which animals were infected when the level of PIR-1 protein is 
presumably very low or null, is meant to show a decrease in the 22G-RNA peak measured by TAP 
cloning compared to the profile shown in B. This suggests that viral 22G-RNA accumulation 
depends on PIR-1. (D) pir-1; pir-1::gfp; avr3x rescued animals exhibit the same viral sRNA profile 
as avr3x, in agreement with their ability to suppress Orsay virus replication. (E) In dcr-1 deletion 
mutant animals the 23-mer peak is lost, in contrast to a very abundant 22G-RNA population, in 
spite of a high viral load. The 22G-RNA accumulation in both pir-1 (panel B) and dcr-1 likely 
reflects early expression of maternally inherited PIR-1 and DCR-1. (F) Genome browser 
representation of miRNA-normalized reads mapping to RNA1 in wild type and pir-1 mutant 
animals by direct cloning, to reflect 23-mer reads. Each peak corresponds to the first nucleotide of 






Figure 5.5. The drh-1 mutation suppresses the accumulation of 23-mers in pir-1 mutant 
animals. Small RNA reads map to Orsay RNA1 and RNA2. A, B, and C correspond to samples 
from Fig. 5.2B, page 226. In drh-1 mutant animals, 23-mer peaks are lost. As in Figure 5.4, the tall 
blue bars across all sizes indicate extensive degradation of the viral (+)RNA strand. (A) drh-1 
mutant animals show a loss of the 23-mer peak and a relatively small 22G-RNA peak (compared to 
other antisense read sizes). (B) pir-1 mutant animals again show prominent 23-mer and 22G-RNA 
peaks. (C) drh-1; pir-1 double mutant animals exibit a sRNA profile similar to the drh-1 single 
mutant, suggesting that DRH-1 is required for the accumulation of 23-mers upstream of PIR-1. 
 
 
PIR-1 Functions Upstream of Secondary 22G-RNA Production along with 
Factors Required for Primary 23-mer Synthesis and Function  
 We next analyzed the relationship between viral load, 23-mers and antisense 22G-
RNAs in greater detail for some of the libraries (Fig. 5.6). For simplification, and because 
viral load was measured through qRT-PCR of Orsay RNA1 (Fig. 5.6A), we only present 
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sequences derived from this genome segment. It should be noted that the qRT-PCR 
analysis did not distinguish between strands. However, because studies of FHV replication 
showed that only 1-5% of viral RNA is of the negative polarity (Ball, 1994), we assume 
that our measurements reflect mostly the accumulation of genomic and mRNA of the 
positive/sense polarity. We also have preliminary deep-sequencing data suggesting that 
this is the case in Orsay virus replication (not shown). 
 Regarding 23-mers, in libraries where degradation was not significant, the ratio of 
sense to antisense 23-mer reads tended to be close to one (e.g., Fig. 5.4B, page 231). In 
contrast, in libraries where more degradation products were cloned (e.g., Fig. 5.4E, page 
231), the sense 23-mer peak (blue) was higher than the antisense 23-mer peak (red; Fig. 
5.6A). Considering this, the actual number of 23-mer duplexes should be judged by the 
height of the red, antisense bars.  
In order to increase the stringency of our analysis, we restricted ourselves to 22G-
RNAs with a flanking YR motif, which is defined as a purine (R= A or G) being the first nt 
(+1) in the sRNA, and a pyrimidine (Y= C or T) being the adjacent 5′ nt. This motif and 
extended consensus is similar to the initiator element that Pol II uses to initiate 
transcription in plants, mammals and flies (Smale and Baltimore, 1989; de Hoon and 
Hayashizaki, 2008; Juven-Gershon et al., 2008). The YR motif was found in our laboratory 
to be associated with capped sRNA precursors of Pol II-dependent Type II 21U-RNAs (Gu 
et al., 2012), but also with RdRP-dependent 22G-RNAs (Weifeng Gu, unpublished 
results). Since the cloning of degradation products varied substantially from library to 
library, confining our analysis of the TAP-cloned libraries to YG 22-mer reads, eliminated 
most sense and antisense 22G-RNA reads that derived from the degradation of viral RNA 
(i.e., not bona fide RdRP-dependent 22G-RNAs). Furthermore, we subtracted the 
normalized antisense 22G-RNAs reads cloned by the direct method from the normalized 
22G-RNA reads cloned by the TAP method (Fig. 5.6B). Since Dicer cutting is not precise, 
not all primary viral siRNAs are exactly 23-nt long (some are 22-nt long, and will start 
with a 5' guanosine, based on chance alone). Therefore, this subtraction accounted for 
those Dicer products which were also cloned through the 5'-independent TAP method, but 
could not be distinguished from real RdRP-generated antisense 22G-RNAs. 
 When we considered the mutant rde-1, the dramatic accumulation of 23-mers (Fig. 
5.6A, first and second panels, independent samples) was accompanied by a sharp reduction 
in 22G-RNAs (Fig. 5.6B). This explains why the viral load is so high in these animals 
(~400-fold increase relative to wild-type viral RNA1 level, Fig. 5.6A) and implies that 




RDE-1 is the main Argonaute using primary 23-mers to trigger 22G-RNA synthesis. rde-4 
mutant animals, on the other hand, despite a very high viral RNA load and a high 23-mer 
peak, were still able to generate an appreciable amount of 22G-RNAs compared to wild 
type. As we have discussed before, the fact that so many antisense 22G-RNAs are 
generated is probably a consequence of the high availability of viral template molecules. 
However, since 23-mer generation is probably inefficient and thus delayed relative to wild-
type, and because the availability of downstream RNAi machinery (such as secondary 
effector Argonautes) is limited, the replication of the virus outpaces the rate at which the 
22G-RNA-loaded Argonautes can destroy the viral (+)RNAs. Therefore, if we factor in the 
viral load into the number of antisense 22G-RNAs (by dividing it by the qRT-PCR fold-
change), the number of 22G-RNAs per viral (+)RNA in the rde-4 mutant is extremely low 
compared to wild type.  
Perhaps a more accurate way of estimating the ability of each mutant to produce 
antiviral 22G-RNAs, is to consider the ratio of antisense 22G-RNAs to antisense 23-mers 
(Fig. 5.6D). Since RDE-1-loaded 23-mers that are antisense to the viral (+)RNA strand 
trigger the synthesis of antisense 22G-RNAs, this ratio is a measure of the efficiency with 
which 23-mers can lead to 22G-RNA accumulation. When we calculated this ratio for N2, 
it was of about 30, meaning that for every antisense 23-mer, approximately 30 secondary 
22G-RNAs were produced. In contrast, the ratio was nearly zero for rde-1, meaning that 
the abundant 23-mers are unable to generate 22G-RNAs. In rde-4, this ratio also 
approaches zero, despite the fact that a substantial amount of bona fide 22G-RNAs 
accumulate. In contrast to RDE-1, which is absolutely required for 22G-RNA generation, 
RDE-4 likely just adds efficiency to the anti-viral silencing response. Without it the 
response is still elicited but it is not sufficient to keep up with viral replication. 
 Extending this analysis to other mutants, only rrf-1 behaved like rde-1: it 
accumulated a very large amount of 23-mers, but failed to generate 22G-RNAs, in 
agreement with RRF-1 being the main RdRP in the process. drh-1 mutant animals had a 
reduced amount of 23-mer duplexes (if we consider the height of the accumulating 
duplexes to match that of the antisense (red) 23-mers), but still generated an almost wild-
type amount of 22G-RNAs. pir-1 mutant animals (two independent replicates, central 
panels) accumulated 23-mers, albeit to a lower extent than in the rde-1 or rde-4 
backgrounds, and still generated a large amount of 22G-RNAs relative to wild-type. The 
drh-1; pir-1 double mutant exhibited a 23-mer decrease similar to the drh-1 single mutant, 
in contrast to the accumulation observed in the pir-1 background, confirming that DRH-1 
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likely acts upstream of PIR-1. It should be noted that in this particular panel of mutants (all 
grown under the same conditions), the viral loads were relatively low compared to other 
experiments, reflected in the higher 22G-RNA/23-mer ratios relative to the wild-type ratio. 
In dcr-1 mutant animals, the level of 23-mers was similar to those of wild-type animals, 
regardless of whether the normalization was performed with miRNAs or total nonstructural 
sRNAs (asterisks). But again, as we have mentioned earlier, most of the antisense 23-mers 
cloned in the dcr-1 and drh-1 backgrounds, based on the size profiles of reads (Figures 5.5 
and 5.6) are likely the result of nonspecific degradation and not of Dicer cleavage. Despite 
the fact that 22G-RNAs in dcr-1 still accumulated to an appreciable level, the 22G-
RNA/23-mer ratio still revealed a defect in the production of 22G-RNAs from 23-mers. 
These 23-mers were likely produced by residual maternal DCR-1 protein. Finally, in 
rescued pir-1 animals the 23-mer/22G-RNA ratio was restored to a wild-type value (Fig. 
5.6, rightmost panels), showing that, similarly to all other mutants analyzed, pir-1 is 
required for a timely and robust generation of effector antiviral 22G-RNAs.  
Lastly, when we took into account the high viral load in pir-1 mutant animals, the 
amount of 23-mer reads was consistently lower than in wild-type (Fig. 5.6C). This 
argument also held true for rde-1, rde-4, dcr-1, and drh-1, all of which act at the 23-mer 
production/function levels. In contrast, the rrf-1 mutant accumulated 23-mers to a level 
almost ten-fold higher than in rde-1 without exhibiting a proportional increase in viral 
load. As a result, when we normalize the 23-mer amount in rrf-1 animals to the respective 
viral load, the levels approximate the 23-mer levels in wild-type. As expected from the 
absence of RdRP activity, this indicates that 23-mer RNA synthesis occurs normally and 
that the only block occurs at the 22G-RNA level. Collectively, these results reveal that 
PIR-1 plays an important role in limiting Orsay virus replication. We hypothesize that 
Dicer-associated PIR-1 promotes early and robust accumulation of 23-mers, downstream 
of DRH-1, to ensure an effective 22G-RNA response. The fact that 23-mers are still 
detected in pir-1 animals can be tentatively rationalized by a lowered, but still present, 
activity of Dicer on viral dsRNA intermediates.  
 
 






Figure 5.6. PIR-1 is necessary for the robust accumulation of antiviral 22G-RNAs. 
Comparison between Orsay RNA1 23-mer reads, antisense 22G-RNA reads and viral RNA levels 
in different mutants. (A) miRNA-normalized RNA1 23-mer reads obtained by direct cloning. 
Higher sense read columns are indicative of degradation in the samples. (B) miRNA-normalized 
YR-motif 22G-RNAs (see main text for explanation) obtained by TAP cloning, from which YR 
22G-RNA reads obtained by direct cloning were subtracted. This subtraction accounted for 5'-P 22-
nt products of Dicer cleavage that were indistinguishably cloned together with bona fide 5'-PPP 
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22G-RNAs through the TAP-based method. (C) qRT-PCR measurements of RNA1 from Figure 
5.2 for individual samples subjected to sRNA deep-sequencing. (D) Ratio of antisense YR 22G-
RNA reads to antisense 23-mer reads, as a measure of the ability of 23-mers to trigger secondary 
22G-RNA synthesis. A lower ratio indicates a decreased ability to produce 22G-RNAs from 




The Interaction of Viral Primary 23-mers with RDE-1 Is Partially 
Compromised in pir-1 Mutant Animals 
Having found that pir-1 mutant animals accumulate viral 23-mers to high levels 
without, however, generating enough 22G-RNAs to control viral replication, we asked 
whether such 23-mers were properly loaded into the RDE-1 Argonaute. To answer this 
question we generated transgenic strains carrying multi-copy extrachromosomal arrays of a 
gfp::rde-1 construct under the control of native regulatory sequences. One strain was 
generated in an rde-1 null mutant background and another in a genetically balanced pir-1; 
rde-1 double mutant background. The lines we obtained were tested for rescue of RDE-1 
activity through recovery of the muscle twitching phenotype elicited upon RNAi of unc-22 
(not shown). We assessed transgene expression by performing GFP IP/western blotting 
from rescued lines exhibiting the highest transgene transmission rates (Fig. 5.7A). 
Additionally, we demonstrated that the gfp::rde-1 transgene could also rescue the 
deficiency in Orsay virus suppression of the rde-1 mutant (Fig. 5.7B). We then counter-
selected rde-1-rescued pir-1 mutant animals (referred to as ‘pir-1’) for seven days followed 
by a three-day infection with Orsay virus, and grew the rescued rde-1 line on virus for 
three days until they reached the L4-YA stage (referred to as ‘wt’). We then TAP-cloned 
and deep-sequenced sRNAs from both input (extracted from intact animals) and 
GFP::RDE-1 immunoprecipitates, and analyzed Orsay-derived sRNAs.  
As a control for specificity of binding to viral 23-mers, we also included the 
miRNA Argonaute ALG-1, which, similarly to RDE-1, also predominately binds 5'-P 22- 
and 23-mer RNAs and is ubiquitously expressed (Vasquez-Rifo et al., 2012). Since loss-
of-function mutants for ALG-1 or its redundant sister Argonaute ALG-2 were still able to 
suppress Orsay virus infection as well as wild-type animals, we expected that few viral 23-
mers would be loaded into these Argonautes (Fig. 5.7C). We therefore analyzed sRNAs 
associated with ALG-1 not only in the wild-type background, but also in the rde-1 mutant 
background in order to increase the availability of viral 23-mers in infected cells.  




Analysis of the sRNA composition of the different libraries (from absolute, non-
normalized reads) allowed us to make important observations (Fig. 5.7D). First, as a 
percentage of all reads mapping to expressed genomic loci, reads corresponding to Orsay 
sequences never exceeded 15% of the total. Second, in wt rde-1 rescued animals, Orsay 
sRNAs were enriched by 40% compared to input, whereas in the pir-1 mutant background 
they were enriched by just ~20%. Third, ALG-1 IPs specifically enriched the libraries with 
miRNAs by 75-80% relative to inputs, irrespective of genetic background. Additionally, 
the interaction of ALG-1 with Orsay sRNAs was almost null and did not increase with 
higher viral loads, despite the fact that the fraction of viral sRNAs in inputs increased from 
0.7% in N2 animals to 5% in rde-1 animals. These results show that indeed RDE-1 
specifically and abundantly interacts with Orsay sRNAs, and, further, that this interaction 
may be perturbed by the absence of PIR-1.  
We next analyzed these numbers in greater detail, by decomposing the reads into 
23-mers and YR-motif 22G-RNAs (Fig. 5.8). In our initial analyses, we chose miRNAs as 
the normalization standard because they are mostly expressed in the soma, where Orsay 
infection also takes place. We found, however, that using total miRNAs was not ideal for 
our comparisons primarily for two reasons: (1) RDE-1 engages a large proportion of 
sRNAs mapping to protein coding RNAs (Fig. 5.7D, gray lines), but a small proportion of 
miRNAs compared to input; and (2) the proportion of miRNAs associating with RDE-1 in 
the pir-1 mutant was almost 20% higher than in the wild-type rescued animals (Fig. 5.7D, 
orange lines). Instead, we resorted to normalization using only miR-243, which has been 
shown to specifically interact with RDE-1 but not ALG-1, to direct the synthesis of 22G-
RNAs from the somatic Y47H10A.5 transcript (Correa et al., 2010). We confirmed this 
result in our libraries, where miR-243 was enriched in RDE-1 IP libraries relative to inputs, 
but not in ALG-1 IP libraries (Fig. 5.8B). Focusing on miR-243-normalized Orsay RNA1-
matching reads, we observed a predominance of 22G-RNAs in the wild-type rde-1 rescued 
input library (Fig. 5.8A; compare to the overall nucleotide composition of the RNA1 
genome segment on the far right panels). After RDE-1 IP, a clear peak at 23 nt with 
roughly equal read numbers of the sense and antisense polarities was obtained, with the 
proportion of first nucleotides losing their G bias (due to depletion of antisense 22G-RNA 
reads). This shows that RDE-1 preferentially interacts with viral 23-mers without a strand 
bias. In the pir-1 input library, the 22G-RNA peak was still detected, although the large 
numbers of sense reads of all sizes denoted cloning of degraded viral RNA. After RDE-1 
IP, a 23-mer duplex peak was recovered but, curiously, both polarities exhibited a bias 
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toward sRNAs beginning with a uridine with a concomitant reduction in the proportion of 
sequences starting with A and G compared to wild-type 23-mers (in wild-type, U-23-mers 
occurred at frequency of ~20%, whereas in pir-1 they constituted 40-45% of total Orsay 
23-mers). Mapping of these U-23-mers revealed that they were still distributed along the 
length of the entire Orsay RNA1 sequence, as were A-, G-, and C-23-mers (not shown).  
When we compared the RDE-1 IPs (Fig. 5.8C), 23-mers were recovered in the pir-
1 mutant background at a ~4.5-fold lower abundance than in the wild-type (rde-1 rescued) 
animals. As the cloning was performed through the 5'-independent TAP method, it must be 
considered that in the input antisense 23-mer reads there is a significant contribution of 23-
nt RdRP sRNAs (i.e., 22G-RNAs that are actually 23-nt long, represented in the yellow 
portion of each bar). In the wild-type input, these constitute ~75% of the antisense reads, 
while in the pir-1 input these make up ~60% of all antisense 23-mer reads. If we take into 
account the roughly equitative proportions of the first nucleotide found in the Orsay 
genome, then an approximate estimate for the real number of Dicer-produced 23-mers of 
each polarity should be of ~9,000 reads in the wild-type input and ~5,000 reads in the pir-1 
input. This means that while in the wild-type RDE-1 IP sample there is an enrichment of 
about five-fold in 23-mers relative to the input, in pir-1 the enrichment is only about two-
fold. Not surprisingly, antiviral 22G-RNAs were heavily depleted in RDE-1 IP samples 
from both wt and pir-1 animals (Fig. 5.8D). This result, together with the peculiar bias 
towards 5'U-23-mers, hints that in the pir-1 background 23-mers are not loaded into RDE-
1 as effectively as in a wild-type context. 
Finally, in both wild-type N2 animals and rde-1 mutant animals, 23-mers were 
depleted in ALG-1 IP samples compared to reads measured in inputs (Fig. 5.8C bottom 
panel). In the case of the N2 input, considering that 84% of reads begin with a guanosine, 
the depletion was of almost four-fold. In the rde-1 sample, there was no 5'-nucleotide bias 
in the antisense reads, and the depletion of reads in the ALG-1 IP was of approximately 
three-fold. Predictably, 22G-RNAs were also not enriched in the ALG-1 IPs (Fig. 5.8D 
bottom panel). Since the miR-243 read numbers in the ALG-1 IP samples are very low 
(Fig. 5.8B, bottom panel), the numbers of viral 23-mers in these samples are 
overestimated, such that the real depletion of 23-mers is much higher than three- to four-
fold (we have confirmed that this is the case when the normalization was performed with 
total miRNAs). These results demonstrate that the miRNA Argonaute ALG-1 is not used 
by cells to induce the antiviral RNAi response. 
 






Figure 5.7. GFP::RDE-1 transgenic lines and fraction of small RNA classes cloned from 
RDE-1 and ALG-1 immunoprecipitates. (A) Western blot of immunoprecipitated GFP::RDE-1 
expressed in non-integrated lines where the rde-1 mutation was rescued (assessed by RNAi of unc-
22). Lines from lanes 2 and 3 were used for IP/sRNA cloning. (B) qRT-PCR of Orsay RNA1 
normalized to actin from infected rde-1 and rde-1 transgenic line 4 animals showing that viral 
suppression is restored by the gfp::rde-1 transgene. (C) qRT-PCR of Orsay RNAi in infected alg-1 
and alg-2 loss-of-function mutants. (D) Graphic comparison between the fraction of major sRNA 
groups cloned from total (inputs) or immunoprecipitated sRNA as a percentage (y axis) of total 
nonstructural reads (indicated below graphs). ‘wt’ refers to the rde-1 rescued transgenic line and 
‘pir-1’ refers to the pir-1; rde-1 double mutant, in which only the rde-1 phenotype is rescued.  
 
 




Figure 5.8. The specific association of Orsay 23-mers with RDE-1 is weakened in the pir-1 
mutant background. Cloning of sRNAs from total RNA or RDE-1 and ALG-1 
immunoprecipitates was performed using the 5'-independent TAP method. Reads were normalized 
to miR-243, which interacts preferentially with RDE-1. For simplicity, only Orsay RNA1 
sequences were considered. (A) Size distribution of reads and fraction of the identity of the first 
nucleotide according to read polarity in RDE-1 IP samples and respective inputs. The far right 
panels represent the proportion of each nucleotide present in the entire RNA1 genome segment for 
comparison with the sRNA read nucleotide proportions. (B) Total miRNA-normalized miR-243 
read numbers in the eight different libraries. (C) 23-mer read numbers in each sample, separated 




into sense and antisense reads and further into first nucleotide identity. The asterisks indicate that 
the antisense 23-mer reads have a large proportion of reads with a 5'G, indicating that they 
correspond to longer products of RdRP synthesis, or “23-nt long 22G-RNAs”. Note that 23-mers 
binding RDE-1 in the pir-1 mutant background exhibit a 5'U bias. (D) YR-motif 22G-RNA reads 




Daniel Chaves constructed and grew all C. elegans strains, performed viral infections, 
RNA extractions and qRT–PCRs. Some sRNA cloning libraries were prepared by Daniel 
Chaves, but most were prepared in our laboratory by Weifeng Gu.  Mapping of reads and 
preliminary analyses of deep-sequencing data were performed by Weifeng Gu, and 
subsequent analyses were performed by Daniel Chaves and Weifeng Gu. The GFP::RDE-1 
IP experiment was performed by Daniel Chaves, including sRNA library preparation, 
while the ALG-1 IP experiment was entirely performed by Weifeng Gu. Additional 
libraries were prepared by Ruidong Li, a student at the University of California Riverside 
in the laboratory of Weifeng Gu. Sequencing of all libraries was performed at UMass 
Medical School.  





The experiments presented in this chapter have demonstrated that pir-1 mutant 
animals are unable to suppress replication of Orsay virus, a (+)-strand ssRNA virus related 
to nodaviruses (Felix et al., 2011). By showing that the suppression of Orsay virus 
replication does not depend on 26G-RNAs, we have discovered an additional biological 
function for PIR-1 in C. elegans, whereby it promotes an effective antiviral 22G-RNA 
response. When the pir-1 deletion was combined with loss-of-function mutations for 
factors previously implicated in sRNA-based immunity against Orsay including DRH-1, 
RDE-1, and RRF-1 (Felix et al., 2011; Ashe et al., 2013), the relative viral loads measured 
in the double mutants never exceeded the viral loads of the individual mutants. This 
suggested that PIR-1 acts in concert with these factors to mediate viral defense rather than 
being part of a parallel immune pathway. Analysis of viral sRNAs in these mutant 
backgrounds revealed that PIR-1 functions downstream of DRH-1, which has been 
postulated to sense 5'-triphosphorylated dsRNA viral molecules (Guo et al., 2013; Ashe et 
al., 2013). Moreover, we showed for the first time that RDE-1 specifically interacts with 
Dicer-produced viral 23-mers and that in the absence of PIR-1, loading of RDE-1 with 
these sRNAs is partially compromised.  
The addition of PIR-1 to the repertoire of proteins required for the RNAi antiviral 
response is somewhat puzzling, considering that at least two Dicer protein complexes with 
enzymes capable of recognizing RNA 5' triphosphates act in the same pathway: PIR-
1/DCR-1 and DRH-1/DCR-1. Since much remains to be understood about the dynamics of 
viral RNA recognition and the molecular details of how Dicer complexes engage and 
process viral dsRNA, characterizing PIR-1 activity in this context is likely to provide key 
insights. Given that PIR-1 is conserved in all metazoans, and that RNAi has been reported 
as an important antiviral barrier evolutionarily extending to vertebrates (Parameswaran et 
al., 2010; Li et al., 2013; Maillard et al., 2013), further elucidation of this process will get 
us closer to understanding the interplay and balance that must occur between distinct, co-
existing antiviral immunity pathways in metazoans. Below, we propose a model for Orsay 
small-RNA based suppression taking into consideration the RNA phosphatase activity of 
PIR-1, and discuss the potential for functional conservation of this protein in antiviral 
pathways of more complex animals. 
 
 




A Model for PIR-1 Function in Promoting Small RNA-Based Antiviral 
Immunity 
Based on the results reported here and elsewhere, we propose an integrated 
working model for Dicer-associated PIR-1 activity in suppressing the replication of the 
nematode-infecting Orsay ssRNA virus (Fig. 5.9). Since our data suggest that DRH-1 acts 
upstream of PIR-1, the first step in the control of viral infection is likely to be the DRH-1-
mediated recognition of triphosphorylated viral dsRNA molecules. 5'-PPP dsRNA is 
generated during the synthesis of (-)RNA template strands and during the amplification of 
(+)RNA by the viral RdRP. The latter provide genomic RNA to be incorporated into new 
viral particles and mRNA to be translated into structural and functional components of the 
virus. We speculate that DRH-1, perhaps by virtue of a very high affinity to its substrate, is 
able to recognize viral RNAs at very low cellular concentrations, during the early stage of 
the viral replicative cycle. As DRH-1 has long been found to form a stable complex with 
DCR-1, RDE-4 and RDE-1 (Tabara et al., 2002), recognition of viral dsRNA may trigger 
Dicer cleavage and loading of 23-mers into the RDE-1 primary Argonaute. Since this step 
occurs very early in infection and dsRNA intermediates are probably unstable, loaded 
RDE-1 complexes do not accumulate to a sufficiently high level to trigger a robust 22G-
RNA response. Rather, these early events could activate signaling pathways or act directly 
to recruit additional factors that lead to a potent response capable of restricting the 
increasing concentration of viral RNA. One attractive and unexplored possibility is that 
initial recognition by the DRH-1 complex may nucleate the binding of RDE-4 molecules 
along the regions of dsRNA. RDE-4 has been shown to promote the accumulation of 
dsRNA in vivo (Tabara et al., 2002) and to bind dsRNA in a cooperative manner in vitro 
(Parker et al., 2006; Parker et al., 2008). With these properties in mind, one can imagine 
that multiple RDE-4 molecules could cover regions of duplexed viral RNA, triggered by 
the initial binding of DRH-1 complexes at dsRNA termini. This could not only result in the 
sequestration of dsRNA away from viral machinery, but perhaps also establish a molecular 
platform for the recruitment of additional processing factors, including the DCR-1/PIR-1 
complex. Such a mechanism could be especially relevant in the battle against Orsay virus 
considering that its replication, similarly to that of its cousin Flock House Virus in 
Drosophila cells, could be restricted to specialized cellular compartments. Specifically, the 
RdRP of FHV has the capacity to insert itself into the outer membrane of mitochondria of 
the host cell, leading to invaginations inside of which replication complexes and dsRNA 
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intermediates are thought to be sequestered and “hidden” from host defense systems 
(Miller et al., 2001; Miller and Ahlquist, 2002; Kopek et al., 2007). 
Given that the phosphatase activity of PIR-1 is required to suppress Orsay 
replication, we speculate that the dephosphorylation of the ends of dsRNA molecules may 
interfere with the ability of the virus to separate the two strands. In this scenario, PIR-1 
would be in direct competition with the potential unwinding and capping activities of the 
viral RdRP (several viral RdRPs incorporate RNA capping activity; reviewed in Aartjan 
and te Velthuis, 2014). This would lead to the accumulation of stable, full-length viral 
dsRNA that would be cleaved by DCR-1 to provide a steady source of primary 23-mer 
viral siRNAs to be loaded into RDE-1. Alternatively, the stabilization of dsRNA molecules 
could occur not as a consequence of dephosphorylation, but rather due to the elimination of 
terminal sequences in the viral RNA required for viral RdRP initiation. In FHV, negative 
strand synthesis is dictated by elements within the 3'-proximal 108 and 50 nucleotides of 
(+)RNA1 and (+)RNA2, respectively, while positive strand synthesis relies on 3-14 
nucleotides at the 3' ends of      (-)RNA strands (Venter and Schneemann, 2008). Assuming 
that Orsay replication requires similar elements, PIR-1 could act as a sensor for terminal 5'-
PPP followed by a Dicer cleavage event that would destroy such critical sites and halt 
initiation of further rounds of viral RdRP synthesis. Regardless of the dsRNA stabilization 
mechanism, this would guarantee an abundant cytoplasmic synthesis of antisense 22G-
RNAs by the host RdRP RRF-1 using the existing viral (+)RNA strands as templates. 
Since the stabilized viral dsRNA substrates would encompass the entire viral genome 
sequence, primary 23-mers, and consequently secondary 22G-RNAs, would also cover the 
entire sequence, in agreement with our results.  
Regarding RDE-1 loading, while the DRH-1 complex incorporates RDE-1 (Tabara 
et al., 2002), the PIR-1 complex does not (Chapter III), such that it may require other 
factors to couple the cleavage of 23-mers to RDE-1 loading. It is plausible that upon the 
first cleavage by the PIR-1/DCR-1 complex at either end of the dsRNA intermediates, PIR-
1 is no longer required for additional rounds of cleavage, since the remaining dsRNA 
would now have Dicer-generated 5'-P receded ends. In this case, a DCR-1/RDE-4/RDE-1 
complex would be sufficient to cleave the rest of the dsRNA molecule, with the added 
advantage of ensuring coupling of Dicer cleavage to RDE-1 loading. In this scenario, it is 
not clear to us how to interpret our observation that in the pir-1 mutant the interaction of 
RDE-1 with 23-mers is less pronounced (especially considering that 23-mers still 
accumulate and are distributed along the entire length of the viral genome). We cannot rule 




out, however, that in the context of viral infection, RDE-1 could be recruited to PIR-
1/DCR-1/RDE-4 complexes already localized to foci of viral replication, and facilitate 
cleavage and/or loading by an unknown mechanism.   
Due to gaps in our knowledge regarding the molecular details of the Orsay virus 
replicative cycle and the biochemical properties (e.g., RNA binding affinities, rate and 
processiveness of cleavage) of several of the C. elegans factors involved in this process, 
this is a highly speculative model. As such, it is far from being the only possible model, but 
it is one that tries to integrate the little we have learned from recent studies and our own 
work. As a working model it generates interesting and testable hypotheses that are worthy 
of future pursuit. Perhaps the most interesting hypothesis concerns stabilization of dsRNA 
precursors for Dicer cleavage. Specifically, the accumulation of dsRNAs could be tested in 
a dcr-1 mutant, where they would potentially be preserved by the absence of cleavage 
(assuming that other RNA degradation pathways would not take over). The proof that PIR-
1 has a stabilizing effect on viral dsRNA intermediates would come from the inability to 
detect these molecules in a dcr-1; pir-1 double mutant. Experiments such as this one could 
not only help us define the precise molecular function of PIR-1, but also expand the 














Figure 5.9. Model for PIR-1 function in the control of Orsay virus replication. After entry of 
viruses into the cell and translation of the first viral RdRP molecules from the genomic segments, 
the generation of negative polarity template strands is initiated. As enough template strands 
accumulate, the balance shifts toward a more abundant production of positive strands to be 
incorporated into new virions. Many of these molecules are likely immediately capped by the viral 
RdRP or the host capping enzyme. In competition with this activity, DRH-1, with very high affinity 
for RNA 5' triphosphates, is able to bind the ends of some of these temporary dsRNA 
intermediates. Although it may contain DCR-1, the DRH-1 complex is not able to generate enough 
23-mers to produce sufficient effector 22G-RNAs, but may rather provide a signal for the 
recruitment of additional dsRNA processing factors. Among these could be a PIR-1/DCR-1 
complex capable of dephosphorylating the ends of the labile dsRNA intermediates and perhaps 
permit their stabilization by keeping viral factors, or cellular factors recruited by the virus, from 
separating the strands. This would allow DCR-1 to initiate cleavage of the whole viral sequence 
providing a steady source of 23-mers to be loaded into RDE-1. In turn, RDE-1/sRNA complexes 
would bind viral (+)RNA molecules to trigger the abundant primer-independent synthesis of 
effector 22G-RNAs by RRF-1, thereby allowing the host cell to destroy viral RNAs at a fast rate. 
Since PIR-1-mediated dephosphorylation would only be required at the ends of the full-length viral 
dsRNAs, the majority of cleavage could be performed by DCR-1/RDE-1 complexes, facilitating 
the loading of primary viral 23-mers. Alternatively or in parallel, RDE-1 may transiently associate 
with a complex of DCR-1/PIR-1/RDE-4 (in parentheses) to execute the cleavage, coupled to RDE-










Why Do 22G-RNAs Accumulate in Mutants That Cannot Suppress Viral 
Replication? 
The abundant production of 22G-RNAs in mutants where Orsay virus replicates 
uncontrollably seems paradoxical. When taking into account the high viral load present in 
these mutants, however, the relative amount of antiviral 22G-RNAs is lower than in wild-
type animals, and clearly unable to keep up with viral replication. Nonetheless, the fact that 
they are produced in mutants where maternal effects are not at play is suggestive that the 
system is relatively permissive to the lack of accessory components, such as DRH-1 or 
RDE-4. In a context where these components are absent, Dicer may be able to elicit 
cleavage of dsRNA intermediates after viral RNAs reach a high enough cytoplasmic 
concentration, bypassing, for instance, the DRH-1-mediated 5'-PPP recognition step. In the 
case of the drh-1 mutant, the virus takes advantage of a prolonged period without cellular 
surveillance during which replication is unobstructed. Viral RNA therefore accumulates to 
a level that can no longer be downregulated by 22G-RNAs due to a delayed accumulation 
of trigger 23-mers.  
In dcr-1 mutants, it is likely that by the time RNA is extracted, enough 22G-RNAs 
have been triggered by 23-mers made earlier with maternal DCR-1. 23-mer primary 
species may have a much more rapid turnover than 22G-RNA/Argonaute complexes, 
explaining the disappearance of the 23-mer peak. Again, the lack of 23-mers does not 
allow cells to keep up enough 22G-RNA synthesis to destroy viral RNAs. In the rde-1 
background, the accumulation of 23-mers is made possible by unperturbed production by 
Dicer. Assuming that RDE-1 is the only Argonaute that can engage viral 23-mers, this 
implies that their production rate amply exceeds the rate at which cells can degrade them. 
Additionally, 23-mer duplexes may be intrinsically more stable than other cellular RNAs, 
also contributing to their accumulation. In the case of rde-1, however, as with rrf-1 mutant 
animals, 22G-RNAs are never synthesized, and the unrestricted synthesis of viral RNA is 
easily explained. 
 
In the Absence of PIR-1, RDE-1 Engages Fewer and 5'U-Biased Antiviral 23-
mers   
While it is undeniable that PIR-1 is required for suppression of Orsay virus 
replication, the reason for accumulation of 23-mers is unclear and confounded by the 
maternal load effect. In this regard, pir-1 behaves like the rde-1 mutant. As shown in 
Figure 5.4 (page 233), when maternally loaded PIR-1 is reduced by counter-selecting 
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animals for a longer period before infection, the 22G-RNA peak is decreased relative to the 
23-mer peak. This suggests that in the theoretical complete absence of maternal load, only 
23-mers would accumulate, and that the reduction in 22G-RNAs would be even more 
pronounced. Since proper loading of RDE-1 with 23-mers is absolutely necessary to 
generate 22G-RNAs, we believe that this outcome holds a connection to the observation 
that immunoprecipitated RDE-1 in the pir-1 background is able to engage a lower and 
qualitatively different (5'U bias) fraction of 23-mers than in a wild-type context. We do not 
understand, however, how PIR-1 could increase the efficiency of loading of RNA into 
RDE-1. In one possibility, the PIR-1 complex may engage accessory factors that mediate 
this process during infection. Based on this reasoning, we tentatively place PIR-1 upstream 
of RDE-1 in the viral silencing pathway. 
Some important caveats to the RDE-1 IP/cloning experiments should be mentioned. 
First, no perfect normalization standards applied to this experiment. miR-243 is adequate 
for normalization between RDE-1 IPs, but may skew results for inputs, due to low read 
numbers in those samples. Despite this, when we normalized the data with total miRNAs, 
although the numbers produced were different, the overall conclusions were maintained 
(i.e., RDE-1 IP enrichment of 23-mers in wild type, much lower enrichment in pir-1, and 
depletion in ALG-1 IPs.). Second, in addition to TAP cloning, the preparation of direct 
cloning libraries would have helped to provide better estimates of Dicer-dependent 23-
mers. Third, since we did not sequence more 23-mer reads in pir-1 than in wild type, we 
suspect that the expression levels of the rescuing gfp::rde-1 transgene in the pir-1 
background could have been lower than in the control strain, at least in the intestinal cells 
where Orsay virus replicates. While this does not invalidate our conclusion (23-mers still 
heavily interact with RDE-1 in the pir-1 background), future studies should eliminate this 
source of variability by using integrated transgenic lines with uniform and ubiquitous 
expression of the transgene. Nonetheless, we believe that these results suggesting that PIR-
1 acts upstream of RDE-1 loading are important enough to warrant further investigation. 
Finally, we exclude the possibility that pir-1 mutants are not able to produce 
enough 22G-RNAs due to a decreased level of RDE-1 because (1) arrested mutants can 
sustain a normal RDE-1-dependent exo-RNAi response (Chapter IV), (2) they express 
higher levels of rde-1 mRNA than wild-type (mRNA-seq, Appendix D), (3) and pir-
1(tm1496) animals express wild-type levels of RDE-1 protein (not shown). 
 
 




The Pattern of PIR-1 Expression Is Compatible with a Constitutive Role in 
Antiviral Immunity 
 The ubiquitous spatio-temporal expression of PIR-1 in C. elegans is in agreement 
with it being a key component of antiviral immunity. The Orsay replicative cycle, for 
instance, is restricted to the cytoplasm of a few somatic cells (Felix et al., 2011; Franz et 
al., 2014), but the fact that PIR-1 is expressed in practically every cell of the organism 
suggests that cells are permanently primed for defense against (yet-to-be-discovered) 
viruses that exhibit wider cell and tissue tropisms than Orsay. Additionally, although we 
think that the expression of PIR-1 in the nucleus may be related to its role in 26G-RNA 
biogenesis, and perhaps in broader functions encompassing gene expression regulation and 
cell division (discussed in Chapter II), it may also be required for suppression of viruses 
that replicate in cell nuclei. These include viruses belonging to the Orthomyxoviridae 
family (including Influenza viruses), which also contains a vertebrate/invertebrate-
infecting genus named Thogotovirus. Orthomyxoviruses carry multipartite (-)RNA 
genomes and replicate in the nuclei of infected cells, with the likely formation of dsRNA 
intermediates. A role in the defense against such viruses would explain why the nuclear 
localization of PIR-1 is maintained throughout the entire life of C. elegans. The hypothesis 
that PIR-1 may restrict viral replication in the nucleus will be easily testable once such 
viruses are identified in C. elegans.  
 
Does PIR-1 Contribute to Antiviral Immunity in Other Animals? 
Our findings concerning the involvement of PIR-1 in suppressing the replication of 
an RNA virus led us to question whether this highly conserved phosphatase is required for 
antiviral defense in other metazoans. In Chapter III we showed that in human cells PIR1 
can interact with Dicer, at least when PIR1 is overexpressed. Those results were extended 
by a former member of the laboratory, Darryl Conte, who asked whether human orthologs 
of DRH-3 interacted with Dicer in human cells. He considered the three cytoplasmic RIG-
I-like receptors (RLRs) that sense viral RNA: RIG-I, MDA5 (Melanoma Differentiation-
Associated protein 5) and LGP2 (Laboratory of Genetics and Physiology 2) (reviewed in 
Bruns and Horvath, 2014; Errett and Gale, 2015). All three proteins are highly homologous 
to C. elegans DRH-1, DRH-2 and DRH-3, namely by the shared presence of a DExD/H 
box and a RIG-I-like C-terminal domain. Notably, the worm RLR orthologs lack the N-
terminal tandem caspase activation and recruitment (CARD) domains found in RIG-I and 
MDA5 (for an interspecies comparison of viral RNA sensing by duplex RNA-activated 
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ATPases, consult Paro et al., 2015). Upon dsRNA binding through the helicase domain of 
these proteins, the CARD domains provide a platform onto which signaling cascade-
initiating complexes can assemble. Such signaling leads to expression of IFN genes, which 
in turn heighten immune response pathways in the infected and neighboring cells. The 
experiment consisted of overexpressing tagged versions of the human RLRs in HEK293T 
cells, followed by immunoprecipitation and western analysis. The IP of LGP2, but not 
RIG-I or MDA5, robustly co-immunoprecipitated not only endogenous Dicer, but also 
endogenous PIR1 (Darryl Conte, unpublished results). The interaction of Dicer with LGP2 
was later independently confirmed in a proteomics-based study of HEK293 cells with an 
activated IFN response (Li et al., 2011). This reinforced the idea that the Dicer-PIR1 
interaction is maintained in vertebrates, but also led to the hypothesis that human PIR1 is 
involved in antiviral immunity.  
LGP2 has the highest RNA binding affinity among the RLRs, and is able to 
recognize dsRNAs regardless of length or 5'-phosphorylation state. It cannot, however, 
trigger the IFN response on its own due to the lack of CARD domains (Bamming and 
Horvath, 2009; Takahasi et al., 2009). Despite a variety of reports showing that LGP2 can 
positively modulate RIG-I and MDA5 activity (Satoh et al., 2009; Moresco and Beutler, 
2010 and references therein; Bruns and Hovarth, 2015), the robust association of LGP2 
with Dicer and PIR1 in the absence of viral infection, tempts us to speculate that this may 
represent a constitutive complex functioning outside of the canonical IFN response. In this 
context, LGP2 may act as a highly sensitive cytosolic dsRNA sensor that may rapidly 
place Dicer and PIR1 on invading dsRNA to promote the generation of viral siRNAs. This 
idea is especially plausible in light of a study demonstrating that an effective Dicer-
dependent RNAi-based antiviral immunity response was mounted in mice infected with 
Nodamura virus, a bipartite (+)RNA virus related to FHV (Li et al., 2013). In this study, 
the IFN response was not manipulated and therefore assumed to occur concurrently with 
the siRNA-based response. One can imagine that because the IFN pathway often leads to 
apoptosis of the infected cells (reviewed in Barber, 2001), it would be beneficial for the 
host to avoid this response as much as possible, in favor of a non-destructive RNAi-based 
response. The balance between the two pathways may depend on both the type of virus and 
the number of initial viral particles with which cells are challenged. It is unclear how the 
dephosphorylation activity of PIR1 could contribute to the efficacy of antiviral RNAi in 
conjunction with Dicer and LGP2. One interesting possibility could involve the 
dephosphorylation of 5' tri- and diphosphate viral dsRNAs in order to prevent recognition 




by RIG-I, which has been demonstrated to specifically bind to 5'-PP and 5'-PPP ends of 
viral dsRNA (Hornung et al., 2006; Lu et al., 2010; Goubau et al., 2014). This would favor 
an initial antiviral response based solely on RNA restriction, relegating the IFN response to 
a second barrier of defense that would only be activated if the initial response failed to 
contain viral replication. Based on our laboratory’s discovery that Dicer, LGP2 and PIR1 
may function together in a complex, a PIR1 knockout mouse was created in the laboratory 
of Robert Finberg at UMass Medical School. Thus far, results suggest that mouse PIR1 
modulates the response to viral infection, although it is still unclear how it does so, and 
whether it acts in synergy with the IFN pathway or as part of an independent pathway 
(Christopher MacKay, personal communication). Lastly, as described in Chapter III, the 
LGP2 helicase ortholog DRH-3, which is also required for suppression of Orsay virus 
replication in C. elegans (Ashe et al., 2013), was found to stabilize the smaller PIR-1a 
isoform, which appears to be confined to the cytoplasm (Fig. 3.7, page 133 and Fig. 3.8, 
page 136). It is therefore tempting to propose that a DRH-3/PIR-1a complex could 
constitute the C. elegans equivalent of an LGP2/PIR1 complex. This possibility should not 
be disregarded in future work on the involvement of C. elegans PIR-1 in antiviral 
immunity.  
In Drosophila, as in other insects, there are no direct orthologs of RIG-I, MDA5 or 
LGP2. Flies express two Dicer proteins: Dicer-1, which produces miRNAs, and Dicer-2, 
which generates siRNAs from dsRNA. Viral dsRNA is sensed by Dicer-2, which in 
association with the dsRNA-binding protein R2D2 (an ortholog of C. elegans RDE-4) 
generates 21-nt siRNAs that are loaded into the effector Argonaute-2 (Ago-2) to destroy 
viral RNA (Galiana-Arnoux et al., 2006; van Rij et al., 2006; Wang et al., 2006; Zambon 
et al., 2006). In addition to this activity, upon viral dsRNA binding, Dicer-2 is capable of 
activating the Jak-STAT (Janus Kinase and Signal Transducer and Activator of 
Transcription) signaling cascade, which induces a more global innate immune response, 
and is reminiscent of the signaling events that lead to the vertebrate IFN response 
(Deddouche et al., 2008; Paradkar et al., 2012; reviewed in Kingsolver et al., 2013).   
Despite the fact that in flies the association of the PIR-1 ortholog CG13197 has not 
yet been shown to occur with either of the organism’s two Dicer proteins, we have 
gathered preliminary results showing that Drosophila PIR1 is required for suppression of 
FHV replication in whole animals. The experiment consisted of injecting FHV into one-
day old male flies and following the accumulation of FHV RNA1 by qRT-PCR and 
survival of the animals over a 20-day period (unlike Orsay in C. elegans, FHV is lethal to 
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flies). In Ago-2 and Dcr-2 loss-of-function mutants, which served as positive controls, the 
viral load increased approximately 1,000-fold relative to wild-type flies. In Drosophila 
CG13197 mutants, the accumulation of FHV RNA1 was three orders of magnitude higher 
than in the positive controls. This dramatic difference presumably results from the 
presence of maternally loaded PIR1 in infected animals (as with C. elegans, mutants are 
sterile and are maintained as genetically-balanced heterozygotes). This maternal load 
results in a later onset of death associated with infection, giving the virus more time to 
replicate than in the Dcr-2 and Ago2 mutants, which die earlier (experiments performed by 
Keith Boundy, in the laboratory of Phillip Zamore). While this result awaits full 
confirmation through rescue of the mutant by a wild-type CG13197 transgene, it is a strong 
indication that Dm PIR1 functions in concert with Dicer-2 to provide antiviral immunity in 
flies. Since it is currently not known how Dicer-2 is able to distinguish non-viral dsRNA 
(which only triggers siRNA production) from viral dsRNA (which triggers both siRNA 
production and the Jak-STAT response), it is plausible that PIR-1 functions in a 
mechanism that allows this distinction based on the 5'-phosphorylation state of the dsRNA 
molecules engaged by Dicer-2.  
In summary, there is strong evidence supporting the involvement of the mammalian 
and insect orthologs of PIR-1 in suppressing the replication of RNA viruses. The fact that 
PIR-1 exhibits functional conservation makes it a very attractive target for deeper studies 
regarding its molecular mechanisms, namely through the use of simpler and more 
technically amenable immortalized cell models, currently inexistent for C. elegans.  




MATERIALS AND METHODS 
 
Preparation of Orsay Virus Filtrates for Infection 
 Preparation of Orsay virus filtrates was performed essentially as described in Felix, 
et al., 2011 from the original wild isolate C. elegans strain JU1580 (a kind gift from Dr. 
David Wang from Washington University in Saint Louis). Briefly, per batch of filtrate 
prepared, JU1580 animals were grown on six large (15 cm) NGM plates with 3 ml of 
concentrated OP50 per plate at 20˚C until they reached starvation. Worms were collected 
from the plates by washing them 2x with 15 ml of sterile 20 mM Tris-HCl pH 7.5 buffer, 
followed by transfer to 15 ml conical tubes and centrifugation to eliminate the animals in 
the suspension. This suspension was then passed through successively finer filters (5 µm, 
1.2 µ and 0.22 µm) attached to a 30 ml syringe for elimination of debris and contaminating 
fungi and bacteria. The filtrates were aliquoted into sterile 1.5 ml microtubes and frozen at 
-80˚C. 
 
Growth and Infection of C. elegans Strains 
 In general, strains used for infection were expanded in 15 cm NGM plates and 
bleached for recovery of clean embryos and establishment of synchronized populations. 
Infections were established by mixing 20-40,000 synchronized animals (depending on 
stage at time of infection or stage to be collected post-infection) with 1 ml of concentrated 
OP50 and 150 µl of freshly thawed viral filtrate. Infection periods varied from 2-4 days at 
20˚C. Strains requiring ivermectin counter-selection were selected under the same 
conditions as described in Chapter II Materials and Methods. For aging of non-sterile 
strains during or prior to infection, progeny were eliminated as L1/L2 larvae every day 
until final collection. This was achieved by collecting all animals from their plates in M9 
buffer into 50 ml conical tubes, and letting most adult animals settle by gravity for about 2-
3 minutes. Larvae remaining in suspension were aspirated and fresh M9 buffer was added. 
This process was repeated at least five times to eliminate all larvae. This step was required 
to ensure that viral mRNA would not be measured from newly infected larvae. 
 
Extraction of RNA 
20,000-40,000 worms growing on 10 cm plates were washed 5x with M9 buffer 
followed by a 30-minute to 1-hour incubation in M9 buffer to eliminate as much virus as 
possible from the intestinal lumen and outer surface of the animals, in order to restrict our 
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analysis to intracellular viral RNA. The resulting pellets (100-200 µl) were resuspended in 
1 ml of TRI Reagent, transferred to 1.5 ml Safe-Lock tubes (Eppendorf) with 200 µl of 
fine glass beads (Sigma), and vortexed vigorously for 20 minutes at 4˚C using a foam 
adaptor to accommodate multiple tubes. After addition of 100 µl of BCP, samples were 
vortexed for 2-3 minutes at room temperature and further processed according to the TRI 
Reagent instructions. Pellets were dissolved in ultrapure water and quantified with a 
NanoDrop instrument. 
 
qRT-PCR of Orsay Virus 
cDNA synthesis and qRT-PCR were performed as described in Chapter II and SEM 
was calculated as described in Chapter IV. Orsay RNA1 was amplified using the primers 
GW194 and GW195 from Felix et al., 2011 (O127/O128, Appendix B) and normalized to 
actin mRNA levels. The magnitude of the increase in viral RNA fold-change varied 
considerably from experiment to experiment. Among other potential causes for this 
variation, are the fact that the extent of viral RNA accumulation varies according to the 
stage at which animals are infected as well as the duration of infection (Sterken et al., 
2014), and that we could not titrate the concentration of infectious Orsay virions used in 
each experiment as no such method is currently available. Such variability in qRT-PCR 
measurements was also observed by Ashe and colleagues (2013). We therefore always 
compared samples that were infected in parallel under identical conditions of viral stock, 
worm age, and infection period. 
 
Small RNA Cloning  
Small RNA libraries for deep sequencing were prepared as described in Chapter IV 
Materials and Methods.  
 
IP/Cloning of RDE-1- and ALG-1-Associated Orsay Viral Small RNAs 
Due to the lack of enough anti-RDE-1 antibody, transgenic animals expressing 
GFP::RDE-1 were generated to permit IP with an anti-GFP antibody. For this, both rde-
1(ne300); unc-119(ed3); avr3x and pir-1(tm3198)/mnC1*; rde-1(ne300); unc-119(ed3); 
avr3x strains were microinjected with a construct carrying the wild-type C. briggsae unc-
119 gene and a gfp::rde-1 fusion under the control of its own regulatory sequences 
(provided by Masaki Shirayama in the laboratory). Progeny whose unc-119 paralysis 
phenotype was rescued were picked and assessed for genetic transmission of the rescuing 




non-integrated transgenic arrays formed by the injected constructs. Only lines with >90% 
transmission rates were selected to test for rescue of RNAi resistance due to the rde-1 
mutation. For this, animals were placed on unc-22 (expressed in somatic muscle cells) or 
pos-1 (germline) dsRNA-expressing bacteria as early larvae. In the case of pir-1 animals, 
balanced heterozygotes were used. The majority of lines were still resistant to pos-1 RNAi 
(an expected outcome due to germline silencing of high-copy transgenic arrays), but 
sensitive to unc-22 RNAi with manifestation of the characteristic twitching/paralysis 
phenotype. GFP signal could be observed in many tissues of the selected lines and 
GFP::RDE-1 could be detected from IPs of rde-1; gfp::rde-1 and ivermectin 
counterselected pir-1; rde-1; gfp::rde-1 lines. Exposure of the selected rde-1; gfp::rde-1 
line to Orsay virus also led to rescue of viral suppression to wild-type levels compared to 
rde-1(ne300) alone. 
For the GFP::RDE-1 IP experiment, animals were grown on ivermectin plates. The 
rde-1 rescued animals were grown from L1s on OP50 with Orsay virus for 3 days and 
harvested as L4-young adults. pir-1 animals were counter-selected for 7 days prior to 
exposure to Orsay for 3 days. For the ALG-1 IP experiment, wild-type N2 and rde-
1(ne300) strains were used. Animals were grown for 2.5 days in the presence of Orsay and 
harvested as young adults. All worms were cultured at 20˚C. 
The IP protocol was based on an ALG-1 IP procedure optimized in the laboratory 
of Victor Ambros in our department. Frozen worm pellets were thawed and lysed in 2-3 
volumes of a buffer composed of HEPES-KOH, pH 7.4, 50 mM KCl, 0.1% Triton X-100, 
2 mM MgCl2, and 10% glycerol supplemented with 2 mM DTT, Superasin RNase 
inhibitor (50 µl/10 ml; Ambion), EDTA-free protease inhibitor cocktail (1 tablet/10 ml; 
Roche), Phostop phosphatase inhibitor cocktail (1 tablet/10 ml; Roche). 15 mg of each 
lysate at a 5 mg/ml concentration were split into 3 tubes and each was pre-cleared with 
washed beads from 200 µl of magnetic Dynabeads Protein G suspension (Life 
Technologies) for 1 hour at 4˚C. 80 µl of pre-cleared lysate was set aside to collect total 
RNA to be used as input. For GFP IPs, 5 µl (~6 µg) of monoclonal anti-GFP antibody 
(Wako) was used per 5 mg of protein. For ALG-1 IPs, 15 µg of polyclonal ALG-1 
antibody (kindly provided by Victor Ambros) was used per 5 mg of protein. The lysates 
were incubated with the antibodies for 1 hour at 4˚C and then transferred to tubes with 
washed Dynabeads for an additional 1-hour incubation at 4˚C, using 50 µl and 125 µl of 
bead suspension for GFP and ALG-1 IPs, respectively. Beads were then washed 3x 10 
minutes with cold wash buffer (same composition as lysis buffer except for an increased 
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salt concentration to 100 mM KCl) and transferred to fresh tubes (to avoid recovering 
nonspecific RNA stuck to the tube walls). For elution, the beads were incubated with 50 µl 
of TRI Reagent twice. 30 µl of ultrapure water and 20 µl of BCP phase separation reagent 
were added to the 100 µl of TRI Reagent and vortexed. Phase separation was carried out in 
250 µl PCR tubes adapted as mini Phaselock tubes to which ~30 µl of phase-lock gel was 
added. This minimized loss of material from the aqueous phase. All subsequent phase 
separation and precipitation steps were carried out in small tubes. Centrifugations for phase 
separation were performed at 10,000x g for 4 minutes at room temperature. Precipitation 
took place at -20˚C overnight after the addition of 20 µg of glycogen (Roche) and 1 
volume of isopropanol. Samples were centrifuged at 15,000x g for 15 minutes at 4˚C and 
then washed with cold 75% ethanol. Pellets were resuspended and pooled in 10 µl of TE 
buffer to which 10 µl of gel loading buffer II with formamide (Ambion) was added. For 
inputs, 80 µl of pre-cleared lysate was subjected to two consecutive phenol:chloroform 
extractions using the adapted Phase-lock PCR tubes. Precipitation was carried out by 
addition of 1/10 volumes 3 M sodium acetate pH 5.2, 20 µg of glycogen and 1 volume of 
isopropanol. The rest of the procedure was as described above. Input material was 
resuspended in 30 µl of TE buffer and quantified in a NanoDrop instrument. 10 µg were 
set aside to mix with gel loading buffer for a final volume of 20 µl. All samples were 
denatured at 65˚C for 5 minutes and run on a 15% polyacrylamide/7 M urea/0.5X TBE gel 
for size separation, followed by staining with ethidium bromide in 0.5X TBE buffer, and 
destaining for 10-20 minutes. Gel slices corresponding to ~18-40 nt were excised and 
processed as described in Chapter IV Materials and Methods.  
Small RNAs were cloned using the 5'-independent TAP method described in 
Chapter IV with the exception of the scheme for the post-ligation PCRs which was 
adjusted to the very low amount of starting material. For this, different numbers of cycles 
were tested in the first round of PCR (12, 16, 20, 24 and 28 cycles) with 0.1 µM of the 
short oligos, using 2 µl of cDNA in a 50 µl reaction volume. After running 3 µl of each 
condition on a non-denaturing 10% polyacrylamide/0.5X TBE gel, the optimal cycle 
number was chosen for each sample and a 50 µl production PCR was performed and run 
on another non-denaturing gel. The ~70 bp products were excised from the gel (between 60 
and 80 bp), eluted, precipitated and resuspended in 20 µl of Tris-HCl pH 7.5 buffer. This 
purification was intended to get rid of very abundant primer dimers in the IP samples 
which would prevent amplification of the desired sequences in the second round. For the 
second PCR with the long oligos containing the Illumina sequences, a 50 µl test reaction 




was again performed, using oligos at 0.5 µM and 2 µl of the purified first-round PCR 
products. Optimal production was assessed at 4, 7, 10 and 13 PCR cycles and a 3x 50 µl 
production PCR was prepared for each sample, followed by gel purification between 90 
and 110 bp. Purified products were diluted to 10 ng/µl and some samples were TOPO 
cloned and sequenced for quality control. Samples were then mixed for a 1 ng/µl final 
concentration of each individually barcoded library and submitted for deep-sequencing in 
an Illumina HiSeq instrument.  
 
Assembly of the Orsay Virus Genome and Small RNA Analysis 
We assembled the Orsay virus genome using sRNAs derived from Orsay virus 
using a custom PERL script before a complete genome sequence became publicly available 
(Felix et al., 2011). Our sequences are almost identical to the published ones with two 
exceptions: (1) for the viral segment encoding the alpha-delta fusion protein (capsid 
protein and protein delta; GenBank: HM030970.2), our sequence is 1 nt shorter due to a 
single deletion in the CCCCCCCCCCC region. This is likely a homopolymer mutation 
caused by sequencing errors in either the published sequences or our own. Otherwise the 
two sequences are 99.7% identical, with the remaining differences consisting of 9 different 
single-nucleotide polymorphisms (SNPs); (2) for the viral segment encoding the RdRP 
(HM030971.2), our sequence has an additional AG at the 5' end. Otherwise the two 
sequences are 99.7% identical with the remaining differences being 8 SNPs. The assembly 
custom PERL script and fully assembled sequences are available upon request. 
 Mapping of reads to the Orsay genome and analysis was performed as described in 
Chapter IV Materials and Methods, with some modifications. The direct cloning mostly 
cloned primary siRNAs (including viral 23-mers), 21U-RNAs and miRNAs. However, the 
TAP procedure cloned not only secondary triphosphate 22G-RNAs, but also 
monophosphate viral primary siRNAs that were 22-nt long and began with a G. To remove 
contamination of primary 22G-RNAs from secondary 22G-RNAs, only 22G-RNAs 
preceded with C or T (the ‘YR’ motif described in the Results section) were considered as 
real secondary 22G-RNAs, because we previously demonstrated that secondary 22G-
RNAs prefer a non-coded 5'C or T. For the RDE-1 IP, miR-243 was used to normalize 
sRNA reads, because miR-243 specifically interacts with RDE-1 and can therefore be used 
as a good indicator for the extent of RDE-1 enrichment in each sample. For non-IP 





















This work constitutes the first characterization of the highly conserved metazoan 
RNA 5' phosphatase PIR1/DUSP11 in a whole animal. Our studies uncovered two distinct 
biological functions for C. elegans PIR-1. As expected from its association with the 
ribonuclease Dicer (Duchaine et al., 2006), both of these functions are related to the 
production of small RNAs. In the context of a stable association with the sRNA-producing 
ERI complex in vivo, we found PIR-1 to be required in the germline for the biogenesis of 
nematode-specific endogenous primary 26G sRNAs, which promote proper sperm cell 
differentiation (Han et al., 2009; Pavelec et al., 2009; Conine et al., 2010). In somatic 
cells, and upon infection by the naturally-occurring C. elegans Orsay RNA virus (Felix et 
al., 2011), we found PIR-1 to be required for the suppression of viral replication by 
participating in an RNAi-like antiviral pathway. These functions correlate well with the 
nearly ubiquitous expression of PIR-1 along development in both the soma and germline. 
Additionally, we showed that endogenous germline sRNAs targeting protein-coding 
transcripts are significantly downregulated in pir-1 mutant animals, suggesting that PIR-1 
may promote their synthesis and consequently play a potentially crucial role in the 
coordination of germline sRNA-dependent processes. Experimental constraints, however, 
precluded further investigation of this interesting result. 
Importantly, we have established that C. elegans PIR-1 indeed functions as an RNA 
triphosphatase in vitro, converting 5'-triphosphorylated RNA to 5'-monophosphorylated 
molecules, and that, similarly to its human ortholog, this activity is abolished when the 
active site cysteine residue is substituted (Deshpande et al., 1999). In vivo, both functions 
that PIR-1 promotes depend on an intact catalytic site. Moreover, the developmental arrest 
and sterility manifested in pir-1 null mutant animals cannot be overcome by catalytically 
inactive PIR-1. As neither of the processes in which we have implicated PIR-1 is required 
for general development, we conclude that PIR-1 possesses additional functions that we 
have not yet been able to unveil.  
Since RNA-dependent RNA polymerases in C. elegans generate 5'-
triphosphorylated RNA products starting with a guanosine (Aoki et al., 2007; Pak and Fire, 
2007; Sijen et al., 2007), we presume that the precursors of 26G-RNAs that are 
synthesized by the RdRP RRF-3 are originally triphosphorylated. The discovery that PIR-1 
is necessary for the accumulation of these 5'-monophosphorylated RNAs solves the 
mystery of how 26G-RNAs lose their two terminal phosphates. This modification could be 
necessary for loading of 26G-RNAs into the correct Argonaute proteins, or, alternatively, 





mRNAs. In the context of viral infection, pir-1 mutant animals are unable to generate 
enough antiviral 22G-RNAs to suppress replication of the virus. We propose that by 
converting the ends of triphosphorylated (+) and (-) viral RNA strands to monophosphates, 
viral replication/transcription intermediates may be stabilized in a dsRNA form. This 
would provide Dicer with enough substrate molecules to generate abundant primary viral 
siRNAs, which would in turn lead to a potent secondary amplification of silencing 22G-
RNAs. The common denominator between these two PIR-1-dependent processes is the 
need for a dsRNA substrate that Dicer can cleave. It is therefore possible that the molecular 
activity of PIR-1 serves the same purpose in these two distinct pathways. While we have 
not gathered evidence that this is the case, experiments designed to measure the 
accumulation of dsRNA intermediates in different mutants should be considered in the 
future. Recent studies have successfully characterized dsRNA populations at a genome-
wide level in C. elegans through the use of dsRNA-enrichment strategies such as ssRNA-
specific RNases to digest total RNA, or dsRNA immunoprecipitation with anti-dsRNA 
antibodies, followed by cloning and deep sequencing (Li et al., 2012; Saldi et al., 2014; 
Whipple et al., 2015). The potential for PIR-1 to regulate dsRNA levels should be studied 
using animals undergoing spermatogenesis or viral infection, in both wild-type and mutant 
genetic backgrounds where dsRNA may be more stable (e.g., in a dcr-1 null background or 
in the dcr-1(mg375) helicase mutant, in which 26G-RNA production is specifically 
abrogated (Pavelec et al., 2009; Welker et al., 2010)).  
 We have demonstrated here that PIR-1 strongly concentrates in the nucleus of 
most cells, where it also associates with chromatin. We found that PIR-1 maintains its 
interactions with Dicer and other components of the ERI complex in nuclear protein 
extracts. Most interestingly, when we profiled the sRNA content of wild-type nuclei, we 
found that PIR-1-dependent 26G-RNAs were the only species to show an appreciable 
enrichment, strongly suggesting that synthesis of Dicer-dependent sRNAs occurs in the 
nuclei of C. elegans. In further support of this possibility, one of the two main protein 
isoforms of PIR-1 that we were able to identify, is highly enriched in nuclei and strictly 
requires Dicer for stability. These findings add to the increasing body of work in diverse 
organisms that demonstrates the pervasiveness of sRNA biogenesis and effector pathways 
in cell nuclei (reviewed in Cecere and Grishok, 2014; Huang and Li, 2014; Schraivogel 
and Meister, 2014). Additionally, we observed that cells undergoing high DNA replication 
and transcription, such as the endoreduplicating cells of the intestine or the mitotic cells of 




correlates well with the impaired growth and germline underproliferation phenotypes of 
pir-1 mutant animals. As human PIR1 has also been shown to localize to nuclei, to interact 
with proteins implicated in RNA processing, and to participate in rRNA processing (Yuan 
et al., 1998; Andersen et al., 2005; Caprara et al., 2009; Tafforeau et al., 2013), we would 
ultimately like to know whether PIR-1 can function in processes beyond the realm of 
sRNAs to modulate growth and development in all animals. Therefore, potential alterations 
in splicing patterns and transcription levels of mRNAs, as well as in levels and processing 
states of non-coding RNAs (such as long non-coding RNAs, rRNAs, snRNAs, snoRNAs 
and tRNAs) should be addressed in greater detail, as such changes could plausibly lead to 
the phenotypes observed in pir-1 loss-of-function mutant animals.  
One surprising result of this study was the specific upregulation of innate immunity 
and stress response gene expression in pir-1 mutant animals. This matched the results of a 
prior study where a similar gene expression change was identified in loss-of-function 
mutants for DCR-1, RDE-4 and RDE-1, but for which the mechanistic basis and biological 
purpose were not found (Welker et al., 2007). The effect is unlikely to derive from the 
downregulation of miRNAs, as Dicer is the only enzyme of the four required for their 
accumulation. Given that (1) PIR-1 may have an important role in dsRNA accumulation 
destined for Dicer cleavage of primary sRNAs, that (2) RDE-4 binds dsRNA and may 
assist Dicer in the cleavage/loading process (Parrish and Fire, 2001; Tabara et al., 2002; 
Parker et al., 2006), and that (3) RDE-1 is the Argonaute into which primary siRNAs are 
loaded (Yigit et al., 2006; Steiner et al., 2007), the four proteins may cooperate to silence 
the innate immune response by an RNAi-like mechanism, analogous to the suppression of 
viral replication. This raises the hypothesis that during a viral infection these factors are 
co-opted to combat the virus, loosening the repression of innate immunity response genes. 
The result would be the amplification of the antiviral response by the concomitant activity 
of the sRNA-based pathway and of a broader, sRNA-independent immune response. As C. 
elegans lacks the potent IFN response that is central to antiviral defense in vertebrates 
(reviewed in Stifter and Feng, 2015), studying the expression of these genes during acute 
viral infection in diverse genetic backgrounds could potentially lead to the discovery of 
complementary antiviral immune pathways in nematodes and other invertebrates. But 
perhaps more interestingly, this would demonstrate the existence of an incredibly well-
orchestrated mechanism of gene regulation whereby the very same proteins required for 
the suppression of viral infection have the ability to constitutively repress gene expression 





would fit well with the fact that PIR-1 is constantly and ubiquitously expressed, as if in a 
permanent state of alert to incoming viruses. 
Notably, we have gathered preliminary evidence strongly suggesting that the 
antiviral immunity role of PIR-1 is conserved. In a Drosophila mutant of the PIR-1 
counterpart, Flock House Virus replicates uncontrollably (Keith Boundy, unpublished 
results), as it does in Dicer-2 and Argonaute-2 loss-of-function mutants (reviewed in Ding, 
2010; Kingsolver et al., 2013). In human cells, we have shown that PIR1 physically 
interacts with Dicer. Furthermore, both Dicer and PIR1 are specifically pulled down by 
LGP2 (Darryl Conte, unpublished results), an important dsRNA binding cytoplasmic 
receptor implicated in the response against RNA viruses in vertebrates (reviewed in 
Rodriguez et al., 2014). The link to LGP2 supports the hypothesis that mammalian PIR1 
also plays a role in the defense against RNA viruses, perhaps as part of the antiviral RNAi 
response already demonstrated to occur in mice (Li et al., 2013; Maillard et al., 2013). 
Regarding other pathways, functional conservation is less certain: insects and vertebrates 
seem to lack RdRPs, which are central to PIR-1-dependent sRNA biogenesis. However, a 
strong indication that functional conservation extends beyond antiviral immunity stems 
from the observation that adult PIR-1-deficient flies are unable to reproduce, implying that 
Drosophila PIR-1 may participate in central aspects of germline development and/or 
gamete differentiation. As more examples of Dicer-dependent endogenous sRNA 
regulatory pathways emerge in flies and vertebrates (reviewed in Piatek and Werner, 
2014), the potential involvement of PIR-1 in these processes should not be disregarded.   
Is PIR-1 activity circumscribed to sRNA pathways or does it participate in broader 
gene regulatory processes in the nucleus? The answer to this fundamental question will 
depend on the identification of the RNAs and chromatin loci with which PIR-1 associates 
at different stages along development. Future experiments must extend our efforts to 
identify PIR-1 targets by employing iPAR-CLIP (in vivo Photoactivatable Ribonucleoside-
Enhanced UV Cross-Linking and IP; Rybak-Wolf et al., 2014) and optimized versions of 
ChIP-seq (Chromatin Immunoprecipitation followed by deep-sequencing of associated 
DNA). Such experiments should focus on PIR-1 obtained from isolated nuclei, since we 
believe that the sensitivity of these methods is decreased by the large pool of PIR-1 
residing in the cytoplasm. As both C. elegans and cultured cells are currently equally 
amenable to these techniques, the parallel study and comparison of results obtained from 
both systems would be especially powerful. The success of these approaches would 




pir-1 mutant animals, the inability to silence pir-1 by RNAi, and the inexistence of 
conditional mutants, all of which prevented us from studying the effects arising from lack 
of PIR-1 at distinct developmental stages.  
Lastly, in addition to the questions that this study raised, there are some 
evolutionary peculiarities regarding this phosphatase that are equally worthy of future 
inquiry. For instance, what is the role of the PIR-1 paralog F54C8.4? Orthologs of this 
protein can be found throughout the nematode lineage, but are also present in insects, 
suggesting that it evolved specifically in the common ancestor of this group of animals 
(both are protostomes grouped in ecdysozoa). Since the catalytic site of F54C8.4 contains 
the conserved asparagine that distinguishes RNA 5' triphosphatases from protein tyrosine 
phosphatases, it is presumed to have in vivo RNA 5' phosphatase activity (see Fig. 1.6, 
page 62; Changela et al., 2005). Intrigued by this, we superficially characterized F54C8.4, 
showing that (1) its mRNA expression levels across development are similar to those of 
pir-1, that (2) homozygote animals for a null deletion allele die as early-stage larvae after 
about seven days, and that (3) RNAi results in embryonic lethality. Unlike PIR-1, F54C8.4 
was not identified via proteomic analysis of DCR-1 complexes. Studying F54C8.4 could 
therefore reveal important parallels and differences to help us understand PIR-1 function 
across the evolutionary spectrum of metazoans. Another intriguing PIR-1-related 
evolutionary mystery concerns the presence of homologous RNA 5' phosphatases in 
animal-infecting dsDNA viruses from the Baculoviridae and Poxviridae families (the latter 
comprising not only invertebrate-, but also vertebrate-infecting viruses, such as Vaccinia 
and Smallpox). Why did these viruses acquire RNA triphosphatases when they already 
encode their own mRNA capping machinery? Are they used to promote viral expression, 
or are they used to regulate or disable host systems? The fact these viruses incorporated 
and still maintain PIR-1-like enzymes in their genomes lends strength to the idea that they 
must perform important roles in all metazoans. 
We believe that our demonstration of specific biological functions for C. elegans 
PIR-1 will propel further studies to understand how it promotes the synthesis of Dicer-
dependent sRNAs and to address its essential requirement for growth and development. 
Ultimately, we hope that our work will spark a renewed interest in the biology of this 
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List of C. elegans Strains Used in This Study 
 





alg-3; alg-4;  
gfp::alg-3 
alg-4(ok1041) III; alg-3(tm1155) IV; In[gfp::alg-3]   
avr-14; glc-1 avr-14(ad1305) I; glc-1(pk54::Tc1) V  DA1384 
avr-15 avr-15(ad1051) V  DA1051 
avr3x DA1316 avr-14(ad1305) I; glc-1(pk54::Tc1) avr-15(ad1051) V  DA1316 
avr3x outcrossed avr-14(ad1305) I; glc-1(pk54::Tc1) avr-15(ad1051) V 
D.C.; outcrossed 6x 




sensitive sterile and 
Eri allele of Dicer 
YY470 
dcr-1; avr3x 
avr-14(ad1302) I; dcr-1(ok247)/qC1*[neIs 
(Pmyo-2::avr-15, rol-6(su1006), unc-22(RNAi))] III; 
avr-15(ad1051) glc-1(pk54::Tc1) V 
  
drh-1; avr3x 
avr-14(ad1302) I; drh-1(tm1328) IV; avr-15(ad1051) 
glc-1(pk54::Tc1) V  
D.C.  
drh-1; pir-1; avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1*(In[Psur-5::gpf, 
Pmyo-2::avr-15]) II; drh-1(tm1328) IV; avr-15(ad1051) 
glc-1(pk54::Tc1) V 
D.C.  
eat-2 eat-2(ad1113) II  DA1113 
eft-3; avr3x 
avr-14 (ad1302) I; eft-3(q145)/qC1*[neIs(Pmyo-2::avr-
15, rol-6(su1006), unc-22(RNAi))] III; avr-15(ad1051) 
glc-1(pk54::Tc1) V 
D.C.  
eri-1 eri-1(mg366) IV  GR1373 
N2 wild type 





mnC1[dpy-10(e128), unc-52(e444)]  II 





avr-14(ad1302) I; pir-1(tm1496)/mnC1* 
[In[Psur-5::gfp, Pmyo-2::avr-15] dpy-10(e128)  
unc-52(e444)] II; avr-15(ad1051) glc-1(pk54::Tc1) V 
D.C.  
pir-1(tm3198) pir-1(tm3198)/mnC1* II D.C.  
pir-1(tm3198) pir-1(tm3198)/mnC1 II D.C.  
pir-1;  
pir-1(mut ATG1)::gfp 
avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  
Pglh-2::transposase, Phsp-16.48::transposase,  
Cb-unc-119(+), pir-1(M1A)::gfp] 
D.C.; mutated 
positions based on 




avr-14(ad1302) I; pir-1(tm3198)/mnc1* II; unc-
119(ed3) III; cxTi10882 IV; avr-15 (ad1051) glc-1 
(pk54::Tc1) V; Ex [Pmyo-2::mCherry, Pmyo3::mCherry, 
Pglh-2::transposase, Phsp-16.48::transposase,  
Cb-unc-119(+), pir-1(M29L)::gfp] 
D.C.; mutated 
positions based on 




avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  
Pglh-2::transposase, Phsp-16.48::transposase,  
Cb-unc-119(+), pir-1(M89L)::gfp] 
D.C.; mutated 
positions based on 





?(q782) qIs48(Pmyo-2::gfp; Ppes-10::gfp; Pges-1::gfp)] I; 
pir-1(tm3198)/mnc1*(In[Psur-5::gpf, Pmyo-2::avr-15]) II; 








avr-14(ad1302) I; pir-1(tm3198) II; dcr-1(ok247)/ 
qC1*[neIs(Pmyo-2::avr-15, rol-6(su1006), unc-
22(RNAi))] unc-119(ed3) III; In [Cb-unc-119(+);  








pir-1(tm3198) rde-4(ne337) II; unc-119(ed3) III;  










avr-14(ad1305) I; pir-1(tm3198)/mnC1 II;  
avr-15(ad1051), glc-1(pk54::Tc1) V  
D.C.  
pir-1; cep-1 cep-1(gk138) I; pir-1(tm3198)/mnc1* II  D.C.  
pir-1; cxTi10882; 
avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
unc-119(ed3) III; cxTi10882 IV; avr-15 (ad1051)  
glc-1 (pk54::Tc1) V 
D.C.  
pir-1; dcr-1; avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
dcr-1(ok247)/ qC1*[neIs(Pmyo-2::avr-15,  
rol-6(su1006), unc-22(RNAi))] III; avr-15(ad1051)  
glc-1(pk54::Tc1) V 
D.C.  
pir-1; gfp::alg-3 pir-1(tm3198)/mnc1* II; In[gfp::alg-3] D.C.  
pir-1; gld-1 
gld-1(ar202)/hT2[bli-4(e937) let-?(q782) qIs48] I;  
pir-1(tm3198)/mnc1* II; +/hT2 III 
D.C.  





pir-1; pgl-1::RFP pir-1(tm3198) )/mnC1* II; In[pgl-1::rfp, Cb-unc-119]   
pir-1; pir-1(R28A); 
avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
unc-119(ed3) III; cxTi10882 IV; avr-15 (ad1051)  









avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  







avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  







avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
In [Cb-unc-119(+), pir-1(K118R)::gfp] IV;  








avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
unc-119(ed3) III; In[Cb-unc-119(+);  
pir-1(C150S)::gfp] IV; 








avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
In [Cb-unc-119(+), pir-1(T151S)::gfp] IV;  








avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1(pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  







avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
unc-119(ed3) III; cxTi10882 IV; avr-15 (ad1051)  
glc-1 (pk54::Tc1) V; Ex[Pmyo-2::mCherry, 
Pmyo3::mCherry, Pglh-2::transposase,  







avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
In [Cb-unc-119(+), pir-1(T151S)::gfp] IV;  








avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  








avr-14(ad1302) I; pir-1(tm3198) III; cxTi10882 IV; 
avr-15 (ad1051) glc-1 (pk54::Tc1) V;  
Ex[Pmyo-2::mCherry, Pmyo3::mCherry,  
Pglh-2::transposase, Phsp-16.48::transposase,  










avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  
Pglh-2::transposase, Phsp-16.48::transposase,  







avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
unc-119(ed3) III; cxTi10882 IV; avr-15 (ad1051)  
glc-1 (pk54::Tc1) V; Ex[Pmyo-2::mCherry, 
Pmyo3::mCherry, Pglh-2::transposase,  








avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  
Pglh-2::transposase, Phsp-16.48::transposase,  







avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
cxTi10882 IV; avr-15 (ad1051) glc-1 (pk54::Tc1) V; 
Ex [Pmyo-2::mCherry, Pmyo3::mCherry,  




















pir-1(tm3198) II; unc-119(ed3) III; 
In [Cb-unc-119(+); pir-1::gfp] IV 
transgene integrated 





avr-14(ad1302) I; pir-1(tm3198) II; unc-119(ed3) III; 
In [Cb-unc-119(+); pir-1::gfp] IV; avr-15(ad1051)  















pir-1; pir-1::gfp; eri-1 






pir-1; pir-1::gpf;  
pgl-1::RFP 
pir-1(tm3198) II; unc-119(ed3) III; In[pir-1::gfp,  





pir-1; seam cell gfp pir-1(tm3198)/mnc1* II; In[Pseam cell::gfp] D.C.  
pir-1; unc-119 pir-1(tm3198)/mnc1* II; unc-119(ed3) III D.C.  
pir-1; unc-119; avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1* II;  
unc-119(ed3) III; avr-15 (ad1051) glc-1 (pk54::Tc1) V   
D.C.  
rde-1 rde-1(ne300) V   
rde-1; avr3x 
avr-14(ad1302) I;  
avr-15(ad1051) glc-1(pk54::Tc1) rde-1(ne300) V  
D.C.  
rde-1; pir-1; avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1* II; 
avr-15(ad1051) glc-1(pk54::Tc1) rde-1(ne300) V 
D.C.  
rrf-1 rrf-1(pk1417) I  PD8488 
rrf-1; avr3x 
avr-14(ad1302) rrf-1(pk1417) I;  
avr-15(ad1051) glc-1(pk54::Tc1) V 
D.C.  
rrf-1; pir-1; avr3x 
avr-14(ad1302) rrf-1(pk1417) I;  
pir-1(tm3198)/mnc1* II;  
avr-15(ad1051) glc-1(pk54::Tc1) V 
D.C.  
rrf-3 rrf-3(pk1426) II  NL2099 
sec-5 sec-5(tm1443)/mnC1* II D.C.  
ergo-1 ergo-1(tm1860) V  WM158 
rde-1; unc-119; avr3x 
avr-14(ad1302) I; unc-119(ed3) III; 
avr-15(ad1051) glc-1(pk54::Tc1) rde-1(ne300) V 
D.C.  
rde-1; pir-1; unc-119; 
avr3x 
avr-14(ad1302) I; pir-1(tm3198)/mnc1*;  




avr3x Line 4 
avr-14(ad1302) I; unc-119(ed3) III; 












avr-14(ad1302) I; pir-1(tm3198)/mnc1*(In[Psur-5::gpf, 
Pmyo-2::avr-15]); unc-119(ed3) III; 





alg-1 alg-1(tm1492) X   
alg-2 alg-2(ok304) II  WM53 
pir-1(tm1496); rrf-1 




nst-1(vr6) I; unc-119(ed3) III; 
In[Cb-unc-119(+), nst-1::gfp] 
bombardment line  
pir-1; pir-1::3xflag; 
nst-1::gfp 
pir-1(tm3198) II; unc-119(ed3) III;  






F54C8.4 +/mT1 II; F54C8.4(tm2568)/mT1[dpy-10 (e128)] III D.C.  
rde-4 rde-4(ne337) III   
dcr-1; dcr-1::HA::flag 





The CGC – Caenorhabditis Genetics Center, University of Minnesota – is the official repository 
for important C. elegans strains. Each name specifies the laboratory where the strain was created. 
‘Ex’ denotes non-integrated extrachromosomal DNA that is stably transmitted at each generation 
(the rate of transmission varies with each particular line). 
‘In’ refers to sequences integrated in the genome, regardless of the transgenesis method utilized. 
The mnC1* genetic balancer is modified from the original balancer mnC1, which contains dpy-
10(e128) and unc-52(e444) recessive markers. mnC1* contains an integrated transgene with      
Psur-5::gpf and Pmyo-2::avr-15. These markers were not displayed in front of every balancer for 
simplification. For an extensive list of genetic balancers and their characteristics refer to  
WormBook.org. 
All strains marked with ‘D.C’ were made by Daniel Chaves. 
 









sequence (5'-3') purpose/remarks 
O1 pir-1(tm3198) CGCCCACGCGGATATGAAAG genotyping 
O2 pir-1(tm3198) CCCGCTCCATTGGATGTCCA genotyping 
O3 18S rRNA TTGCGTACGGCTCATTAGAGCA qRT-PCR 
O4 18S rRNA GCCTTGCGTTGGGGTATAGTTG qRT-PCR 
O5 gpd-2 mRNA GGAGCCAAGAAGGTCATCATCTCT qRT-PCR 
O6 gpd-2 mRNA TAGTGGTGCAGGAAGCATTGGA qRT-PCR 
O7 sec-5 mRNA GATTGGAGGATATTAATCAAATGC qRT-PCR 
O8 sec-5 mRNA GCAAATTGATCTCCGTACTGC qRT-PCR 
O9 pir-1 mRNA GGAAAGAGACTCCCAGACAGATGG qRT-PCR 
O10 pir-1 mRNA CAGGCATATTTTTCCCATCGAAGA qRT-PCR 
O11 unc-22 mRNA GTCTTATCTCCATTTGTCAATTCTTGTCC qRT-PCR 





























with T7 promoter for dsRNA 
feeding vector 
O19 gfp mRNA GGTGATGTTAATGGGCACAA qRT-PCR 



















C-terminal tagging of pir-1 with 
XbaI site 
O25 pir-1 GCGGCCGCGCCGGAGCCTCGTTGCACAGC 
N-terminal tagging of pir-1 with 
NotI site in frame with gfp cassette 
O26 pir-1 CGCGGCCGCCATTCCGCTTAGCGCCTTGT 
N-terminal tagging of pir-1 with 
NotI site in frame with gfp cassette 
O27 pir-1 GGCGGCCGCGCCGGAGCCTCGTTGCACAGC 
N-terminal tagging of pir-1 with 
NotI site in frame with 3xflag 
cassette 
O28 pir-1 CGCGGCCGCCCATTCCGCTTAGCGCCTTGT 
N-terminal tagging of pir-1 with 
NotI site in frame with 3xflag 
cassette 
O29 pir-1 GCGGCCGCGTAACACCCAATACTGTTGTT 
C-terminal tagging of pir-1 with 
NotI site in frame with gfp cassette 
O30 pir-1 CGCGGCCGCTTGAGAATTATTTCGATGCA 
C-terminal tagging of pir-1 with 
NotI site in frame with gfp cassette 
O31 pir-1 GGCGGCCGCGTAACACCCAATACTGTTGTT 
C-terminal tagging of pir-1 with 
NotI site in frame with 3xflag 
cassette 
O32 pir-1 CGCGGCCGCCTTGAGAATTATTTCGATGCA 
C-terminal tagging of pir-1 with 





TOPO cloning of tagged pir-1 
sequences 












Cloning of tagged pir-1 sequences 
into pDONR-201 gateway vector. 




Cloning of tagged pir-1 sequences 
into pDONR-201 gateway vector. 
Contains attB2 site. 
O37 cxTi10882 AGCTGCTTGAAGAACCCTGA genotyping 


























































































































































































(assuming 261 aa protein) 














(assuming 261 aa protein) 
O72 SL1 GGTTTAATTACCCAAGTTTGAG mapping of SL1 splice site 
O73 SL2 GGTTTTAACCCAGTTACTCAAG mapping of SL1 splice site 
O74 pir-1 mRNA CGGCCGACGTTATCGTAAAT mapping of SL1 splice site 
O75 sec-5 mRNA TTGATGGGGATTTCCATTTC mapping of SL1 splice site 
O76 human PIR1 TTTTTGCGGCCGCAAGCCAGTGGCATCATCCC 
cloning of human PIR1 cDNA with 
NotI site 
O77 human PIR1 TTTTTTCTAGACTGGGTCCATTCCCAACAGG 
cloning of human PIR1 cDNA with 
XbaI site 
O78 act-3 mRNA GGCCCAATCCAAGAGAGGTATCC qRT-PCR 
O79 act-3 mRNA GGGCAACACGAAGCTCATTGTA qRT-PCR 
O80 pos-1 mRNA 
rArUrUrCrCrCrGrUrUrGrGrUrCrCrArU 
rUrCrArGrGrA 
sense control for sRNA northern 
blotting 
O81 pos-1 mRNA 
rUrCrCrUrGrArArUrGrGrArCrCrArArC 
rGrGrGrArArU 
anti-sense control for sRNA 
northern blotting 
O82 pos-1 mRNA CGGCTTCCAATGAACCCTCGTGGGAG qRT-PCR 
O83 pos-1 mRNA CTA GCT TCG CGG CAT TCC CAT CGA C qRT-PCR 
O84 pos-1 mRNA 
TCGGAGATTATTCCCGTTGGTCCATTCAGGAA
GCCAAGAC/Starfire/ 
starfire oligo for northern probe 
O85 unc-22 mRNA 
rGrGrUrArUrCrGrUrArUrCrCrArGrUrG 
rArUrUrUrCrU 
anti-sense control for sRNA 
northern blotting 
O86 unc-22 mRNA AGAAATCACTGGATACGATACC/Starfire/ starfire oligo for northern probe 
O87 miR-66 TCACATCCCTAATCAGTGTCATG/Starfire/ starfire oligo for northern probe 
O88 SL1 precursor CTCAAACTTGGGTAATTAAACC/Starfire/ starfire oligo for northern probe 
O89 let-7 miRNA 
AACTATACAACCTACTACCTCACC 
GGATCC/Starfire/ 








starfire oligo for northern probe 
O92 26G-RNA 1 CGGAATCTCAAACTTTTCCATCTTGC/Starfire/ starfire oligo for northern probe 
O93 26G-RNA 263 TAGCATATGCATGCACCATAAACAAC/Starfire/ starfire oligo for northern probe 
O94 21U-RNA 1 GCACGGTTAACGTACGTACCA/Starfire/ starfire oligo for northern probe 
O95 T01C8.5 CAACCCAACATGGGGAAATC qRT-PCR 
O96 T01C8.5 GACAGACTTCTCTGGGGCTGA qRT-PCR 
O97 Y47H10A.5 CGTTTATCAGGTTGAAACACTCG qRT-PCR 
O98 Y47H10A.5 TCATCGGATCTGGTGAAAACG qRT-PCR 
O99 E01G4.5 CGGCAATTTATTCTAGAGCACAC qRT-PCR 
O100 E01G4.5 GTCAAACAACAGCTTTCCAACG qRT-PCR 
O101 F39E9.7 CCCAGTGGCCCAATTAAACG qRT-PCR 
O102 F39E9.7 CCCACGGCTTGTTCTTTGACA qRT-PCR 
O103 Y43F8B.9 CCCAGTGGCCCAATTAAACG qRT-PCR 
O104 Y43F8B.9 CCCACGGCTTGTTCTTTGACA qRT-PCR 
O105 Y57G11C.51 AATGATGCAGCGAAGGAGGTCG qRT-PCR 
O106 Y57G11C.51 AGGATGATGGCGTGGAAG qRT-PCR 
O107 klp-16 mRNA CGTCGAGGAGTTCATTCGGTCG qRT-PCR 
O108 klp-16 mRNA CGGGATGATTCCTTCCTCTT qRT-PCR 
O109 bub-1 mRNA AAAGCTGCATTTGGACCAAAAACC qRT-PCR 
O110 bub-1 mRNA CGGGATGATTCCTTCCTCTT qRT-PCR 
O111 vig-1  mRNA TCCATCCGACGACGACGATGAG qRT-PCR 
O112 vig-1 mRNA GGGCTTCACAGACTTTTCCTC qRT-PCR 
O113 hcp-3 mRNA GTCTATGGATTTCACGGTCGGC qRT-PCR 
O114 hcp-3 mRNA TTCTTCGTCGGAGCTATCGT qRT-PCR 












5' linker (DNA/RNA hybrid); 
barcode is rNrNrNrN using diferent 

























long 3' PCR primer (Illumina P7 
sequence underlined) 
O122 M13 Forward GTAAAACGACGGCCAG 
PCR of inserts cloned into TOPO-
TA vector 
O123 M13 Reverse CAGGAAACAGCTATGAC 
PCR of inserts cloned into TOPO-
TA vector 
O124 T7 promoter TAATACGACTCACTATAGGG 
Sanger sequencing of inserts 







sense oligo for T7 synthesis of 








antisense oligo for T7 synthesis of 












qRT-PCR GW195 (Felix et al., 
2011) 
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short protein description  
adapted from WormBase  
small RNA 
pathway 
ALG-1  • 3     
alg-1 encodes an Argonaut ortholog; alg-1 is involved in RNA 
interference and affects developmental timing along with alg-2 and 
dcr-1 by regulating expression of the lin-4 and let-7 small temporal 
RNAs. 
ALG-2  • 4  • 3   
alg-2 encodes a PAZ and PIWI-domain containing protein that is a 
member of the highly conserved eukaryotic RDE-1/AGO1/PIWI 
family of proteins that regulate posttranscriptional gene silencing 
(PTGS); ALG-2 functions with ALG-1 to control specific 
developmental timing events by positively regulating expression of 
small temporal RNAs (stRNAs) encoded by lin-4 and let-7; ALG-2 
and ALG-1 are also required for RNAi in the germ line, although 
they are not required for RNAi in the soma; ALG-2 is expressed in 
nearly all cells from embryogenesis through adulthood and localizes 
to the cytoplasm. 
CSR-1 • 4  • 11   • 3 
csr-1 encodes, by alternative splicing, two isoforms of an Argonaute 
protein required for chromosome segregation, embryonic viability, 
Slicer activity induced by secondary siRNAs, and (partially) for 
germline RNAi. 
NRDE-1      • 3 
nrde-1 encodes a novel protein conserved amongst nematodes; 
NRDE-1 activity is required, along with that of NRDE-2, NRDE-3, 
and NRDE-4, for regulation of gene expression via a nuclear RNAi 
pathway that inhibits RNA polymerase II elongation and deposits 
histone H3K9 methylation on genomic regions targeted by RNAi; an 
NRDE-1:GFP fusion protein localizes to the nucleus. 
RDE-8 (ZC477.5) • 5      
rde-8 encodes a Zc3h12a-like endoribonuclease required for RNAi 
and localizes to mutator foci. 
VIG-1 • 20 • 15 • 45 • 7   
vig-1 encodes a predicted RNA-binding protein orthologous to 
Drosophila VIG (Vasa Intronic Gene). VIG-1 is a component of the 
250 kDa RNA-induced silencing complex (RISC) complex and co-
immunoprecipates with both TSN-1, the C. elegans Tudor-SN 
ortholog, and the let-7 miRNA. 
P-granule 
associated  
CAR-1 • 22 • 19 • 24   • 4 
car-1 encodes a putative RNA-binding protein orthologous to 
budding yeast Scd6p, fission yeast Sum2p, Drosophila TRAL, and 
human LSM14A and LSM14B; CAR-1 expressed in the germline; 
CAR-1 associates with CGH-1, DCAP-1, and CEY-2/3/4, in P 
granules and other cytoplasmic particles of the early embryo; CAR-
1 also localizes to the mitotic spindle of dividing 1-cell embryos, and 
to ER; CAR-1 requires CGH-1 for normal localization in meiotic 
germ cells, and binds CGH-1 in an RNA-dependent manner. 
CEY-2 • 18 • 13 • 14    
cey-2 encodes a cold-shock/Y-box domain-containing protein; by 
homology, CEY-2 is predicted to function as either an RNA-binding 
protein involved in translation or RNA processing, or a DNA-binding 
protein involved in transcriptional regulation; CEY-2 associates with 
CGH-1 and CEY-3/4 in cytoplasmic particles of the gonad and early 
embryo. 
CEY-3 • 7 • 5 • 8    
cey-3 encodes a protein with a cold-shock/Y-box domain; CEY-3 
associates with CGH-1, CEY-2, and CEY-4 in cytoplasmic particles 
of the gonad and early embryo. 
CEY-4  • 8 • 9    
cey-4 encodes a Y box-containing protein with no known function in 
vivo; CEY-4 associates with CGH-1 and CEY-2/3 in cytoplasmic 
particles of the gonad and early embryo. 
CGH-1 • 10 • 7 • 6    
cgh-1 encodes a putative DEAD-box RNA helicase, orthologous to 
budding yeast Dhh1p, fission yeast Ste13p, Drosophila ME31B, and 
human DDX6; CGH-1 is expected to enable decapping-dependent 
mRNA degradation. 
GLH-1 • 2     • 3 
glh-1 encodes a putative DEAD-box RNA helicase that contains 
four CCHC zinc fingers and is homologous to Drosophila VASA, a 
germ-line-specific, ATP-dependent RNA helicase; GLH-1 is a 
constitutive P granule component and thus, with the exception of 




CPF-1    • 13 • 14  
cpf-1 encodes an ortholog of human cleavage stimulation factor, 3' 
pre-RNA, subunit 1 (HGNC:CSTF1). 




HRP-1 (F42A6.7) • 2      
hrp-1 encodes a putative heterogeneous nuclear ribonucleoprotein 
(hnRNP); HRP-1 has two N-terminal RRM domains and a low-
complexity C-terminal domain; HRP-1's homologs include 
HNRNPA0 (OMIM:609409), HNRNPA1 (HNRPA1; OMIM:164017; 
overexpressed in vitamin D resistance); HNRPA3 (OMIM:605372); 
and HNRNPA1L2. 
HRP-2      • 4 
hrp-2 encodes an ortholog of human heterogeneous nuclear 
ribonucleoprotein R (HGNC:HNRNPR); hrp-2 is predicted to have 
nucleotide binding activity and nucleic acid binding activity. 
PAB-1 • 15 • 10 • 13 • 2   
pab-1 encodes a polyadenylate-binding protein (i.e., poly(A)-binding 
protein, or PAB). 
PAB-2 • 5      
pab-2 encodes a polyadenylate-binding protein 1 homolog with high 
similarity to human PABP 1. 
SQD-1 • 13 • 10 • 8    
sqd-1 encodes an ortholog of human heterogeneous nuclear 
ribonucleoprotein D-like (HGNC:HNRNPDL); sqd-1 is predicted to 
have nucleotide binding activity and nucleic acid binding activity. 
SUF-1    • 26 • 24  
suf-1 encodes an ortholog of human cleavage stimulation factor, 3' 
pre-RNA, subunit 3 (HGNC:CSTF3). 
UAF-1 • 2      
uaf-1 encodes the large subunit of splicing factor U2AF (U2 
Auxiliary Factor), orthologous to mammalian and Drosophila 
U2AF65; UAF-1 has been shown to bind RNA and this binding is 
enhanced by UAF-2. 
nucleolus-
associated 
DAO-5 • 2      
dao-5 encodes a predicted nucleolar phosphoprotein related to 
Saccharomyces cerevisiae SRP40 and the vertebrate Nopp140 
proteins that may play a role in rRNA gene transcription and 
nucleolar structural organization. 
FIB-1 • 9 • 9 • 6    
fib-1 encodes the C. elegans ortholog of fibrillarin and 
Saccharomyces cerevisiae Nop1p, an essential component of the 
U3 SnoRNP; FIB-1 localizes to the nucleolus. 
K07H8.10     • 3 • 2 
K07H8.10 encodes an ortholog of human nucleolin (HGNC:NCL); 
K07H8.10 is predicted to have nucleotide binding activity and 
nucleic acid binding activity. 
LPD-7 • 3      
lpd-7 encodes a BRCT domain-containing protein that is 
orthologous to Saccharomyces cerevisiae Nop7p and the 
vertebrate pescadillo proteins required for nucleolar assembly, 
ribosome biogenesis, and cell proliferation. 
NGP-1 • 4      
ngp-1 encodes an ortholog of human guanine nucleotide binding 
protein-like 2 (nucleolar) (HGNC:GNL2); ngp-1 is predicted to have 
GTP binding activity. 
NOL-1 • 3      
nol-1 encodes an ortholog of human NOP2 nucleolar protein 
(HGNC:NOP2); nol-1 is predicted to have RNA binding activity and 
S-adenosylmethionine-dependent methyltransferase activity. 
NOL-5 • 10 • 13 • 8    
nol-5 encodes an ortholog of human NOP58 ribonucleoprotein 
(HGNC:NOP58). 
NOLA-3 • 3    • 3  
nola-3 encodes an ortholog of human NOP10 ribonucleoprotein 
(HGNC:NOP10); nola-3 is predicted to have snoRNA binding 
activity. 
NST-1 • 8      
nst-1 encodes a homolog of human GNL3 (OMIM:608011, 
nucleostemin) and GNL3L, and of S. cerevisiae NUG1. 
T04A8.6 • 2      
T04A8.6 encodes an ortholog of S. cerevisiae NOP15 that may 
suppress tumorous growth in the germ line by ensuring robust larval 
germline proliferation. 
Y66H1A.4 • 9 • 10 • 7   • 5 
Y66H1A.4 encodes an ortholog of human GAR1 ribonucleoprotein 
(HGNC:GAR1). Nucleolar. Necessary for ribosome biogenesis and 
telomere maintenance. 
miscelaneous 
C44E4.4 • 6  • 3    
C44E4.4 encodes an ortholog of human Sjogren syndrome antigen 
B (autoantigen La) (HGNC:SSB); C44E4.4 is predicted to have 
nucleotide binding activity and RNA binding activity. The human 
protein has tRNA processing activities in the nucleus. 
CEY-1  • 7 • 8    
cey-1 encodes a protein with a cold-shock/Y-box domain that is 
expressed in early embryonic blastomeres (at the 15-cell stage, i.e., 
pre-gastrulation), but is normally repressed in early germline 
blastomeres by PIE-1. 
DDB-1 • 10     • 7 
ddb-1 encodes a protein orthologous to human DNA damage-
binding protein 1 (DDB1); ddb-1 is part of a ubiquitin ligase E3 
complex, CUL-4/DDB-1, and targets the replication licensing factor, 
cdt-1, for ubiquitin-mediated proteolysis. 
DDX-17 (F58E10.3) • 8 • 4 • 7    
ddx-17 encodes an ortholog of human DEAD (Asp-Glu-Ala-Asp) 
box helicase 17 (HGNC:DDX17). 
F08B12.4      • 4 F08B12.4 is localized to the nucleus. 
IMA-3      • 2 
ima-3 encodes one of three C. elegans importin alpha nuclear 
transport factors and the importin alpha that is most similar to the 
alpha3-subtype; ima-3 is required for normal embryonic, larval, and 
germline development. 
LAF-1  • 4     
laf-1 encodes a DEAD-box RNA helicase; laf-1 is required for 
embryonic development and sex determination. 
MADF-6    • 4   MADF domain transcription factor. 
PLP-1 • 7 • 5 • 4    
plp-1 encodes a protein containing three PUR repeats that has 
similarity to the mammalian transcription factor pur alpha. 
PSF-1 • 11      
psf-1 encodes an ortholog of human GINS complex subunit 1 (Psf1 
homolog) (HGNC:GINS1). DNA replication factor. 
PUF-12 • 7      
puf-12 encodes an ortholog of human KIAA0020 
(HGNC:KIAA0020); puf-12 is predicted to have RNA binding 
activity. 
TCER-1 • 2      
tcer-1 encodes an ortholog of human transcription elongation 






List of Two-Fold Down- and Upregulated Genes in pir-1 Mutant Animals 
 
This list is appended as an electronic Excel spreadsheet due to its large size. The list 
includes genes grouped by relevant biological categories which were used to build the 
graphs depicted on Figure 4.10, page 184. As mentioned previously, the data was collected 
by mRNA-seq of poly(A)-selected RNA from three-day and ten-day old counter-selected 
pir-1 mutant animals. Only the genes that were consistently down- or upregulated in both 
sets were considered in the analysis, increasing our confidence that they are truly 
misregulated in the absence of PIR-1. We include the fold-misregulation relative to wild-
type as well as normalized reads per million for each sample. The tables display functional 
information about each gene, where available, collected from the WormBase Gene 
Ontology Browser at WormBase.org. For the downregulated genes, we also added 
phenotypes obtained by RNAi (where available) to illustrate how silencing some of these 
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